Studies of new natural products and their biosynthesis spearheaded by high-resolution mass spectrometry by Bumpus, Stefanie B.
 
 
 
 
 
 
 
 
 
 
 
STUDIES OF NEW NATURAL PRODUCTS AND THEIR BIOSYNTHESIS  
SPEARHEADED BY HIGH-RESOLUTION MASS SPECTROMETRY 
 
 
 
 
 
 
BY 
 
STEFANIE BRYNN BUMPUS 
 
 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Chemistry 
in the Graduate College of the 
University of Illinois at Urbana-Champaign, 2010 
 
 
 
 
Urbana, Illinois 
 
 
 
 
   Doctoral Committee: 
 
    Professor Neil Kelleher, Chair, Director of Research 
    Professor Wilfred van der Donk 
    Professor John Hartwig 
    Research Assistant Professor Peter Yau  
 
ii 
 
ABSTRACT 
 
Many natural products with anticancer, antibiotic, and immunosuppressant activity are 
synthesized by non-ribosomal peptide synthetases (NRPSs) and polyketide synthases (PKSs).  In 
NRPS and PKS biosynthesis, monomer units are incorporated into a growing natural product 
chain in an assembly line fashion using a covalent thiotemplate mechanism.  Because the 
growing natural product is covalently tethered to the enzyme, incorporation of a new monomer 
unit into the growing chain can be measured as a mass shift to the biosynthetic proteins by mass 
spectrometry.  Specifically, Fourier-transform mass spectrometry (FTMS) (and an associated 
suite of custom MS tools) is a high-resolution analytical technique well suited to the study of 
NRPS and PKS enzymes because of low detection limits and high mass accuracy measurements.   
In this work, FTMS-based studies characterized the biosynthesis of numerous NRPS and 
PKS derived natural products.  In Chapter 2, the development of the phosphopantetheinyl 
(Ppant) ejection assay and its application to the study of natural product halogenation is 
presented.  Additionally, the expansion of the Ppant ejection assay into a high-throughput liquid 
chromatography (LC)-MS platform is presented and its application to characterization of 
mycosubtilin biosynthesis is discussed.  In Chapter 3, the on-line Ppant ejection assay using LC-
MS is applied to the study of keto- and enoyl reductions during the biosynthesis of the natural 
product bacillaene.  Using FTMS and a variety of biochemical assays, the mechanism of the 
reductions catalyzed by the enzymes PksJ and PksE were established. 
Chapters 4 and 5 discuss the evolution of FTMS from a characterization tool into the 
basis for a natural product discovery platform.  A proteomics platform for the discovery of new 
natural product biosynthetic gene clusters was developed (PrISM, for the Proteomic 
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Investigation of Secondary Metabolism) to complement previously established genomics and 
metabolomics approaches.  Chapter 4 presents the early development of the PrISM method, 
including the analysis of a variety of separations and chromatographic techniques and proof-of-
concept experiments applying PrISM to known natural product producers.  Chapter 5 presents 
PrISM as a full discovery platform applied to environmental isolates of the genera Bacillus and 
Streptomyces, where new natural products and undiscovered biosynthetic gene clusters were 
characterized.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To Mom & Doyle and Dad & Diane 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
ACKNOWLEDGEMENTS 
 
 
 
 The work presented here would not have been possible without the support, 
encouragement, teaching and friendship of many people.  First, I thank my advisor, Professor 
Neil L. Kelleher, of the Department of Chemistry at the University of Illinois at Urbana-
Champaign.  Dr. Kelleher was an insightful and exciting teacher, a supportive mentor, and a 
never ending source of encouragement.  Also, thank you to my committee members – Professor 
Wilfred van der Donk, Professor John Hartwig, Professor John Cronan, and Dr. Peter Yau – for 
their support of my work and wonderful ideas and discussion.  This work was supported by 
research grants from the National Institutes of Health (NIH) (GM067725 and GM077596), in 
addition to a NIH Cellular & Molecular Biology Training Grant (GM007283) and a Graduate 
Fellowship from the American Chemical Society Division of Analytical Chemistry (supported 
by the Society for Analytical Chemists of Pittsburgh). 
 I could have not asked for a better group of lab mates than those I worked with during my 
time in the Kelleher Research Group (KRG).  First, I must thank all of the past members of the 
KRG I had the privilege to know and work with for their guidance.  I especially thank Leslie 
Hicks and Pieter Dorrestein (for their amazing training in all things NRPS and PKS), as well as 
Mike Boyne and Nertila Siuti.  Much of the work presented here is the result of a very 
productive collaboration in the KRG, and I thank Brad Evans, Paul Thomas and Ioanna Ntai for 
their very significant contributions; it was a truly invaluable experience.  I thank all of the 
current members of the KRG for their friendship and assistance: Brad Evans, Ioanna Ntai, Paul 
Thomas, Haylee Thomas, Dorothy Ahlf, Leonid Zamdborg, Adai Vellaichamy, Yunqiu Chen, 
Jack Kellie, Adam Catherman, Ji Eun Lee, Ken Durbin, Steve Sweet, Cong Wu, John Tran and 
vi 
 
MingXi Li.  I worked with a stellar crew of undergraduate students while in the KRG, and I 
thank Josh Norris and Jeff Osuji for their hard work and dedication.   
I would like to thank the many wonderful collaborators I had the privilege to work with 
during the completion of this research, especially Professor Christopher T. Walsh (Harvard 
Medical School) and his wonderful graduate students and post-doctoral fellows:  Danica 
Galonic, Ph.D., Nathan Magarvey, Ph.D., Chris Calderone, Ph.D., Darren Hansen, Ph.D., and 
Marie Hollenhorst.  I am thankful to have had the opportunity to work with Professor Craig 
Townsend (Johns Hopkins University) and his extremely intelligent and talented graduate 
student Anna Vagstad.  During the majority of my time at the University of Illinois, I worked in 
the newly opened Institute for Genomic Biology (IGB) and I would be remiss to not thank my 
lab mates at the IGB:  John Whitteck, Juan Valesquez, Ben Circello, Joel Cioni, JinHee Lee, 
Svetlana Borisova, and Courtney Evans.  Two Department of Chemistry area coordinators, Julie 
Sides and Casondra Anastasiadis, made my experience here much easier than it should have 
been, and I thank them for all their help and dearly value their friendship. 
 Thank you to all of my friends who made my time in Urbana-Champaign much more fun 
and exciting than I ever expected.  Thank you to JTH for your companionship, encouragement, 
and sense of humor.  Finally, I thank my family for their love and support, not just over the last 
few years, but throughout my whole life.  To Mom & Doyle and Dad & Diane, this 
accomplishment is as much yours as mine – thank you. 
 
 
 
 
vii 
 
TABLE OF CONTENTS 
 
CHAPTER 1: THE IMPORTANCE OF NATURAL PRODUCTS AND THE  
ROLE OF MASS SPECTROMETRY IN THEIR ANALYSIS…………………………… ……..1 
 
CHAPTER 2: ADVANCES IN MASS SPECTROMETRIC ANALYSIS OF  
THIOTEMPLATE BIOSYNTHESIS……………………………………………………………58 
 
CHAPTER 3:  INVESTIGATIONS INTO THE BIOSYNTHESIS OF BACILLAENE 
 USING FOURIER-TRANSFORM MASS SPECTROMETRY………………………………130 
 
CHAPTER 4: A PROTEOMICS APPROACH TO DISCOVERY OF NATURAL  
PRODUCTS AND THEIR BIOSYNTHETIC PATHWAYS, PART 1………………………..190 
 
CHAPTER 5: A PROTEOMICS APPROACH TO DISCOVERY OF NATURAL  
PRODUCTS AND THEIR BIOSYNTHETIC PATHWAYS, PART 2………………………..256 
 
CHAPTER 6:  CONCLUSIONS AND FUTURE DIRECTIONS……………………………..341 
 
CURRICULUM  VITAE……………………………………………………………………….352 
1 
 
CHAPTER 1: THE IMPORTANCE OF NATURAL PRODUCTS AND THE ROLE OF 
MASS SPECTROMETRY IN THEIR ANALYSIS 
 
The information and contents for this chapter were partially taken with permission from the 
publisher from the following article: Stefanie B. Bumpus and Neil L. Kelleher (2008). 
“Accessing natural product biosynthetic processes by mass spectrometry.” Current Opinion in 
Chemical Biology, 12(5):475-482. 
 
1.1 THE IMPORTANCE OF NATURAL PRODUCTS 
 Natural products, chemical entities biosynthesized by bacteria, fungi, plants and other 
organisms, have a rich and important history in the treatment of disease.  These molecules have 
bioactivities ranging from antifungals and antimicrobials to immunosuppressive agents and 
anticancer therapies.  Most bioactive natural products are produced during the secondary 
metabolic activities of the producing organism; that is, they are not required for the survival of 
the organism in a given environment, differing from primary metabolic activities and 
metabolites.  From ancient medicinal therapies to the first antibiotic isolated and characterized 
more than half a century ago, it is apparent that the isolation, characterization and development 
of natural products-based drugs are critical.  However, the use of natural products as 
chemotherapeutics, especially as antimicrobials, has introduced a host of challenges - the most 
critical being the dramatic rise in microbial resistance to antibiotics.  With infectious diseases as 
a leading cause of death worldwide, and the third leading cause of death in the United States of 
America, we must rise to meet the challenge of providing new therapeutic options through the 
development of new techniques for the discovery and characterization of novel natural products 
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(Pinner, Teutsch et al. 1996).  Understanding the types of molecules used as chemotherapeutics, 
changes in the research landscapes of drug discovery programs and the important role of natural 
products-based drugs sets the stage for development of novel approaches to discover and 
characterize these important chemical entities. 
1.1.1 Discovery and Characterization of Chemotherapeutics 
The modern age of antibiotic discovery began in 1928 with the discovery of the β-lactam 
antibiotic, penicillin, by Alexander Fleming and was followed by the clinical studies of the 
action of penicillin in the 1940s (Butler 2004).  In the two decades spanning 1940-1962, 
numerous new natural product scaffolds with antibiotic activity were isolated and characterized, 
including chloramphenicol (1 in Figure 1.1), tetracycline (2 in Figure 1.1), vancomycin (3 in 
Figure 1.1) and erythromycin (4 in Figure 1.1).  The size of the natural product molecules 
isolated ranges from the small molecular weight of ~350 Da for the penicillins (5 in Figure 1.1) 
to the relatively large molecular weight of 1200 Da for cyclosporin A (6 in Figure 1.1).  The 
structures of these early identified antimicrobials highlight the vast chemical space occupied by 
natural products (Ertl and Schuffenhauer 2008).  The mode of action of these classic antibiotics 
includes inhibition of cell wall biosynthesis (e.g. the β-lactams (Wilkins, Fareau et al. 1984)) and 
inhibition of protein biosynthesis (e.g. the tetracyclines (Schnappinger and Hillen 1996)).  The 
search for novel natural product therapeutics, specifically antimicrobial compounds, continued 
for more than fifty years, with very fruitful results.   
The two major sources for antimicrobial compounds are natural products-derived 
compounds and those that are produced synthetically and through combinatorial chemistry of 
small molecules.  Of the major classes of antibiotics, all except three are natural products-based 
(Singh and Barrett 2006).  While the use of natural product discovery platforms yielded many 
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important chemotherapeutics during the mid- and late twentieth century (with natural products 
accounting for more than 80% of all drugs discovered prior to 1990 (Li and Vederas 2009)), a 
dramatic shift in the drug discovery paradigm occurred approximately twenty-five years ago.  
The introduction of combinatorial chemistry to generate large libraries of small molecules and 
the advent of high-throughput screening (HTS) technologies eventually replaced many natural 
product discovery programs (Lee and Breitenbucher 2003).  The hope was that screening such a 
vast number (often >1 x 106
The importance of natural products in the discovery of new chemotherapeutic compounds is 
 compounds in just a few weeks (Gillet 2008)) of chemical entities 
against a specific screen for a disease related phenotype would undoubtedly lead to identification 
of drug candidates.  However, a frightening trend is observed in the past two decades regarding 
the output of new drugs from the pharmaceutical industry.  As shown in Figure 1.2 (adapted 
from (Newman and Cragg 2007)), the level of new chemical entities (NCEs) per year has 
become stagnant (with even the spike in 2005 not reaching the heights of previous years).   
Despite the high hopes of the pharmaceutical industry for combinatorial chemistry to yield a 
large number of NCEs, only one NCE was discovered by this method prior to 2007 (Newman 
and Cragg 2007).  While the original implementations of high-throughput screening were not 
successful in the identification of new drug candidates for most major therapeutic areas, there 
was a shift toward the development of natural products-based libraries through diversity oriented 
synthesis (Burke, Berger et al. 2003) and the generation of combinatorial libraries based on 
natural product scaffolds (Hall, Manku et al. 2001; Horton, Bourne et al. 2003).  Additionally, 
the technological advances that occurred during the height of HTS, including the ability to screen 
hundreds of thousands of compounds in very few weeks, can all be transferred into improved 
chemotherapeutic discovery modes. 
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highlighted in numerous recent reviews, all reaching a similar conclusion on the necessity to 
continue natural product discovery (Butler 2004; Singh and Barrett 2006; Newman and Cragg 
2007).  From the years 1981-2006, >75% of all NCEs with antibacterial activity were natural 
products or natural product derivatives (Newman and Cragg 2007) (Figure 1.3A-B).  In the area 
of anticancer therapies, >75% of all small molecule NCEs were natural products or based on 
natural product structural scaffolds (Newman and Cragg 2007) (Figure 1.3C-D).  The wealth of 
evidence supporting the role of natural products in development of new drugs is immense, and 
sets the stage for the development of novel strategies for discovery.  Given the fact that the 
number of new medicines introduced in 2006 was at a level 50% less than that just a decade 
earlier (Harvey 2007), it is encouraging to note that there are still natural products discovery 
pipelines.  The future of drug discovery relies on the ability to exploit the chemical diversity 
provided by nature and using the wealth of combinatorial and synthetic chemistry strategies 
available to further improve natural product drug candidates.   
The major steps in the discovery of new natural products with antibiotic activity include 
the isolation of natural product producers, the development of robust assays for assessment of 
antimicrobial activity, and the complete characterization of antimicrobial compounds.    Growth 
extracts of putative natural product producers are tested in bioassays for the ability to prevent 
growth of another organism(s) or in higher-throughput, enzyme-based assays.  While there have 
been advances in antibiotic discovery, including those discussed below, these basic methods still 
remain a core of natural product antibiotic discovery platforms.  There are challenges faced at 
each step of the discovery process, but recent improvements in the ability to isolate slow growing 
strains more efficiently (Connon and Giovannoni 2002), culture bacterial isolates in a much 
increased number of media to promote natural product production (Duetz, Ruedi et al. 2000) and 
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dereplicate previously identified compounds more efficiently (Koehn 2008) are addressing these 
challenges.  Additionally, there have been great strides in the ability to screen large natural 
products libraries by automating the purification of small molecules from natural products 
extracts (Schaffrath, von Roedern et al. 2005) and optimization of techniques for structure 
determination, including nuclear magnetic resonance (NMR)- and mass spectrometry (MS)-
based methods (Exarchou, Krucker et al. 2005; Lambert, Wolfender et al. 2007).  While HTS 
technology is available for use in screening natural product libraries, many of the extracts from 
growth of producing organisms are not suitable for analysis using the current methodology due 
to the complexity of the extracts.  Advances in the use of pre-fractionated extracts is helping to 
alleviate this problem, further promoting the use of natural products for modern drug discovery 
(Abel, Koch et al. 2002; Eldridge, Vervoort et al. 2002).  One challenge that still must be 
addressed is the ability to culture strains that seem to be uncultivable in laboratory settings to 
access natural products that have not been identified in previous screening efforts (Baltz 2006). 
1.1.2 The Growing Need for Discovery of Novel Chemotherapeutics 
The rise in resistance due to the misuse and overuse of antimicrobial compounds (Levy 
and Marshall 2004) and the emergence of resistant strains via natural selection during even the 
last three decades is extreme, as exemplified by Figure 1.4.  In addition to the widely publicized 
resistant strains of methicillin resistant Staphlococcus aureus (MRSA, (Chambers and Deleo 
2009)) and vancomycin resistant Enterococci  (VRE, (Tacconelli and Cataldo 2008)), resistance 
has been observed in infectious organisms such as Actinobacter baumannii, Klebsiella 
pneumoniae, and Pseudomonas aerugenosa.   
Despite this increasing level of antimicrobial resistance, there has not been a 
corresponding increase in the success of the pharmaceutical industry to develop new antibiotics 
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(Spellberg, Powers et al. 2004).  Despite a 31% increase in total research and development 
expenditures by ten leading pharmaceutical companies from 1998-2002 (Spellberg, Powers et al. 
2004), it is unclear if the current, waning efforts in antimicrobial development could meet the 
needs of the worldwide population.  Figure 1.4 shows the number of new antibiotics discovered 
in a twenty-five year period (Quadri 2007; Taubes 2008). From 1992-2002, there were seven 
new chemical entities (NCEs) approved as antibacterial agents, a drop of more than 50% from 
the period 1983-1987.  As of 2008, there were six drug candidates currently under development 
or approved for use in the treatment of infections caused by MRSA and other Gram-positive 
bacteria.  The fight against Gram-negative bacteria, many of which are resistant to all or most 
current antimicrobial treatments and are often more difficult to target, is not nearly as strong, 
with just a single drug candidate even surviving past phase I clinical trials (Taubes 2008).   
The reasons provided for this lack of effort in the discovery of new antimicrobials, such 
as the level of profitability as compared to other drug families, the need to identify 
chemotherapeutics with novel structures and/or novel mechanisms of action, and the possibility 
that resistance to an antimicrobial could arise so quickly as to make the drug obsolete, have kept 
the development of these highly desired compounds at a frightening minimum (Quadri 2007; Li 
and Vederas 2009).  At one time, fifteen different pharmaceutical companies had programs 
dedicated to the discovery of new antibiotics; the number now stands at just five (Taubes 2008).  
Even in the height of the research programs dedicated to antimicrobial discovery, the 
identification of novel chemotypes was overtaken by efforts to improve upon previously 
identified antimicrobial structural scaffolds (Singh and Barrett 2006).  This begs to find an 
answer to the following question:  What can researchers do to fight back against these bacteria in 
an environment that is not supportive of or conducive to the search for new antimicrobials?     
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The chemical diversity that is found in natural products, and the corresponding regions of 
chemical space they occupy, makes them optimal for discovering new drugs, specifically new 
antimicrobials.  In fact, the chemical space occupied by natural products more closely resembles 
that of drug molecules than the chemical space occupied by combinatorial synthetic libraries 
(Henkel 1999; Feher M. 2003; Harvey 2007).  Natural products provide an important resource of 
compounds which have been evolutionarily designed to interact with protein targets important to 
disease treatment and modulate protein-protein interactions (Koehn and Carter 2005).  These 
characteristics are among the many reasons to develop methods for discovery and 
characterization of new natural products, and the work described herein seeks to apply 
bioanalytical techniques to the discovery and characterization of novel natural products with 
important bioactivities. 
1.2 BIOSYNTHESIS OF NON-RIBOSOMAL PEPTIDES AND POLYKETIDES 
1.2.1 An Introduction to Thiotemplate Biosynthesis 
 Two families of natural products that have provided a wealth of structural diversity and a 
wide range of bioactivities are the non-ribosomal peptides (NRPs) and the polyketides (PKs).  In 
fact, when one considers just the polyketide metabolites, of which there are ~7000 known 
structures, more than twenty drugs have been developed from these scaffolds; this hit rate of 
0.3% far exceeds that of HTS (Weissman and Leadlay 2005).  Of the bacterial genomes 
complete by 2007, 50% of the genomes contained genes suspected of producing NRP or PK 
products (Donadio, Monciardini et al. 2007); those genes expected to direct NRP and PK 
biosynthesis account for almost 1% of the total gene sequence available.  This prevalence 
indicates that natural product discovery platforms have not yet reached the limit of NRPS and 
PKS diversity.  While the NRP and PK small molecules produced by these biosynthetic 
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processes (biosynthesized by non-ribosomal peptide synthetases (NRPSs) and polyketide 
synthases (PKSs), respectively) show great diversity, the enzymes and catalytic steps involved in 
their biosynthesis are highly conserved.   
NRPS and PKS biosynthetic systems act by assembling monomer units into chains 
through a series of condensation reactions and both use a “thiotemplate” strategy to covalently 
assemble the natural products (Fischbach and Walsh 2006).  The monomer units used are simple 
– NRPSs use amino and other carboxylic acids as their precursors and assemble them via peptide 
bond formation, while PKSs utilize acyl-CoA monomers that are joined by Claisen 
condensations.  The thiotemplate strategy utilized by NRPS and PKS systems is based upon the 
covalent tethering of all biosynthetic intermediates to the enzyme complex during assembly 
using thioester chemistry. The thiotemplate mechanism was first proposed more than thirty years 
ago and much work has since been completed to characterize this biosynthetic method (Laland 
and Zimmer 1973).  Nature’s choice of this thiotemplate mechanism has important implications 
in the assembly process, and provides not only the thermodynamic energy needed for the chain 
extension but also provides a set of nucleophiles that are kinetically available for condensation 
reactions (Fischbach and Walsh 2006).  The tethering of the intermediates within the complex 
may provide the necessary protection to prevent hydrolysis of the thioester-bound intermediates 
in solution and provide them to the next catalytic domain. 
 As mentioned previously, NRPSs and PKSs are responsible for the production of a wide 
variety of chemically diverse compounds with a broad range of bioactivities.  Some of these are 
highlighted here and in Figure 1.5.  The known members of the NRP family have shown 
antibacterial, antifungal, anticancer, antiviral and immunosuppressant activities (Felnagle, 
Jackson et al. 2008).  Two examples of antibacterial NRPSs are the β-lactam cephalosporins (7 
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in Figure 1.5) and the recently FDA-approved lipopeptide daptomycin (8 in Figure 1.5) (Martin 
1998; Baltz, Miao et al. 2005).  By inactivating the transpeptidation reaction involved in the 
biosynthesis of the bacterial cell walls, β-lactams inhibit Gram-negative bacterial growth and 
have seen widespread medicinal use (Yotsuji, Mitsuyama et al. 1988).  Daptomycin represents 
the first new class of antibiotics identified in more than thirty years; its activity is based on the 
calcium-dependent disruption of bacterial cell membranes (Baltz 2009).  Cyclosporin A (6 in 
Figure 1.1) is an immunosuppressant agent produced by a very large NRPS and has seen 
widespread use during organ transplants; cyclosporin prevents the activation of T cells during the 
immune response (Mascarell and Truffa-Bachi 2003).  In the family of polyketides, there are 
again many known members with important bioactivities, including antibiotics and 
antiproliferatives.  Erythromicin (4 in Figure 1.1) is a broad spectrum 14-carbon macrolide 
antibiotic synthesized by polyketide synthase logic and modified with two sugar moieties; it 
exerts its antibiotic activities through interaction with ribosomal subunits and thus interferes with 
protein synthesis (Mazzei, Mini et al. 1993).  The polyketide C-1027 (9 in Figure 1.5), a member 
of enediyne family of antibiotic antitumor agents, has shown great promise for development as a 
chemotherapeutic agent (Liu, Christenson et al. 2002). 
1.2.2 Assembly of Non-ribosomal Peptides 
 Non-ribosomal peptide synthetases are large enzyme complexes responsible for the 
generation of small peptides (ranging from two to greater than twenty amino acids) through the 
sequential incorporation of amino acid monomers into a growing natural product chain (Marahiel 
and Essen 2009).  Figure 1.6 is a representation of a canonical NRPS and a general scheme for 
biosynthesis of a hypothetical pentapeptide.  The large synthetases are divided into modules, 
where each module is responsible for the incorporation of a single monomer unit.  Each module 
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is composed of catalytic domains that are required for natural product assembly; the domains 
essential to biosynthesis are the adenylation domain (A), the peptidyl carrier protein (PCP, or 
thiolation domain (T)) and the condensation domain (C).  Typically, all modules will contain 
each of these domains in the order C-A-T, except for the initiation module (responsible for 
incorporation of the starter unit and thus does not require condensation domain activity).  An 
additional domain is found in many systems, the thioesterase domain (TE), which is responsible 
for release of the natural product after it is fully assembled (Kopp and Marahiel 2007).  Each of 
these domains (A, C and TE) typically catalyzes a single reaction in the biosynthetic process and 
their roles have been well defined.  The order of these domains within the synthetase structure 
encodes the necessary information for natural product assembly and directs the incorporation of 
the monomer units in the correct order and timing. 
 The PCP in NRPS biosynthesis is a critical component of the biosynthetic process, 
despite the fact that is does not serve a catalytic role.  These 80-100 residue domains are located 
throughout the assembly-line machinery and serve as the sites for covalent attachment of the 
growing peptide natural product (Stachelhaus, Huser et al. 1996; Lai, Koglin et al. 2006).  
During biosynthesis, the PCP is translated as its inactive, apo form, but is converted to its active, 
holo form through the action of a phosphopantetheinyl (Ppant) transferase (PPTase) which 
transfers the Ppant arm (~20 Å in length) from coenzyme A (CoA) to a conserved serine (Ser) 
residue within the PCP active site (Figure 1.7) (Lambalot, Gehring et al. 1996).  The transfer of 
this Ppant arm to the PCP active site provides a free thiol group to tether the growing natural 
product to the enzymatic machinery during assembly.  When examined in the context of all 
cellular enzymes, NRPSs (and the PKSs as discussed below), are relatively inefficient; reported 
kcat values are in the range of 0.1-10 min-1 (Weissman and Muller 2008).  However, by 
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covalently tethering all intermediates within the protein complex, the assembly system has an 
intermediate that is kinetically and thermodynamically primed for condensation, has the ability 
to sequester the necessary intermediates that are diverted from primary metabolism, can stabilize 
the intermediates from bulk solvent, and provides an increased local concentration of substrate 
for catalysis (Weissman and Muller 2008). 
 For an amino acid to be incorporated into the growing natural product chain, it must first 
be activated as an aminoacyl-adenylate in an ATP-dependent process catalyzed by the 
adenylation domain (~50 kDa) (Stachelhaus, Mootz et al. 1998) (Figure 1.8A).  In catalyzing this 
activation, the A domain will activate the carboxylate group of the amino acid through transfer of 
AMP from an ATP molecule, and then transfer the resulting acyl group to the T domain 
downstream in the assembly-line structure.  The decision to form aminoacyl-AMP activated 
substrates as opposed to using aminoacyl-CoA substrates likely results from the need to generate 
an intermediate that is both activated thermodynamically but also kinetically labile (Fischbach 
and Walsh 2006).  The adenylation domain protects this activated substrate until the Ppant arm 
of the T domain can reach in for tethering.  In regard to the monomer units selected, NRPSs are 
differentiated from ribosomally-directed peptide assembly in that they are not restricted to using 
the twenty proteinogenic amino acids.  Instead, hundreds of monomer units have been 
incorporated into NRPs.  The substrate specificity of adenylation domains has been studied in 
detail and led to the ability to, in some cases, predict the substrate specificity of an adenylation 
domain based on its primary amino acid sequence.  Based on the crystal structure of an 
adenylation domain involved in gramicidin S biosynthesis, a set of ten amino acids were 
determined to direct substrate specificity and this “amino acid code” is used to predict the A 
domain substrate (Stachelhaus, Mootz et al. 1999; von Dohren, Dieckmann et al. 1999) 
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 Once the monomer unit is installed on the downstream T domain, the condensation 
domain (~50 kDa) catalyzes peptide bond formation in a directional fashion between the 
upstream peptidyl biosynthetic intermediate (acting as the electrophilic donor) and the free 
amino group of the downstream monomer unit (acting as the nucleophilic acceptor) (Bergendahl, 
Linne et al. 2002) (Figure 1.8B).  This cycle of substrate selection and peptide bond formation 
continues along the synthetases involved in NRP assembly until all monomer units have been 
incorporated and tailoring reactions are complete.  After assembly is complete, a thioesterase 
domain present at the terminal module of the NRPS can catalyze release of the natural product 
via either hydrolysis or cyclization (Kopp and Marahiel 2007) (Figure 1.9).  In addition to the 
three domains required for assembly of NRPs, there are numerous additional domains that can be 
included in NRPSs responsible for tailoring the chemical structure of the natural product.  These 
domains can include epimerases (E), for altering amino acid chirality, oxidation domains (Ox), 
responsible for the generation of thiazoles and oxazoles within the peptide structure, 
aminotransferase domains (AMT), and even halogenases (Hal), responsible for inserting halogen 
atoms into the chemical structure (Walsh, Chen et al. 2001).   
1.2.3 Assembly of Polyketides 
 PKSs are akin to NRPSs, in that they are large, multi-modular enzyme complexes that 
direct the sequential incorporation of monomer units into a growing natural product chain 
(Fischbach and Walsh 2006).  However, the two biosynthetic systems share similarity in only 
one domain, the T domain, with PKSs sharing more homology to fatty acid synthases (FASs) 
(Schweizer and Hofmann 2004).  Figure 1.10 depicts the canonical arrangement and activity of a 
PKS, including the associated modules and domains.  There are three major families of 
polyketide synthases, represented in Figure 1.11 (Hertweck 2009).  Type I PKSs utilize multi-
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modular enzymes for natural product assembly, with each catalytic domain in a module acting 
once in biosynthesis.  Type II PKSs share the same domains as Type I PKSs, but the domains are 
not assembled into modules and instead act as discrete domains that iteratively catalyze the steps 
in polyketide biosynthesis.  Type III PKSs are unique in that they do not utilize carrier proteins, 
but instead the catalytic domains act directly on acyl-CoA precursors.  Despite the varied 
arrangements between the Type I, II, and III PKSs, the specific domains carry out essentially the 
same chemistry.   
 In Type I and Type II PKSs, the acyl carrier protein (ACP) carries out a very similar role 
to the PCP in NRPSs; its role is to covalently tether the growing natural product via its post-
translationally added Ppant arm and shuttle the intermediates along the assembly line (Lai, 
Koglin et al. 2006).  The other two domains critical to the assembly of PKs are the 
acyltransferase domain (AT) and the ketosynthase domain (KS).  AT domains are ~50 kDa in 
molecular weight and select the substrate for incorporation in the natural product.  In this, they 
provide selectivity to the biosynthetic process and determine the backbone of the PK structure.  
Chemically, the AT domains carry out an energy-neutral, two-step transthiolation reaction, 
transferring the acyl monomer unit from the sulfhydryl group of CoA onto the Ppant arm of the 
downstream thiolation domain (Figure 1.12).   
 After the AT domain has loaded a downstream thiolation domain with the appropriate 
substrate, the KS domain is responsible for catalyzing carbon-carbon bond formation via a 
Claisen condensation (Figure 1.12C).  The process involves the decarboxylation of the substrate 
on the downstream T domain harboring the newly loaded monomer unit, transfer of the upstream 
growing natural product to a conserved cysteine residue in the KS active site, and Claisen 
condensation between the intermediate and the monomer unit.  This results in an extension of the 
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natural product structure by two carbons (in the case of incorporation of a typical malonyl unit).  
The cycle of substrate selection by the AT domain and condensation catalyzed by the KS domain 
is continued until assembly is complete, often including the action of tailoring domains as 
discussed below. 
 Similar to NRPSs, PKSs can contain a thioesterase domain that is responsible for the 
release of the natural product via hydrolysis or cyclization once elongation and tailoring are 
complete.  Several tailoring domains are common to PKS assembly lines; these include the 
ketoreductase domain (KR), the dehydratase domain (DH) and the enoyl reductase domain (ER) 
(Figure 1.12D), operating in the order listed (Fischbach and Walsh 2006).  The KR domain 
reduces the β-ketone group generated by the condensation reaction to a hydroxyl.  If a DH 
domain is present, it will dehydrate at this same location to generate an α,β-enoyl intermediate.  
If an ER domain is present, it reduces the double bond to generate the fully saturated 
intermediate at that location.  It is common for these tailoring domains to be present in different 
combinations, resulting in PK structures with increased chemical diversity.  Additionally, there 
are linker domains within PKS biosynthetic systems that facilitate the interaction between 
domains within a single PKS and between synthases acting in trans, presumably helping to 
coordinate the transfer of an intermediate from one synthase to another (Kumar, Li et al. 2003; 
Tran, Tosin et al. 2008). 
 The size of the assembly lines, specifically NRPSs and Type I PKSs, is often astounding.  
For example, the single NRPS responsible for the biosynthesis of the immunosuppressant 
cyclosporin contains more than forty domains and has a molecular weight of 1.5 MDa 
(Kleinkauf, Dittmann et al. 1991).  There are numerous reported cases of assembly lines that are 
hybrid NRPS-PKS systems (Du and Shen 2001).  These proteins contain domains of both NRPS 
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and PKS origin and assemble natural products with both amino acyl and acyl constituents (e.g 
.(Wu, Chung et al. 2000)).  The chemistry involved in the transfer of a growing intermediate 
between NRPS and PKS modules, including the formation of both C-C and C-N bonds, is now 
well defined (Du and Shen 2001).   
 While the guidelines for NRPS and PKS assembly presented here are (more often than 
not) the rule, there are exceptions to each biosynthetic strategy employed.  There are times when 
the adenylation domain in NRPS assembly does not select and activate the correct amino acid for 
incorporation into the natural product.  To correct this, some gene clusters contain an additional 
thioesterase, called a Type II TE, which can serve as an editor of assembly and remove the 
wrongly incorporated monomer unit (Schwarzer, Mootz et al. 2002).  Cases have also been 
reported where synthases lack the seemingly required AT domains within a multi-modular 
synthase, yet assembly is supplemented by the action of AT domains acting in trans (Cheng, 
Coughlin et al. 2009).  Finally, examples of module skipping or the use of a module two times in 
PKS assembly are known, again highlighting the subtle complexities of these biosynthetic 
processes (Tang, Cheng et al. 2006). 
1.3 MASS SPECTROMETRIC ANALYSIS OF NON-RIBOSOMAL PEPTIDE AND 
POLYKETIDE BIOSYNTHESIS 
 Many biochemical and analytical tools are used in modern research programs to study the 
biosynthetic processes associated with NRPS and PKS systems; one of the most important tools 
is mass spectrometry (Kelleher and Hicks 2005; Dorrestein and Kelleher 2006; Bumpus and 
Kelleher 2008).  NRPS- and PKS-directed processes are conducted using a covalent mechanism 
– the growing natural product intermediate is tethered to the protein complex at the T domain 
during all steps of biosynthesis.  Because of this, almost all biosynthetic steps can be measured 
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as a mass shift to the apo-T domain (Figure 1.13).  This includes the generation of the holo-T 
domain through transfer of the Ppant arm from CoA, the loading of (amino) acyl substrates onto 
the T domain via action of A or AT domains, condensation reactions catalyzed by C and KS 
domains, and also any tailoring domain activities that result in a mass shift to the growing 
intermediate.  This brief introduction to the use of mass spectrometry for the analysis of 
thiotemplate biosynthesis highlights the types of mass spectrometry used and introduces current 
advances in techniques that have improved the ability to analyze NRPS and PKS systems in this 
manner. 
1.3.1 Analysis of Thiotemplate Biosynthesis by Mass Spectrometry 
Most often, the MS instrumentation of choice for analysis of NRPS and PKS systems 
uses electrospray ionization (ESI) with Fourier-transform mass spectrometry (FTMS) (Marshall, 
Hendrickson et al. 1998) due to its ability to obtain high-resolution mass spectra of large peptide 
and protein species, detect small mass changes, and be coupled to a variety of tandem mass 
spectrometry (MS2 or MS/MS) methods; however, several studies have seen success with other 
ionization and detection methods (Arthur, Szafranska et al. 2006; Izumikawa, Cheng et al. 2006).  
Electrospray ionization is selected as the ionization mechanism of choice for the studies 
presented here due to the ability to generated multiply charged ions (important in the analysis of 
large protein species where you wish to measure the mass-to-charge (m/z) ratio of the ion) and 
ease of coupling to both FTMS and liquid chromatography (LC) systems (Hendrickson and 
Emmett 1999).  In brief, the use of ESI as a sample introduction method for FTMS involves the 
introduction of analyte into tubing biased at a specified potential (1-5 kV).  The drastic change in 
potential at the exit tip of the capillary causes dispersion of the analyte solution into droplets; 
these droplets eventually evaporate into ions after they are directed into the MS ion source using 
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a pressure gradient (Hendrickson and Emmett 1999).   
In regard to measuring the mass of an ion using FTMS, the m/z of the analyte is 
determined by measurement of its ion cyclotron orbital frequency (υc), a value that is dependent 
on (and directly proportional to) the magnetic field in which the measurement is taken (Marshall, 
Hendrickson et al. 1998; Hendrickson and Emmett 1999).   Within the mass spectrometer, a 
packet of ions within the magnetic field in the bore of the instrument are excited together to a 
higher radius; this packet of ions moves along this orbit and results in an oscillating charge 
difference between detection electrodes that are at opposed to each other.  The charge balance is 
converted to a voltage (between the detection electrodes) and then converted into a time domain 
signal that is Fourier-transformed into a frequency domain spectrum (Marshall, Hendrickson et 
al. 1998).  There are many factors that go into making an FTMS measurement more accurate, 
including the strength of the magnetic field.  As the strength of the magnetic field increases, the 
resolving power of the instrument also increases in a linear fashion; this increase in resolving 
power results an increased signal-to-noise (S/N) ratio and an increase in the accuracy of the mass 
measurements (Marshall, Hendrickson et al. 1998).  For the data presented herein, a variety of 
different FTMS systems were used.  These include a custom built quadrupole-FTMS system for 
direct infusion of protein samples (Patrie, Charlebois et al. 2004) and three hybrid linear ion trap-
FTMS instruments coupled to LC systems (ThermoFisher Scientific LTQ-FT operating at 7 T 
and 12 T) (Figure 1.14).   
Both Top Down (Reid and McLuckey 2002; McLafferty, Breuker et al. 2007; Kellie 
2008) and Bottom Up (Bogdanov and Smith 2005) MS strategies are applicable to NRPS and 
PKS investigations (Figure 1.15).  Top Down MS analyzes intact proteins directly (no protease) 
and therefore has been most often applied to stand-alone T domains (only ~10-15 kDa) 
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(Dorrestein, Yeh et al. 2005; Chan, Boyne et al. 2006; Dorrestein, Blackhall et al. 2006; 
Garneau-Tsodikova, Dorrestein et al. 2006), although protein constructs 20-126 kDa have been 
studied directly (Dorrestein, Van Lanen et al. 2006; Hicks, Mazur et al. 2006).  The use of FTMS 
with >50,000 resolving power for most recent studies has allowed detection of biosynthetic 
transformations involving small mass changes (e.g. from stable isotope labeling experiments or 
the mass increase of 1 Da resulting from amine transfer catalyzed by a novel tailoring domain in 
mycosubtilin biosynthesis (Aron, Dorrestein et al. 2005)).  This contrasts sharply with the 
resolving power of ~1,000 provided by ion trap instruments which have been used to track 
transformations involving large mass shifts (e.g. from cofactor or monomer unit loading).    
Briefly, in a typical Bottom Up FTMS experiment, in vitro NRPS and PKS reactions are 
conducted, followed by enzymatic or chemical digestion (Figure 1.16).  The peptides are 
subjected to reverse phase LC (RPLC), and eluent fractions are analyzed by “off-line” FTMS 
one-by-one for peptides of interest based on mass values of intact peptides (Figure 1.16, middle 
left).  Peptide identities are confirmed by matching fragment ions and/or amino acid sequence 
information generated by MS/MS and the Ppant modification is localized to the active site serine 
residue (Figure 1.16, bottom).  After the peptide is confirmed to contain the active site, loading, 
condensation and tailoring reactions involving mass changes are monitored.  A variety of 
MS/MS methods have been employed in the analysis of NRPS and PKS systems.  Collision 
induced dissociation (CID) is a common method of fragmenting peptide species, and involves 
the collisional activation of a peptide or protein ion with a neutral gas, resulting in backbone 
cleavages (Wells and McLuckey 2005).  These backbone cleavages occur at the amide bond in 
the primary peptide or protein structure (the parent ion), resulting in fragment ions containing 
both the N-terminal (b ions) and C-terminal portions of the parent ion (y ions).   
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1.3.2 Current Advances in Mass Spectrometric Analysis 
 During tandem mass spectrometry using so-called “low-energy” ion activation methods 
(e.g. CID (Wells and McLuckey 2005) or infrared multi-photon dissociation (IRMPD) (Little, 
Speir et al. 1994)), the covalently bound Ppant arm is ejected from the peptide or protein, 
forming two specific small molecular marker ions at m/z values of 261.1267 and 359.1036 
(Dorrestein, Bumpus et al. 2006) for a T domain in the holo state (Figure 1.17).  These Ppant 
ejection products are also generated from T domains loaded with a natural product intermediate, 
and the ejected ions for covalent intermediates provide a simple way to identify the protein 
biosynthetic state.  Ejection ions are typically less than 1 kDa and can be measured with sub-
part-per-million (ppm) mass accuracy in high-resolution instruments.  Reduction of a >100 kDa 
protein ion to a <1 kDa Ppant ejection ion detected with low mDa mass accuracy in FTMS 
instruments often results in unambiguous assignment of empirical formulas for covalent 
intermediates.  Ppant ejection ions are detectable with ~0.2 Da mass accuracy in ion trap 
instruments, which is often sufficient for confirmation of an expected product.  Additionally, 
MS3 
 In an effort to streamline analysis of complicated samples in Bottom Up analysis of 
NRPS and PKSs, an on-line RPLC-MS strategy has increasingly been used.  Proteolytic 
of the ejected Ppant ion results in characteristic marker ions for use in confirming Ppant 
ejection (Meluzzi, Zheng et al. 2008).  The Ppant assay has proven entirely general for any 
thioester-bound species and has greatly sped up the study of diverse systems (Calderone, 
Kowtoniuk et al. 2006; Chan, Boyne et al. 2006; Calderone, Iwig et al. 2007; Kelly, Boyne et al. 
2007; Kopp, Linne et al. 2008) – even when used in a fraction-by-fraction search for active site 
peptides (Figure 1.16, middle left).  The development of the Ppant ejection assay and its 
application to the analysis of large proteins will be discussed in more detail in Chapter 2. 
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digestions of in vitro reactions are loaded onto an RPLC column connected in-line with a mass 
spectrometer, and the LC eluent directed to the MS for fast, on-line analysis.  Species entering 
the mass spectrometer can be subjected to a variety of MS and MS/MS analyses, including 
fragmentation in the ESI source (all ions) or after isolation of a single peptide’s ions for MS/MS 
and the Ppant ejection assay for active site peptide identification and characterization – even 
during analysis of highly complex mixtures of peptides (Figure 1.16, middle right).  The 
observation of a Ppant ejection ion at a specific elution time alerts one to the presence of a 
peptide containing the T domain active site, resulting in a significant reduction in the time 
required to identify the active site containing peptide of interest.   
The on-line LC-FTMS platform incorporating the Ppant ejection assay has been used to 
study activation and loading of a fatty acid chain in initiation of mycosubtilin biosynthesis 
(Hansen, Bumpus et al. 2007), in development of a method for characterization of lipopeptide 
fatty acid tailoring enzymes (Kopp, Linne et al. 2008), and in study of the role of epimerization 
domains in intermodular peptide transfer (Stein, Linne et al. 2006).  Recently, the LC-Ppant 
assay was used to characterize an iterative PKS involved in aflatoxin B1 biosynthesis (Crawford, 
Thomas et al. 2008).  In this study, LC-FTMS analysis determined the relative abundances of 
seven acylated protein forms in the presence and absence of a product template (PT) domain, 
assisting in the biochemical characterization of ring formation in aflatoxin biosynthesis.  The role 
of the on-line Ppant ejection assay in the analysis of mycosubtilin biosynthesis will be covered in 
more detail in Chapter 2. 
1.3.3 The Future of Mass Spectrometric Analysis of NRPS and PKS Biosynthetic Systems 
 From the many examples available in the current literature, it is obvious that application 
of MS to the analysis of NRPS and PKS processes continues to expand and improve.  The 
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discovery rate of putative NRPS and PKS gene clusters continues to increase, and MS-based 
platforms are on trajectory to easily keep pace with studies of their biosynthetic machinery.   As 
MS methods merge with those used in proteomics-based platforms, sample complexity will no 
longer be an issue.  With several data acquisition and reduction tools already in place for 
proteomics, their application to thiotemplate systems opens the door to move beyond in vitro 
analysis for eventual study of endogenous biochemical processes ongoing in native producers of 
high value natural products and their analogues. 
1.4 THE CURRENT STATE OF NATURAL PRODUCTS RESEARCH 
Having established the importance of discovering new small molecules with 
chemotherapeutic activities and the likelihood that these important compounds will be natural 
products, it is important to highlight the current methods used in the discovery of new natural 
products and the challenges faced by these platforms.   
1.4.1 Bioassay-guided Discovery of New Natural Products 
 From the earliest discoveries of bioactive natural products, a major detection platform has 
been the use of bioassay-guided searches for small molecules able to prevent the growth of one 
or more organisms.  In this method, suspected chemotherapeutic producers are grown under a 
variety of conditions and the growth medium is collected (and should contain excreted natural 
products made during the growth).  The ability of this culture extract to inhibit or prevent the 
growth of another organism (or panel of organisms) is then analyzed; this can be completed 
using zone of inhibition assays on agar plates or in high-throughput formats monitoring the 
density of growth (Koehn 2008).  Modern bioassay-guided strategies employ differing levels of 
fractionation of the culture extract prior to analysis of bioactivity (Abel, Koch et al. 2002; 
Eldridge, Vervoort et al. 2002).  Despite the success of bioassay-guided searches for natural 
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product chemotherapeutics over the last century, there are still challenges in these methods.  
These include the bias introduced by testing for activity against only one or a few organisms, the 
lack of knowledge on the biosynthesis of the natural product detected, and inherent challenges in 
structure determination of the natural product identified. 
1.4.2 Small Molecule and Metabolomic Approaches to Natural Product Discovery 
 In addition to the bioassay-guided strategies described above, there are also a suite of 
approaches that fit into a systems biology approach to natural product discovery.  These include 
both genomic and metabolomic analysis, in addition to some RNA-based approaches.  In a 
metabolomics approach, one seeks to generate a metabolite profile of a system grown under a 
specific set of conditions (Rochfort 2005).  Using analytical platforms combining LC, NMR and 
MS, one can profile the secondary metabolome of an organism to identify new small molecule 
entities not present in either control samples or samples grown under different conditions.  Use 
of metabolomics in natural products research could include the development of profiling systems 
for the dereplication of known structures (Pierens, Palframan et al. 2005) and also in the efforts 
to determine the putative modes of action of metabolites based on spectroscopic signatures 
(Yang, Shyur et al. 2004).   
 A specific metabolomic approach used in the search for new natural products is the 
OSMAC (one strain, many compounds) approach (Bode, Bethe et al. 2002).  In this method, 
instead of employing a very expensive high-throughput screen of a very large number of 
organisms and culture extracts, one would instead focus on the complete suite of natural products 
produced by one or just a few organisms.  Alteration of growth conditions in the hopes of 
affecting the organism at the levels of transcription, translation and small molecule production 
exploits the diversity already present in an organism and allows detection of many secondary 
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metabolites (Bode, Bethe et al. 2002).  As in bioassay-based and high-throughput screening 
approaches, there are challenges faced when examining the small molecule profile of a particular 
organism; these range from the ability to detect low levels of secondary metabolites to the 
correlation of natural product biosynthesis with its biosynthetic machinery. 
1.4.3 Natural Product Discovery in the Post-genomic Era 
 One of the most significant shifts in the natural product discovery landscape came with 
the ability to analyze the full genome sequence of an organism.  Currently, there are more than 
1100 complete microorganism genome sequences available.  From even a quick glance through 
several genomes, it is evident that the capacity of an organism to produce secondary metabolites 
is far greater than the number of natural products detected in either environmental or laboratory 
conditions.  These “cryptic” gene clusters are an exciting area of natural product research, as 
they could provide novel natural products with important bioactivities.  The expansion of 
biotechnology and bioinformatics techniques has enabled not only a dramatic decrease in the 
time it takes to complete a genome sequence, but also an increase in the efficiency and 
robustness of genome annotation.   
 As a first pass genome-based analysis for biosynthetic capacity, there are well-established 
degenerate primers to probe genomic DNA for the presence of NRPS and PKS domains 
(including adenylation domains (Christiansen, Dittmann et al. 2001), ketosynthase domains 
(Shimizu, Kinoshita et al. 2005) and halogenase domains (Hornung, Bertazzo et al. 2007)).  
However, these methods simply reveal the presence of these genes within a genome, but do not 
report on the expression of the biosynthetic gene cluster or the structure of the natural product. 
 A strategy for natural product discovery that has risen in the post-genomic area is that of 
“genome mining” – searching the genome of an organism for the putative genes necessary for 
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the production of secondary metabolites and using a variety of tools to determine if the natural 
product is produced and characterize its biosynthesis (Gross 2007; Challis 2008; Corre and 
Challis 2009; Zerikly and Challis 2009).  Analysis of NRPS and PKS biosynthetic capacity is 
especially suited to genome mining due to the presence of megasynthases in most biosynthetic 
gene clusters and the clustering of biosynthetic enzymes together in the genome.  Additionally, 
the co-linearity of NRPS and PKS processes and the bioinformatics tools available for predicting 
substrate specificity allow one to make an educated guess as to the structure of the natural 
product.   
 Several approaches have been developed for mining the genomes of putative secondary 
metabolite producers.  In the case of NRPS and PKS gene clusters, one may use bioinformatics 
tools to infer the sequence specificity and order of substrate incorporation in the assembly lines 
(1.18A).  This allows prediction of certain structural features and physiochemical properties of 
the putative natural product, allowing one to select fractionation and separation techniques to 
target the small molecule of interest (Challis 2008).  This method was successful in the 
identification of the polyene macrolactam salinilactam produced by Salinispora tropica 
(Udwary, Zeigler et al. 2007).   
 Another method is the genomisotopic approach (Gross, Stockwell et al. 2007) (Figure 
1.18B).  In this method, bioinformatics is again used to predict NRPS substrates; based on the 
predicted substrates, precursors labeled with stable isotopes are included in the growth medium, 
incorporated into the natural product if the prediction is correct, and used to guide the 
identification of the natural product using two-dimensional (2D) NMR.  Because a genome 
sequence provides all necessary information for cloning of putative gene clusters, heterologous 
expression of full NRPS and PKS biosynthetic pathways for in vitro reconstitution of 
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biosynthesis has also been successful in identifying new natural products (Figure 1.18C).  
Successful cases include the identification of the two component lantibiotic haloduracin (a 
ribosomally-synthesized natural product) (McClerren, Cooper et al. 2006) and identification of 
the lasso peptide capistruin (Knappe, Linne et al. 2008).  
  Successful identification of new natural products has also been completed by comparing 
the metabolic profiles of genetically manipulated organisms, either by comparison between a 
wild type organism with an organism that has a gene inactivated or through comparison of a 
heterologous host with and without the genes required for biosynthesis.  One of the most 
successful examples of this is the identification of NRP siderophore coelichelin through 
inactivation of a gene thought to be required for its biosynthesis and growth of the organism in 
iron limiting conditions (Lautru, Deeth et al. 2005).  In the fungal species Aspergillus nidulans, a 
regulatory gene specific to a hybrid NRPS-PKS biosynthetic pathway was expressed in the 
organism under the control of an inducible promoter.  Induction of expression of this regulatory 
gene induced expression of a previously cryptic gene cluster and the aspyridones were identified 
(Bergmann, Schumann et al. 2007). 
 Despite these early successes in genome mining approaches for discovery of new natural 
products, the need to have a genome sequence of an organism for analysis of its biosynthetic 
capacity is a challenge within itself.  In both physiochemical-guided searches for the natural 
product and in the genomisotopic approach, there remains the need to confirm the link between a 
natural product and its biosynthetic gene cluster through genetic methods; additionally, 
bioinformatics does not guarantee selection of the appropriate natural product precursor.  
Challenges in the in vitro reconstitution method lie in the difficulty in the cloning and 
heterologous overexpression of each gene in a putative biosynthetic pathway; this is likely to be 
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a very laborious process (Wenzel and Muller 2005).  A major challenge faced when using the 
gene inactivation approach is the lack of genetic tools in many organisms that would prevent the 
genetic manipulation necessary for inactivation (Donadio, Monciardini et al. 2002).  When 
attempting heterologous expression of a full biosynthetic pathway, one must overcome 
challenges faced by transferring very large (often >50 kb) sections of genomic DNA into a 
heterologous host and determining the appropriate conditions for expression.   
 RNA-based methods, while not as well developed as DNA-based approaches, have been 
employed for the discovery and characterization of natural products, specifically in the detection 
of expressed clusters.  In a study of the natural product biosynthesis by A. nidulans, 
transcriptomic analysis identified secondary metabolic clusters that are upregulated either in the 
presence or absence of the fungal regulatory gene laeA; this study identified a novel antitumor 
compound terrequinone A by combining metabolic profiling approaches with the RNA-based 
method (Bok, Hoffmeister et al. 2006).  However, for this approach to be successful, one must 
have the genome sequence of the organism under question; additionally, the ability to complete 
high-throughput transcriptomics on hundreds, or even thousands, of strains is at this time not 
economically feasible for all research programs. 
1.4.4 The Future of Natural Products Discovery 
From the above discussion, it is obvious there are still unmet challenges in the systems 
biology approach to the discovery of new, bioactive natural products.  One major gap in the 
current approaches is the lack of any proteomics-based platform for the discovery of small 
molecules.  The proteomics tools, as discussed above, are ready for implementation in discovery 
mode but as of yet there is not an established platform.  The work described within (Chapters 4 
and 5) provides a proteomics method for the discovery of natural products.  This development 
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seeks to establish a new platform for the discovery of novel NRPs and PKs that is not dependent 
on the use of a bioassay, does not require a genome sequence for the species under investigation, 
and can unambiguously link the expression of a biosynthetic gene cluster with its product. 
1.5 STATEMENT OF PURPOSE 
 The work described here encompasses the development of new mass spectrometric-based 
assays for the analysis of thiotemplate biosynthetic systems, in vitro characterization of non-
ribosomal peptide and polyketide biosynthesis, and the development of a new method for the 
discovery of novel natural products.  In Chapter 2, the development of a novel, cofactor-specific 
mass spectrometry-based assay, the phosphopantetheinyl ejection assay, is discussed, in addition 
to its application to the study of halogenation of the natural product barbamide.  Additionally, 
Chapter 2 describes the development of an on-line LC-MS extension of the ejection assay and its 
application to the study of mycosubtilin biosynthesis.  Chapter 3 details the use of mass 
spectrometry, in conjunction with other biochemical assays, to decipher the activities of 
reductases in the biosynthesis of the hybrid NRP-PK bacillaene.  In Chapters 4 and 5, 
information on the development of a novel platform for the discovery of non-ribosomal peptides 
and polyketides is provided, along with detailed information on the application of that platform 
in a variety of systems.  This work sets the stage for the future role of mass spectrometry and 
proteomics in the study of natural products biosynthesis. 
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Figure 1.1  Representative natural products with antibiotic activity.  These molecules were 
discovered during the peak of natural products discovery research in the mid- to late 1900s. 
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Figure 1.2  The number of NCEs introduced in the United States of America from 1981-2006 
(adapted from (Newman and Cragg 2007)). 
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Figure 1.3  Distribution of NCEs with antibiotic and anticancer properties (introduced from 
1981-2006).  A.  Distribution of NCEs with antibiotic activity between fully synthetic molecules 
and those that are derived from natural products or other biologics.  B.  Detailed distribution of 
NCEs with antibiotic activity.  C.  Distribution of NCEs with anticancer activity between fully 
synthetic molecules and those derived from natural products.  D.  Detailed distribution of NCEs 
with anticancer activity (adapted from (Newman and Cragg 2007)). 
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Figure 1.4  The rise in antibiotic resistance in the United States does not correspond to an 
increase in the number of new antibiotic drugs developed.  Top:  The percent incidence of 
MRSA and VRE in the United States.  Bottom:  The number of new antimicrobial drugs 
developed in the United States from 1983-2009.  (Adapted from (Quadri 2007) and (Taubes 
2008)). 
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Figure 1.5  Representative structures of NRPS and PKS products. 
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Figure 1.6  General organization of NRPSs and their biosynthetic activity.  A.  A representative 
NRPS, responsible for the biosynthesis of a hypothetical, unmodified pentapeptide.  B.  Initiation 
and elongation module organization in NRPSs.  C.  Domains required for NRPS biosynthesis.  
D.  General process of NRPS-directed biosynthesis, including post-translational modification to 
generate active, holo carrier proteins, selection and loading of substrates, peptide bond formation 
and release of the final product. 
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Figure 1.7  Conversion of an inactive, apo-T domain into an active, holo-T domain via 
phosphopantetheinylation.  A.  An apo-thiolation domain is converted to its holo form through 
transfer of the Ppant arm from CoA to the active site Ser of the T domain by a PPTase.  B.  
Representation of a holo-T domain, showing the available thiol for covalent tethering of growing 
intermediates. 
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Figure 1.8  Activities of the adenylation domain and condensation domain in NRPS-directed 
biosynthesis.  A.  The adenylation domain catalyzes the conversion of the selected amino acid 
substrate into an aminoacyl-adenylate and transfers this acyl group to the Ppant arm on the active 
site Ser of the T domain.  B.  The condensation domain catalyzes peptide bond formation 
between the amino acyl substrate on the downstream T domain and the growing intermediate on 
the upstream T domain. 
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Figure 1.9  The activity of a thioesterase domain in NRPS biosynthesis.  The thioesterase of a 
NRPS can catalyze release of the natural product via hydrolysis to release a linear peptide 
(orange arrows) or intramolecular cyclization to generate a cyclic peptide (pink arrows). 
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Figure 1.10  General organization of PKSs and their biosynthetic activity.  A.  A representative 
PKS, responsible for the biosynthesis of a hypothetical, unmodified polyketide.  B.  Initiation 
and elongation module organization in PKSs.  C.  Domains required for PKS biosynthesis.  D.  
General process of PKS-directed biosynthesis, including post-translational modification to 
generate active, holo carrier proteins, selection and loading of substrates, condensation and 
release of the final product. 
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Figure 1.11  Representative domain organization for Type I, Type II and Type III PKSs.   
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Figure 1.12  Reactions catalyzed by specific domains during polyketide assembly.  A.  In 
polyketide assembly, the AT domain catalyzes the transfer of the acyl monomer unit from CoA 
to the active site serine of the downstream T domain.  B.  Malonyl-CoA and methylmalonyl-
CoA, two common substrates in PKS assembly. C.  In polyketide assembly, the KS domain 
catalyzes the transfer of the upstream intermediate to a conserved cysteine residue, 
decarboxylation of the downstream monomer unit, and the condensation reaction.  D.  In 
polyketide assembly, KR, DH and ER domains can be present in many combinations.  The KR 
catalyzes conversion of the β-keto group to a hydroxyl, the DH catalyzes dehydration an α-β 
unsaturated compound, and the ER catalyzes reduction of the double bond. 
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Figure 1.13  General analysis of NRPS and PKS biosynthetic processes by mass spectrometry.  
A.  Representative active site peptide from an NRPS peptidyl carrier protein, with the active site 
serine highlighted in red.  B.  Mass spectrum of the apo active site peptide.  C.  Mass spectrum of 
the holo active site peptide after transfer of the Ppant from CoA, resulting in a mass shift of 
340.09 Da.  D.  Mass spectrum of the active site peptide loaded with a substrate, with the amino 
acid phenylalanine used as an example (a mass shift of 147.08 Da). 
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Figure 1.14  FTMS instrumentation used in the analysis of NRPS and PKS biosynthesis.           
A.  A custom built quadrupole-FTMS operating at 8.5 T (Patrie, Charlebois et al. 2004).            
B.  A ThermoFisher Scientific hybrid linear ion trap-FTMS (LTQ-FT) operating at 7 T.             
C.  A ThermoFisher Scientific hybrid linear ion trap-FTMS (LTQ-FT Ultra) operating at 12 T.  
D.  A ThermoFisher Scientific hybrid linear ion trap-FTMS (LTQ-FT Ultra) operating at 12 T. 
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Figure 1.15  A comparison of Bottom Up and Top Down MS.  A.  In Bottom Up MS, a protein 
(or group of proteins) is proteolytically or chemically digested prior to MS analysis.  The peptide 
mixture is analyzed, where the intact masses of the peptides and the corresponding amino acid 
sequences generated by MS/MS are used to identify the protein(s).  B.  In Top Down MS, intact 
proteins are analyzed directly by MS.  The intact mass of the protein and MS/MS are used to 
identify and characterize the protein (such as determining any post-translational modifications) 
(Adapted from (Kellie, Tran et al. 2008)). 
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Figure 1.16  General scheme for Bottom Up MS analysis of in vitro NRPS and PKS reactions.  
(Left)  Off-line work flow.  Peptides generated from digests of in vitro reactions are separated by 
off-line RPLC and each fraction analyzed individually by FTMS for active site peptides, which 
are then characterized by MS/MS and the Ppant ejection assay.  (Right) “On-line” work flow.  
Peptide mixtures generated from digests of in vitro reactions are separated on-line by RPLC 
connected directly to the mass spectrometer, where MS/MS and the Ppant ejection assay are 
conducted on the LC time scale.  The on-line work flow greatly speeds up analysis time (total 
data collection time of ~1 h/experiment) and is more amenable to systems where less sample is 
available. 
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Figure 1.17  Ions generated during the phosphopantetheinyl ejection assay.  A.  An apo-T 
domain is converted to its holo form via transfer of the Ppant arm from CoA, catalyzed by a 
PPTase.  B.  The holo-T domain is analyzed by MS and subjected to MS/MS.  C.  During 
MS/MS, four different marker ions are generated from ejection of the Ppant arm from the T 
domain.  i) A peptide marker ion is generated that retains the phosphate group, resulting in an 
observed mass that is 80 Da greater than the apo-T domain (apo + 80 Da species). ii) The small 
molecular ion observed from generation of the apo + 80 Da species (m/z 261.1267).  iii) A 
peptide marker ion is generated from elimination of the full Ppant arm from the T domain, 
resulting in generation of a dehydroalanine (Dha) at the active site serine and an observed mass 
that is 18 Da less than the apo-T domain (apo – 18 Da species).  iv) The small molecular ion 
observed from generation of the apo – 18 Da species (m/z 359.1036). 
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Figure 1.18  Methods for genome mining in the search for new NRPS and PKS gene clusters.  A.  
The use of genome sequence, bioinformatics and physiochemical property-guided searches to 
identify novel natural products.   One starts with a genome sequence and identifies a putative 
NRPS and PKS cluster (i). ii) Bioinformatics tools are used to determine the domain and module 
structure for the predicted synthase(s).  iii) Additional bioinformatics tools are used to predict the 
biosynthetic substrates and putative natural product structures.  iv) Strategies for isolation of the 
natural products are selected based on the predicted chemical structure.  B.  The genomisotopic 
approach.  i) After a putative NRPS or PKS gene cluster is identified, the domain and module 
structure is predicted.  ii) Using bioinformatics, the substrates are predicted.  iii)  The producing 
strain is grown in the presence of a substrate that is isotopically labeled (*).  iv) 2D NMR is used 
to identify compounds containing the isotopically-labeled substrate in the culture supernatant.  C.  
Heterologous expression of putative NRPS and PKS gene clusters.  i) After a gene cluster is 
identified, it is cloned in its entirety into a vector for transformation into a host strain (ii) and 
expression using the host strain (iii).  iv) The culture supernatant from the host strain without the 
vector (top) is compared to culture supernatant from a host strain with the vector (bottom) and 
new compounds are identified. 
 
 
 
46 
 
1.7 LITERATURE CITED 
Abel, U., C. Koch, et al. (2002). "Modern methods to produce natural-product libraries." Curr 
Opin Chem Biol 6(4): 453-8. 
Aron, Z. D., P. C. Dorrestein, et al. (2005). "Characterization of a new tailoring domain in 
polyketide biogenesis: the amine transferase domain of MycA in the mycosubtilin gene 
cluster." J Am Chem Soc 127(43): 14986-7. 
Arthur, C. J., A. E. Szafranska, et al. (2006). "The malonyl transferase activity of type II 
polyketide synthase acyl carrier proteins." Chem Biol 13(6): 587-96. 
Baltz, R. H. (2006). "Marcel Faber Roundtable: is our antibiotic pipeline unproductive because 
of starvation, constipation or lack of inspiration?" J Ind Microbiol Biotechnol 33(7): 507-
13. 
Baltz, R. H. (2009). "Daptomycin: mechanisms of action and resistance, and biosynthetic 
engineering." Curr Opin Chem Biol 13(2): 144-51. 
Baltz, R. H., V. Miao, et al. (2005). "Natural products to drugs: daptomycin and related 
lipopeptide antibiotics." Nat Prod Rep 22(6): 717-41. 
Bergendahl, V., U. Linne, et al. (2002). "Mutational analysis of the C-domain in nonribosomal 
peptide synthesis." Eur J Biochem 269(2): 620-9. 
Bergmann, S., J. Schumann, et al. (2007). "Genomics-driven discovery of PKS-NRPS hybrid 
metabolites from Aspergillus nidulans." Nat Chem Biol 3(4): 213-7. 
Bode, H. B., B. Bethe, et al. (2002). "Big effects from small changes: possible ways to explore 
nature's chemical diversity." Chembiochem 3(7): 619-27. 
Bogdanov, B. and R. D. Smith (2005). "Proteomics by FTICR mass spectrometry: top down and 
bottom up." Mass Spectrom Rev 24(2): 168-200. 
47 
 
Bok, J. W., D. Hoffmeister, et al. (2006). "Genomic mining for Aspergillus natural products." 
Chem Biol 13(1): 31-7. 
Bumpus, S. B. and N. L. Kelleher (2008). "Accessing natural product biosynthetic processes by 
mass spectrometry." Curr Opin Chem Biol 12(5): 475-82. 
Burke, M. D., E. M. Berger, et al. (2003). "Generating diverse skeletons of small molecules 
combinatorially." Science 302(5645): 613-8. 
Butler, M. S. (2004). "The role of natural product chemistry in drug discovery." J Nat Prod 
67(12): 2141-53. 
Calderone, C. T., D. F. Iwig, et al. (2007). "Incorporation of nonmethyl branches by isoprenoid-
like logic: multiple beta-alkylation events in the biosynthesis of myxovirescin A1." Chem 
Biol 14(7): 835-46. 
Calderone, C. T., W. E. Kowtoniuk, et al. (2006). "Convergence of isoprene and polyketide 
biosynthetic machinery: isoprenyl-S-carrier proteins in the pksX pathway of Bacillus 
subtilis." Proc Natl Acad Sci U S A 103(24): 8977-82. 
Challis, G. L. (2008). "Mining microbial genomes for new natural products and biosynthetic 
pathways." Microbiology 154(Pt 6): 1555-69. 
Chambers, H. F. and F. R. Deleo (2009). "Waves of resistance: Staphylococcus aureus in the 
antibiotic era." Nat Rev Microbiol 7(9): 629-41. 
Chan, Y. A., M. T. Boyne, 2nd, et al. (2006). "Hydroxymalonyl-acyl carrier protein (ACP) and 
aminomalonyl-ACP are two additional type I polyketide synthase extender units." Proc 
Natl Acad Sci U S A 103(39): 14349-54. 
Cheng, Y. Q., J. M. Coughlin, et al. (2009). "Type I polyketide synthases that require discrete 
acyltransferases." Methods Enzymol 459: 165-86. 
48 
 
Christiansen, G., E. Dittmann, et al. (2001). "Nonribosomal peptide synthetase genes occur in 
most cyanobacterial genera as evidenced by their distribution in axenic strains of the 
PCC." Arch Microbiol 176(6): 452-8. 
Connon, S. A. and S. J. Giovannoni (2002). "High-throughput methods for culturing 
microorganisms in very-low-nutrient media yield diverse new marine isolates." Appl 
Environ Microbiol 68(8): 3878-85. 
Corre, C. and G. L. Challis (2009). "New natural product biosynthetic chemistry discovered by 
genome mining." Nat Prod Rep 26(8): 977-86. 
Crawford, J. M., P. M. Thomas, et al. (2008). "Deconstruction of iterative multidomain 
polyketide synthase function." Science 320(5873): 243-6. 
Donadio, S., P. Monciardini, et al. (2002). "Microbial technologies for the discovery of novel 
bioactive metabolites." J Biotechnol 99(3): 187-98. 
Donadio, S., P. Monciardini, et al. (2007). "Polyketide synthases and nonribosomal peptide 
synthetases: the emerging view from bacterial genomics." Nat Prod Rep 24(5): 1073-109. 
Dorrestein, P. C., J. Blackhall, et al. (2006). "Activity screening of carrier domains within 
nonribosomal peptide synthetases using complex substrate mixtures and large molecule 
mass spectrometry." Biochemistry 45(6): 1537-46. 
Dorrestein, P. C., S. B. Bumpus, et al. (2006). "Facile detection of acyl and peptidyl 
intermediates on thiotemplate carrier domains via phosphopantetheinyl elimination 
reactions during tandem mass spectrometry." Biochemistry 45(42): 12756-66. 
Dorrestein, P. C. and N. L. Kelleher (2006). "Dissecting non-ribosomal and polyketide 
biosynthetic machineries using electrospray ionization Fourier-Transform mass 
spectrometry." Nat Prod Rep 23(6): 893-918. 
49 
 
Dorrestein, P. C., S. G. Van Lanen, et al. (2006). "The bifunctional glyceryl 
transferase/phosphatase OzmB belonging to the HAD superfamily that diverts 1,3-
bisphosphoglycerate into polyketide biosynthesis." J Am Chem Soc 128(32): 10386-7. 
Dorrestein, P. C., E. Yeh, et al. (2005). "Dichlorination of a pyrrolyl-S-carrier protein by 
FADH2-dependent halogenase PltA during pyoluteorin biosynthesis." Proc Natl Acad Sci 
U S A 102(39): 13843-8. 
Du, L. and B. Shen (2001). "Biosynthesis of hybrid peptide-polyketide natural products." Curr 
Opin Drug Discov Devel 4(2): 215-28. 
Duetz, W. A., L. Ruedi, et al. (2000). "Methods for intense aeration, growth, storage, and 
replication of bacterial strains in microtiter plates." Appl Environ Microbiol 66(6): 2641-
6. 
Eldridge, G. R., H. C. Vervoort, et al. (2002). "High-throughput method for the production and 
analysis of large natural product libraries for drug discovery." Anal Chem 74(16): 3963-
71. 
Ertl, P. and A. Schuffenhauer (2008). "Cheminformatics analysis of natural products: lessons 
from nature inspiring the design of new drugs." Prog Drug Res 66: 217, 219-35. 
Exarchou, V., M. Krucker, et al. (2005). "LC-NMR coupling technology: recent advancements 
and applications in natural products analysis." Magn Reson Chem 43(9): 681-7. 
Feher M., S., J.M. (2003). "Property distributions: differences between drugs, natural products, 
and molecules from combinatorial chemistry " J Chem Inf Comput Sci 43: 218-227. 
Felnagle, E. A., E. E. Jackson, et al. (2008). "Nonribosomal peptide synthetases involved in the 
production of medically relevant natural products." Mol Pharm 5(2): 191-211. 
 
50 
 
Fischbach, M. A. and C. T. Walsh (2006). "Assembly-line enzymology for polyketide and 
nonribosomal Peptide antibiotics: logic, machinery, and mechanisms." Chem Rev 106(8): 
3468-96. 
Garneau-Tsodikova, S., P. C. Dorrestein, et al. (2006). "Protein assembly line components in 
prodigiosin biosynthesis: characterization of PigA,G,H,I,J." J Am Chem Soc 128(39): 
12600-1. 
Gillet, V. J. (2008). "New directions in library design and analysis." Curr Opin Chem Biol 12(3): 
372-8. 
Gross, H. (2007). "Strategies to unravel the function of orphan biosynthesis pathways: recent 
examples and future prospects." Appl Microbiol Biotechnol 75(2): 267-77. 
Gross, H., V. O. Stockwell, et al. (2007). "The genomisotopic approach: a systematic method to 
isolate products of orphan biosynthetic gene clusters." Chem Biol 14(1): 53-63. 
Hall, D. G., S. Manku, et al. (2001). "Solution- and solid-phase strategies for the design, 
synthesis, and screening of libraries based on natural product templates: a comprehensive 
survey." J Comb Chem 3(2): 125-50. 
Hansen, D. B., S. B. Bumpus, et al. (2007). "The loading module of mycosubtilin: an adenylation 
domain with fatty acid selectivity." J Am Chem Soc 129(20): 6366-7. 
Harvey, A. L. (2007). "Natural products as a screening resource." Curr Opin Chem Biol 11(5): 
480-4. 
Hendrickson, C. L. and M. R. Emmett (1999). "Electrospray ionization Fourier transform ion 
cyclotron resonance mass spectrometry." Annu Rev Phys Chem 50: 517-36. 
 
 
51 
 
Henkel, T., Brunne, R.M., Muller, H., Reichel, F. (1999). "Statistical investigation into the 
structural complementarity of natural products and synthetic compounds." Angew Chem 
Int Ed 38: 643-647. 
Hertweck, C. (2009). "The biosynthetic logic of polyketide diversity." Angew Chem Int Ed Engl 
48(26): 4688-716. 
Hicks, L. M., M. T. Mazur, et al. (2006). "Investigating nonribosomal peptide and polyketide 
biosynthesis by direct detection of intermediates on >70 kDa polypeptides by using 
Fourier-transform mass spectrometry." Chembiochem 7(6): 904-7. 
Hornung, A., M. Bertazzo, et al. (2007). "A genomic screening approach to the structure-guided 
identification of drug candidates from natural sources." Chembiochem 8(7): 757-66. 
Horton, D. A., G. T. Bourne, et al. (2003). "The combinatorial synthesis of bicyclic privileged 
structures or privileged substructures." Chem Rev 103(3): 893-930. 
Izumikawa, M., Q. Cheng, et al. (2006). "Priming type II polyketide synthases via a type II 
nonribosomal peptide synthetase mechanism." J Am Chem Soc 128(5): 1428-9. 
Kelleher, N. L. and L. M. Hicks (2005). "Contemporary mass spectrometry for the direct 
detection of enzyme intermediates." Curr Opin Chem Biol 9(5): 424-30. 
Kellie, J. F., Tran, J. C., Lee, J. E., Ahlf, D. A., Thomas, H. M., Vellaichamy, A., Kelleher, N. L. 
(2008). The Emerging Process of Top Down Mass Spectrometry: Biomarkers, Protein-
Therapeutics, and Achieving High Throughput. Lab Plus International. 22: 10-13. 
Kelly, W. L., M. T. Boyne, 2nd, et al. (2007). "Characterization of the 
aminocarboxycyclopropane-forming enzyme CmaC." Biochemistry 46(2): 359-68. 
Kleinkauf, H., J. Dittmann, et al. (1991). "Cell-free biosynthesis of cyclosporin A and 
analogues." Biomed Biochim Acta 50(10-11): S219-24. 
52 
 
Knappe, T. A., U. Linne, et al. (2008). "Isolation and structural characterization of capistruin, a 
lasso peptide predicted from the genome sequence of Burkholderia thailandensis E264." J 
Am Chem Soc 130(34): 11446-54. 
Koehn, F. E. (2008). "High impact technologies for natural products screening." Prog Drug Res 
65: 175, 177-210. 
Koehn, F. E. and G. T. Carter (2005). "The evolving role of natural products in drug discovery." 
Nat Rev Drug Discov 4(3): 206-20. 
Kopp, F., U. Linne, et al. (2008). "Harnessing the chemical activation inherent to carrier protein-
bound thioesters for the characterization of lipopeptide fatty acid tailoring enzymes." J 
Am Chem Soc 130(8): 2656-66. 
Kopp, F. and M. A. Marahiel (2007). "Macrocyclization strategies in polyketide and 
nonribosomal peptide biosynthesis." Nat Prod Rep 24(4): 735-49. 
Kumar, P., Q. Li, et al. (2003). "Intermodular communication in modular polyketide synthases: 
structural and mutational analysis of linker mediated protein-protein recognition." J Am 
Chem Soc 125(14): 4097-102. 
Lai, J. R., A. Koglin, et al. (2006). "Carrier protein structure and recognition in polyketide and 
nonribosomal peptide biosynthesis." Biochemistry 45(50): 14869-79. 
Laland, S. G. and T. L. Zimmer (1973). "The protein thiotemplate mechanism of synthesis for 
the peptide antibiotics produced by Bacillus brevis." Essays Biochem 9: 31-57. 
Lambalot, R. H., A. M. Gehring, et al. (1996). "A new enzyme superfamily - the 
phosphopantetheinyl transferases." Chem Biol 3(11): 923-36. 
Lambert, M., J. L. Wolfender, et al. (2007). "Identification of natural products using HPLC-SPE 
combined with CapNMR." Anal Chem 79(2): 727-35. 
53 
 
Lautru, S., R. J. Deeth, et al. (2005). "Discovery of a new peptide natural product by 
Streptomyces coelicolor genome mining." Nat Chem Biol 1(5): 265-9. 
Lee, A. and J. G. Breitenbucher (2003). "The impact of combinatorial chemistry on drug 
discovery." Curr Opin Drug Discov Devel 6(4): 494-508. 
Levy, S. B. and B. Marshall (2004). "Antibacterial resistance worldwide: causes, challenges and 
responses." Nat Med 10(12 Suppl): S122-9. 
Li, J. W. and J. C. Vederas (2009). "Drug discovery and natural products: end of an era or an 
endless frontier?" Science 325(5937): 161-5. 
Little, D. P., J. P. Speir, et al. (1994). "Infrared multiphoton dissociation of large multiply 
charged ions for biomolecule sequencing." Anal Chem 66(18): 2809-15. 
Liu, W., S. D. Christenson, et al. (2002). "Biosynthesis of the enediyne antitumor antibiotic C-
1027." Science 297(5584): 1170-3. 
Marahiel, M. A. and L. O. Essen (2009). "Chapter 13. Nonribosomal peptide synthetases 
mechanistic and structural aspects of essential domains." Methods Enzymol 458: 337-51. 
Marshall, A. G., C. L. Hendrickson, et al. (1998). "Fourier transform ion cyclotron resonance 
mass spectrometry: a primer." Mass Spectrom Rev 17(1): 1-35. 
Martin, J. F. (1998). "New aspects of genes and enzymes for beta-lactam antibiotic 
biosynthesis." Appl Microbiol Biotechnol 50(1): 1-15. 
Mascarell, L. and P. Truffa-Bachi (2003). "New aspects of cyclosporin a mode of action: from 
gene silencing to gene up-regulation." Mini Rev Med Chem 3(3): 205-14. 
Mazzei, T., E. Mini, et al. (1993). "Chemistry and mode of action of macrolides." J Antimicrob 
Chemother 31 Suppl C: 1-9. 
 
54 
 
McClerren, A. L., L. E. Cooper, et al. (2006). "Discovery and in vitro biosynthesis of 
haloduracin, a two-component lantibiotic." Proc Natl Acad Sci U S A 103(46): 17243-8. 
McLafferty, F. W., K. Breuker, et al. (2007). "Top-down MS, a powerful complement to the high 
capabilities of proteolysis proteomics." FEBS J 274(24): 6256-68. 
Meluzzi, D., W. H. Zheng, et al. (2008). "Top-down mass spectrometry on low-resolution 
instruments: characterization of phosphopantetheinylated carrier domains in polyketide 
and non-ribosomal biosynthetic pathways." Bioorg Med Chem Lett 18(10): 3107-11. 
Newman, D. J. and G. M. Cragg (2007). "Natural products as sources of new drugs over the last 
25 years." J Nat Prod 70(3): 461-77. 
Patrie, S. M., J. P. Charlebois, et al. (2004). "Construction of a hybrid quadrupole/Fourier 
transform ion cyclotron resonance mass spectrometer for versatile MS/MS above 10 
kDa." J Am Soc Mass Spectrom 15(7): 1099-108. 
Pierens, G. K., M. E. Palframan, et al. (2005). "A robust clustering approach for NMR spectra of 
natural product extracts." Magn Reson Chem 43(5): 359-65. 
Pinner, R. W., S. M. Teutsch, et al. (1996). "Trends in infectious diseases mortality in the United 
States." JAMA 275(3): 189-93. 
Quadri, L. E. (2007). "Strategic paradigm shifts in the antimicrobial drug discovery process of 
the 21st century." Infect Disord Drug Targets 7(3): 230-7. 
Reid, G. E. and S. A. McLuckey (2002). "'Top down' protein characterization via tandem mass 
spectrometry." J Mass Spectrom 37(7): 663-75. 
Rochfort, S. (2005). "Metabolomics reviewed: a new "omics" platform technology for systems 
biology and implications for natural products research." J Nat Prod 68(12): 1813-20. 
 
55 
 
Schaffrath, M., E. von Roedern, et al. (2005). "High-throughput purification of single 
compounds and libraries." J Comb Chem 7(4): 546-53. 
Schnappinger, D. and W. Hillen (1996). "Tetracyclines: antibiotic action, uptake, and resistance 
mechanisms." Arch Microbiol 165(6): 359-69. 
Schwarzer, D., H. D. Mootz, et al. (2002). "Regeneration of misprimed nonribosomal peptide 
synthetases by type II thioesterases." Proc Natl Acad Sci U S A 99(22): 14083-8. 
Schweizer, E. and J. Hofmann (2004). "Microbial type I fatty acid synthases (FAS): major 
players in a network of cellular FAS systems." Microbiol Mol Biol Rev 68(3): 501-17. 
Shimizu, T., H. Kinoshita, et al. (2005). "Polyketide synthase gene responsible for citrinin 
biosynthesis in Monascus purpureus." Appl Environ Microbiol 71(7): 3453-7. 
Singh, S. B. and J. F. Barrett (2006). "Empirical antibacterial drug discovery--foundation in 
natural products." Biochem Pharmacol 71(7): 1006-15. 
Spellberg, B., J. H. Powers, et al. (2004). "Trends in antimicrobial drug development: 
implications for the future." Clin Infect Dis 38(9): 1279-86. 
Stachelhaus, T., A. Huser, et al. (1996). "Biochemical characterization of peptidyl carrier protein 
(PCP), the thiolation domain of multifunctional peptide synthetases." Chem Biol 3(11): 
913-21. 
Stachelhaus, T., H. D. Mootz, et al. (1998). "Peptide bond formation in nonribosomal peptide 
biosynthesis. Catalytic role of the condensation domain." J Biol Chem 273(35): 22773-
81. 
Stachelhaus, T., H. D. Mootz, et al. (1999). "The specificity-conferring code of adenylation 
domains in nonribosomal peptide synthetases." Chem Biol 6(8): 493-505. 
 
56 
 
Stein, D. B., U. Linne, et al. (2006). "Impact of epimerization domains on the intermodular 
transfer of enzyme-bound intermediates in nonribosomal peptide synthesis." 
Chembiochem 7(11): 1807-14. 
Tacconelli, E. and M. A. Cataldo (2008). "Vancomycin-resistant enterococci (VRE): 
transmission and control." Int J Antimicrob Agents 31(2): 99-106. 
Tang, G. L., Y. Q. Cheng, et al. (2006). "Polyketide chain skipping mechanism in the 
biosynthesis of the hybrid nonribosomal peptide-polyketide antitumor antibiotic 
leinamycin in Streptomyces atroolivaceus S-140." J Nat Prod 69(3): 387-93. 
Taubes, G. (2008). "The bacteria fight back." Science 321(5887): 356-61. 
Tran, L., M. Tosin, et al. (2008). "Covalent linkage mediates communication between ACP and 
TE domains in modular polyketide synthases." Chembiochem 9(6): 905-15. 
Udwary, D. W., L. Zeigler, et al. (2007). "Genome sequencing reveals complex secondary 
metabolome in the marine actinomycete Salinispora tropica." Proc Natl Acad Sci U S A 
104(25): 10376-81. 
von Dohren, H., R. Dieckmann, et al. (1999). "The nonribosomal code." Chem Biol 6(10): R273-
9. 
Walsh, C. T., H. Chen, et al. (2001). "Tailoring enzymes that modify nonribosomal peptides 
during and after chain elongation on NRPS assembly lines." Curr Opin Chem Biol 5(5): 
525-34. 
Weissman, K. J. and P. F. Leadlay (2005). "Combinatorial biosynthesis of reduced polyketides." 
Nat Rev Microbiol 3(12): 925-36. 
Weissman, K. J. and R. Muller (2008). "Protein-protein interactions in multienzyme 
megasynthetases." Chembiochem 9(6): 826-48. 
57 
 
Wells, J. M. and S. A. McLuckey (2005). "Collision-induced dissociation (CID) of peptides and 
proteins." Methods Enzymol 402: 148-85. 
Wenzel, S. C. and R. Muller (2005). "Recent developments towards the heterologous expression 
of complex bacterial natural product biosynthetic pathways." Curr Opin Biotechnol 
16(6): 594-606. 
Wilkins, J., G. E. Fareau, et al. (1984). "The mechanisms of action for beta-lactam antibiotics 
and inhibitors of bacterial protein synthesis." Clin Orthop Relat Res(190): 23-30. 
Wu, K., L. Chung, et al. (2000). "The FK520 gene cluster of Streptomyces hygroscopicus var. 
ascomyceticus (ATCC 14891) contains genes for biosynthesis of unusual polyketide 
extender units." Gene 251(1): 81-90. 
Yang, N. S., L. F. Shyur, et al. (2004). "Medicinal herb extract and a single-compound drug 
confer similar complex pharmacogenomic activities in mcf-7 cells." J Biomed Sci 11(3): 
418-22. 
Yotsuji, A., J. Mitsuyama, et al. (1988). "Mechanism of action of cephalosporins and resistance 
caused by decreased affinity for penicillin-binding proteins in Bacteroides fragilis." 
Antimicrob Agents Chemother 32(12): 1848-53. 
Zerikly, M. and G. L. Challis (2009). "Strategies for the discovery of new natural products by 
genome mining." Chembiochem 10(4): 625-33. 
58 
 
CHAPTER 2: ADVANCES IN MASS SPECTROMETRIC ANALYSIS OF 
THIOTEMPLATE BIOSYNTHESIS 
 
The information and contents for this chapter were taken partially from the following articles 
with permission from the publishers: Stefanie B. Bumpus and Neil L. Kelleher (2008). 
“Accessing natural product biosynthetic processes by mass spectrometry.” Current Opinion in 
Chemical Biology, 12(5):475-482; Pieter C. Dorrestein, Stefanie B. Bumpus, Christopher T. 
Calderone, Sylvie Garneau-Tsodikova, Zachary D. Aron, Paul D. Straight, Roberto Kolter, 
Christopher T. Walsh and Neil L Kelleher (2006). “Facile detection of acyl and peptidyl 
intermediates on thiotemplate carrier domains via phosphopantetheinyl elimination reactions 
during tandem mass spectrometry.” Biochemistry, 45(42):12756-15766; and Darren B. Hansen, 
Stefanie B. Bumpus, Zachary D. Aron, Neil L. Kelleher and Christopher T. Walsh (2007). “The 
loading module of mycosubtilin: an adenylation domain with fatty acid selectivity.” Journal of 
the American Chemical Society, 129(20):6366-6367. 
 
2.1 BACKGROUND AND ACKNOWLEDGEMENTS  
2.1.1 Challenges in Mass Spectrometric Analyses of Thiotemplate Biosynthetic Systems 
 The analysis of thiotemplate biosynthetic enzymes by mass spectrometry (MS) has 
proven an invaluable bioanalytical tool, but still suffers from challenges inherent to the enzymes 
themselves.  The large size of non-ribosomal peptide synthetases (NRPSs) and polyketide 
synthases (PKSs) (often >>500 kDa) does not often make them tractable for Top Down MS 
analysis (Kelleher 2004), but instead most often requires use of Bottom Up proteomics 
(Bogdanov and Smith 2005) techniques involving a chemical or enzymatic proteolysis step.  This 
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generates a complex peptide mixture that must be probed for the intermediate harboring 
thiolation (T) domain active site peptides, a task proven to be very laborious.  In the instances 
where Top Down analysis is possible (for enzymes <50 kDa), there can still be ambiguity in the 
biosynthetic state of the enzyme, especially when probing biosynthetic events resulting in small 
mass changes.  To circumvent these issues, several mass spectrometry-based tools have been 
developed, including an assay specific for phosphopantetheinylated enzymes and an LC-MS 
platform for analysis of thiotemplate enzymes in complex peptide mixtures.  Discussed below 
are my contributions to the development of the phosphopantetheinyl (Ppant) ejection assay and 
two examples of application of MS methods to the study of natural product biosynthetic 
processes, highlighting the shift away from laborious off-line analysis to a more high-throughput 
platform. 
 2.1.2 Acknowledgements 
 I thank Pieter Dorrestein, Ph.D., for his invaluable work in development of the Ppant 
ejection assay and for assistance in my continued development using large proteins and peptide 
mixtures.  Much of this work was completed in collaboration with the lab of Professor 
Christopher T. Walsh at Harvard Medical School (Boston, MA, USA).  For the analysis of 
barbamide biosynthesis, Danica Galonic-Fujimori, Ph.D., cloned the barbamide biosynthetic 
genes, prepared proteins involved in the study, completed in vitro amino acid loading and 
halogenation reactions, and performed radio-HPLC assays.  For the analysis of mycosubtilin 
biosynthesis, Darren Hansen, Ph.D., cloned the mycosubtilin biosynthetic genes, prepared 
proteins used for mass spectrometric analysis, and completed all non-MS biochemical analyses. 
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2.2 DEVELOPMENT OF THE PHOSPHOPANTETHEINYL EJECTION ASSAY 
2.2.1 The Need for Improved Mass Spectrometric Analysis of Thiotemplate Systems 
Early investigations into thiotemplate biosynthesis catalyzed by NRPSs and PKSs by 
Fourier-transform mass spectrometry (FTMS) most often followed the analysis platform outlined 
in the left side of Figure 1.16 (Dorrestein and Kelleher 2006).  Typically, in vitro reactions 
containing all enzymes, substrates and required cofactors are completed to generate intermediate-
loaded T domains.  For Bottom Up FTMS analysis of large protein constructs, the reaction 
mixture is subjected to chemical or enzymatic digestion; in Top Down analysis of intact proteins, 
such as the analysis of barbamide discussed below, the digestion step is eliminated (Bumpus and 
Kelleher 2008).  The peptide or protein mixture is then separated by reverse phase liquid 
chromatography (RPLC) with fractions collected throughout the chromatographic run.  Each LC 
fraction is dried completely under vacuum and resuspended in a solution for electrospray 
ionization (ESI) before introduction into the mass spectrometer.  The first goal of the MS 
analysis is to identify the active site peptides from T domains (or the intact T domain in the case 
of Top Down MS analysis), as these species will harbor any biosynthetic intermediates.  After 
the peptide or protein of interest is identified and the active site serine (Ser) localized by tandem 
mass spectrometry (MS/MS), one continues with analysis of subsequent biosynthetic reactions to 
monitor changes in the mass of the intermediate on the T domain. 
From the above generalized protocol, it is obvious that MS analysis of NRPS and PKS 
biosynthetic events, especially using Bottom Up FTMS (requiring the search for a specific T 
domain active site peptide of interest), is often laborious.  Thus, the development and 
implementation of new and improved MS methods is advantageous.  One of the most important 
of these new innovations is the Ppant ejection assay.  In NRPS and PKS biosynthetic systems, 
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carrier proteins (T domains) are translated in their inactive, apo form.  They are converted to 
their holo, active form through the action of a Ppant transferase (PPTase) which transfers the 
Ppant arm from coenzyme A (CoA) to a Ser in the T domain active site (Lambalot, Gehring et al. 
1996).  This post-translational modification provides the free sulfhydryl group required for 
tethering of the growing natural product to the enzyme complex during biosynthesis (Figure 
2.1A). 
In one of the earliest applications of MS to analysis of NRPS biosynthesis, loss of the 
Ppant arm from an active site peptide targeted by tandem mass spectrometry was observed 
(Stein, Vater et al. 1994).  In this analysis of a NRPS involved in the biosynthesis of gramicidin 
S in Bacillus brevis (Mootz and Marahiel 1997), a complex scheme of protein purification, 
enzyme digestion, multi-dimensional chromatographic separation of all peptides, and two MS 
methods was used to confirm the presence of Ppant at a T domain active site and its tethering of 
an amino acid substrate (valine (Val)).  During ESI-MS/MS of the T domain active site peptide 
of interest (with a mass corresponding to the holo Ppant arm tethering Val), the loss of two small 
molecular ions was observed; the masses of these ions corresponded to the loss of the Ppant arm 
tethering Val with and without the Ppant phosphate group.  Additionally, two peptide fragment 
ions were observed that corresponded to the mass of the apo active site peptide plus a phosphate 
group (+ 80 Da) and the apo active site minus 18 Da (assumed to correspond to dehydration of 
the active site Ser to dehydroalanine (Dha)).  This was proof that the active site peptide was 
harboring the Ppant arm and set the stage for the subsequent characterization of the multiple 
carrier model of NRP biosynthesis.   
Despite the historical observation of the loss of the Ppant arm during MS analysis and its 
usefulness in the characterization of carrier proteins, relatively few research programs exploited 
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MS as a tool for NRPS and PKS analysis (Hong, Appleyard et al. 2005; Schnarr, Chen et al. 
2005; Dorrestein and Kelleher 2006; Gu, Jia et al. 2006) and, as of 2006, none were employing 
the molecular signature of Ppant ejection as a characterization tool.  However, during analysis of 
numerous biosynthetic systems by the Kelleher Research Group at the University of  Illinois it 
was observed that the elimination of the Ppant arm was consistently observed during MS/MS of 
a wide variety of holo and substrate-loaded T domains (Dorrestein, Bumpus et al. 2006).  As 
discussed below, the development of this MS/MS reaction into a robust tool for the 
characterization of NRPS and PKS systems has revolutionized the analysis of thiotemplate 
biosynthesis by MS. 
2.2.2 Experimental Procedures for Development of the Ppant Ejection Assay 
2.2.2.1 Preparation of GliP for FTMS analysis  
 Full-length His6-tagged GliP was cloned, overexpressed in Escherichia coli, and purified 
by Carl Balibar, Ph.D., in the Walsh Research Group at Harvard Medical School (Boston, MA, 
USA) (Balibar and Walsh 2006). 242 µg of apo-GliP was converted to its holo form by 
incubation with 2 µl of 2.5 mg/mL Sfp (Quadri, Weinreb et al. 1998) and 2 µL of 10 mg/mL 
CoA in 50 mM Tris-HCl (pH 8), 10 mM MgCl2, and 2 mM tris(2-carboxyethyl)-phosphine 
(TCEP) (pH 6) (in a final reaction volume of 100 µL).  The reaction proceeded for 3 h at 30 °C.  
After 3 h, 32 µg of LysC in 50 mM Tris-HCl (pH 8) and 2 mM EDTA were added for proteolytic 
digestion (in a final reaction volume of 140 µL).  The reaction was quenched by the addition of 
140 µL of 10% formic acid and frozen at -80 °C.  For loading of phenylalanine (Phe) onto GliP, 
the holo protein was incubated with 10 mM ATP and 10 mM Phe for at least 1 hour at 30 °C and 
then digested as above. The resulting peptide mixtures were separated by RPLC using an Agilent 
HP1100 binary pump and a Jupiter C18 column (Phenomenex, 150 mm x 4.6 mm, 300 Å, 5 µm) 
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with a gradient of 10%-90% solvent B in solvent A (where solvent A is H2O + 0.1% 
trifluoroacetic acid (TFA) and solvent B is acetonitrile (MeCN) + 0.1% TFA).  One mL fractions 
were collected, frozen at -80 °C, and dried to completion under vacuum.  For analysis by FTMS, 
samples were resuspended in 50 µL nanospray solution (49:49:2 H2O: methanol (MeOH): formic 
acid). 
2.2.2.2 Preparation of GrsA for FTMS analysis 
  For experiments with GrsA (PheATE), the holo protein was generated by incubating 
500-600 μg of apo protein for 1 h in a reaction mixture containing 50 mM Tris-HCl (pH 8), 10 
mM MgCl2, 2 mM TECP (pH 6), 2 mM CoA and 4 μL 0.5 mg/mL Sfp.  After 1 h, the reaction 
mixture was supplemented with 10 mM ATP and 10 mM amino acid (L-Phe or 2
 For mass spectrometric analysis, a custom 8.5 T ESI-FTMS equipped with a front-end 
quadrupole was utilized (Patrie, Charlebois et al. 2004).  The samples were introduced into the 
H5-L-Phe (ring 
labeled)) and incubated for an additional 30 min to generate loaded protein.  Reaction mixtures 
were stored at -80 °C until they were prepared for MS analysis.  Immediately before injection 
into the mass spectrometer, samples were prepared using C4 ZipTips (Millipore).  To prepare 
each sample, the ZipTip was washed 5 times with 10 μL of MeCN and 5 times with 10 μL of 
H2O + 0.1% TFA.  The sample was loaded onto the ZipTip by pipetting into the sample 10-15 
times, each time injecting back into the reaction vile.  The ZipTip was washed again 8 times with 
10 μL of H2O + 0.1% TFA and the sample was eluted into 5 μL of 78% MeCN + 2% acetic acid.  
The eluted sample was diluted with 25 μL of nanospray solution and mixed thoroughly.  The 
reported values of GrsA are the neutral most abundant masses, and the standard deviation shown 
is calculated from the averaging of all masses calculated from observable charge states. 
2.2.2.3 FTMS analysis of GrsA and GliP 
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FTMS using a NanoMate 100 instrument for automated nanospray (Advion Biosciences).  To 
introduce the samples, a back pressure of 0.45-0.8 psi and a voltage of 1.4-1.8 V were used.  
Typical instrument settings for the initial broadband analysis are as follows:  50-500 ms for ion 
accumulation per scan and 10-300 scans acquired per spectrum.  For quadrupole enhancement of 
the peptide or protein species of interest, the accumulation times were adjusted to 500-700 ms 
with the quadrupole isolation window set depending on the isolation width desired.  For stored 
waveform inverse Fourier-transform (SWIFT) excitation (Chen, Wang et al. 1987) to isolate 
specific ions the amplitude was set to 0.27 Vp-p and 30-50 waveform loops were used.  For 
octupole collisionally activated dissociation (OCAD), the ions were subjected to -10 to -40 V in 
the accumulation octupole (Patrie, Charlebois et al. 2004).  Infrared multi-photon dissociation 
(IRMPD) was accomplished with a CO2 laser by irradiation on axis with regard to the ion 
cyclotron resonance (ICR) cell for 80-300 ms.  The instrument was externally calibrated using 
ubiquitin (monoisotopic Mr value of 8559.616 Da).  The FTMS settings were typically as 
follows:  tube lens, 200-275 V; capillary heater, 3.5-4 A; quad filter, -20 V; skimmer off; 
capillary offset, 34 V; transfer of -10 to -80 V; transfer times, 1.00-1.25 ms; leak gas 3.5-4.5 x 
10-5
 The loss of the Ppant cofactor results from the gas phase elimination of the Ppant arm 
during collisionally activated tandem mass spectrometry; the two methods most commonly used 
to generate the Ppant ejection ions are collision induced dissociation (CID, or OCAD as 
employed in these initial studies) and IRMPD (Little, Speir et al. 1994; Wells and McLuckey 
2005).  As described above, this gas phase elimination reaction results in the generation of two 
small molecular ions (the hypothesized structures are provided in Figure 2.1A).  There are two 
 Torr.  These settings apply to all off-line FTMS data acquired and presented in Chapter 2. 
2.2.3 Results and Discussion on the Development of the Ppant Ejection Assay 
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mechanisms that can be imagined for the generation of a Ppant ejection ion retaining the 
phosphate group and leaving an apo protein or peptide with the loss of 18 Da (Figure 2.2A and 
2.2B).  In the first, the α-carbon of phosphopantetheinylated Ser is deprotonated and there is a 
rearrangement; this results in the loss of 18 Da in the peptide or protein and formation of a Dha 
at the active site Ser.  In the second mechanism, which is analogous to the elimination of a 
phosphate from a per-protonated phosphorylated Ser or threonine (Thr) (Syka, Coon et al. 2004), 
an oxazolium-containing protein ion is produced that also results in a mass shift of -18 Da for the 
peptide or protein.  A mechanism can also be envisioned for the loss of the Ppant ejection ion 
that does not retain the phosphate group.  Following the elimination reaction, a phosphate anion 
is retained on the active site peptide or protein and the carbonyl of an amide displaces the Ppant 
moiety.  This is purported to form a five member ring with a protonated imine that is positively 
charged (Figure 2.2C). 
 Figures 2.3 and 2.4 are representative results for application of the Ppant ejection assay in 
Bottom Up proteomics, collected during a study of gliotoxin biosynthesis (Balibar and Walsh 
2006).  The NRPS responsible for incorporation of the Phe and Ser residues into the gliotoxin 
core structure, GliP, has unique domain architecture:  A1-T1-C1-A2-T2-C2-T3 (A – adenylation 
domain, C – condensation domain).  The Ppant ejection assay was applied to identify of all three 
T domains by FTMS, as exemplified by the characterization of GliP-T1.  Holo-GliP was 
proteolytically digested with LysC and the resulting peptide mixture was separated by RPLC.  
Each of the resulting fractions was interrogated by FTMS for the presence of peptides 
corresponding to the T domain active site peptides.  As shown in Figure 2.3, a peptide 
corresponding to the mass of the holo-T1 active site peptide was observed and was quadrupole 
and SWIFT isolated.  This isolated species was subjected to IRMPD and the resulting spectra 
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analyzed for the presence of Ppant ejection ions.  As shown, the small molecular ion at m/z 261 
was observed, in addition to both peptide marker ions (the apo + 80 Da and apo – 18 Da 
species), confirming that this was the T1 active site peptide.  Additionally, GliP-T1 was loaded 
with Phe and a similar analysis was performed to confirm amino acid loading catalyzed by A1.   
The small molecular Ppant ejection ion (corresponding to the eliminated Ppant arm tethering 
Phe) and both peptide marker ions were observed, confirming amino acid loading (Figure 2.4).  
This set of experiments was applied to all T domains in GliP, providing additional information 
on the biosynthetic activities catalyzed by this enzyme.   
 The first report of the Ppant ejection assay as a tool for MS analysis of NRPSs and PKSs 
provided 33 different examples of application of the Ppant ejection assay to differentially loaded 
T domains (Dorrestein, Bumpus et al. 2006).  Several important insights into the broad 
applicability of this assay were gained from this initial study.  First, the utility of the ejection 
assay in the study of halogenated NRP substrates was demonstrated in analysis of chlorinated 
and brominated substrates loaded onto the carrier protein PltL from pyoluteorin biosynthesis 
(Dorrestein, Yeh et al. 2005).  The theoretical (based upon the natural isotopic abundances of 
chlorine and bromine) and experimental isotopic distributions for the eliminated ions matched 
very closely; this is discussed in more detail in Section 2.3.  Second, the ability to observe very 
small mass changes occurring during in vitro biosynthetic assays was demonstrated, even when 
occurring on large protein constructs.  For example, using the carrier domain from MycA 
(involved in mycosubtilin biosynthesis (Aron, Dorrestein et al. 2005)), the +1.032 Da mass shift 
occurring from in cis amine transfer converting acetoacyl-S-MycA to β-aminobutyryl-S-MycA 
was observed as a +1.031 Da mass shift between the Ppant ejection ions generated from each 
species.  Third, it was demonstrated that the Ppant ejection assay could be adapted to low-
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resolution, bench-top MS instrumentation, an important characteristic if the Ppant ejection assay 
is to be employed in a wide variety of research programs with diverse instrumentation.  An ion 
trap mass spectrometer was easily employed for detection of both holo and substrate-loaded 
Ppant ejection ions, even when applied to differentiating Ppant ejection ion mass shifts of as 
small as 2 Da.   
Fourth, the utility of the Ppant ejection assay to study large, undigested proteins was 
demonstrated.  Even using FTMS, one lacks the ability to isotopically resolve very large protein 
species to determine an accurate mass; the average mass of the species must be determined from 
the observed charge states.  In biosynthetic transformations, large protein mass shifts (for 
example, due to phosphopantetheinylation or amino acid loading) may be observed at the intact 
protein level, but the mass accuracy of the measurement may not unequivocally confirm the 
biosynthetic state of the protein.  However, the Ppant ejection assay can be used to 
unambiguously confirm the mass shift in question, even in the case of mass shifts <1 Da.   
For example, the intact protein GrsA (PheATE, ~126 kDa) involved in gramicidin S 
biosynthesis (Mootz and Marahiel 1997) was interrogated by Top Down FTMS and the Ppant 
ejection assay.  The intact protein was loaded with two different substrates, the cognate substrate 
L-Phe and also 2H5-L-Phe, and each loaded species was analyzed by FTMS (Figure 2.5).  The 
intact mass of Phe-loaded GrsA (Phe-S-GrsA) was calculated to be 126,714 ± 15 Da, while the 
2H5-Phe-loaded GrsA (2H5-Phe-S-GrsA) had a calculated intact mass of 126,726 ± 12 Da.  These 
intact masses do not allow one to confidently conclude that the protein has been differentially 
loaded with the two substrates; this would require several more measurements or digestion and 
analysis by Bottom Up FTMS.  However, when each of the protein species was subjected to 
IRMPD, Ppant ejection ions were generated and the mass shift between the ejection ions was 
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calculated to be 5.033 Da, in agreement with the theoretical mass shift of 5.031 Da.   
In summary, the initial reports of the Ppant ejection assay for analysis of NRPSs and 
PKSs highlighted its utility in MS analysis of thiotemplate systems.  One is able to 
unambiguously identify the biosynthetic state of a carrier domain and track in vitro biosynthetic 
transformations, even those resulting in mass shifts of as small as 1 Da.  This gas-phase 
elimination reaction results in predictable product ions that allow one to monitor changes to 
natural product intermediates in a robust fashion, and confirms that the substrate is linked to the 
Ppant arm.  In the past four years, the Ppant ejection assay has seen widespread use and 
seemingly increased the number of research groups able to apply MS to the study of thiotemplate 
systems (Calderone, Iwig et al. 2007; Kelly, Boyne et al. 2007; Kopp, Linne et al. 2008; 
Meluzzi, Zheng et al. 2008; Gu, Wang et al. 2009).  The extension of the Ppant ejection assay to 
track diverse biochemical transformations and implementation in more high-throughput fashion 
only increases its applicability and value in the NRPS and PKS analysis toolbox. 
2.3 MASS SPECTROMETRIC INVESTIGATION OF NATURAL PRODUCT 
HALOGENATION 
 The work presented in Section 2.3 is a detailed example of the application of traditional 
FTMS analysis of NRPS and PKS biosynthetic pathways, incorporating in vitro biochemical 
analyses, off-line separation by RPLC, and analysis of RPLC fractions containing proteins of 
interest by FTMS.  This work is placed in the context of the development of FTMS assays for the 
study of natural product halogenation, specifically in the trichlorination of the natural product 
barbamide.   
2.3.1 Introduction to Halogenation of Non-ribosomal Peptides 
Halogenation is a common natural product modification, yet the enzymes responsible for 
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halogenation are not fully characterized.  There are several mechanisms possible for enzymatic 
halogenation, including those catalyzed by a new family of halogenases that require α-
ketoglutarate (α-KG), oxygen (O2), and Fe(II) for halogenation at aliphatic carbon centers 
(Neumann, Fujimori et al. 2008).  There are biochemical assays for the study of enzymatic 
halogenation, the majority of which do not involve direct analysis of the natural product but 
require synthesis of complex small molecule standards or generation of radioactive substrates.  A 
MS-based assay for the analysis of enzymatic halogenation would allow clear and direct 
visualization of halogenation events and provide a method for kinetic and mechanistic studies. 
Several halogenated natural products, including barbamide and syringomycin (Figure 
2.6), are synthesized by NRPSs, PKSs, or hybrid NRPS-PKS systems (Fischbach and Walsh 
2006).  These biosynthetic machineries are large, multi-modular protein complexes that 
synthesize natural products in an assembly-line fashion.  There are conserved domains within 
NRPS and PKS systems that are responsible for the incorporation of one monomer unit (amino 
acids in the case of NRPSs, acyl-CoAs for PKSs) into the growing natural product in a co-linear 
manner.  The common domains in NRPSs are the adenylation domain (A), responsible for the 
activation of a single amino acid unit, the peptidyl carrier protein domain (PCP, or T domain), 
responsible for covalently tethering the growing amino acid chain, and the condensation domain 
(C), responsible for the condensation of two amino acid units of the natural product.  In addition 
to these three domains, there are tailoring domains to modify the chemical backbone, including 
halogenation domains (Hal), and thioesterase domains responsible for the release of the full 
product.   
As stated previously, a new mechanism for enzymatic halogenation of NRPS and PKS 
natural products was recently proposed based upon biochemical and structural analysis of 
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barbamide and syringomycin biosynthesis (Vaillancourt, Yeh et al. 2005; Vaillancourt, Yin et al. 
2005; Galonic, Vaillancourt et al. 2006; Ueki, Galonic et al. 2006; Vaillancourt, Yeh et al. 2006; 
Galonic, Barr et al. 2007; Krebs, Galonic Fujimori et al. 2007).  The mechanism requires a non-
heme Fe(II) center, α-KG, and molecular oxygen; the following mechanism is proposed (Figure 
2.7) (Neumann, Fujimori et al. 2008).  The initial state of the halogenase has a mononuclear 
Fe(II) center coordinated to two conserved histidine (His) residues, a water molecule, a halogen 
atom, and the ketone and one carboxylate oxygen of α-KG.  The substrate (e.g. an amino acid 
residue tethered to a T domain) enters the active site and displaces the water molecule.  
Molecular oxygen enters the active site and fills an empty coordination site of Fe(II).  This is 
followed by decarboxylation of α-KG by attack of molecular oxygen at the α-KG carbonyl 
ketone to generate succinate, free CO2, and a high valency Fe(IV)=O species.  This highly 
reactive species generates a carbon radical on the substrate at an unactivated carbon center, 
which is followed by halogenation of the substrate through generation of a halogen radical.  The 
halogenated substrate exits the active site and the initial active site state is regenerated by the 
binding of α-KG and water.   
 Barbamide (Figure 2.6) is a lipopeptide natural product with molluscicidal activity 
isolated from the marine cyanobacterium Lyngbya majuscula  (Orjala and Gerwick 1996).  The 
structure of barbamide includes a trichloromethyl group, determined in feeding studies to be 
derived from a leucine (Leu) moiety incorporated by NRPS logic (Sitachitta 1998).  
Identification and annotation of the barbamide biosynthetic gene cluster revealed enzymes 
responsible for generation of a hybrid NRP-PK, incorporation of the trichloroleucine moiety, and 
also generation of a thiazole ring and catalysis of a one carbon truncation (Flatt, O'Connell et al. 
2006).  From annotation of the gene cluster (Figure 2.8) (Chang, Flatt et al. 2002), it was 
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predicted that two enzymes, the gene products of barB1 and barB2, could be responsible for 
trichlorination of the Leu residue activated by BarD (an A domain) and covalently tethered to the 
BarA thiolation domain.  Further work confirmed BarB1 and BarB2 as the enzymes responsible 
for chlorination of Leu, with BarB2 catalyzing mono- and dichlorination, and BarB1 responsible 
for the incorporation of the final chlorine atom (Galonic, Vaillancourt et al. 2006).  The 
correlation of mass spectrometry data with these results is provided below.  
Biosynthetic investigations of halogenated natural products, such as barbamide, present 
many opportunities for FTMS characterization.  Characteristic of their NRPS and PKS origins, 
distinct domains and modules are responsible for loading, condensing, and modifying specific 
amino acids.  FTMS is well suited for characterizing mixtures of these enzymes, allowing the 
visualization of the order of events involved in biosynthesis by monitoring covalent biosynthetic 
intermediates (Dorrestein and Kelleher 2006).  High-resolution FTMS measurements provide 
high mass accuracy (part-per-million (ppm) range) during analysis of peptides and intact 
proteins.  In each step of NRPS and PKS biosynthesis, the growing natural product is covalently 
tethered to the enzyme complex through the Ppant arm of CoA that is in turn covalently attached 
to the active site Ser of the T domain.  Loading of the substrate units or modification to the 
substrates can be robustly monitored by mass spectrometry because each addition or 
modification results in a mass shift on the apo T domain.   
The T domain BarA (responsible for tethering the L-Leu moiety in barbamide 
biosynthesis) is of particular interest for FTMS analysis because of the possibility for monitoring 
chlorination of amino acid moieties.  Thus, mass spectrometric assays were developed to 
complement previously established biochemical assays to monitor enzymatic halogenation by 
non-heme Fe(II), α-KG, and oxygen-dependent halogenases.  Within this assay scheme, 
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halogenation reactions are carried out on substrates tethered to NRPS T domains.  The T domain 
(and other proteins in the mixture) is then (optionally) proteolytically or chemically digested, and 
the intact proteins or peptides are separated by RPLC.  The protein species are infused into a 
high-resolution FTMS instrument and a broadband scan is obtained of all protein species in the 
spectrum.  A single charge state of a protein(s) of interest is isolated and subjected to tandem 
mass spectrometry for active site mapping.  The Ppant ejection assay is used to confirm 
halogenation of the substrate through detection of the small molecular ion containing the 
covalent intermediate that is generated during tandem mass spectrometry of T domains 
(Dorrestein, Bumpus et al. 2006). 
2.3.2 Experimental Procedures for Barbamide Analyses 
 The procedures for expression of barbamide synthetic genes, synthesis of substrates used 
and generation of samples for FTMS analysis are published previously and summarized here, 
highlighting the components critical to analysis of halogenation by mass spectrometry (Galonic, 
Vaillancourt et al. 2006). 
2.3.2.1 Expression and purification of barbamide biosynthetic proteins 
 Methods for the cloning, overexpression and purification of BarA, BarD, BarB1 and 
BarB2 were completed are reported previously (Galonic, Vaillancourt et al. 2006).  
2.3.2.2 Substrate synthesis 
 For the synthesis of (2S,4S)-5,5-dichloroleucine · TFA salt, the substrate was prepared 
according to a previously published procedure (Arda 2004). 
2.3.2.3 Formation of chlorinated L-Leu on BarA 
 To generate holo-BarA, BarA (100 µM) was incubated with CoA (200 µM), MgCl2 (2 
mM), BarD (20 µM) and Sfp (2.5 µM) in 20 mM HEPES (pH 7.5) for 40 min at room 
73 
 
temperature.  To generate L-Leu-loaded BarA (Leu-S-BarA), there was subsequent addition of 
5.8 µL of 50 mM L-Leu followed by addition of ATP (final concentration 2 mM).  The loading 
assay mixtures were incubated at room temperature for 60 min.  After incubation, α-KG (final 
concentration 2 mM), chloride (~15 mM) and BarB1 and/or BarB2 were added (final 
concentration of each of the halogenating enzymes was 40 µM).  For kinetic analyses, the ratio 
of BarA to halogenating enzyme was varied as discussed in Subsection 2.3.3, but all other assay 
preparation procedures were the same.  The samples were incubated for 1 h (or at a specified 
time for kinetic analyses) at room temperature.  For samples to be analyzed by FTMS, the 
reaction was quenched by flash freezing or addition of glacial acetic acid and stored at -80 °C 
until analysis.  For analysis by radio-HPLC, the assay mixtures were prepared and analyzed as 
described previously (Galonic, Vaillancourt et al. 2006).  In kinetic analysis of the barbamide 
trichlorination, synthetic (2S,4S)-5,5-dichloroleucine · TFA salt was substituted for L-Leu. 
2.3.2.4 Preparation of barbamide biosynthetic assays for FTMS analysis 
BarA loading and halogenation reactions were stored at -80 °C until preparation for MS 
analysis. Samples were thawed and injected onto a Jupiter C4 Column (Phenomenex, 4.6 mm x 
150 mm, 300 Å, 5 µ) equilibrated with 95% solvent A, where solvent A is H2O + 0.1% TFA.  
Intact protein species were separated by a gradient from 10-75% solvent B in solvent over 40 
min, where solvent B is MeCN + 0.1% TFA, and 0.5 mL fractions were collected every 30 s.  
Protein containing samples (observation of an UV absorbance signal at 220 nm and/or 280 nm) 
were dried completely using a Speed-Vac concentrator and stored at -80 °C until MS analysis.  
All MS analysis was completed on a custom 8.5 T FT-ICR-MS (Patrie, Charlebois et al. 2004) 
equipped with ESI source and OCAD, IRMPD, and electron capture dissociation (ECD) 
(Zubarev, Horn et al. 2000) MS/MS capabilities.  Samples were resuspended in nanospray 
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solution (49% H2O, 49% MeOH, 2% formic acid) at approximately 50 µL nanospray 
solution/200 mAU (220 nm detection).  Samples were injected into the mass spectrometer and 
broadband spectra collected at the following average parameters:  100-200 scans with 150-300 
ms accumulation time per scan.  Ions were directed through a heated metal capillary, skimmer, 
quadrupole, and multiple octupoles into the ion cell (at a pressure of approximately 2 x 10-10
Top Down FTMS was performed on a variety of reactions to monitor 
phosphopantetheinylation, amino acid loading, and chlorination of substrates on the intact BarA 
thiolation domain.  In this platform (Figure 2.9), intact proteins were separated by RPLC and 
protein containing fractions collected and dried to completion under vacuum.  Fractions were 
resuspended in a solution for ESI and analyzed by FTMS using a variety of assays, including 
measurement of intact carrier protein masses, MS/MS to identify the carrier proteins and localize 
the Ppant modification to the active site Ser and monitor chlorination, and the Ppant ejection 
assay to confirm the biosynthetic state of each protein species.  A variety of different analyses 
were completed, including identification of the apo, holo and Leu-loaded forms of the BarA 
peptidyl carrier protein, determination of the chlorination activities of the halogenases BarB1 and 
 torr) 
of the FTMS.  MS/MS data were collected by quadrupole and SWIFT isolation of individual 
protein species, followed by IRMPD (average irradiation: 150-250 ms, 75% laser power).  All 
data were acquired using the MIDAS data acquisition software (Senko, Canterbury et al. 1996) 
as 512K data sets and analyzed by an in-house software package that includes THRASH (Horn, 
Zubarev et al. 2000), IsoPro, and ProsightPTM (LeDuc, Taylor et al. 2004).  Spectra were 
calibrated externally using bovine ubiquitin (Mr = 8559.65 Da).    The theoretical and 
experimental masses of all protein species and Ppant ejection ions are provided in Table 2.1. 
2.3.3 Results and Discussion of FTMS Analysis of Barbamide Halogenation 
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BarB2 (both alone and in tandem), and some initial kinetic analysis of Leu halogenation. 
2.3.3.1 Identification of the BarA carrier protein in apo, holo and loaded forms 
RPLC allowed for separation of all protein species in the reaction mixtures, including the 
separation of apo, holo and amino acid-loaded BarA from the halogenating enzymes.  First 
observed was apo-BarA with an experimental mass of 12786.2 Da, an error of 0.8 Da from the 
theoretical intact mass for the specific protein form (Figure 2.10A).  Holo-BarA was observed in 
the RPLC fraction adjacent to apo protein, and the mass spectrum showed a species with an 
intact mass of 13127.4 Da, a mass shift of 342.1 Da from the apo protein and within 2 Da of the 
theoretical mass shift for phosphopantetheinylation (340.1 Da)  (Figure 2.10B).  MS/MS was 
conducted using IRMPD and the Ppant modification was localized to a single Ser (Ser49 in the 
BarA protein sequence), the residue predicted to be the active site Ser by sequence alignment.  
After active site mapping of the Ppant arm to the active site Ser residue, Leu-S-BarA was 
analyzed by FTMS.  Leu-S-BarA eluted at the same time in the RPLC run as the holo form, but 
the protein species were sufficient m/z units apart for isolation and characterization of individual 
protein species (Figure 2.10C).  A protein species was observed with an intact mass of 13238.01 
Da, a mass shift of 451.8 Da from the mass of apo-BarA and an error of 0.5 Da from the 
theoretical mass of Leu-S-BarA.  During MS/MS of holo- and Leu-S-BarA, both predicted Ppant 
ions were observed, and the masses were within 5 ppm of the theoretical mass for holo and Leu-
loaded Ppant ejection ions (Figures 2.10D and 2.10E).  
2.3.3.2 Characterization of the halogenation activity of BarB1 and BarB2 
Prior analysis using radio-HPLC of substrates released and derivatized from Leu-S-BarA 
incubated with BarB2 alone resulted in the observation of di- and trichloroleucine-loaded BarA 
(Cl2-Leu-S-BarA and Cl3-Leu-S-BarA) (Figure 2.11) (Galonic, Vaillancourt et al. 2006).  In 
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analysis by FTMS, incubation of Leu-S-BarA with BarB2 and all required cofactors and 
cosubstrates resulted in the observation of a new trio of protein species, each with an observed 
intact mass shift of ~34 Da from each other (Figure 2.12A).  To confirm these protein species 
were indeed chlorinated Leu-S-BarA, the 11+ charge states of these three species were isolated 
together (using quadrupole and SWIFT isolation) and subjected to MS/MS using IRMPD to 
confirm the modification of BarA.  It is important to note that residual thrombin present from 
His-tag cleavage of BarB1 and BarB2 resulted in cleavage of the His-tag from BarA after 
incubation with halogenase, resulting in different masses for the intact protein species than 
reported for the apo, holo, and Leu-loaded forms.   
The three species isolated had intact masses of 11522.9 Da (monochloroleucine-loaded 
BarA (Cl-Leu-S-BarA), theoretical mass of 11522.7 Da), 11556.9 Da (Cl2-Leu-S-BarA, 
theoretical mass of 11556.7 Da), and 11591.3 Da (Cl3-Leu-S-BarA, theoretical mass of 11590.7 
Da) (Figure 2.12A).  The MS/MS experiment resulted in the observation of the Ppant ejection 
ions expected for BarA loaded with halogenated Leu.  For the species of 11522.7 Da, an ejection 
product was observed with a mass of 408.174 Da, a 5 ppm error from the theoretical mass of a 
Ppant ejection ion from Cl-Leu-S-BarA (Figure 2.12B).  This was the first observation of Cl-
Leu-S-BarA by any analytical or biochemical method.  For the species of 11556.9 Da, an 
ejection product was observed with a mass of 442.134 Da, a 2 ppm error from the theoretical 
mass of the Ppant ejection product from Cl2-Leu-S-BarA (Figure 2.12B).  Finally, for the species 
at 11592.1 Da, an ejection product was observed with a mass of 476.096 Da, a 4 ppm error from 
the theoretical mass for Cl3-Leu-S-BarA (Figure 2.12B).  These results confirmed the previously 
published results showing BarB2 is capable of catalyzing di- and trichlorination of Leu-S-BarA, 
and provided the first evidence that BarB2 could catalyze monochlorination of Leu-S-BarA. 
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Prior results had shown that incubation of Leu-S-BarA with BarB1 and required cofactors 
and cosubstrates resulted in observation of no Cl-Leu-S-BarA or Cl2-Leu-S-BarA and  
very trace amounts of Cl3-Leu-S-BarA (Figure 2.11) (Galonic, Vaillancourt et al. 2006).  When a 
similar assay was analyzed by FTMS, a similar result was obtained - only Leu-S-BarA was 
observed (Figure 2.13); from this, it can be concluded that BarB1 is not responsible for the 
mono- or dichlorination of Leu-loaded BarA, but instead could play a role in the complete 
conversion to the trichlorinated substrate.  Indeed, radio-HPLC analysis had confirmed that when 
BarB1 was added after incubation of Leu-S-BarA, BarB2 and all required cofactors and 
cosubstrates, the level of Cl3-Leu-S-BarA increased dramatically to a level even higher than that 
generated by incubation with BarB1 and BarB2 concurrently (Figure 2.11). The results from 
FTMS analysis of similar assays confirmed these results, as shown in Figure 2.14; these results 
confirm that addition of BarB1 after incubation of BarB2 and Leu-S-BarA converts the substrate 
to the trichlorinated form.   
2.3.3.3 Qualitative kinetic analysis of barbamide halogenation 
 Kinetic analyses of barbamide halogenation were attempted, specifically targeting the 
formation of Cl3-Leu-S-BarA by BarB1 or BarB2 through incubation of Cl2-Leu-S-BarA with a 
single halogenase and all required cofactors and cosubstrates.  However, these analyses were 
suspended due to the apparent rate of halogenation being much faster than could be measured 
using the instrumentation available in the required anaerobic environment.  Figures 2.15-2.19 are 
representative of the data collected in initial development of the kinetic assays; these results were 
valuable in reaffirming the ability of the Ppant ejection assay to confirm if a specific protein 
species is present.  For example, to determine the ratio of Cl2-Leu-S-BarA to BarB2 to use in 
kinetic analysis (varying the ratio of Cl2-Leu-S-BarA: BarB2 to 20:1, 50:1 and 100:1), the 
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observation of a Ppant ejection ion corresponding to the trichloroleucine-loaded species 
confirmed the presence of this intermediate even though the intact peptide was very low in 
abundance or not observed (Figure 2.15).  A similar trend was observed in the analysis of 
conversion to the trichloroleucine intermediate by BarB1 in the presence of Cl2-Leu-S-BarA. 
(Figure 2.16) 
 It was determined that a ratio of 20:1 Cl2-Leu-S-BarA: halogenase would have been used 
in kinetic assays and an initial set of assays were completed where the halogenation reaction was 
quenched at 1, 5, 10 and 20 min; this was completed with both BarB1 and BarB2, varying the 
substrate concentration to either 10 µM or 100 µM.  In the presence of BarB2, Cl3-Leu-S-BarA 
was observed at the earliest time point, and remained at a consistent level throughout all other 
time points analyzed; a similar result was obtained for BarB1 halogenation (Figures 2.17, 2.18 
and 2.19).  This data revealed that the speed of halogenation would be too rapid to detect by the 
methods available, and further analysis was suspended. 
2.3.3.4 Advantages to using phosphopantetheinyl ejection in analysis of halogenation 
A unique advantage of using the Ppant ejection assay for the analysis of halogenated 
substrates tethered to NRPS and PKS thiolation domains is the ability to compare the isotopic 
distribution of the small molecular ion generated by tandem mass spectrometry to the theoretical 
isotopic distribution for the theoretical halogenated ejection product.  The natural abundance of 
chlorine isotopes is unique and provides an additional level of confirmation for the halogenation 
of barbamide.  For all chlorinated Ppant ejection ions, the theoretical isotopic distribution closely 
matched the isotopic distribution observed for the MS/MS generated Ppant ejection products.  
This is demonstrated by the comparison of the theoretical and experimental isotopic distributions 
of Ppant ejection ions generated from Cl2-Leu-S-BarA and Cl3-Leu-S-BarA (Figure 2.20).   
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Another advantage of application of the Ppant ejection assay to the detection of natural 
product halogenation using Top Down MS is the ability to unambiguously identify low 
abundance species of interest.  For example, FTMS analysis of barbamide halogenation provided 
the first observation of Cl-Leu-S-BarA (Figure 2.12).  This observation confirmed that the 
monochlorinated species is indeed a biosynthetic intermediate, but is quickly converted to the 
more highly chlorinated species.  
Additionally, these studies provided the first evidence for the ability to qualitatively 
compare intact protein (or peptide) species abundance to the abundance of Ppant ejection ions 
that are generated from the intact proteins during MS/MS.  As can be seen in Figure 2.21, there 
is an obvious correlation between the abundance of the intact Cl2-Leu-S-BarA and Cl3-Leu-S-
BarA ions harboring halogenated intermediates and the Ppant ejection ions generated from 
MS/MS of the species.  This will be useful to concurrently confirm the biosynthetic state of the 
protein and determine relative ratios of different protein species, and also in the characterization 
of large protein species for which isotopically-resolved intact protein spectra can not be obtained 
but the Ppant ejection assay can performed to provide information on the biosynthetic state of the 
protein. 
2.4 MASS SPECTROMETRIC ANALYSIS OF MYCOSUBTILIN BIOSYNTHESIS 
2.4.1 Justification for Development of the On-line Ppant Ejection Assay 
 Previously, the development of the Ppant ejection assay and its application to the analysis 
of intact proteins and peptides using an uncoupled RPLC and FTMS platform was described.  
While there has been great success in the application of the off-line separation and Bottom Up 
MS analysis protocol, including biosynthetic analysis of natural products such as epothilone 
(Hicks, O'Connor et al. 2004), bacillaene (Calderone, Kowtoniuk et al. 2006) and yersiniabactin 
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(McLoughlin and Kelleher 2005), the method is rather laborious (Dorrestein and Kelleher 2006).  
Identification of the T domain active site peptide of interest involves the completion of in vitro 
assays, digestion of the reactions to generate highly complex peptide mixtures, separation of the 
peptide mixtures by RPLC and collection of peptide containing fractions (typically 30-35 
fractions), analysis of each of the fractions to identify the active site peptide from the T 
domain(s) of interest, and then detailed MS and MS/MS analysis of the peptides identified.  This 
process could take many hours – or even days – of instrument use to identify the peptide(s) of 
interest, especially if additional complication is introduced due to missed cleavages during 
proteolysis.  Even when the Ppant ejection assay is applied, the search for peptides of interest is 
still the rate limiting step. 
  It would be extremely beneficial to streamline this process, and with the introduction of 
new instrumentation into the Kelleher Research Group, this became possible.  The acquisition of 
hybrid linear ion trap-FTMS systems (Thermo Fisher Scientific LTQ-FTs operating at either 12 
T or 7 T), each coupled to an on-line LC system, provided the tools necessary to develop an on-
line analysis platform for the study of thiotemplate biosynthesis.  Proteolytic digestions of in 
vitro reactions are loaded onto an RPLC column connected in-line with a mass spectrometer, and 
the LC eluent directed to the MS for fast, on-line analysis.  Species entering the mass 
spectrometer can be subjected to a variety of MS and MS/MS methods, including fragmentation 
of all ions in the ESI source by nozzle-skimmer dissociation or after isolation of a single peptide 
ion for MS/MS and the Ppant ejection assay for active site peptide identification and 
characterization – even during analysis of highly complex mixtures of peptides (Figure 1.16, 
middle right).  The observation of a Ppant ejection ion at a specific elution time alerts one to the 
presence of a peptide containing the T domain active site, resulting in a significant reduction in 
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the time required to identify the active site containing peptide of interest.  As an example, the 
application of this platform to the analysis of mycosubtilin biosynthesis is presented. 
Mycosubtilin, a potent antifungal natural product of the iturin class of cyclic lipopeptides, 
was isolated from B. subtilis (Duitman, Hamoen et al. 1999).  The iturin family of lipopeptide 
antibiotics is characterized by a β-amino fatty acid containing octapeptide (Figure 2.22) (Maget-
Dana and Peypoux 1994).  Cloning and sequencing of the gene cluster responsible for the 
biosynthesis of mycosubtilin reveals four ORFs, fenF, mycA, mycB, and mycC.  MycA, a single 
459 kDa protein, contains elements of PKSs, NRPSs, fatty acid synthases and amino transferases 
(AMT) (Figure 2.22). It is predicted that palmitic acid is loaded by an acyl ligase (AL) on to 
ACP1 and malonyl-CoA is loaded on to ACP2 in trans by FenF, then condensed via a 
ketosynthase (KS) domain to give a β-keto thioester that is reductively aminated by the AMT 
domain (Aron, Dorrestein et al. 2005) (Figure 2.22).  The β-amino fatty thioester is then 
presumably passed on to the NRPS portion of MycA through a non-canonical C and PCP 
didomain. 
Hybrid NRPS-PKSs are unique combinations of NRPS and PKS units.  NRPS and PKS 
natural products have been a valuable source of many drugs, suggesting that hybrid NRP-PK 
natural products could provide another class of structurally diverse medicinal therapeutics (Du, 
Sanchez et al. 2001).  The lipopeptide natural products such as surfactin, calcium-dependent 
antibiotic and daptomycin are composed of non-ribosomally synthesized cyclic peptides 
appended with an N-acyl fatty acid. Daptomycin, under the trade name Cubicin, is the first of 
this class of natural products to have been approved for human clinical use in treating 
vancomycin resistant infections (Kirkpatrick, Raja et al. 2003).  A number of other lipopeptides 
are being investigated for clinical uses but have been limited by deleterious side-effects. 
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Recently it has been shown that the activity of these natural products is significantly influenced 
by the length and structure of the fatty acid (Barrett 2002).  In the fermentation of these natural 
products there has been some flexibility in length of the fatty acid group incorporated.  These 
two facts taken together, coupled with a complete biochemical understanding of this process, 
may allow for the utilization of this relaxed specificity in fatty acid side chains for novel hybrid 
NRPS-PKS-based natural products. 
The fatty acid priming of ACP1 in MycA is proposed to occur via the AL domain.  
Loading of ACP1 can be envisioned to occur in one of two pathways, the first being the fatty 
acyl-CoA ligase mechanism.  The fatty acid is activated as an acyl-adenylate then reacts with 
CoA to form an acyl-CoA thioester intermediate that undergoes transthiolation with the 
phosphopantetheine of ACP.  Alternatively, there are a number of fatty acyl-AMP ligases 
(FAAL) recently described that activate the fatty acid as an acyl-adenylate which is directly 
transferred to an ACP domain (Figure 2.22) (Trivedi, Arora et al. 2004).  Using a series of 
assays, including FTMS and the on-line Ppant ejection assay, it is reported below how the fatty 
acid is incorporated in mycosubtilin.  
2.4.2 Experimental Procedures for Mycosubtilin Analyses 
2.4.2.1 Preparation of mycA10 
 MycA10N2 was cloned, overexpressed and purified as described previously by D. 
Hansen (Hansen, Bumpus et al. 2007).  To prepare holo-MycA10, to a 54 µM solution of 
MycA10N2 in buffer (50 mM Tricine (pH 8), 50 mM NaCl, 5 mM MgCl2, 2 mM DTT and 5% 
glycerol) was added Sfp (10 µM) and CoA trilithium salt (250 µM).  The reaction was incubated 
at 25 °C for 1 h, then purified directly by Superdex 200 gel filtration column and concentrated 
and frozen.  The assays in Sub-subsections 2.4.2.2-2.4.2.6 were completed by D. Hansen and are 
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included to aid in understanding of the MycA loading mechanism as discussed in Subsection 
2.4.3. 
2.4.2.2 Phosphopantetheinylation of MycA10 by trichloroacetic acid (TCA) precipitation 
To MycA10 (5, 10, 20 µM) in buffer (50 mM Tris (pH 7.5), 50 mM NaCl, 5 mM MgCl2 
and 5 mM TCEP) was added [1-14C]-Ac-CoA (20 mCi/mmol, 50 µM).  The reaction was started 
by the addition of Sfp (1 µM).  At 0, 5, 10, 15, 30 and 60 min, 50 µL of the reaction mixture 
were quenched in 0.5 mL of 10% (w/v) TCA.  The protein was pelleted by centrifugation and the 
resulting pellet was washed with 0.5 mL 10% TCA, dissolved in 100 µL of formic acid and 
counted by liquid scintillation counting. The amount of bound radioactivity was converted to % 
conversion (based on 1 equivalent of [1-14C]-Ac-CoA binding to 1 equivalent of MycA10) using 
the specific activity of [1-14
The 15 µL reaction mixture contained 50 mM HEPES (pH 8), 8 mM MgCl2, MycA10 
(10 µM) plus a combination of materials as listed in Figure 2.23.  The reactions were incubated 
for 30 min at 25 °C then quenched with 5 µL of 5% acetic acid.  The reaction mixture was then 
spotted directly on silica gel thin TLC plates.  The products were resolved on TLC in an n-
butanol/acetic acid/water (80:25:40) solvent system.  The radioactive spots on TLC were 
detected using a phosphoimager (Typhoon 9410, GE Healthcare). To confirm the identity of the 
product the use of [8-
C]-Ac-CoA. 
2.4.2.3 Thin layer chromatography (TLC) of fatty acid adenylates 
14C]-ATP and [1-14C]-decanoic acid were alternated to give spots of 
identical Rf. Addition of CoA (100 µM) to the reaction mixture did not result in any additional 
products by TLC. 
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2.4.2.4  SDS-PAGE of MycA10 loading 
To the reaction buffer (50 mM Tris (pH 7.5), 50 mM NaCl, 5 mM MgCl2 and 5 mM 
TCEP) was added MycA10 (10 µM).  In 1 experiment was added [1-14C]-decanoic acid (100 
µM) and ATP (5 mM), in the second experiment was added just [1-14
To the reaction buffer (50 mM Tris (pH 7.5), 50 mM NaCl, 5 mM MgCl2 and 5 mM 
TCEP) was added MycA10 (10 µM), ATP (5 mM), and the putative substrate (100 µM).  The 
reaction was incubated at 25 °C for 30 min then 100 µL reaction aliquots were applied to 
individual Bio-Spin 6 micro gel filtration columns (Bio-Rad) that had been prequilibrated with 
the reaction buffer.  The protein fraction of the applied sample was eluted from the microspin 
column as directed by the manufacturer's instructions. 50 µL of each protein fraction was 
supplemented with ATP (5 mM) and [1-
C]-decanoic-CoA (100 
µM).  The reaction was incubated at 25 °C, 50 µL aliquots were taken at 5 time points (0, 5, 10, 
20 and 30 min), and the reactions were quenched in 6X Laemlli SDS-PAGE loading buffer and 
placed in boiling water for 5 min.  The proteins were resolved on 4-12% Nupage (Invitrogen) 
SDS-PAGE gel.  The gel was then transferred to a PVDF membrane at 100 V for 60 min at 4 °C, 
then stained with Coomassie Blue, and the radioactive bands were detected using a 
phosphoimager. 
2.4.2.5  Chase experiment to examine substrate specificity in MycA10 loading 
14C]-decanoic acid (100 µM).  The reactions were 
incubated at 25°C for 30 min then quenched in 6X Laemlli SDS-PAGE loading buffer and 
placed in boiling water for 5 min.  The proteins were resolved on 4-12% Nupage (Invitrogen) 
SDS-PAGE gel.  The gel was then transferred to a PVDF membrane at 100 V for 60 min at 4 °C, 
then stained with Coomassie Blue and the radioactive bands were detected using a 
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phosphoimager. 
2.4.2.6  ATP-PPi exchange assay 
To the reaction buffer (50 mM Tricine (pH 8), 10 mM MgCl2 and 5 mM DTT) was added 
MycA10 (5 µM), [32
To the reaction buffer (50 mM HEPES (pH 7.5), 50 mM NaCl, 2 mM DTT) 34 µM apo-
MycA10, 7 μM Sfp, and 0.4 mM CoA were added in a final volume of 100 μL and incubated for 
1.25 hours at 30 °C to generate holo-MycA10.  CoA was omitted as an apo-MycA10 control.  
For each reaction, 20 μg of sequencing-grade trypsin (Promega) were resuspended in 20 μL 
Promega trypsin resuspension buffer and activated at 30 °C for 15 min.  The activated trypsin 
was added to 55 μL 0.1 M NH4HCO3 (pH 7.8) and added to the reaction.  The digestion was 
incubated for 15 minutes at 30 °C and then quenched by addition of 10% formic acid to a final 
volume of 500 μL.   
2.4.2.8 Generation of fatty acid-loaded MycA10 for FTMS analysis 
P]-NaPPi (1 mM, 1 µCi/µmol) and fatty acids (0-500 µM). The reaction was 
started with the addition of ATP (5 mM).  At 0, 5, 10, 15, 30, 60 min time points, 100 μL of the 
reaction mixture was quenched with 500 µL of a charcoal solution (500 µL of 1.6% (w/v) 
activated charcoal, 4.46% (w/v) tetrasodium pyrophosphate, and 3.5% perchloric acid in water). 
The charcoal solution was pelleted by centrifugation, washed twice with wash buffer (500 µL of 
4.46% (w/v) tetrasodium pyrophosphate, 3.5% perchloric acid in water), then resuspended in 500 
µL water and the bound radioactivity was determined by liquid scintillation counting.  The 
reaction was complicated by enzyme denaturation at higher fatty acid concentrations and at 
lower concentration by contaminating fatty acids that co-purified with the protein. 
2.4.2.7 Generation of samples for active site mapping of holo-MycA10 by FTMS 
To the reaction buffer (50 mM HEPES (pH 7.5), 50 mM NaCl, 2 mM DTT) was added 
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34 µM holo-MycA10, 1 mM decanoic acid and 2 mM ATP to a final volume of 100 μL, and 
incubated for 1.25 hours at 30 °C to generate decanoic acid-loaded MycA10 (decanoyl-S-
MycA10).  As control reactions, holo-MycA10 was incubated in reaction buffer in the presence 
of decanoic acid and absence of ATP or in the presence of decanoic acid and CoA.  Samples 
were prepared for FTMS analysis as above.   
2.4.2.9 Online LC-MS analysis 
All mass spectrometric analyses were performed on a 7 T LTQ-FT mass spectrometer 
(ThermoFisher Scientific).  Separations were performed on a Jupiter C18 Column (Phenomenex, 
4.6 mm x 150 mm, 5 µ, 300 Å) equilibrated with solvent A, using a gradient from 5%-95% 
solvent B in solvent A over 80 min, where solvent A was H2O + 0.1% formic acid and solvent B 
was MeCN + 0.1% formic acid.  Multiple MS and MS/MS experiments were performed on each 
sample.  The first MS experiment collected MS and MS/MS data on tryptic peptides for peptide 
sequencing and active site mapping.  Data-dependent MS/MS spectra were collected on the top 3 
peaks in each parent spectrum using CID.  MS and MS/MS data were analyzed with the program 
cRAWler, developed in house, and fragmentation data were searched against a custom 
ProSightPC database (ThermoFisher Scientific).  In the second MS experiment, the Ppant 
ejection assay was performed on the tryptic peptide ions (Dorrestein, Bumpus et al. 2006).  The 
Ppant ejection ions were generated by nozzle-skimmer dissociation of all peptides entering the 
mass spectrometer (SID = 50 or 75V) or by CID of peptide species at <m/z 900 (see Subsection 
2.4.3) and data analyzed using the Qualbrowser software package (ThermoFisher Scientific).  
Ppant ejection data and MS/MS data were combined for the characterization of MycA10 loading 
with decanoic acid (Table 2.2). 
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2.4.3 Results and Discussion of the Biochemical and Mass Spectrometric Characterization of 
MycA Loading 
To explore fatty acid incorporation we sought to reconstitute the activity of the MycA 
AL-ACP1 didomain in vitro.  The AL-ACP1 (MycA10) didomain was cloned and expressed in 
E.coli as a N-terminally His6-tagged 77 kDa protein. The activity of the ACP domain was 
confirmed by incorporation of radiolabel upon incubation with [14C]-Ac-CoA and Sfp (Figure 
2.23) (Quadri, Weinreb et al. 1998).  Loading of the fatty acid was examined with radioactive 
decanoic acid, which was a compromise between lipophilic character and aqueous solubility of 
potential substrates and was used with great success in the production of daptomycin.  Incubation 
of holo-MycA10 with MgCl2, ATP and [1-14C]-decanoic acid was followed by SDS-PAGE and 
the protein bound radioactivity was analyzed by autoradiography.  A clear time-dependent 
incorporation of radiolabel was observed corresponding to covalent loading of decanoic acid.  By 
contrast, incubation of holo-MycA10 with [1-14
Direct observation of the activated intermediates may provide a more accurate picture of 
the mechanism of fatty acid loading. Accumulation of the reactive acyl-adenylate or acyl-CoA 
intermediate should occur with apo-MycA10 because of the absence of the thiol nucleophile of 
the phosphopantetheine cofactor of the apo ACP domain.  Incubation of apo-MycA10 with [1-
C]-decanoyl-CoA followed by SDS-PAGE and 
autoradiography gave no significant incorporation of radiolabel (Figure 2.23).   
14C]-decanoic acid, MgCl2 and ATP both in the presence and absence of CoA followed by TLC 
and autoradiography showed new spots of identical retention factor (Rf) distinct from both 
decanoic acid and an authentic [1-14C]-decanoyl-CoA standard.  This result is consistent with the 
previous result that acyl-CoAs are not involved in the loading of ACP1.  To further corroborate 
the acyl-adenylate mechanism two reactions were compared, incubating [1-14C]-decanoic acid 
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and ATP, or [8-14C]-ATP and decanoic acid with MycA10. Analysis by TLC gave spots of 
identical Rf consistent with the decanoyl-adenylate intermediate (Figure 2.23). 
To examine the substrate specificity of the loading domain MycA a simple chase 
experiment was used.  Holo-MycA10 was incubated with the putative unlabeled acid substrate 
and ATP under standard conditions for 30 min, the small molecules were removed and chased 
with additional ATP and [1-14C]-decanoic acid. Any unlabeled substrate that was activated and 
subsequently loaded would block the [1-14
High-resolution FTMS was used to further characterize the loading of a fatty acid on 
MycA; the general scheme for analysis is provided in Figure 2.25.  As introduced in Chapter 1, 
the first step in FTMS analysis of NRPS and PKS T domains is identification of the active site 
peptides in the apo and holo forms.  MycA10 incubated with the PPTase Sfp (Quadri, Weinreb et 
al. 1998) in the absence or presence of CoA (generating apo and holo forms of MycA10, 
respectively) was subjected to trypsin digestion and the entire digestion mixture was loaded onto 
a RPLC column connected in-line to a 7 T LTQ-FT mass spectrometer (ThermoFisher 
Scientific).  As the peptides eluted from the LC column directly into the mass spectrometer, the 
peptides were subjected to multiple FTMS experiments, the first being measurement of intact 
peptide masses, the second being data-dependent MS/MS of intact peptides for T domain active 
site mapping, and the third the Ppant ejection assay (Dorrestein, Bumpus et al. 2006).  The data-
dependent MS/MS acquisition allows for identification of peptides in the mixture by analyzing 
the data collected with a suite of software, including the Qualbrowser analysis package provided 
C]-decanoic acid chase loading leading to little or 
reduced bound radioactivity when examined by SDS-PAGE and autoradiography (Figure 2.24).  
From this experiment, it was determined that decanoic, myristic and palmitic acids showing the 
highest activity among the substrates tested. 
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with LTQ-FT instrumentation and ProSightPC, developed in the Kelleher Research Group 
(ThermoFisher Scientific).  MS/MS data were collected using CID (Wells and McLuckey 2005) 
of peptides in the ion trap with detection of fragment ions in the FTMS.  Ppant ejection ions were 
generated by nozzle-skimmer dissociation of all peptides entering the MS.   
Analysis of a tryptic digest of holo-MycA10 revealed a 95 amino acid peptide with a 
mass of 11053.4 Da, 340.0 Da higher than the theoretical mass of the apo peptide and within 0.1 
Da from the mass shift expected for phosphopantetheinylation of this peptide (Figure 2.26B). 
The MS/MS data confirmed that it contained the active site Ser of MycA10 and localized the 
modification to one of two Ser residues on the peptide (one of which is predicted to be the site of 
phosphopantetheinylation) (Figure 2.26D).  Holo-MycA10 was incubated with decanoic acid in 
the presence or absence of ATP, proteolytically digested with trypsin, and the peptide mixture 
was separated by RPLC.  Upon incubation of holo-MycA10 with decanoic acid and ATP, the 
mass of the active site peptide (11208.9 Da) shifted by +155.5 Da, consistent with formation of 
decanoyl-S-MycA10 (Figure 2.27A). Further, the Ppant ejection assay resulted in observation of 
the 415.2576 Da ion shown in Figure 2.27B.  This ion is within 5 mDa of the expected value and 
consistent with the empirical formula of the decanoyl-S-Ppant ejection product (Figure 2.27B, 
inset).  The structures and masses of all Ppant ejection ions observed in this study are shown in 
Figure 2.28.  Figure 2.29 confirms the ATP-dependent loading of decanoic acid onto MycA10, 
as the fatty acid-loaded species was only observed in the presence of ATP and not decanoyl-
CoA. 
 The data presented clearly characterizes the function and mechanism by which fatty 
acids are loaded in the biosynthesis of mycosubtilin. The loading domain functions in an 
analogous fashion to A-T didomains of NRPS systems where the substrate is activated as an 
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(amino) acyl-adenlyate and then directly loaded on the thiolate of the Ppant arm of the carrier 
protein.  The loading domain of MycA presents an entry into the understanding the initial steps 
in the biosynthesis of lipopeptides of hybrid NRPS-PKS origin. In conjunction with an 
understanding of fatty acid incorporation the observed tolerance for loading a variety of fatty 
acids may provide for the combinatorial biosynthesis of lipopeptides of hybrid NRPS-PKS 
origin. 
This example of the on-line Ppant ejection assay as applied to the loading of a T domain 
in mycosubtilin biosynthesis highlights the power of the method.  Using a tryptic digest of a T 
domain in the holo or loaded form, one can complete a single ~1 h LC-MS analysis that 
identifies peptides by MS/MS and confirms the biosynthetic state of the protein by the Ppant 
ejection assay.  Chapter 3 presents additional examples of the utility of this assay, expanding it to 
the detection of multiple T domain active site peptides in a single LC-MS run.  However, there 
are challenges in implementation of this assay.  
 In ThermoFisher Scientific LTQ-FT instrumentation, the “one-third rule” prevents one 
from detecting fragment ions that are less than one-third the size of the parent ion when using 
CID.  Thus, for a parent ion at a m/z value greater than ~900, one would not detect the Ppant 
ejection ion at m/z 261.1267 (the most abundant Ppant ejection small molecular ion generated).  
The implementation of nozzle-skimmer dissociation allows MS/MS of all peptide species 
entering the mass spectrometer and generation of Ppant ejection ions with high efficiency for 
species at all m/z values, but does not provide the specificity of data-dependent MS/MS due to 
the lack of correlation of a MS/MS event with a specific parent ion.  However, in situations 
where one knows the amino acid sequence for the T domain active site peptide of interest (as in 
the case of MycA), one can observe the elution of a Ppant ejection ion and mine the intact 
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peptide spectrum for a species of a predicted mass eluting at the same time.  Additionally, data-
dependent CID during that same elution time confirms identification of abundant peptides, even 
if the Ppant ejection ion generated can not be detected, as was shown in identification of the 
MycA holo T domain active site peptide. 
2.5 THE FUTURE OF FTMS ANALYSIS OF NRPS AND PKS SYSTEMS 
 As exemplified by the examples above, FTMS is an invaluable tool for the analysis of 
covalent biosynthetic processes.  By monitoring the incorporation and tailoring of biosynthetic 
building blocks, one gains important insight into the biosynthesis of the NRP and PK families of 
natural products.  The early methods for FTMS analysis of NRPSs and PKSs were successful in 
many cases, but the off-line LC separation and fraction-by-fraction search for peptides of interest 
was laborious and time consuming.  Development of the on-line Ppant ejection assay provided a 
way to streamline the analysis of in vitro biochemical samples and allows for more high-
throughput analysis.  The next step in the expansion of the MS tool-box is the application of 
these tools in the study of complex proteomic samples and application to not only biosynthetic 
characterization but discovery platforms; Chapters 4 and 5 provide a first glimpse into the power 
of these tools in proteomics and discovery modes. 
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2.6 FIGURES 
 
Figure 2.1  The phosphopantetheinyl ejection assay.  A.  Inactive, apo-T domains are converted 
to their active, holo form through the post-translational modification with the Ppant arm from 
CoA, catalyzed by a PPTase.  When subjected to MS/MS, the Ppant arm from a holo (or loaded) 
T domain protein or active site peptide is ejected and four marker ions (two small molecular ions 
and two peptide ions) are generated.  A species with a mass equal to the mass of the apo protein 
or peptide minus 18 Da (apo – 18 Da) is generated from loss of the Ppant ejection ion that retains 
the phosphate and generates a dehydroalanine (Dha) at the active site Ser.  A species with a mass 
equal to the mass of the apo protein or peptide species plus 80 Da (apo + 80 Da) is generated 
from loss of a Ppant ejection ion and retention of the phosphate on the protein or peptide. B.  
Theoretical mass spectra for the two small molecular ions generated from a holo T domain and a 
hypothetical protein/peptide marker ion. 
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Figure 2.2  Proposed mechanisms for gas phase elimination reactions of the Ppant arm from 
thiolation domains.  Each mechanism generates a peptide marker ion and a 1+ small molecular 
Ppant ion.  R is H or an acyl substituent and z is the charge.  In panels A and B, the amide on the 
right side of the 1+ ejection ion is shown as protonated, but it is also possible that the other 
amide is protonated. 
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Figure 2.3  Application of the Ppant ejection assay to a holo-T domain.  The data presented were 
generated by FTMS analysis of GliP (domain structure:  A1-T1-C1-A2-T2-C2-T3).  The T domain 
analyzed is GliP-T1. A.  In a RPLC fraction (fraction #25), a peptide with an intact mass 
corresponding to the GliP-T1 active site peptide was observed.  B.  The putative T domain active 
site peptide was quadrupole and SWIFT isolated.  C.  The isolated peptide was subjected to 
MS/MS using IRMPD and the expected Ppant ejection ion for a holo-T domain was observed.  
D.  In addition to the small molecule Ppant ion, the two peptide marker ions were observed.  
Left:  The apo – 18 Da species, corresponding to formation of a Dha at the active site Ser 
residue.  Right:  The apo + 80 Da species, corresponding to a phosphorylated active site Ser. 
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Figure 2.4  Application of the Ppant ejection assay to an amino acid-loaded T domain.  The data 
presented were generated by FTMS analysis of GliP (domain structure:  A1-T1-C1-A2-T2-C2-T3).  
The T domain analyzed is GliP-T1 which was loaded with Phe by GliP-A1. A.  In a RPLC 
fraction (fraction #27), a peptide with an intact mass corresponding to the Phe-loaded GliP-T1 
(Phe-S-GliP-T1) active site peptide was observed.  B.  The putative loaded T domain active site 
peptide was quadrupole and SWIFT isolated.  C.  The isolated peptide was subjected to MS/MS 
using IRMPD and the expected Ppant ejection ion for a Phe-loaded T domain was observed.  D.  
In addition to the small molecule Ppant ion, the two peptide marker ions were observed.  Left:  
The apo – 18 Da species, corresponding to formation of a Dha at the active site Ser residue.  
Right:  The apo + 80 Da species, corresponding to a phosphorylated active site Ser. 
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Figure 2.5  Observation of Ppant ejection ions from intact GrsA loaded with two different 
substrates.  A.  Left:  Intact Phe-S-GrsA charge states observed by FTMS.  The region shown 
was subjected to MS/MS and the Ppant ejection ion corresponding to the Phe-loaded form was 
observed (right).  B.  Left:  Intact 2H5-Phe-S-GrsA charge states observed by FTMS.  The region 
shown was subjected to MS/MS and the Ppant ejection ion corresponding to the 2H5-Phe-loaded 
form was observed (left).  Note that while the mass difference between the intact protein ions 
could not confirm differential loading of the two substrates, the mass difference of the Ppant 
ejection ions corresponds almost exactly with the theoretical mass shift. 
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Figure 2.6  Structures of two halogenated natural products.   
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Figure 2.7  Current proposed mechanism for enzymatic halogenation at unactivated carbon 
centers by non-heme Fe(II), α-KG and oxygen-dependent halogenases.  Image adapted from 
(Neumann, Fujimori et al. 2008). 
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Barbamide Gene Cluster
barF barI barJbarHbarGbarEbarCbarB2barA barB1 barD barK
barA PCP domain
barB1 non-heme FeII-dependent halogenase, SyrB2 homolog
barB2 non-heme FeII-dependent halogenase, SyrB2 homolog
barC thioesterase/transferase, CmaE homolog
barD adenylation domain
barE multimodular NRPS-PKS
barF multimodular NRPS
barG multimodular NRPS
barH hydrolase
barI membrane protein
barJ amino acid deaminase
barK glycosyltransferase
 
Figure 2.8  The barbamide biosynthetic gene cluster (Chang, Flatt et al. 2002).  The genes 
highlighted are suspected to perform halogenation of a leucine residue in the assembly of 
barbamide. 
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Figure 2.9  General method for the analysis of carrier proteins by off-line RPLC and FTMS.  
Proteins are separated by RPLC and protein containing fractions are analyzed by FTMS to obtain 
intact mass measurements for each species.  A region of the spectrum containing (typically) a 
single charge state of the species of interest is quadrupole (quad) and SWIFT isolated and the 
protein species subjected to MS/MS to identify the protein from the fragment ions obtained and 
confirm the biosynthetic state of the protein through Ppant ejection. 
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Figure 2.10  FTMS analysis of the BarA thiolation domain.  FTMS detection of apo- (A), holo- 
(B), and Leu-S-BarA (C).  Panels D and E show the Ppant ejection ions generated from MS/MS 
of the holo and leucine-loaded species, respectively. 
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Figure 2.11  Halogenation activities of BarB1 and BarB2 as determined by radio-HPLC 
(Galonic, Vaillancourt et al. 2006).  A.  Detection of standards for all predicted intermediates 
using LC and detecting absorbance at 338 nm.  B.  In the presence of BarB1, only trace amounts 
of Leu-S-BarA are halogenated, as determined by detection of a very small amount of Cl3-Leu-S-
BarA.  C.  In the presence of BarB2, Leu-BarA is converted to both Cl2-Leu-S-BarA and Cl3-
Leu-S-BarA, with Cl2-Leu-S-BarA being the abundant species.  D.  In the presence of both 
BarB1 and BarB2, Cl3-Leu-S-BarA becomes the major product.  E.  When BarB1 is added after 
incubation of BarB2 with Leu-S-BarA, there is a significant increase in the amount of Cl3-Leu-S-
BarA detected. 
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Figure 2.12  Halogenation of Leu-S-BarA by BarB2.  Holo-BarA was generated by incubation 
with Sfp and CoA and then leucine was loaded onto the carrier protein in an ATP-dependent 
manner by BarD.  The addition of BarB2, O2, Cl- and α-KG resulted in the halogenation pattern 
shown above.  A.  Intact protein species detected: Leu-S-BarA, Cl-Leu-S-BarA, Cl2-Leu-S-BarA 
and Cl3-Leu-S-BarA.  B.  Ppant ejection ions generated during MS/MS of each of the chlorinated 
protein species in (A). 
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Figure 2.13  Comparison of halogenation of Leu-S-BarA by BarB2 and BarB1.  A.  In the 
presence of α-KG, O2 and Cl-, Leu-S-BarA is converted to Cl-, Cl2-, and Cl3-Leu-S-BarA by 
BarB2.  B.  In the presence of α-KG, O2 and Cl-, no chlorination of Leu-S-BarA by BarB1 can be 
detected. 
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Figure 2.14  Barbamide chlorination by both BarB1 and BarB2.  A.  In the presence of BarB2 
(plus O2, α-KG and Cl-), Leu-S-BarA is chlorinated.   Mono-, di- and trichlorinated forms are 
observed, with the dichlorinated form in the highest abundance.  B.  When BarB1 is added after 
incubation of Leu-S-BarA with BarB2, the there is full conversion to the trichlorinated form. 
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Figure 2.15  Observation of chlorinated species generated after incubation of Cl2-Leu-S-BarA 
with BarB2 at varying ratios.  Left panel:  Ratio of Cl2-Leu-S-BarA to BarB2.  Middle left panel:  
Intact BarA species detected (13+ charge state).  Middle right panel:  Ppant ejection observed 
from MS/MS of the Cl2-Leu-S-BarA species.  Right panel:  Ppant ejection observed from 
MS/MS of Cl3-Leu-S-BarA (if present).  A.  Proteins and ejection ions observed with a Cl2-Leu-
S-BarA: BarB2 ratio of 20:1.  B.  Proteins and ejection ions observed with a Cl2-Leu-S-BarA: 
BarB2 ratio of 50:1.  Notice that even though the intact Cl3-Leu-S-BarA species is not observed, 
a Ppant ejection is still generated.  C.  Proteins and ejection ions observed with a Cl2-Leu-S-
BarA: BarB2 ratio of 100:1. 
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Figure 2.16  Observation of chlorinated species generated after incubation of Cl2-Leu-S-BarA 
wih BarB1 at varying ratios.  Left panel:  Ratio of Cl2-Leu-S-BarA to BarB1.  Middle left panel:  
Intact BarA species detected (13+ charge state).  Middle right panel:  Ppant ejection observed 
from MS/MS of the Cl2-Leu-S-BarA species.  Right panel:  Ppant ejection observed from 
MS/MS of Cl3-Leu-S-BarA species (if present).  A.  Proteins and ejection ions observed with a 
Cl2-Leu-S-BarA: BarB1 ratio of 20:1.  B.  Proteins and ejection ions observed with a Cl2-Leu-S-
BarA: BarB1 ratio of 50:1.  C.  Proteins and ejection ions observed with a Cl2-Leu-S-BarA: 
BarB1 ratio of 100:1. 
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Figure 2.17  Trichlorination of Cl2-Leu-S-BarA (10 µM) by BarB2:  a time course.  From this 
qualitative data, it was concluded that the rate of chlorination of Cl2-Leu-S-BarA (at a 
concentration of 10 µM) by BarB2 was too fast to measure by the methods tested and no increase 
in trichlorinated substrate was observed over the time period tested (at a substrate: enzyme ratio 
of 20:1). 
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Figure 2.18  Trichlorination of Cl2-Leu-S-BarA (100 µM) by BarB2:  a time course.  From this 
qualitative data, it was concluded that the rate of chlorination of Cl2-Leu-S-BarA (at a 
concentration of 100 µM) by BarB2 was too fast to measure by the methods tested and no 
increase in trichlorinated substrate was observed over the time period tested (at a substrate: 
enzyme ratio of 20:1). 
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Figure 2.19  Trichlorination of Cl2-Leu-S-BarA (100 µM) by BarB1:  a time course.  From this 
qualitative data, it was concluded that the rate of chlorination of Cl2-Leu-S-BarA (at a 
concentration of 10 µM) by BarB1 was too fast to measure by the methods tested and no increase 
in trichlorinated substrate was observed over the time period tested (at a substrate: enzyme ratio 
of 20:1). 
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Figure 2.20  Comparison of theoretical and experimental isotopic distributions for halogenated 
Ppant ejection ions.  A.  Simulated isotopic distribution for a Ppant ejection ion generated from 
Cl2-Leu-S-BarA.  B.  Experimental isotopic distribution for a Ppant ejection ion generated from 
Cl2-Leu-S-BarA.  C.  Simulated isotopic distribution for a Ppant ejection ion generated from Cl3-
Leu-S-BarA.  D.  Experimental isotopic distribution for a Ppant ejection ion generated from Cl3-
Leu-S-BarA. 
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Figure 2.21  Comparison of the abundance of two intact protein species with their Ppant ejection 
ions.  A.  Intact Cl2-Leu-S-BarA and Cl3-Leu-S-BarA protein ions.  B.  When the protein ions in 
(A) are subjected to MS/MS (using IRMPD), Ppant ejection ions are generated and are in 
abundances similar to their parent ions.  Shown at the bottom are the structures of the di- and 
trichlorinated Ppant ejection ions. 
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Figure 2.22  The biosynthesis of mycosubtilin.  A.  The organization of MycA and the structure 
of mycosubtilin.  The AL and ACP domains analyzed are highlighted in red.  B.  The AL domain 
of MycA is hypothesized to catalyze the activation of a fatty acid precursor as an acyl-adenylate, 
followed by transfer of the fatty acyl-adenylate to MycA ACP1.  AL – acyl ligase, ACP – acyl 
carrier protein, KS – ketosynthase, AMT – aminotransferase, C – condensation domain, PCP – 
peptidyl carrier protein, A – adenylation domain. 
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Figure 2.23  Biochemical analyses of MycA10 loading.  A.  Phosphopantetheinylation of 
MycA10 with [1-14C]-AcCoA.  The substrate was incorporated onto MycA10 in a time-
dependent manner, confirming the ability of MycA10 to be phosphopantetheinylated.  B.  
MycA10 loading with decanoic acid + ATP compared to loading with decanoic-CoA.  Decanoyl-
S-MycA10 is only formed in the presence of decanoic acid and ATP.  C.  TLC of fatty acid 
intermediates, providing further evidence for the formation of an acyl-adenylate as part of the 
MycA loading mechanism. 
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Figure 2.24  Additional biochemical analyses of MycA10 loading.  A.  ATP-PPi exchange time 
course with MycA10 and various fatty acids.  This assay was complicated by the insolubility of 
the protein at high fatty acid concentrations and by the presence of fatty acids that co-purified 
with MycA10.  B.  Substrate screen for MycA10 loading. Autoradiography of a SDS-PAGE gel 
containing MycA10 chased with [1-14C]-decanoic acid after incubation with no substrate (lane 
1); acetic acid (lane 2); propionic acid (lane 3); butyric acid (lane 4); hexanoic acid (lane 5); 
trans-2-decenoic acid (C10, lane 6); decanoic acid (C10, lane 7); myristic acid (C14, lane 8); 
palmitic acid (C16, lane 9); no substrate (lane 10). 
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Figure 2.25  General scheme for on-line analysis of NRPS and PKS enzymes.  A.  Recombinant 
proteins (from in vitro assays) are (optionally) chemically or proteolytically digested and loaded 
onto an RPLC column connected on-line with a mass spectrometer (shown:  ThermoFisher 
Scientific LTQ-FT).  B.  The peptides or proteins are separated on the RPLC column and eluted 
directly into the mass spectrometer where three MS experiments are conducted:  1) Measurement 
of the intact peptides or proteins, 2) Nozzle-skimmer dissociation of all species entering the mass 
spectrometer to generate Ppant ejection ions, and 3) Data-dependent MS/MS to identify the 
peptides or proteins in the sample.  C.  A typical data output from an on-line LC-MS analysis.  
Top:  A total ion chromatogram (TIC) is generated for all ions in the sample.  Middle:  The 
nozzle-skimmer dissociation generates Ppant ejection ions, and a selected ion chromatogram 
(SIC) is generated for the Ppant ejection ion theoretical mass.  Bottom:  The elution of the Ppant 
ejection ion corresponds directly with the elution of the intact T domain protein or active site 
peptide. 
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Figure 2.26  Thiolation domain active site mapping of MycA10.  A.  Apo active site tryptic 
peptide with six missed cleavages as identified by MS/MS; inset: enlargement of 10+ charge 
state of apo peptide  B. Holo active site tryptic peptide with six missed cleavages as identified by 
MS/MS; inset: enlargement of 10+ charge state of holo peptide.  C.  Decanoic acid-loaded active 
site tryptic peptide with six missed cleavages as identified by MS/MS; inset: enlargement of 10+ 
charge state of decanoic acid-loaded peptide.  D. The Ppant modification was localized to two 
Ser residues on the holo peptide, one of which is predicted to be the active site Ser (circled in 
red). 
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Figure 2.27  Identification of decanoyl-S-MycA10 and the corresponding Ppant ejection ion.  A.  
FTMS broadband spectrum of the decanoic acid-loaded MycA T domain active site peptide.  
Inset:  Isotopic distribution of the 10+ charge state.  B.  FTMS spectrum of the Ppant ejection ion 
from MycA loaded with decanoic acid and the structure of the ejection ion. 
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Figure 2.28  Theoretical MycA10 Ppant ejection ions.  
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Figure 2.29  Decanoic acid loading of MycA ACP1 occurs only in the presence of holo-MycA, 
decanoic acid and ATP.  A.  In the absence of ATP, decanoic acid is not loaded onto MycA.  B.  
In the presence of ATP, decanoic acid is loaded onto MycA.  C.  No transthiolation is observed 
when holo-MycA is incubated with decanoyl-CoA.  D.  No decanoic acid is transferred to holo-
MycA in the presence of CoA and absence of ATP. 
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2.7 TABLES 
Table 2.1  Masses of protein and Ppant ejection species detected during analysis of barbamide 
biosynthesis. 
BarA 
    Non-thrombin cleaved* 
    
  Theor. Exp. 
Error 
(Da) 
 Apo-BarA 12785.4 12786.2 0.8 
 Holo-BarA 13125.5 13127.4 1.9 
 Leu-S-BarA 13238.6 13238.0 -0.6 
 Cl-Leu-S-BarA 13272.5     
 Cl2-Leu-S-BarA 13306.5     
 Cl-Leu-S-BarA 13340.5     
 
     BarA 
    Thrombin cleaved* 
    
 
Theor. Exp. 
Error 
(Da) 
 Apo-BarA 11035.6     
 Holo-BarA 11375.7     
 Leu-S-BarA 11488.8 11488.9 0.1 
 Cl-Leu-S-BarA 11522.8 11522.9 0.1 
 Cl2-Leu-S-BarA 11556.8 11556.9 0.1 
 Cl3-Leu-S-BarA 11590.8 11591.3 0.5 
 
     Ppant Ejection 
    
     
 
Theor. Exp. 
Error 
(ppm) 
 Apo-BarA       
 Holo-BarA 261.127 261.128 3.8 
 Leu-S-BarA 374.211 374.212 2.7 
 Cl-Leu-S-BarA 408.172 408.174 4.9 
 Cl2-Leu-S-BarA 442.133 442.134 2.3 
 Cl3-Leu-S-BarA 476.094 476.096 4.2 
 
     * - Thrombin cleavage occurs upon addition of BarB1 and/or 
BarB2  
due to residual thrombin from purification 
  Exp: Experimental, Theor: Theoretical 
  All masses are reported in Da. 
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Table 2.2  MycA10 thiolation domain active site peptide mass values. 
 
Peptide Form 
Theoretical 
Mass 
Experimental 
Mass 
Theoretical 
Mass Shift 
from apo-
MycA10 
Experimental 
Mass Shift 
from apo-
MycA10 
Error from 
Theoretical 
Mass 
(ppm) 
Apo-MycA10 10713.4 Da 10712.9 Da 0.0 Da -0.7 Da -46.7 
Holo- 
MycA10 
11053.5 Da 11053.4 Da 340.1 Da 340.0 Da -9.0 
Decanoyl-S-
MycA10 
11208.6 Da 11208.9 Da 495.2 Da 495.5 Da 26.8 
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CHAPTER 3:  INVESTIGATIONS INTO THE BIOSYNTHESIS OF BACILLAENE 
USING FOURIER-TRANSFORM MASS SPECTROMETRY 
 
The information and contents for this chapter were taken from the following articles with 
permission from the publishers: Christopher T. Calderone, Stefanie B. Bumpus, Neil L. Kelleher, 
Christopher T. Walsh and Nathan A. Magarvey (2008). “A ketoreductase domain in the PksJ 
protein of the bacillaene assembly line carries out both alpha- and beta-ketone reduction during 
chain growth.” Proceedings of the National Academy of Sciences (USA), 105(35):12809-12814; 
and Stefanie B. Bumpus, Nathan A. Magarvey, Neil L. Kelleher, Christopher T. Walsh and 
Christopher T. Calderone (2008). “Polyunsaturated fatty-acid-like trans-enoyl reductases utilized 
in polyketide biosynthesis.” Journal of the American Chemical Society, 130(35):11614-11616.  
N. Magarvey and C. Calderone cloned and overexpressed protein constructs, synthesized 
substrates, and performed analyses using radioactive substrates.  S. Bumpus conducted all other 
in vitro biochemical assays, designed and optimized separation and mass spectrometry methods, 
and performed and analyzed all mass spectrometry experiments. 
 
3.1 BACKGROUND 
Polyketide (PK) and non-ribosomal peptide (NRP) natural products span a wide cross-
section of bioactive molecules including human therapeutics and signaling agents (Clardy and 
Walsh 2004; Walsh 2004).  The hybrid NRP-PKs dihydrobacillaene and bacillaene are 
biosignaling agents produced by Bacillus subtilis where each can be described as a dipeptide of 
ω-amino polyenoic acids that is N-capped with an α-hydroxyisocaproate (α-HIC) moiety (Figure 
3.1) (Butcher, Schroeder et al. 2007). The metabolite initially arising from their shared assembly 
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line is dihydrobacillaene which is later converted to bacillaene by the cytochrome P450 PksS via 
an oxidation of the saturated C14′-C15′ bond of dihydrobacillaene to an olefin (Butcher, 
Schroeder et al. 2007; Moldenhauer, Chen et al. 2007; Reddick, Antolak et al. 2007). Previous 
work has shown the dihydrobacillaene assembly line to be a rich source of unusual biochemistry, 
where hybrid non-ribosomal peptide synthetase (NRPS)-polyketide synthase (PKS) assembly-
line proteins are used in conjunction with enzyme machinery borrowed from both isoprenoid and 
polyunsaturated fatty acid (PUFA) biosyntheses (Calderone, Kowtoniuk et al. 2006).  Little 
precedent exists for α-hydroxyacyl units in NRPs and PKs, and for this reason we chose to probe 
the origins of the unusual α-hydroxyacyl N-cap of dihydrobacillaene. 
The dihydrobacillaene biosynthetic machinery has been partially characterized and 
consists of five large megasynthases (PksJLMNR) and several accessory proteins (Figure 3.1A) 
(Butcher, Schroeder et al. 2007; Straight, Fischbach et al. 2007).  Like other modular 
megasynthases of hybrid NRP-PKs, catalytic domains of PksJLMNR are arranged into modules 
with each module containing thiolation (T) domains which act as covalent way-stations for NRP 
and PK chain elongation intermediates. The T domains are post-translationally modified with 
phosphopantetheinyl (Ppant) moieties to afford the mobile thiol arm upon which chain growth 
occurs.  For dihydrobacillaene, T domains embedded within PKS modules are loaded with 
malonyl units by a trans-acyltransferase (AT).  Ketosynthase (KS) domains catalyze Claisen 
condensations of assembly-line-tethered malonyl units to yield β-ketothioesters.  In keeping with 
logic found in other PK assembly lines, further processing of β-ketothioesters occurs, in part, by 
reductive domains such as β-ketoreductases (β-KR) and dehydratases (DH) found immediately 
adjacent to the acylated T domains. The three NRPS modules found in the dihydrobacillaene 
assembly line include an adenylation (A) domain for adenylating and loading of amino acid units 
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and a condensation (C) domain that catalyzes peptide bond formation.   
At the N-terminus of the first dihydrobacillaene assembly-line enzyme, PksJ, are two 
NRPS modules, an initiating (A1-T1) and an elongating (C1-A2-T2) module, which are followed 
by two polyketide modules.  Working in concert, the two NRPS modules would appear to 
condense the α-HIC N-cap with glycine (Gly) while tethered to the dihydrobacillaene assembly 
line. Previous work on dihydrobacillaene biosynthesis revealed that by the time the growing 
molecule reaches the third module of PksJ, it already possesses the α-hydroxyl, demonstrating 
either (a) that α-HIC is directly loaded onto the bacillaene assembly line, or (b) that an unknown 
α-HIC precursor is converted to the hydroxy acid while it is tethered to a T domain in one of the 
first three modules (Figure 3.1B). Unlike β-hydroxyacyl units, α-hydroxyacyl units are relatively 
rare in polyketides and non-ribosomal peptides.  Among the few characterized examples is the 
fungal secondary metabolite enniatin, in which the α-hydroxyacid is directly adenylated for 
incorporation into the natural product (Feifel, Schmiederer et al. 2007).  Alternatively, in 
cereulide’s depsipeptide assembly-line machinery, α-ketoacids are activated and reduced with 
chiral specificity by an A domain embedded KR to the corresponding α-hydroxyacids while 
tethered to a T domain on the assembly line (Magarvey, Ehling-Schulz et al. 2006).  No such 
module organization (A-KR-T) is found in the dihydrobacillaene assembly line and thus the 
source and origin of the α-HIC N-cap has been enigmatic. 
During the course of exploring the origins of the α-HIC unit in dihydrobacillaene/ 
bacillaene, we identified a novel dual function ketoreductase domain that acts as a canonical β-
ketoreductase as well as a non-canonical α-ketoreductase to convert the remote chain initiating 
α-ketoamide to an α-hydroxyamide.  We also established the stereochemical course of both of 
these reactions, one of which is cryptic.  Mass spectrometry (MS) was an invaluable tool in these 
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investigations, as we were able to directly observe ketoreduction of a substrate covalently 
attached to a T domain.  Ketoreduction results in a substrate mass change of only 2 Da, but high-
resolution MS enabled observation of this small mass change on T domain active site peptides of 
masses up to approximately 11 kDa. 
3.2 EXPERIMENTAL I 
3.2.1 General Methods  
 DNA was propagated in Escherichia coli TOP10 cells, and heterologous protein 
production was performed in E. coli BL21*(DE3) cells (Invitrogen).  Polymerase chain reaction 
(PCR) was performed using Phusion high fidelity DNA polymerase (New England Biolabs).  
Oligonucleotides were obtained from Integrated DNA Technologies.  All molecular biology 
techniques were performed using standard protocols (Sambrook 2000) unless otherwise noted.  
Protein concentrations were determined by Bradford assay (Bio-Rad Laboratories) using bovine 
serum albumin as a standard.  4-(aminomethyl)-6,7-dimethoxycoumarin was obtained from 
Toronto Research Chemicals.  Trypsin used was TPCK-treated sequencing grade (Promega) and 
endoproteinase ArgC was purchased from Worthington Biochemical Company.  All other 
chemicals were obtained from Sigma-Aldrich and used without further purification. 
3.2.2 Cloning and Expression  
 Methods for cloning and overexpression have been previously reported in detail and are 
summarized here (Calderone, Bumpus et al. 2008).  B. subtilis genomic DNA was used as a 
template for PCR amplification of genes of interest using the primers listed in Table 3.1.  The 
amplicons were digested and ligated into similarly digested pET-28a (Novagen) using T4 DNA 
ligase (New England Biolabs).  Clones were verified by sequencing.  PksJ(KR-T3-T4) mutants 
were generated by site directed mutatgenesis.  Plasmids were transformed into chemically 
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competent E. coli BL21*(DE3) cells for gene overexpression.  Proteins PksJ(A1-T1), PksJ(A1-T1-
C1-A2-T2), and PksJ(KR-T3-T4) (each containing an N-terminal hexahistidine tag) were purified 
by Ni2+ affinity chromatography according to standard procedures; additional chromatography 
steps were included where needed to obtain proteins of higher purity.   
3.2.3 Substrate Synthesis, ATP/PPi Exchange Assays and Determination of Stereoselectivity 
 Substrate synthesis, ATP/PPi exchange assays, and assays for determining the 
stereochemical course of α- and β-ketoreduction were performed by C. Calderone and N. 
Magarvey. Detailed methods have been published previously (Calderone, Bumpus et al. 2008).  
3.2.4 Identification of PksJ(A1-T1-C1-A2-T2) Active Site Peptides 
 To generate holo-PksJ(A1-T1-C1-A2-T2), apo-PksJ(A1-T1-C1-A2-T2) (10 μM final 
concentration; 200 μg total protein) was incubated with 7.7 μM Sfp and 0.26 mM coenzyme A 
(CoA) in 50 mM HEPES (pH 7.8), 10 mM MgCl2 and 1 mM tris(2-carboxyethyl)phosphine 
(TCEP) in a volume of 100 μL for 2 h at 30 °C.  Trypsin (20 μg) was resuspended in 20 μL of 
trypsin resuspension buffer (Promega) and incubated at 30 °C for 15 min.  The trypsin was added 
to 80 μL 0.1 M NH4HCO3 (pH 7.8) and the entire volume added to the holo forming reaction 
(1:10 w:w trypsin: total protein).  The digestion was allowed to proceed for 20 min at 30 °C 
followed by quenching with an equal volume of 10% formic acid and freezing at -80 °C.  
Samples were subjected to MS analysis as described below. 
3.2.5 Loading of PksJ(A1-T1-C1-A2-T2) 
Holo-PksJ(A1-T1-C1-A2-T2) was generated as described above, changing the incubation 
time to 1.25 h.  In a volume of 100 μL, 5 mM of substrate (α-ketoisocaproate (α-KIC), α-
hydroxyisocaproate (α-HIC), isocaproate (IC), glycine (Gly) or combinations thereof) and 5 mM 
ATP were added to the reaction in 50 mM HEPES (pH 7.8), 10 mM MgCl2 and 1 mM TCEP and 
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incubated for 1.5 h at 30 °C.  Trypsin digestion and quenching of each reaction were performed 
as described above.   
3.2.6 PksJ(KR-T3-T4) Active Site Peptide Identification 
 Holo-PksJ(KR-T3-T4) was generated by incubation of apo-PksJ(KR-T3-T4) (35.6 μM) 
with 12.5 μM Sfp and 0.45 mM CoA in 50 mM HEPES (pH 7.8) and 10 mM MgCl2 in a reaction 
volume of 30 μL for 2 h at 30 °C.  Apo-PksJ(KR-T3-T4) (in a control reaction omitting CoA) and 
holo-PksJ(KR-T3-T4) were digested by addition of ArgC (:10 w:w ArgC: total protein) and 
incubated at 30 °C for 20 min.  Digestion reactions were quenched by addition of an equal 
reaction volume of 10% formic acid and frozen at -80 °C. 
3.2.7 Time Course of Ketoreduction Using PksJ(KR-T3-T4) T3 and T4 Mutants 
 In a volume of 200 μL of 50 mM HEPES (pH 7.8), 10 mM MgCl2 and 28 μM PksJ(KR-
T3-T4) S3150A or PksJ(KR-T3-T4) S3248A was incubated with 9.6 μM Sfp, 0.26 mM 
acetoacetyl-CoA (Acac-CoA) and 0.26 mM α-KIC-γ-aminobutyryl-CoA (α-KIC-GABA-CoA) 
for 1 h at 30 °C.  Reduction was initiated by the addition of 4 mM NADPH in 50 mM HEPES 
(pH 7.8) in a volume of 50 μL to the loading reaction.  31 μL aliquots of the reduction reaction 
were removed at time points of 0 (removed before addition of NADPH), 10, 20, 40, 60, 150 and 
300 s and added to 50 μL of 10% formic acid to quench reduction.  Quenched reaction mixtures 
were stored at -80° C.  No proteolytic digestion was completed, and the intact proteins were 
analyzed directly using the Ppant ejection assay. 
3.2.8 Ketoreductase Activity of PksJ(KR-T3-T4) 
 Acetoacetyl-S-PksJ(KR-T3-T4) (Acac-S-PksJ(KR-T3-T4)) was generated by incubation of 
apo-PksJ(KR-T3-T4) (34.6 µM) with 19.2 μM Sfp and 0.52 mM Acac-CoA in 50 mM HEPES 
(pH 7.8) and 10 mM MgCl2 in a reaction volume of 30 μL for 1 h at 30 °C.  α-KIC-γ-
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aminobutyryl-S-PksJ(KR-T3-T4) (α-KIC-GABA-S-PksJ(KR-T3-T4)) was generated by incubation 
of apo-PksJ(KR-T3-T4) ( 34.6 μM) with 19.2 μM Sfp and 0.52 mM α-KIC-γaminobutyryl-CoA 
(α-KIC-GABA-CoA) in 50 mM HEPES (pH 7.8) plus 10 mM MgCl2 in a reaction volume of 30 
μL for 1 h at 30 °C.  Reduction was initiated by the introduction of 4 mM NADPH or NADH in 
10 mM HEPES (pH 7.8) in a volume of 10 µL, and the reaction was incubated at 30 °C for 1 h.  
Endoproteinase ArgC was added (1:10 w:w ArgC: total protein) followed by incubation for 30 
min at 30 °C.  Digestion reactions were quenched by addition of an equal reaction volume of 
10% formic acid and frozen at -80 °C until analysis.   Reactions were also performed as 
described using the PksJ(KR-T3-T4) T3 and T4 active site mutants.   
3.2.9 Reverse Phase Liquid Chromatography (RPLC)-Fourier-transform Mass Spectrometry 
(FTMS) 
 For all experiments involving PksJ(A1-T2) and PksJ(A1-T1-C1-A2-T2), all RPLC-FTMS 
analyses were conducted using a hybrid linear ion trap-FTMS (LTQ-FT, ThermoFisher 
Scientific) operating at 7 T coupled to a Surveyor HPLC system; all RPLC analyses were 
conducted using a Jupiter C4 column (Phenomenex, 4.6 mm x 150 mm, 5 µ dp, 300 Å) with a 
linear gradient of 5-95% solvent B in solvent A over 70 min, where solvent A was 0.1% formic 
acid in water and solvent B was 0.1% formic acid in acetonitrile (MeCN).  All samples were 
injected directly onto the RPLC column and eluted into the mass spectrometer.  
  For all experiments involving PksJ(KR-T3-T4), all RPLC-FTMS analyses were 
conducted using a hybrid linear ion trap-FTMS (LTQ-FT Ultra, ThermoFisher Scientific) 
operating at 12 T coupled to an Agilent 1200 HPLC system equipped with autosampler.  All 
RPLC analysis were conducted using a Jupiter C4 column (Phenomenex, 1 mm x 150 mm, 5 μ 
dp, 300 Å) as described above. 
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 All FTMS analysis methods included a full scan (detect m/z 400-2000), nozzle-skimmer 
dissociation for Ppant ejection (50 V (7T) or 75V (12T), detect m/z 250-600), and data-
dependent tandem MS (MS/MS) using collision induced dissociation (CID) with FT detection on 
the top 3 peptide species in each precursor scan.  MS/MS data were analyzed using a software 
package including ProSight PC (ThermoFisher).  All other data were analyzed manually using 
the Qualbrowser software suite provided with LTQ-FT instrumentation.  Theoretical and 
experimental masses of all peptides discussed are provided in Table 3.2.    
3.3 RESULTS I  
3.3.1 The First Two Modules of PksJ Load and Transfer α-KIC 
Our initial experiments set out to identify the substrate of the first A domain (A1) in PksJ, 
which we predicted would adenylate α-HIC or an unknown α-HIC precursor.  The 80 kDa PksJ 
initiation module (A1-T1) was heterologously produced in E. coli and test substrates included 
isocaproate derivatives differing in the oxidation state of the α-carbon: (α-KIC), (R)- and (S)-α-
HIC, IC, and (S)-leucine ((S)-Leu, α-aminoisocaproic acid).  Based on the substrate adenylation 
measured indirectly through ATP/PPi exchange α-KIC was revealed as the preferred substrate of 
the PksJ-A1 domain (Figure 3.2) with a Km of 403 nM.  In the depsipeptide α-ketoacid activating 
A domains, a neutral residue replaces the aspartate that interacts with the positively charged 
substrate amine in α-amino acid-activating A domains (Magarvey, Ehling-Schulz et al. 2006).  
This mutation is also observed in the α-KIC activating PksJ-A1 domain, wherein a valine 
(Val240) replaces the conserved aspartate, further supporting the preference for α-KIC as a 
substrate. 
To observe the loaded amino acids on the holo T domains, FTMS was employed.  The 
first step in the analysis is the identification of the holo active site peptides from the T domains 
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under investigation (PksJ-T1).  The PksJ(A1-T1) construct was analyzed in its apo and holo forms 
by trypsin digestion of the samples followed by analysis using on-line RPLC-FTMS and the 
Ppant ejection assay as described in Section 3.2.  Briefly, all samples were loaded onto the LC 
column connected in-line with a hybrid linear ion trap-FTMS (ThermoFisher Scientific LTQ-FT) 
and peptides eluted directly into the mass spectrometer.  They were subjected to measurement of 
the intact peptide masses, the Ppant ejection assay (as described in Chapter 2) and data-
dependent MS/MS for peptide identification (Dorrestein, Bumpus et al. 2006).  The data 
generated were analyzed for coelution of the Ppant ejection ion with an expected holo thiolation 
domain active site peptide and data analysis software was used to analyze MS/MS data to 
localize the Ppant arm to the active site serine.  Using this method, the PksJ(A1-T1)-T1 active site 
peptide was identified (apo-PksJ(A1-T1): 4+ charge state, m/z 899.9900, 3595.93 Da) and its 
identity confirmed by MS/MS data and the Ppant ejection assay (Figure 3.3). 
Next we attempted to observe covalent loading of α-KIC onto phosphopantetheinylated 
(holo) PksJ(A1-T1). Incubation of holo-PksJ(A1-T1) with α-KIC and ATP followed by 
subsequent analysis via FTMS did not reveal any stable loading of the α-KIC in our hands.  As 
seen in Figure 3.4, only loading of α-HIC and IC were observed in significant abundance on 
PksJ(A1-T1).  This may be because the presumed α-ketothioester generated on PksJ(A1-T1) is 
hydrolytically unstable.  To confirm that α-KIC is in fact activated and loaded onto PksJ(A1-T1), 
we examined loading on a 197 kDa construct corresponding to the first two modules of PksJ 
(PksJ(A1-T1-C1-A2-T2)). We speculated that the condensation domain would catalyze the transfer 
of the T1-loaded α-KIC to the T2-tethered glycine, generating a more stable α-ketoamide at a rate 
sufficiently high relative to β-ketothioester hydrolysis so as to allow observation of the α-KIC-
Gly dipeptide by protein mass spectrometry.  The recombinant PksJ(A1-T1-C1-A2-T2) construct 
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was purified from E. coli and subsequently phosphopantetheinylated by the phosphopantetheinyl 
transferase Sfp (Quadri, Weinreb et al. 1998).   
The active site peptides from apo- and holo-PksJ(A1-T1-C1-A2-T2) were identified by 
FTMS as described above (Figure 3.5) and activity of this construct was confirmed by detecting 
glycine adenylation catalyzed by A2 (Figure 3.6B).  When bis-holo-PksJ(A1-T1-C1-A2-T2) was 
incubated with glycine and either α-KIC, α-HIC or IC, the α-KIC-Gly containing active site 
peptide was observed in much higher abundance than the α-HIC-Gly active site peptide loaded 
on PksJ-T2 (no IC-Gly dipeptidyl intermediate was observed) (Figure 3.6C-E).  When we 
incubated bis-holo-PksJ(A1-T1-C1-A2-T2) with glycine and α-KIC in the presence of the 
competitive adenylation substrates (±)-HIC and IC, we observed exclusive formation of the T2-
tethered α-KIC-Gly dipeptide by FTMS analysis and the Ppant ejection assay (Dorrestein, 
Bumpus et al. 2006), confirming that PksJ(A1) activates and loads α-KIC onto the assembly line 
(Figure 3.7). 
3.3.2 PksJ KR Reduces T Domain-tethered β-Ketothioesters 
Based on the above results, α-KIC is loaded onto the PksJ assembly line as a precursor to 
the dihydrobacillaene α-HIC N-cap and is transported to the second NRPS module as an α-
ketoacyl unit.  Like depsipeptide modules, the PksJ initiation module has an α-ketoacid loading 
A domain, but in contrast to the depsipeptide modules it lacks an in cis fused α-ketoreductase (α-
KR) (Magarvey, Ehling-Schulz et al. 2006). Lack of an in cis fused α-KR implies that the 
ketoreductase functions are supplied either in trans or by a KR module elsewhere in the 
assembly line.  Surveying the unassigned ORFs in the bacillaene gene cluster failed to identify 
any candidate dehydrogenase enzymes, but it was possible that an enzyme encoded by a gene 
outside of the bacillaene cluster serves as an in trans α-KR. 
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Regardless of whether the α-ketoreduction is catalyzed by a trans-KR or a KR harbored 
elsewhere in the dihydrobacillaene assembly line, the above observations combined with work 
by Moldenhauer et al. (observed intermediates shown in Figure 3.1) suggest that the reduction 
likely occurs while the α-KIC containing dihydrobacillaene intermediate is tethered to PksJ 
module 3 (PksJ(KS-DH-KR-T3-T4)) (Moldenhauer, Chen et al. 2007). The jump from module 2 
to 3 is a NRPS to PKS transition, with PKS module 3 possessing features which demand 
attention for understanding the α-ketoreduction scaffold.  First, module 3 has a set of two tandem 
of T domains (T3-T4), a non-canonical domain architecture perhaps indicative of non-canonical 
domain function. Second, the tandem T domains are in juxtaposition with a KR domain. Based 
on inspection of the dihydrobacillaene structure this KR domain can be inferred to act as a β-
ketoreductase to generate a cryptic C15′ hydroxyl which is subsequently dehydrated following 
standard PKS logic by the dehydratase domain and saturated by a non-canonical trans-enoyl 
reduction to yield the C14′-C15′ alkane linkage. However, the position of the tandem T domains 
in module 3 led to the hypothesis that its KR could work twice via action on two different keto 
groups:  the canonical β-keto group at C15’ and also what would be the α-keto group within the 
starter unit, converting α-KIC to α-HIC. 
To test this hypothesis the KR-T3-T4 region of PksJ, including the N-terminal KR 
“structural subdomain” was heterologously produced (Keatinge-Clay and Stroud 2006).  Tests of 
the KR domain catalytic action as a canonical β-ketoreductase used the model β-ketoacyl 
substrate Acac-S-PksJ(KR-T3-T4) generated by incubation of apo-PksJ(KR-T3-T4) with Acac-
CoA and Sfp (Quadri, Weinreb et al. 1998).  Because the T3 and T4 domains have very similar 
protein sequences, they result in T domain active site peptides with the same mass when trypsin 
digestion in used (Figure 3.8A).  Therefore, a new digestion protocol was developed that 
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employes the protease ArgC to generate mass differentiate T domain active site peptides.  The 
digestion of PksJ(KR-T3-T4) was optimized using ArgC at different ratios of protease: substrate 
and differing incubation times, in addition to testing two different digestion buffers.  The optimal 
conditions are reported in Section 3.3.  The digestion was visualized by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and the digestion pattern observed indicated 
that ArgC digestion would generate samples amenable to LC-MS analysis and result in active 
site peptides with different masses (Figure 3.8B).   
Though we were able to distinguish substrates linked to each of the two T domains by 
protease digestion prior to mass analysis, we also generated mutants of PksJ(KR-T3-T4) in which 
the phosphopantetheinylated serine residue in each T domain was individually replaced by 
alanine.  Both active site peptides were identified by FTMS in their apo and holo forms, and the 
peptide identities were confirmed by intact mass measurements and the Ppant ejection assay as 
described above (Figure 3.9A–B).  Additionally, we were able to load both T3 and T4 through 
incubation with Acac-CoA and/or α-KIC-GABA-CoA as substrates (Figure 3.9C-D); Acac-S-T3 
and –T4 were generated to test the β-ketoreduction ability of the PksJ KR, while α-KIC-GABA-
S-T3 and –T4 would report on the α-ketoreduction ability of the same domain.  
 In both the wild-type and mutant Acac-S-PksJ(KR-T3-T4), we observed rapid formation 
of active site peptide and Ppant ejection ions with a mass shift of +2 Da in an NAD(P)H-
dependent fashion, consistent with ketoreduction and formation of β-hydroxybutyryl-S-PksJ(KR-
T3-T4) (Figure 3.10A).  Both NADH and NADPH served as hydride donors with approximately 
equal efficiency, and we were unable to detect any kinetic differentiation between the two T 
domains as β-reduction scaffolds.  These results clearly demonstrate that the PksJ KR domain is 
active as a canonical β-ketoreductase. 
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3.3.3 PksJ KR Reduces α-KIC to α-HIC 
Having confirmed that the PksJ-KR domain of module 3 can act as a canonical β-
ketoreductase, we next tested its ability to reduce the remote α-KIC amide.  We tested α-KIC-
GABA as the PksJ α-KR substrate.  Though according to canonical PKS logic the reductive loop 
domain sequence in PksJ module 3 (DH-KR) would yield an α-KIC-γ-aminocrotonyl KR 
substrate, we have shown that this substrate is reduced to α-KIC-GABA in trans while it is 
tethered to this module (Sections 3.5 and 3.6), and Moldenhauer et al. observed in vivo that the 
α-ketoreduced product is indeed the α-HIC-GABA-S-T thioester (Figure 3.1) (Moldenhauer, 
Chen et al. 2007). 
To access α-KIC-GABA-S-PksJ(KR-T3-T4), α-KIC-GABA-CoA was synthesized and 
used as a donor in the Sfp-catalyzed phosphopantetheinylation reaction.  Both active site 
peptides were again detected in their apo, holo, and α-KIC-GABA-loaded forms (Figure 3.9).  
The loaded wild type and mutant PksJ(KR-T3-T4) constructs were incubated with NAD(P)H.  
Similar to the β-keto substrate mass shifts of 2.0154 Da (calculated from the observed Ppant 
ejection ions) in the T3 and T4 active site peptides were observed, consistent with their reduction 
(Figure 3.10B).  Given that the only site of reduction of the α-KIC-GABA is the α-keto group 
this revealed α-ketoreduction had occurred. As observed in the case of β-reduction, NADH and 
NADPH were interchangeable as hydride donors, and reduction occurred on both T domain 
scaffolds with approximately equal efficiency.  
We attempted to determine the apparent rates of α-ketoreduction versus β-ketoreduction 
using FTMS.  Both constructs of mutant PksJ(KR-T3-T4), containing a serine to alanine mutation 
at a single thiolation domain active site serine, were incubated with a mixture of Acac-CoA and 
α-KIC-GABA-CoA to generate a mixed population of loaded species; previous results had 
143 
 
shown the loading efficiency to be very similar for both substrates (data not shown).  Reduction 
was initiated by the addition of NAD(P)H, and aliquots were removed at specific time points.  
The intact protein was analyzed by LC-MS and the Ppant ejection assay, and the appearance of 
Ppant ejection ions for each reduced species was monitored.  The apparent rate of α-reduction 
was approximately ten fold less than the apparent rate of β-reduction (Figure 3.11).  However, 
these results are purely qualitative, and there are many complications as discussed below. 
3.3.4 Reduction Chirality 
Finally, we sought to determine the stereochemistry of the reductions catalyzed by the 
dual function PksJ KR domain. Using Acac-S-T thioesters as model β-ketoacyl substrates in the 
PksJ(KR-T3-T4) construct, we repeated the β-ketoreduction assay, followed by enzymatic 
cleavage (catalyzed by the type II thioesterase TycF) of the resulting hydroxybutyrate from the T 
domain scaffold (Yeh, Kohli et al. 2004) and derivatization with an amine fluorophore.  The 
stereochemistry of the cryptic C15′ β-hydroxyl was identified by chiral-HPLC to be S (Figure 
3.12A).   The S designation is with respect to the physiological substrate.  In the reduction of the 
model substrate Acac-S-T, the relative priority of the β-substituents is altered with respect to the 
physiological substrate, making the correct stereochemical descriptor for the model product 3-
hydroxybutyryl-S-T R. 
We performed a similar set of experiments on the authentic α-KIC-GABA-S-T thioester 
α-ketoreduction substrate, revealing that PksJ catalyzed α-ketoreduction produces (S)-α-HIC-
GABA (Figure 3.12B).  Based on these observations and the apparent lack of an epimerase that 
could act on the C2" center after reduction, we propose that the previously unknown chirality of 
the dihydrobacillaene C2" is S. 
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3.4 DISCUSSION  I 
 A hallmark of polyketide biosynthesis is the varied level of processing of the β-keto 
group resulting from KS-catalyzed Claisen condensations (Staunton and Weissman 2001).  This 
leads to a large number of structurally diverse polyketides generated by fairly similar 
machineries.  The B. subtilis secondary metabolites bacillaene and dihydrobacillaene are 
comprised of two amino acids of polyketide origin in which the majority of the β-keto groups are 
processed to the olefinic oxidation state, creating a highly conjugated polyene core (Butcher, 
Schroeder et al. 2007).  Bacillaene and dihydrobacillaene are also N-capped with an α-
hydroxyacyl unit which would apparently require incorporation of α-HIC as the starter unit for 
the dihydrobacillaene hybrid PKS/NRPS assembly line.   
 Two precedents for incorporation of α-hydroxyacid residues into NRP scaffolds are 
relevant. In the enniatin synthetase α-hydroxyisovaleric acid is selected by the A domain and 
then loaded as the S-pantetheinyl thioester on the adjacent T domain (Feifel, Schmiederer et al. 
2007). In the case of the potassium ionophores valinomycin and cereulide the modules that 
incorporate α-hydroxyacids have been shown to select and directly install the α-ketoacids 
(Magarvey, Ehling-Schulz et al. 2006).  Ketoreductase (α-KR) domains embedded within the A 
domains then reduce the tethered ketoacid to the α-hydroxyacyl moiety before condensation and 
chain elongation. Such α-ketoacid-activating A domains typically lack the active site aspartate 
that normally forms an ion pair with the α-H3N+ of α-amino acids and is a key selection 
determinant for amino acid substrates (Conti, Stachelhaus et al. 1997; Stachelhaus, Mootz et al. 
1999). 
In the event A1 of the PksJ first module indeed activates and installs α-KIC on the holo 
form of the T1 domain, this suggests that an “on assembly-line” reduction step should occur. 
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There is no α-KR domain embedded within NRPS module 1 or NRPS module 2 of PksJ, nor is 
there a discernible separate KR protein encoded within the bacillaene gene cluster. We 
established that the α-KIC moiety is transferred unreduced to module 2 by observing formation 
of α-KIC-Gly-S-T2 in a purified PksJ(A1-T1-C1-A2-T2) construct by mass spectral interrogation 
of the acylated holo peptide derived proteolytically from T2. 
According to Piel and colleagues (Moldenhauer, Chen et al. 2007), the dihydrobacillaene 
chain elongation intermediate that transits module 3 of PksJ has an α-HIC rather than α-KIC N-
cap (Figure 3.1), establishing that α-KIC reduction occurs on one of the first three modules of 
PksJ.  In this work, a mutant of a dihydrobacillaene producer was prepared that allowed 
detection of dihydrobacillaene chain elongation intermediates, including α-HIC-GABA-S-
pantetheinyl thioesters tethered to module 3, though the intermediates tethered to the first two 
modules could not be detected (Moldenhauer, Chen et al. 2007).  .  In this work, we identify 
these undetected intermediates to be α-KIC and α-KIC-Gly.  The domain architecture of PksJ 
module 3 is KS-DH-KR-T3-T4. The KS domain and DH domain are predicted to be functional 
and extend the α-KIC-Gly from module 2 by two carbons at the olefin oxidation state that are 
ultimately reduced by an in trans enoyl reductase (Figure 3.1). The tandem T domains, T3-T4, are 
unusual and suggestive of the unusual biosynthetic reactivity that occurs on this module. 
To assay the enzymatic activity of KR domain of module 3 of PksJ we expressed the 
three domain fragment PksJ(KR-T3-T4) in the apo form and post-translationally primed both T 
domains with phosphopantetheine through the use of the broad specificity B. subtilis 
phosphopantetheinyl transferase Sfp (Quadri, Weinreb et al. 1998). This methodology also 
allowed us to load the apo construct with acetoacetyl units from Acac-CoA and generate model 
3-ketoacyl-S-pantetheinyl-T3 and -T4 forms of the protein. Using FTMS we were able to detect 
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the acyl-S-pantetheinyl peptides from both T3 and T4 and show PksJ(KR) behaves as a canonical 
β-KR.   
To assess whether the PksJ KR domain also has an α-KR activity we prepared the chain 
elongation intermediate we anticipated might be presented to module 3 of PksJ in vivo. As in the 
assay of β-KR function, there was a NAD(P)H-dependent increase of 2 mass units on the peptide 
fragments from T3 and T4 validating that the only keto group on the α-KIC-GABA chain, the α-
ketoamide moiety, was reduced to the (S)-α-hydroxyamide (Figure 3.10). Therefore, the KR 
domain in PksJ module 3 can reduce both the ketone in the canonical β-ketoacyl-S-pantetheinyl 
arm of an adjacent T domain and the ketone in the α-ketoisocaproyl amide moiety of the growing 
dihydrobacillaene chain as it passes from the two NRPS modules to the first PKS module of 
PksJ.  
In the absence of more detailed structural characterization of the KR, it is difficult to 
assess the molecular determinants of α- and β-ketoreduction stereoselectivity, but it is possible to 
draw several inferences.  PksJ catalyzed generation of the (S)-hydroxylated products when acting 
in both the α-KR and β-KR modes can be rationalized by a model in which the α-KR and β-KR 
substrates are recognized by the PksJ KR active site in a similar fashion and reducing hydride 
equivalents are delivered from NAD(P)H to the same face of the substrate (Figure 3.12C).  It is 
not yet known how both the α- and β-ketoreduction substrates change register to be processed by 
a single set of active site residues. 
Studies of canonical β-KRs have led to a model in which T domain tethered substrates 
enter an active site groove within the KR in one of two orientations, with this substrate 
orientation determining the face to which the reducing hydride equivalent is delivered and 
therefore the stereochemical sense of reduction.  A suite of β-KR active site residues has been 
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identified which directs substrate entry, with “B-type” β-KRs possessing a conserved Leu-Asp-
Asp motif and catalyzing β-ketoreductions with the same stereochemistry as the PksJ(KR), and 
“A-type” β-KRs possessing a conserved tryptophan residue and yielding products epimeric to the 
PksJ(KR) β-hydroxyacyl product (Caffrey 2003; Baerga-Ortiz, Popovic et al. 2006; Keatinge-
Clay and Stroud 2006).  The PksJ KR has a yet another different set of corresponding residues, 
suggesting a different recognition “code.”   At the same time, it has the catalytic serine, aspartate, 
lysine, and asparagine residues as typical β-KRs and members of the short chain dehydrogenase 
family. 
Since there is only a handful of NRP-PK natural products whose biosynthesis requires a 
reduction of both α- and β-keto groups and none of the corresponding KRs have been extensively 
studied, it is not yet known how many KR domains would show relaxed regiospecificity in chain 
tailoring. Blastp searches revealed numerous homologs of the dual function PksJ(KR), 
predominantly in trans-AT clusters, including those responsible for mupirocin, bryostatin, and 
rhizoxin biosyntheses (Brendel, Partida-Martinez et al. 2007; Sudek, Lopanik et al. 2007) (with 
44%, 44%, and 43% amino acid sequence identity, respectively). Notably, many of these KRs 
follow glycine incorporating NRPS modules, perhaps reflecting joint inheritance of the two 
modules in accord with the mosaic assembly of trans-AT modules (Nguyen, Ishida et al. 2008) 
or the need for the conformational flexibility of a glycine residue within the substrate to allow 
the KR to catalyze both α- and β-ketoreductions.  For example, the biosynthetic gene cluster for 
myxovirescin contains a PksJ(KR) homolog (38% identity) as the first KR domain within the 
PKS TaI.  Myxovirescin biosynthesis is initiated with an α-hydroxyvaleryl-glycine unit in 
analogy to the α-ketoisocaproyl-glycine unit identified in the present work in dihydrobacillaene 
(Simunovic, Zapp et al. 2006). A complex assembly of the α-hydroxyvalerate moiety has been 
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proposed which includes the use of two polyketide synthases (TaI and TaL) (Simunovic, Zapp et 
al. 2006). The findings described here allow us to propose an alternative route where α-
ketovaleryl-glycine is generated and tethered to the first T domain of TaI by an as yet unknown 
mechanism which, like in dihydrobacillaene biosynthesis, and is extended by the first PKS 
module (KS-KR-T) followed by α- and β-ketoreduction.  
The kinetic studies on the timing of β- and α-ketoreduction would be quite challenging 
since the substrate is present in an amount stoichiometric to the KR catalyst and is tethered 
covalently in cis. Only by proteolysis and MS analysis of the active site peptides derived from T3 
and T4 can we monitor these catalytic steps of β- and α-keto reduction with the required unit 
mass resolution.  We do not yet know if the tandem T domain arrangement in T3 and T4 acts, 
inter alia, as a pause site before chain transfer to module 4 of PksJ.  If so, this would provide 
extra dwell time which might allow the KR of module 3 to catalyze β-ketone reduction on a 
typical tethered acyl substrate and then carry out reduction of the nearby α-keto moiety of KIC. 
Though the apparent rate of α-reduction using substrates tested here is approximately ten fold 
less than the apparent rate of β-reduction, more detailed analysis is required to establish the 
sequence of reductions.  Among the complicating factors is the fact that along with α- and β-
reduction, dehydration and enoyl reduction also occur while the substrate is tethered to the 
tandem T domains in PksJ; though β-reduction must precede dehydration and enoyl reduction, α-
reduction could occur at any point in the sequence.  Chemical syntheses of the β-keto and 
olefinic α-reduction substrates corresponding to earlier intermediates were not successful due to 
issues of synthetic accessibility and instability of synthetic intermediates. 
The preference for one or the other T domain as an α- or β-reduction scaffold is yet to be 
established.  Both α- or β-reductions were observed to occur on each T domain, regardless of 
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whether the domains were independently assayed by protease digestion followed by mass 
spectral analysis, or by independent mutation of the phosphopantetheinylated serine residue in 
each domain.  Similar tandem T domains have been observed in several other systems, including 
the biosynthetic pathways of sterigmatocystin, albicidin, and curacin, as well as in those of 
polyunsaturated fatty acids, where up to nine consecutive T domains have been observed (Yu 
and Leonard 1995; Metz, Roessler et al. 2001; Chang, Sitachitta et al. 2004; Royer, Costet et al. 
2004). 
The unusual dual function KR found in PksJ represents another example of violation of 
canonical polyketide biosynthetic logic, whereby a given module acts to tailor a monomer 
incorporated by an upstream module.  By exploiting this non-canonical strategy, an assembly 
line can access α-hydroxyacyl-containing structures even when α-hydroxyacids may be lacking 
in the primary metabolic pool.  These promiscuous KRs may represent a third class of KRs in 
addition to the previously delineated A- and B-types.  Current work is directed at identifying 
additional examples of this class of α/β-ketoreductases to help ascertain their catalytic scope and 
biosynthetic prevalence. Meanwhile, the highly hybrid dihydrobacillaene assembly line 
continues to provide new insights into natural product assembly-line principles. 
3.5 EXPERIMENTAL II 
3.5.1 Gene Cloning 
Genes were PCR amplified using genomic DNA of B. subtilis or S. oneidensis MR-1 
(ATCC 700550) as templates and Phusion High-Fidelity DNA polymerase (Finnzymes).  The 
primers for amplification are shown in Table 3.1.  Amplicons were digested with the appropriate 
restriction endonucleases (New England Biolabs), gel-purified, and ligated (T4 DNA ligase, New 
England Biolabs) into similarly digested and purified pET-24b (pfaD, pksE(AT-ER), and 
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pksE(ER)) or pET-28a (pfaA(T4), pksJ(KR-T3-T4), and pksL(T-T)) vectors at 16 ˚C.  Ligation 
mixtures were used to transform chemically competent E. coli TOP10 cells (Invitrogen).  
Identities of individual clones were verified by sequencing (Dana-Farber Cancer Institute 
Molecular Biology Core Facility).  Plasmids were used to transform E. coli BL21*(DE3) 
chemically competent cells (Invitrogen) for heterologous overexpression. 
3.5.2 Protein Expression 
Detailed procedures for gene overexpression and protein purification have been published 
previously and are only summarized here (Bumpus, Magarvey et al. 2008).  All protein 
constructs were produced in E. coli BL21*(DE3) as fusions with hexahistidine tags and purified 
by Ni2+ affinity chromatography according to standard procedures; additional chromatography 
steps were included as needed.   
Samples of PfaD and PksE were heated to 95 °C for 5 min, followed by centrifugation to 
remove precipitated proteins.  HPLC analysis of the supernatant (Vydac 250 x 4.6 mm C18 
column) using a gradient of 10-40% MeCN in 0.1% aqueous TFA over 15 min identified the 
flavin cofactor in both cases as flavin mononucleotide (FMN). 
3.5.3  Determination of Malonyl Transferase Activity 
 Holo-PksJ(T-T), AcpK, and PksL(T-T) were generated by incubating the apo proteins 
(55 µM) with 3.5 µM Sfp and 1 mM CoA in 50 mM HEPES (pH 7.5), 10 mM MgCl2 and 1 mM 
TCEP for 1 h at room temperature.  The holo proteins (17.5 µM final concentration) were then 
combined in the same buffer (18 µL) including 100 µM 2-14C-malonyl-CoA (52 Ci/mol, GE Life 
Sciences) in the presence or absence of 2 µM PksC or PksE and incubated for 5 min before 
analysis by SDS-PAGE.  The gel was visualized by Coomassie staining, dried, and subjected to 
autoradiography. 
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3.5.4 Active Site Mapping of PksJ(KR-T3-T4) 
 To investigate enoyl reduction on PksJ, the protein PksJ(KR-T3-T4) was purified from E. 
coli.  Though the KR played no functional role in the assay, its inclusion in the protein construct 
led to improved protein expression.  Holo-PksJ(KR-T3-T4) was generated by incubation of apo-
PksJ(KR-T3-T4) (35.6 μM) with 12.5 μM Sfp and 0.45 mM CoA in 50 mM HEPES (pH 7.8) and 
10 mM MgCl2 in a reaction volume of 30 μL for 2 h at 30 °C.  Apo-PksJ(KR-T3-T4) (in a control 
reaction omitting CoA) and holo-PksJ(KR-T3-T4) were digested by addition of endoproteinase 
ArgC (1:10 w:w ArgC: total protein) and incubated for 20 min at 30 °C.  Digestion reactions 
were quenched by addition of an equal reaction volume of 10% formic acid and frozen at -80 °C.  
The same digestion and quenching protocol was performed after all reactions described below 
unless noted.  Mass spectra of active site peptides are shown in Figure 3.13 and masses of 
detected peptides are provided in Table 3.3. 
3.5.5 Determination of PksE Enoyl Reductase Activity at PksJ(KR-T3-T4) 
 2-butenoyl-S-PksJ(KR-T3-T4) was generated by incubation of apo-PksJ(KR-T3-T4) (35.6 
μM) with 12.5 μM Sfp and 0.45 mM 2-butenoyl-CoA in 50 mM HEPES (pH 7.8) and 10 mM 
MgCl2 in a reaction volume of 30 μL for 1 h at 30 °C.  In a volume of 40 µL, PksE (1:5 mol: mol 
PksE(AT-ER or ER): PksJ(KR-T3-T4); PksJ(KR-T3-T4) final concentration of 15 μM) was added 
with 4 mM NADPH or NADH, 10 μM FMN and 50 mM HEPES (pH 7.8) (final reaction volume 
of 70 µL) and incubated for 1 h at 30 °C. 
3.5.6 Determination of PksE Activity at PksJ(A1-T1) 
 2-butenoyl-S-PksJ(A1-T1) was generated in a 50 µL reaction by incubation of apo-
PksJ(A1-T1) (66 μM) with 12.5 μM Sfp and 0.50 mM 2-butenoyl-CoA in 50 mM HEPES (pH 
7.8) and 10 mM MgCl2 for 1 h at 30 °C.  In a volume of 50 µL, PksE (1:5 mol: mol PksE(AT-
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ER): PksJ(A1-T1); PksJ(A1-T1) final concentration of 33 μM) was added with 4 mM NADPH, 10 
μM FMN and 50 mM HEPES (pH 7.8) and incubated for 1 h at 30 °C.  Sequencing grade trypsin 
(30 µg, Promega) was resuspended in 30 µL of trypsin resuspension buffer (Promega) and 
incubated at 30 °C for 15 min.  100 µL of 0.1 M NH4HCO3 (pH 7.8) and the activated trypsin 
were added to the PksE reaction and the  reaction mixture was incubated at 30 °C for 20 min.  
The digestion was quenched by the addition of an equal reaction volume of 10% formic acid and 
frozen at -80 °C. 
3.5.7 Determination of S. oneidensis MR-1 PfaD Enoyl Reductase Activity 
 For active site mapping experiments, holo-PfaA(T1-T2-T3-T4) was generated by 
incubating 14 μM apo-PfaA(T1-T2-T3-T4) with 5 μM Sfp and 0.35 mM CoA in a 80 µL reaction 
containing 50 mM HEPES (pH 7.8) and 10 mM MgCl2 for 2 h at 30 °C.  2-butenoyl-S-PfaA(T1-
T2-T3-T4) was generated by incubating 28 μM apo-PfaA(T1-T2-T3-T4) with 10 μM Sfp and 0.70 
mM 2-butenoyl-CoA in a 50 µL reaction containing 50 mM HEPES (pH 7.8) and 10 mM MgCl2 
for 1 hr at 30 °C.  PfaD was added (1:5 mol: mol PfaD: PfaA(T1-T2-T3-T4); PfaA(T1-T2-T3-T4) 
final concentration of 14 μM) with 4 mM NADPH, 10 μM FMN and 50 mM HEPES (pH 7.8) in 
a volume of 30 µL and incubated for 1 h at 30 °C.  Active site peptides were generated by 
digestion with ArgC as described above.  Mass spectra of active site peptides are shown in 
Figure 3.14 and masses of detected peptides are provided in Table 3.3.   
3.5.8 RPLC-FTMS Analysis 
 All RPLC analyses were conducted using a Jupiter C4 column (Phenomenex, 1 mm x 
150 mm, 5 μ dp, 300 Å).  All FTMS analyses were conducted using a LTQ-FT hybrid ion trap-
FTMS (ThermoFisher Scientific) operating at 12 T.  All digested samples were injected directly 
onto the RPLC column and eluted into the mass spectrometer using a linear gradient of 5-95% 
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solvent B in solvent A over 1 h, where solvent A was 0.1% formic acid in water and solvent B 
was 0.1% formic acid in MeCN.  All FTMS analysis methods included a full scan (detect m/z 
400-2000 in the FTMS), nozzle-skimmer dissociation for the Ppant ejection assay (Dorrestein, 
Bumpus et al. 2006) (75V, detect m/z 250-600 in the FTMS), and data-dependent MS/MS using 
CID with FT detection on the top 3 peptide species in each full scan.  MS/MS data were 
analyzed using ProSight PC (ThermoFisher Scientific).  All other data were analyzed using the 
Qualbrowser software suite provided with LTQ-FT instrumentation (ThermoFisher Scientific).  
Theoretical and experimental masses of all peptides discussed are provided in Table 3.3. 
Theoretical structures and masses of Ppant ejection ions are shown in Figure 3.15. 
3.6 RESULTS II AND DISCUSSION II 
The saturated C14′-C15′ bond in dihydrobacillaene is incorporated while the growing 
intermediate is tethered to a non-standard set of two tandem of T domains in the polyketide 
synthase PksJ (Figure 3.16).(Moldenhauer, Chen et al. 2007)  However, the cis-acting catalytic 
domains in PksJ only possess ketoreduction and dehydration activities and as such are only able 
to generate the C14′-C15′ bond at the olefin oxidation state.  We hypothesized that PksE acts as a 
trans-ER to reduce enoyl-S-PksJ and thereby saturate the C14′-C15′ bond in dihydrobacillaene.  
To test this, PksE and a construct bearing the tandem T domains from PksJ (PksJ(KR-T3-T4)) 
were heterologously overexpressed in E. coli. 
Because enoyl reduction results in a mass increase of 2 Da, high-resolution FTMS 
(Dorrestein and Kelleher 2006) and the Ppant ejection assay (Dorrestein, Bumpus et al. 2006) 
were employed to monitor enoyl reduction.  Proteolytic digestion of PksJ(KR-T3-T4) resulted in 
two T domain active site peptides of different mass (identified using the methods described 
above), allowing analysis of mass shifts occurring at each T domain separately; each active site 
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peptide was observed in the apo and holo forms (Figure 3.13).  Upon incubation of the model 
substrate 2-butenoyl-S-PksJ(KR-T3-T4) with PksE and NADPH, protein digestion, and analysis 
by RPLC-FTMS, we observed a gain of 2 Da in approximately half of the substrate bound to 
each T domain active site peptide (Figure 3.17), consistent with the proposed activity of PksE as 
a C14′-C15′ enoyl reductase during dihydrobacillaene biosynthesis.  Replacement of NADPH 
with NADH resulted in similar levels of reduction. 
We next probed the role of the two tandem T domains in PksJ in facilitating in trans 
enoyl reduction.  PksE is comprised of an acyltransferase (AT) domain along with the ER 
domain.  Homologs of the PksE-AT domain load assembly-line T domains in trans with malonyl 
units during polyketide biosynthesis (Aron, Fortin et al. 2007).  Given the ability of these AT 
domains to interact with T domains, we tested the possibility that PksE-AT recognizes the 
tandem T domains in PksJ to recruit its PksE-ER domain to the correct region of PksJ.  We 
heterologously produced a PksE construct that harbors only the ER domain (PksE(ER)), and 
upon incubation of 2-butenoyl-S-PksJ(KR-T3-T4) with PksE(ER), formation of butyryl-S-PksJ 
was observed with no change in enoyl reduction relative to full length PksE (Figure 3.18A).  In 
parallel, we investigated the specificity of AT domains for acylation of a particular T domain.  
PksE(AT) and PksC, another dihydrobacillaene AT, were analyzed for their ability to malonate T 
domains in PksJ, PksL and AcpK.  Both AT domains loaded every dihydrobacillaene T domain 
examined (Figure 3.18B).  Such a lack of specificity suggests that recognition of a specific T 
domain is not required for PksE(AT) or PksC activity.  We therefore conclude that PksE-
AT/PksJ interaction is not required for PksE-ER activity. 
The tethering of substrates in proximity to the catalytic domains controls the selectivity 
of cis tailoring reactions.  In contrast, the selectivity of trans tailoring reactions depends on 
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recruitment of the catalytic machinery to only the appropriate T domain scaffolds.  Inspection of 
the dihydrobacillaene structure suggests that the PksE-ER acts only on substrates tethered to the 
T3-T4 tandem T domains PksJ.  A construct that contains a different T domain from PksJ 
(PksJ(A1-T1)) not predicted to serve as a scaffold for PksE catalyzed enoyl reduction was 
heterologously produced in E. coli.  PksE did not catalyze enoyl reduction of 2-butenoyl units 
tethered to this T1 domain, demonstrating that specific interactions of PksE with the 
dihydrobacillaene polyketide assembly line facilitate enoyl reduction and consequently the 
pattern of unsaturation in dihydrobacillane (Figure 3.19).  The selective association of PksE with 
PksJ in vivo is in accord with fluorescence microscopy studies (Straight, Fischbach et al. 2007).  
Upon disruption of pksR, which encodes another multi-domain dihydrobacillaene synthase 
protein, a PksE-cyan fluorescent protein (CFP) fusion associated with a PksX megacomplex.  In 
contrast, in a strain containing a disruption in pksJ, the PksE-CFP fusion did not co-localize with 
the megacomplex, demonstrating that PksE interacts selectively with PksJ. 
Homologs of PksE are present in several polyketide biosynthetic gene clusters, including 
those of myxovirescin, leinamycin, and mupirocin, among others (El-Sayed, Hothersall et al. 
2003; Piel, Hui et al. 2004; Tang, Cheng et al. 2004; Carvalho, Reid et al. 2005; Chen, Vater et 
al. 2006; Simunovic, Zapp et al. 2006) (Figure 3.20). Comparison of the structures of these 
polyketides and their associated domain architectures reveals that in each case at least one 
carbon-carbon bond can be identified that is saturated in the absence of a cis ER, suggesting that 
trans enoyl reduction by PksE-like ERs is a widely distributed biosynthetic strategy to 
incorporate saturated carbon-carbon bonds in polyketides.  These PksE-like ER domains are 
phylogenetically distinct from ERs utilized in canonical polyketide and fatty acid biosynthesis.  
Instead, the PksE-ER is highly homologous (47% identical) to PfaD, the ER utilized in the 
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biosynthesis of PUFAs.  PUFAs are precursors to numerous essential cellular regulators (e.g. 
eicosanoids and arachidonic acid) (Serhan, Yacoubian et al. 2008); however, humans do not 
possess the biosynthetic machinery necessary for their production.  A thiotemplated assembly-
line pathway to PUFAs in marine microorganisms was recently reported (Metz, Roessler et al. 
2001), and although it is a promising strategy to access large quantities of PUFAs, its 
mechanistic details remain enigmatic.  In analogy to the PksJ tandem T domains, runs of 
multiple T domains are a hallmark of this pathway. 
To confirm the proposed activity of PfaD, we heterologously produced the ER PfaD 
isoform from the model PUFA synthesizing marine microbe Shewanella oneidensis MR-1 
(Jeong, Song et al. 2006), as well as a construct bearing four consecutive T domains (PfaA(T1-
T2-T3-T4)) in E. coli  (Figure 3.21A).  Three of the four PfaA(T1-T2-T3-T4) active site peptides 
were identified by FTMS using the active site mapping strategies described above (Figure 3.14).  
PfaA(T1-T2-T3-T4) was loaded with 2-butenoyl-S-pantetheinyl units and subsequently treated 
with PfaD in the presence of NADPH.  Upon proteolytic digestion and analysis by LC-FTMS, a 
gain of 2 Da was observed in the masses of substrates bound to T domain active site peptides 
corresponding to the acylated T1, T2, and T4 domains of PfaA(T1-T2-T3-T4), consistent with PfaD 
catalyzed enoyl reduction and production of butyryl-S-T thioesters (Figure 3.21B).  As 2-
butenoyl-S-PfaA is a predicted authentic intermediate during PUFA assembly, these observations 
show that PfaD is the ER used in PUFA assembly and acts on substrates tethered to the PUFA 
synthase T domain multiplet. 
Taken together, the above results demonstrate the utility of PUFA-like biosynthetic 
machinery in secondary metabolism.  Variants of PUFA synthases are known which contain 
multiplets of four (as in the S. oneidensis PfaA), six, or nine consecutive T domains, all sharing a 
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striking degree of homology (>95% identical) (Metz, Roessler et al. 2001).   The specific roles of 
the multiple tandem T domains are as yet unknown, but this synthase architecture may ensure 
efficient tailoring of PUFA intermediates.  Once an enoyl intermediate undergoes extension, the 
olefin can no longer be reduced.  It is possible that the extra T domains make the extension step a 
biosynthetic bottleneck, increasing the chances that PfaD will reduce a given PUFA intermediate 
before extension.  Under this model, the T domain multiplets are scaffolds for parallel PUFA 
biosynthesis to ensure production only of the desired metabolite.  Similar models have been 
previously proposed to explain the presence of T domain multiplets in the mupirocin polyketide 
synthase (Rahman, Hothersall et al. 2005).  It is also supported by recent work demonstrating 
that only a single T domain is required for PUFA biosynthesis (Jiang, Zirkle et al. 2008). 
Though canonical polyketide synthases generally contain isolated T domains, several 
polyketide synthases harbor sets of tandem T domains.  We propose that these T domain 
multiplets mark insertion points of alternate biosynthetic logics.  As shown here, the two tandem 
T domains in PksJ mark the insertion of PUFA logic, and the mupirocin (El-Sayed, Hothersall et 
al. 2003) and macrolactin (Schneider, Chen et al. 2007) polyketide synthases possess analogous 
T domain multiplets at positions that correspond to predicted PUFA-like enoyl reductions.  
Similarly, elsewhere in the dihydrobacillaene assembly line, a second set of two tandem T 
domains marks the insertion of isoprenoid logic (Dorrestein, Bumpus et al. 2006).  Multiplets of 
T domains in polyketide assembly lines may be “scars” of the insertion of such multi-T domain-
dependent machinery, and over the course of pathway evolution, the additional T domains could 
be lost.  The myxovirescin biosynthetic machinery, for example, includes PUFA and isoprenoid-
like enzymes to process substrates tethered to T domain singlets, suggesting the myxovirescin 
assembly line has “sloughed off” the extra T domains resulting from the insertion (Simunovic, 
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Zapp et al. 2006; Calderone, Iwig et al. 2007).  
In many cases, the unsaturation pattern in the product small molecule set by the trans-ER 
has functional consequence.  A striking example of the downstream effects of selective trans 
enoyl reduction is observed in lovastatin biosynthesis, during which a trans acting polyketide ER 
processes selected ketidyl-S-T domain intermediates to yield the specific unsaturation pattern 
necessary for conversion of a linear precursor to the polycyclic lovastatin skeleton (Kennedy, 
Auclair et al. 1999).  We propose that dihydrobacillaene represents a second example of an 
unsaturation pattern serving as a determinant of function.  B. subtilis produces dihydrobacillaene 
as a mixture with its C14′-C15′ olefin congener bacillaene, generated by the post-synthetic C14′-
C15′ desaturation of dihydrobacillaene catalyzed by the cytochrome P450 PksS, a formal 
reversal of PksE catalyzed enoyl reduction (Reddick, Antolak et al. 2007).  It is intriguing to 
speculate that the PksE/PksS reaction couple uses PUFA logic to control the function of the 
bacillaene/dihydrobacillaene ensemble by tuning the ratio of alkane and olefin congeners. 
PksE is the first PUFA-like polyketide enzyme, and PfaD the first marine PUFA enzyme, 
whose enoyl reductase activities have been biochemically confirmed.  The above observations 
reinforce the extreme hybridity of the dihydrobacillaene biosynthetic pathway, wherein multiple 
primary and secondary metabolic strategies converge, including polyketide, non-ribosomal 
peptide (red in Figure 3.16), isoprenoid (blue), and PUFA logics (green) (Calderone, Kowtoniuk 
et al. 2006; Butcher, Schroeder et al. 2007).  The opportunism of the dihydrobacillaene 
machinery in recruiting and cobbling together these disparate biosynthetic strategies in a single 
pathway is reflected in its chimeric structure.  Indeed, as our understanding of secondary 
metabolism continues to improve, the use of multiple biosynthetic logics within a single pathway 
may be considered more of a norm than an exception (Tang, Cheng et al. 2004; Wenzel and 
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Muller 2005).  A key challenge in the future is to learn how we can insert multiple logics into 
preexisting systems and bring the full force of Nature’s biosynthetic ingenuity to access novel 
polyketides and other bioactive products. 
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3.7 FIGURES 
 
 
Figure 3.1  Biosynthesis of bacillaene.  A. Gene cluster responsible for 
dihydrobacillaene/bacillaene biosynthesis.  B. Domain organization of PksJ with predicted 
intermediates shown.  The module 3 and module 4 intermediates were observed by Moldenhauer 
et al.; the module 1 and module 2 intermediates are predicted based on the structure of 
dihydrobacillaene.  The cytochrome P450, PksS, oxidizes the C14′-C15′ bond of 
dihydrobacillaene after biosynthesis to generate bacillaene.   
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Figure 3.2  Adenylation catalyzed by PksJ(A1-T1), as assayed by ATP/PPi exchange.   
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Figure 3.3  Identification of the PksJ(A1-T1) T domain active site peptide.  A.  The apo-T1 active 
site peptide.  Inset:  Magnification of the isotopic distribution for the 4+ charge state of the 
peptide.  B.  The holo-T1 active site peptide.  Insets:  Magnification of the isotopic distribution 
for the 4+ charge state of the peptide and the Ppant ejection ion generated from this species. 
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Figure 3.4  Identification of the PksJ(A1-T1) T domain active site peptide loaded with a variety of 
putative substrates.  A.  Loading of T1 with α-HIC.  B.  Loading of T1 with α-KIC.  C.  Loading 
of T1 with IC.  Note that the results of these initial loading studies do not agree well with the 
results in Figure 3.2. 
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Figure 3.5  Active site peptide mapping of PksJ(A1-T1-C1-A2-T2).  Active site peptides were 
generated by proteolytic digestion with trypsin followed by analysis by RPLC-FTMS.  A. Apo 
active site peptides are observed when apo-PksJ(A1-T1-C1-A2-T2) is incubated with Sfp in the 
absence of CoA.  B.  Holo active site peptides are observed when apo-PksJ(A1-T1-C1-A2-T2) is 
incubated with both Sfp and CoA.  Inset:  Ppant ejection ions observed from each holo peptide 
species.  Theoretical and experimental masses of detected peptides are provided in Table 3.1.  
The high abundance peak at m/z ~1320 is a PksJ peptide unrelated to the T2 active site peptide. 
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Figure 3.6  Dipeptide formation on PksJ(A1-T1-C1-A2-T2).  Shown are the active site peptides 
observed from PksJ(A1-T1-C1-A2-T2)-T2.  A. Holo-T2 is observed when apo-PksJ(A1-T1-C1-A2-
T2) is incubated with Sfp and CoA.  B. Gly-S-T2 is observed when holo-PksJ(A1-T1-C1-A2-T2) is 
incubated with ATP and glycine.  C.  α-KIC-Gly-S-T2 is observed when holo-PksJ(A1-T1-C1-A2-
T2) is incubated with α-KIC, Gly and ATP.  Notice the almost complete conversion from Gly-S-
T2 to α-KIC-Gly-S-T2.  D.  Some α-HIC-Gly-S-T2 is observed when holo-PksJ(A1-T1-C1-A2-T2) 
is incubated with α-Gly, HIC and ATP.  The dipeptide levels observed are less than that of α-
KIC-Gly-S-T2, as seen from the remaining Gly-S-T2 observed.  E.  No IC-Gly-S-T2 is observed 
when holo-PksJ(A1-T1-C1-A2-T2) is incubated with IC, Gly and ATP.  Ppant ejection products 
confirmed all dipeptide intermediates observed (data not shown).  Theoretical and experimental 
masses of detected peptides are provided in Table 3.1. 
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Figure 3.7  Exclusive formation of the α-KIC-Gly dipeptide on PksJ-T2 in the presence of 
competing substrates.  The α-KIC-Gly dipeptide is formed exclusively at T2 when holo-PksJ(A1-
T1-C1-A2-T2) is incubated with α-KIC, IC, α-HIC, and Gly in the presence of ATP, as detected at 
the (A) intact peptide and (B) Ppant ejection ion levels by FTMS.  No Ppant ejection products 
are observed other than from the α-KIC-Gly dipeptide. (N/D – ion not detected). 
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Figure 3.8  Digestion of PksJ(KR-T3-T4) with ArgC to generate mass differentiated T domain 
active site peptides.  A.  Comparison of the masses and sequences of T domain active site 
peptides generated by trypsin and ArgC digestion.  The serine that is phosphopantetheinylated is 
highlighted.  B.  Comparison of the digestion of PksJ(KR-T3-T4) by ArgC in two different 
buffers for varying incubation times.  All reactions were quenched with 10% formic acid at the 
time specified to stop digestion. 
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Figure 3.9  Active site peptide identification of PksJ(KR-T3-T4).  Active site peptides were 
generated by proteolytic digestion with ArgC.  A.  Apo active site peptides are observed when 
apo-PksJ(KR-T3-T4) is incubated in the presence of Sfp and the absence of CoA.  B. Holo active 
site peptides are observed when apo-PksJ(KR-T3-T4) is incubated in the presence of Sfp and 
CoA.  C.  Acac-S-T3 and –T4 are observed when apo-PksJ(KR-T3-T4) is incubated with Sfp and 
Acac-CoA.  D.  Mixtures of Acac-S-T3 and -T4 and α-KIC-GABA-S-T3 and -T4 are observed 
when apo- PksJ(KR-T3-T4) is incubated with Acac-CoA, α-KIC-GABA-CoA, and Sfp.  
Theoretical and experimental masses of detected peptides are provided in Table 3.1. 
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Figure 3.10  Analysis of PksJ ketoreduction by FTMS. A. The KR domain in PksJ(KR-T3-T4) 
can perform β-ketoreduction.  Top:  Active site peptides and Ppant ejection ions observed for 
Acac-S-T3 and -T4 in the absence of NAD(P)H.  Bottom:  Upon the addition of NAD(P)H, a 
mass increase of 2 Da is observed in both the peptides and Ppant ejection ions. B. The KR 
domain of PksJ(KR-T3-T4) can perform α-ketoreduction.  Top:  Active site peptides and Ppant 
ejection ions observed for α-KIC-GABA-S-T3 and –T4 in the absence of NAD(P)H.  Bottom:  
Upon the addition of NAD(P)H, a mass increase of 2 Da is observed in the peptides and Ppant 
ejection ions.  Lines in (A) and (B) denote the most abundant peak in the peptide isotopic 
distribution (solid: absence of NAD(P)H; dash: presence of NAD(P)H). Insets show structures of 
theoretical Ppant ejection ions. 
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Figure 3.11  Qualitative time course of α- and β-ketoreduction catalyzed by PksJ(KR).  PksJ(KR-
T3-T4) was first incubated with Acac-CoA and α-KIC-GABA-CoA, followed by initiation of 
reduction by addition of NAD(P)H.  Ppant ejection ions shown were generated from intact 
PksJ(KR-T3-T4) SA mutant proteins.  A. Time course of α- and β-ketoreduction observed 
using PksJ(KR-T3-T4) S3150A.  B.  Time course of α- and β-ketoreduction observed using 
PksJ(KR-T3-T4) S3248A. 
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Figure 3.12  Determination of the ketoreduction stereochemistry by chiral-HPLC.  A. Acac-S-
PksJ(KR-T3-T4) was subjected to β-ketoreduction, and the resulting 3-hydroxybutyryl (3HB) unit 
was cleaved from PksJ(KR-T3-T4) by the action of the thioesterase TycF.  The 3HB was 
amidated in situ with an amine fluorophore (4-(aminomethyl-6,7-dimethoxycoumarin, AMC), 
and the 3HB-AMC amide was subjected to chiral chromatography to identify the stereochemical 
course of reduction.  B. α-KIC-GABA-S-PksJ(KR-T3-T4) was subjected to α-reduction and 
treated as in (A).  C. The observed stereochemical courses of β- and α-ketoreduction can be 
rationalized by a model in which the substrates are held in similar extended conformations and 
the hydride is delivered from the same face (top as drawn). 
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Figure 3.13  Identification of PksJ(KR-T3-T4) active site peptides.  Peptides were generated by 
digestion with the endoproteinase ArgC and analyzed by RPLC-FTMS.  Left:  PksJ-T3.  Right:  
PksJ-T4.  A.  Apo active site peptides are observed in the presence of Sfp and absence of CoA 
(red).  B. Holo active site peptides are generated in the presence of both Sfp and CoA (green).  C. 
2-butenoyl-loaded active site peptides observed in the presence of Sfp and 2-butenoyl-CoA 
(purple). 
 
 
 
 
 
 
 
 
173 
 
 
 
 
 
Figure 3.14  Identification of PfaA(T1-T2-T3-T4) active site peptides.  Peptides were generated by 
digestion with the endoproteinase ArgC and analyzed by RPLC-FTMS.  Left:  Active site 
peptide from PfaA-T1.  Middle:  Active site peptide from PfaA-T2.  Right:  Active site peptide 
from PfaA-T4.  A.  Apo active site peptides observed in the presence of Sfp but absence of CoA 
(red).  B.  Holo active site peptides are observed when apo-PfaA(T1-T2-T3-T4) is incubated in the 
presence of Sfp and CoA (green).  C.  2-butenoyl-loaded active site peptides are observed when 
apo-PfaA(T1-T2-T3-T4) is incubated with Sfp and 2-butenoyl-CoA (purple).  Despite testing 
multiple digestion conditions, the active site peptide from PfaA(T1-T2-T3-T4)-T3 was not 
observed. 
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Figure 3.15  Expected Ppant ejection ions.  A. Ppant ejection ion from a holo T domain.  B.  
Ppant ejection ion from T domain with unreduced 2-butenoyl substrate bound.  C. Ppant ejection 
ion from T domain with reduced butyryl substrate bound. 
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Figure 3.16  Enoyl reduction during bacillaene biosynthesis.  A.  Structure of dihydrobacillaene.  
C, condensation; A, adenylation; HCS, HMG-CoA synthase; ECH, enoyl-CoA hydratase.  B.  
PksE reduces an enoyl substrate tethered to the two tandem T domains inPksJ in trans.   
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Figure 3.17  Confirmation of PksE(AT-ER) enoyl reductase activity.  (Left) PksJ-T3 active site 
peptide.  (Middle)  PksJ-T4 active site peptide.  (Right)  Ppant ejection ions.  Vertical lines 
correspond to the most abundant isotopic peak (solid: absence of PksE, dash: presence of PksE). 
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Figure 3.18  A. Enoyl reduction is efficiently catalyzed by the PksE-ER.  (Left) PksJ-T3 active 
site peptide.  (Middle) PksJ-T4 active site peptide.  (Right) Ppant ejection ions.  Vertical lines in 
(A) correspond to the most abundant isotopic peak (solid: absence of NADPH; dash: presence of 
NADPH).  B. PksC and PksE-AT efficiently load several dihyrobacillaene associated T domains 
(PksJ, PksL, AcpK) with 2-14C-malonate.  C, including PksC; E, including PksE; -, no trans-AT.  
(Left) Coomassie-stained gel.  (Right) Autoradiogram. 
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Figure 3.19  PksE does not show enoyl reductase activity towards PksJ(A1-T1).  PksJ(A1-T1) is 
not predicted to be a scaffold for enoyl reduction.  A.  Holo-PksJ(A1-T1) (green) is observed 
when apo-PksJ(A1-T1) is incubated with Sfp and CoA.  B. 2-butenoyl-S-PksJ(A1-T1) (purple) is 
observed when apo-PksJ(A1-T1) is incubated with Sfp in the presence of 2-butenoyl-CoA.  C. No 
enoyl reduction is observed when 2-butenoyl-S-PksJ(A1-T1) is incubated with PksE in the 
absence of NADPH.  D.  No enoyl reduction is observed when 2-butenoyl-S-PksJ(A1-T1) is 
incubated with PksE in the presence of NADPH.  E.  No enoyl reduction is observed when 2-
butenoyl-S-PksJ(A1-T1) is incubated with PksE(ER) in the presence of NADPH.  The theoretical 
mass shift between holo-PksJ (A1-T1) and 2-butenoyl-S-PksJ(A1-T1) is 68.03 Da.  The theoretical 
mass shift is 70.04 Da if enoyl reduction occurs. 
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Metabolite PUFA-ER homologue Homology to PfaD 
Dihydrobacillaene PksE (AT-ER) 47% identical/65% similar 
Onnamide PedB (ER) 53%/73% 
Myxovirescin TaN (ER) 52%/72% 
Mupirocin MmpIII (AT-ER) 50%/69% 
Leinamycin LnmG (AT-ER) 51%/71% 
Macrolactin MlnA (AT-ER) 47%/66% 
 
Figure 3.20  Polyketide metabolites with PUFA-like enoyl reductases.  The sites of predicted 
PUFA enoyl reduction are highlighted in yellow. 
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Figure 3.21  Enoyl reduction during PUFA biosynthesis.  A. Domain organization in a 
prototypical PUFA biosynthetic cluster.  The number of consecutive T domains (n) can vary; in 
S. oneidensis, n = 4.  B. Confirmation of PfaD enoyl reductase activity.  (Left)  PfaA-T1 active 
site peptide.  (Middle left)  PfaA-T2 active site peptide.  (Middle right)  PfaA-T4 active site 
peptide.  (Right)  Ppant ejection ions. Vertical lines in (B) correspond to the most abundant 
isotopic peak (solid: absence of NADPH; dash: presence of NADPH). 
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3.8 TABLES 
Table 3.1  Primers used for cloning during the study of bacillaene biosynthesis.  The restriction sites are underlined. 
Gene 
Restriction 
Enzyme Primer Sequence 
      
pksJ(A1-T1-C1-A2-T2)  NdeI GTACGCTAGCAGAAATAATGATAATATCCGCATATTAAC 
  XhoI CTAGCTCGAGATCGCCCATTCGCTGTTCAGTGATG 
pksJ(KR-T3-T4)  NheI GGAATTCCATATGTCAACACGGCACGAACGCTTAATGC 
  XhoI GATCCTCGAGGGTCAAATACTCAGCCAGGCTGTGG 
pfaA(T4) NdeI GGAATTCCATATGGCCTTGCAGCAAATCGAGCACGCTATGC 
  XhoI GGTTAACCTCGAGTTAACCAGCATAGAGGGCGACAATTTCACC 
pfaD NdeI GGTTAACCATATGACGAATACCACACTCGATAATAACGC 
  XhoI GGTTAACCTCGAGGCAGCGTTGCAGAGGTTTCCAACGTTG 
pksE(AT-ER) NheI GATCGCTAGCATTACATATGTCTTTCCAGGGCAAG 
  XhoI GATCCTCGAGAACTTTTATTTTTATGTTGTCTCTTTCATG 
pksE(ER) NheI GTACGCTAGCGGGATTACGGCAGAATCTTTAGGAAGTG 
  XhoI GATCCTCGAGAACTTTTATTTTTATGTTGTCTGTTTCATG 
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Table 3.2  Theoretical and experimental masses of active site peptides observed during analysis of PksJ loading and α- and β-
ketoreduction.  All masses are reported in Da and all errors in parts-per-million (ppm).  N.D.: not detected. 
PksJ(KR-T3-T4)-T4 8850.35   8850.35   0.00   9190.45   9190.45   0.00 
PksJ(A1-T1-C1-A2-T2)-T1 3595.93   3595.84   -25.03   3936.07   3935.93   -35.57 
PksJ(A1-T1-C1-A2-T2)-T2 10227.14   10227.12   -1.96   10567.24   10567.18   -5.68 
                          
  
Acac-S-T 
 
Acac-S-T 
 
Acac-S-T 
 
KIC-GABA-
S-T 
 
KIC-GABA-S-
T 
 
KIC-GABA-
S-T 
Active Site Peptide Theor   Exp   Error    Theor   Exp   Error  
PksJ(KR-T3-T4)-T3 11664.69   11665.70   86.59   11777.78   11777.76   -1.70 
PksJ(KR-T3-T4)-T4 9274.47   9274.41   -6.47   9387.56   9387.56   0.00 
                          
  
α-HIC-S-T 
 
α-HIC-S-T 
 
α-HIC-S-T 
 
α-KIC-S-T 
 
α-KIC-S-T 
 
α-KIC-S-T 
Active Site Peptide Theor   Exp   Error    Theor   Exp   Error  
PksJ(A1-T1-C1-A2-T2)-T1 4050.09   4049.97   -29.63   4050.07   N.D.   - 
PksJ(A1-T1-C1-A2-T2)-T2 -   -   -   -   -   - 
                          
  
IC-S-T 
 
IC-S-T 
 
IC-S-T 
 
Gly-S-T 
 
Gly-S-T 
 
Gly-S-T 
Active Site Peptide Theor   Exp   Error    Theor   Exp   Error  
PksJ(A1-T1-C1-A2-T2)-T1 4034.09   4033.98   -27.27   -   -   - 
PksJ(A1-T1-C1-A2-T2)-T2 -   -   -   10624.15   10624.08   -6.59 
                          
  
α-HIC-Gly-
S-T 
 
α-HIC-Gly-S-
T 
 
α-HIC-Gly-
S-T 
 
α-KIC-Gly-S-
T 
 
α-KIC-Gly-S-T 
 
α-KIC-Gly-S-
T 
Active Site Peptide Theor   Exp   Error    Theor   Exp   Error  
PksJ(A1-T1-C1-A2-T2)-T2 10738.23   10738.26   2.79   10736.31   10736.08   -21.42 
                          
  
IC-Gly-S-T 
 
IC-Gly-S-T 
 
IC-Gly-S-T 
      Active Site Peptide Theor   Exp   Error  
      
             PksJ(A1-T1-C1-A2-T2)-T2 10722.23   N.D.    -  
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Table 3.3  Active site peptides observed during analysis of PksE and PfaD enoyl reduction.  All 
masses are reported in Da and as the monoisotopic mass of the peptide.  All mass errors are 
reported in ppm.  
 
#Active site peptide with one N-terminal missed cleavage.   
$Active site peptide could correspond to PfaA(T1-T2-T3-T4)-T4 as well, but is identified at PfaA(T1-T2-T3-T4)-T2 due 
to observation of authentic PfaA(T1-T2-T3-T4)-T4 peptide and observation in a truncated form of PfaA. 
%Active site peptide with one N-terminal missed cleavage and one C-terminal missed cleavage.   
Theor; theoretical mass; Exp: experimental mass, N.D.: peptide not detected 
  
Apo 
 
Apo 
 
Apo 
 
Holo 
 
Holo 
 
Holo 
Active Site Peptide Theor   Exp   Error    Theor   Exp   Error  
             PksJ(KR-T3-T4)-T3# 11240.57   11241.51   83.63   11580.67   11581.71   89.80 
             PksJ(KR-T3-T4)-T4 8850.35   8850.35   0.00   9190.45   9190.45   0.00 
             PfaA(T1-T2-T3-T4)-T1 4958.40   4958.40   0.00   5298.49   5298.49   0.00 
             PfaA(T1-T2-T3-T4)-T2$ 3758.80   3758.79   -2.66   4098.89   4098.88   -2.44 
             PfaA(T1-T2-T3-T4)-T3 8503.24   N.D.   -   8843.33   N.D.   - 
             PfaA(T1-T2-T3-T4)-T4% 8790.33   8790.32   -1.14   9130.42   9130.40   -2.19 
            
 
 
2-butenoyl-S-T 
 
2-butenoyl-S-T 
 
2-butenoyl-S-T 
Active Site Peptide Theor   Exp   Error  
       PksJ(KR-T3-T4)-
T3# 11648.70   11649.68   84.31 
       PksJ(KR-T3-T4)-T4 9258.48   9258.45   -3.24 
       PfaA(T1-T2-T3-T4)-
T1 5366.52   5366.50   -3.73 
       PfaA(T1-T2-T3-T4)-
T2$ 4166.91   4166.91   0.00 
       PfaA(T1-T2-T3-T4)-
T3 8911.35   N.D.   - 
       PfaA(T4)-T4% 9198.45   9198.43   -2.17 
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CHAPTER 4: A PROTEOMICS APPROACH TO DISCOVERY OF NATURAL 
PRODUCTS AND THEIR BIOSYNTHETIC PATHWAYS, PART 1 
 
A portion of the information and contents of this chapter were taken from the following article 
with permission from the publisher: Stefanie B. Bumpus, Bradley S. Evans, Paul M. Thomas, 
Ioanna Ntai and Neil L. Kelleher (2009). “A proteomics approach to discovery of natural 
products and their biosynthetic pathways.” Nature Biotechnology, 27(10):951-956. 
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expression in Escherichia coli, B. brevis, and S. lividans (except gel-based analysis of B. brevis), 
assisted in development of nanoLC-MS methods, prepared samples for the analysis NK2018 and 
completed the identification and characterization of novel natural products discovered from the 
strain, isolated all strains from soil collected in Wisconsin and performed all reported work on 
those strains.  Brad Evans developed the gel-based PrISM platform, isolated all strains from soil 
collected in Louisiana, directed the development of nanoLC-MS platforms, developed the 
genomic methods in PrISM and directed their application in NK2018 and is currently very active 
in the application of PrISM to additional Bacillus isolates.  Paul Thomas was instrumental in 
development of LC-MS platforms for PrISM and performed the gel-based and nanoLC-MS 
analysis of strain NK2018; Dr. Thomas also developed the pseudo-MS3 assay for Ppant ejection.  
Ioanna Ntai assisted in the identification of small molecules produced by strain NK2018 and is 
currently very active in the application of PrISM to additional organisms and in the development 
of improved separations platforms for PrISM. 
 As a technical note, in all Chapters 4 and 5 figures and text, Ppant ejection product 
masses are reported as the mass (in Da) of the 1+ Ppant ejection ion.  All peptide masses are 
reported as the neutral monoisotopic mass (in Da).   
4.2 INTRODUCTION 
Over half of the nearly 1000 new chemical entities introduced as antibacterial or 
anticancer drugs over the twenty-five years from 1981 to 2006 are natural products or derivatives 
thereof (Newman and Cragg 2007). However, traditional bioassay-guided discovery strategies, 
where an iterative cycle of metabolite fractionation and bioassay panels attempts to isolate the 
chemical compound responsible for the observed bioactivity (Weinstein and Wagman 1978), 
tend to rediscover known compounds most of the time. Systems biology approaches—such as 
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genomics, transcriptomics and metabolomics—are now being adapted to update natural product 
discovery platforms and bypass this so called dereplication bottleneck (see Section 1.4 for 
detailed descriptions). These strategies continue to evolve as more microbial genomes become 
available, and the availability of more sequenced genomes facilitates use of bioinformatics to 
predict the organisms’ biosynthetic potentials.  
There have been cases where sequence-based approaches have successfully guided the 
search for new natural products (Lautru, Deeth et al. 2005; Knappe, Linne et al. 2008).  
Nonetheless, there remains a great disparity between the genetic potential for natural product 
production and the actual expression of biosynthetic gene clusters under laboratory culture 
conditions to produce a useful metabolite. Although several reports demonstrate diverse methods 
to force expression of ‘cryptic’ gene clusters, accessing novel compounds and the enzymes that 
make them is still a low-throughput affair (Bode, Bethe et al. 2002; Zazopoulos, Huang et al. 
2003; Brakhage, Schuemann et al. 2008). Discovery of secondary metabolites with new scaffolds 
and/or clinically relevant antibiotic, immunosuppressive and antiproliferative properties remains 
the primary constraint to progress in this field.  
In developing a complementary approach to address these problems, we set out to 
circumvent the bias that arises when screening against only one drug target or indicator cell line 
by bioassay-based screening, and to develop a strategy that identifies robustly expressed genes 
without the requirement for DNA sequence information a priori. Our method, called PrISM 
(Proteomic Investigation of Secondary Metabolism; Figure 4.1), permits targeted detection of 
peptides produced non-ribosomally (NRPs) and polyketides (PKs) produced by non-ribosomal 
peptide synthetases (NRPSs) and/or polyketide synthases (PKSs) with simultaneous 
identification of the gene cluster responsible for synthesis of the natural product. Tandem 
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discovery of a gene cluster and its associated secondary metabolite can expedite the downstream 
goal of pathway engineering to improve yield, bioactivity or bioavailability (Du, Sanchez et al. 
2001; Baltz 2008).  
Multi-modular NRPS and PKS enzymes are enormous (often >200 kDa) and have many 
domains that act as a molecular assembly line to create complex natural product scaffolds 
(Fischbach and Walsh 2006). The various domains are responsible for substrate activation, 
condensation and tailoring, while the growing natural product is covalently tethered to carrier 
regions, also called thiolation (T) domains, that uniformly harbor a phosphopantetheinyl (Ppant) 
cofactor bound to a serine residue in their active sites (Lambalot, Gehring et al. 1996). 
In even the earliest implementations of mass spectrometry (MS) to detect covalent 
intermediates on the thiotemplate family of NRPS/PKS enzymes, the facile release of the Ppant 
cofactor was noted; its phosphodiester linkage is labile during tandem MS (MS/MS) (Stein, 
Vater et al. 1994), which is conceptually similar to the ion chemistry used in modern 
phosphoproteomics (Carr, Annan et al. 2005).  More recently, mass spectrometry has revealed a 
great diversity of covalent chemistry occurring on NRPS and PKS enzymes in vitro, with the 
Ppant ejection assay now established for single enzymes using liquid chromatography–mass 
spectrometry (LC-MS) (Figure 4.2) (Dorrestein, Bumpus et al. 2006; Dorrestein and Kelleher 
2006). The Ppant ejection assay specifically transforms covalent intermediates attached to large 
enzymes into small ions where detection by mass spectrometry is both sensitive and accurate.  
This makes the unambiguous assignment of empirical formula easy to achieve. Benchtop 
(Meluzzi, Zheng et al. 2007) and high performance Fourier transform mass spectrometers 
(FTMS) (e.g. (Crawford, Thomas et al. 2008)) have both been used to investigate NRPS and 
PKS intermediates in reconstituted systems. A mass accuracy of <2 ppm of FTMS for ions 
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diagnostic of Ppant (that is, m/z 261.1267 and m/z 359.1036) translates into high selectivity for 
detection of Ppant containing peptides in complex proteomes (Figure 4.1C) and forms one aspect 
of the integrated approach described here. Combining with Ppant ejection assay with traditional 
proteomics methods, we can confidently target NRPS and/or PKS biosynthetic systems in a 
complex proteome. 
 In very general terms, the PrISM platform seeks to identify holo T domain active site 
peptides from producers of secondary metabolites using the on-line Ppant ejection assay, convert 
the sequences of those T domain peptides and other detected peptides into PCR primers to gain a 
hook into the genome of the organism, and use this combined proteomic and genomic 
information to guide the search for the natural product produced.  Specifically, bacterial strains 
known or suspected to produce NRPs and/or PKs are grown in liquid culture and the soluble 
proteome of the organism is collected at one or multiple growth time points (Figure 4.1A).  The 
proteomes of the organisms are screened for the presence of high molecular weight proteins 
(HMWPs), indicative of the expression of NRPSs and PKSs (Figure 4.1B).  Those strains that 
are HWMP positive (HMWP+) are selected for further analysis and the proteomes are 
proteolytically digested with trypsin and subjected to Bottom Up proteomics (Bogdanov and 
Smith 2005) using LC-MS/MS and the on-line Ppant ejection assay to determine if NRPS and/or 
PKS proteins are expressed (Figure 4.1C).  The identified NRPS or PKS peptides are used to 
generate sets of degenerate nucleotide probes for polymerase chain reactions (PCRs); the 
sequences of these PCR products provide a hook into the genome of an organism, even if no 
prior genome sequence is known (Figure 4.1D-E).  Once the entire gene cluster sequence is 
determined, it guides the search for the natural product produced based upon the colinearity rules 
of NRPS and PKS biosynthesis (Fischbach and Walsh 2006) (Figure 4.1F). 
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Contained within is a detailed description of the development of PrISM and its successes 
in discovery mode.  In Chapter 4, I describe the initial developments of the PrISM platform, 
including testing of a variety of separation methods for simplification of complex proteome 
samples, analyzing methods for increasing the amount of holo protein (and thus observable Ppant 
ejection ions) and application of the platform to proof-of-concept systems.  This chapter focuses 
on initial proof-of-concept experiments that set the stage for implementation of PrISM in 
discovery mode.  In Chapter 5, I discuss the continued optimization of the PrISM platform to 
successfully probe bacterial strains for their natural product biosynthetic capacity. 
4.3 EXPERIMENTAL  
4.3.1 Materials  
Trypsin (TRL3) for digests of bacterial proteomes was purchased from Worthington 
Biochemicals. Sequencing grade trypsin (Promega) was used for all in-gel digestions. 
Escherichia coli BL21(DE3) cells were purchased from EMD Biosciences. All other chemicals 
used were purchased from either ThermoFisher Scientific or Sigma-Aldrich
 This general procedure was applied to both proteins unpurified from E. coli or to native 
natural product producer proteomes.  Cells were grown under the conditions described for 
specific samples, lysed by passage through a French press or by sonication, and the soluble 
lysate collected by centrifugation (1 h, 4 °C, 47,000 x g).  Streptomycin sulfate was added to a 
final concentration of 5 mg/mL and incubated on ice for 20 min.  The soluble fraction was 
collected by centrifugation (15 min, 4 °C, 47,000 x g).  The soluble fraction was then used for 
 unless otherwise 
noted. 
4.3.2 Preparation of Samples by Streptomycin Sulfate Precipitation and Ammonium Sulfate 
Precipitation 
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further ammonium sulfate precipitation. 
 For general ammonium sulfate precipitation (not for sample fractionation), ammonium 
sulfate was added to the soluble fraction to a final saturation level of 80% (0.8 g/mL) and 
incubated on ice for 30 min.  The soluble fraction was collected by centrifugation (15 min, 4 °C, 
47,000 x g).  The supernatant was saved and the pellet was resuspended in buffer A (50 mM Tris 
(pH 7), 10% v:v glycerol, 1 mM dithiothreitol (DTT) and 0.25 mM EDTA).  The sample was 
dialyzed overnight using 3.5 kDa molecular weight cutoff (MWCO) Slide-a-Lyzer dialysis 
cassettes (ThermoFisher Scientific) and then concentrated to <5 mL using Vivaspin 20 3.5 kDa 
MWCO centrifugal concentrators (Millipore).  The protein concentration was determined by the 
Bradford assay (Bradford 1976). 
 For proteome fractionation by ammonium sulfate precipitation (Spitnik-Elson 1963), 
cells were lysed by either passage through a French press or sonication on ice.  The soluble 
lysate was collected by centrifugation (4 °C, 1 h, 47,000 x g) and subjected to streptomycin 
sulfate precipitation as described above.  Ammonium sulfate was first added at a final 
concentration of 30% w/v, allowed to incubate on ice 30 min, and the precipitated protein was 
collected by centrifugation (4 °C, 20 min, 47,000 x g).  The soluble fraction was transferred to a 
new vial, and ammonium sulfate was supplemented to reach a final concentration of 40% w/v, 
followed by incubation, centrifugation and soluble fraction transfer as before.  This was repeated 
until ammonium sulfate final concentrations of 50%, 60%, 70% and 80% w/v had been achieved.  
The precipitated proteins from each step were resuspended in 2 mL buffer A and stored at -80 
°C. 
4.3.3 Separation of Intact Proteins by Size Exclusion Chromatography 
 All size exclusion chromatography (SEC) was conducted using a Sephacryl S200 column 
197 
 
(GE Healthcare, 2.6 x 60 cm) and an AKTA Purifier FPLC system (GE Healthcare) coupled to a 
fraction collector at a constant flow rate of 0.5 mL/min.  Fractions were collected every 6 min.  
The column was preequilibrated with SEC solvent A (50 mM Tris (pH 7.5), 1 mM DTT, 0.25 
mM EDTA, 10% v:v glycerol, 0.15 mM NaCl).   After the sample was injected, SEC solvent A 
was flowed through the column for 360 min and fractions were collected after 150 min.  The 
protein content of the collected fractions was analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) using precast gels (4-20% T Tris-HCl, Bio-
Rad, 10 lane, 30 µL/lane).  The gels were stained with a previously published silver staining 
protocol (Gatlin, Kleemann et al. 1998). 
B. brevis ATCC 9999 samples were prepared by inoculation of 1 L YP + NaCl medium 
(per L: 9 g peptone, 5 g yeast extract, 5 g NaCl (pH 7.2–7.25)) with 10 mL of an overnight B. 
brevis culture in the same medium, and grown until the entrance to stationary phase as monitored 
by O.D.600 measurements (Figure 4.3).  Previous reports have shown that maximal production of 
the natural product gramicidin S produced by B. brevis occurs during the entry to stationary 
phase (Matteo 1975).  The cultures were harvested by centrifugation (4 °C, 10 min, 4,200 x g) 
and the cells were resuspended in 9 mL buffer A plus 1 mg/mL lysozyme and incubated for 30 
min on ice.  The cells were lysed by 2 passages through a French press. The soluble lysate was 
collected by centrifugation (4 °C, 30 min, 47,000 x g).  Streptomycin sulfate and ammonium 
sulfate precipitations were completed as described previously.  The precipitate from ammonium 
sulfate precipitation was collected by centrifugation (4 °C, 30 min, 47,000 x g) and resuspended 
in 3 mL buffer A.  The resuspended protein was stored at -80 °C until separation by SEC. 
4.3.4 Overexpression of MycA in E. coli 
 The cloning of MycA10 is described in Section 2.4.  mycA10-pET-28A was transformed 
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into E. coli BL21(DE3) and plated on Luria-Burtani medium (LB) agar plates supplemented with 
kanamycin (50 µg/mL final concentration).  A single colony was selected and used to inoculate 
50 mL LB plus kanamycin (25 µg/mL final concentration) and grown overnight at 37 °C with 
shaking at ~200 rpm.  Ten mL of this starter culture were used to inoculate 2 X 1 L LB 
supplemented with kanamycin (50 µg/mL final concentration) and grown for 4 h at 37 °C at 
~250 rpm (to an O.D.600 of ~0.7).  At this time, MycA10 expression was induced with 1 mL of 1 
M isopropyl-β-D-1-thiogalactopyranoside (IPTG) and grown overnight at 18 °C.  The cultures 
were harvested by centrifugation (4,200 x g, 10 min, 4 °C), the supernatant discarded, and the 
cells resuspended in 15 mL of buffer A.    The resuspended cells were lysed by sonication (4 
cycles of 30 s sonication followed by 30 s rest on ice) and the soluble lysate collected by 
centrifugation (47,000 x g, 1 h, 4 °C).  The sample was split into two fractions of equal volumes 
(sample A and sample B).  Sample A was transferred to a 3-12 mL dialysis cassette (3.5 kDa 
MWCO Slide-a-Lyzer, ThermoFisher Scientific) and dialyzed overnight into 25 mM Tris (pH 
7.5) plus 10% v:v glycerol.  The dialyzed sample was transferred to a 3.5 kDa MWCO Vivaspin 
20 centrifugal concentrator (Millipore) and concentrated by centrifugation to <5 mL.  The total 
protein concentration of the sample was determined by the Bradford assay (Bradford 1976). 
Sample B was prepared by precipitating nucleic acids with streptomycin sulfate (final 
concentration of 5 mg/mL) followed by precipitation with ammonium sulfate using the protocol 
described previously.  The ammonium sulfate precipitated pellet was resuspended in 20 mL 
buffer A and dialyzed overnight in a 20 mL dialysis cassette (3.5 kDa MWCO Slide-a-Lyzer, 
ThermoFisher Scientific) into 25 mM Tris (pH 7.5) plus 10% v:v glycerol.  The dialyzed sample 
was transferred to a 3.5 kDa MWCO Vivaspin 20 centrifugal concentrator (Millipore) and 
concentrated by centrifugation to <5 mL.  The total protein concentration of the sample was 
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determined by the Bradford assay (Bradford 1976). 
4.3.5 Phosphopantetheinylation Assays Using BODIPY-FL-N-(2-aminoethyl)-maleimidyl-S-
coenzyme A  
 BODIPY-FL-N-(2-aminoethyl)-maleimidyl-S-coenzyme A (BODIPY-CoA) was 
synthesized by B.S. Evans according to previously published protocols (Meier JL 2008).  The 
following protocol applies to all samples, including purified, recombinant proteins and full 
proteomes.  200 µg of total protein was incubated in 50 mM Tris (pH 8) and 10 mM MgCl2 with 
2 µL of 10 mg/mL Sfp (Quadri, Weinreb et al. 1998) and 3 µL of 10 mg/mL BODIPY-CoA in a 
final volume of <100 µL.  The reaction was incubated at 30 °C for 3 h and then quenched by 
freezing.  Fifteen µL of the reaction was added to 15 µL of 2X SDS-PAGE loading buffer (50 
mM Tris (pH 6.8), 20% v/v glycerol, 4% w/v SDS, 0.2% w/v bromophenol blue) and loaded on a 
4-20% T Tris-HCl SDS-PAGE gel (Bio-Rad, 10 lane, 30 µL/lane).  The gel was visualized using 
a laser scanner at an excitation wavelength for the BODIPY fluorophore (500 nm).  The gel was 
then stained with Coomassie blue overnight and then destained to visualize the total protein in 
the sample (staining solution: 0.1% w/v Coomassie brilliant blue, 10% v/v glacial acetic acid, 
50% v/v methanol (MeOH) in H2O; destaining solution: 10% v/v glacial acetic acid, 50% v/v 
MeOH in H2O). 
4.3.6 Precipitation of Samples Using the Universal Protein Precipitation Agent 
 Three mg of E. coli soluble proteome containing overexpressed apo-MycA10 was 
incubated in 50 mM HEPES (pH 8), 40 mM NaCl, 10 mM MgCl2, and 2 mM DTT with 10 μL of 
10 mg/mL Sfp (Quadri, Weinreb et al. 1998) and 10 μL of 10 mg/mL CoA for 3 h at 30 °C (final 
reaction volume of 200 μL); the reaction was completed in duplicate.  One of the reactions was 
left in the reaction buffer, while the other was precipitated and resuspended using the Universal 
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Protein Precipitation Agent (UPPA, G-Biosciences) according to the manufacturer’s instructions 
(final resuspension in 60 mM Tris (pH 7.5), resuspended overnight at 30 °C); 6 M urea was 
supplemented in the resuspension as necessary.  The holo, unprecipitated reaction was added to 
200 μL of 0.1 M NH4HCO3 (pH 7.8) and 20 μL of 25 μg/μL trypsin and incubated at 30 °C 
overnight.  The resuspended UPPA precipitated reaction was added to 300 μL 0.1 M NH4HCO3 
(pH 7.8) and 20 μL of 25 µg/µL trypsin and incubated overnight at 30 °C.  The reactions were 
frozen at -80 °C until SCX analysis. 
4.3.7 Strong Cation Exchange Chromatography, Reverse Phase Liquid Chromatography and 
FTMS of MycA10 in E. coli 
 Strong cation exchange chromatography (SCX) was conducted using a Polysulfoethyl A 
column (Poly LC, 4.6 mm x 200 mm, 300 Å, 5 µ) and SCX solvents A (20 mM citric acid (pH 
2.65), 25% acetonitrile (MeCN)) and B (20 mM citric acid (pH 2.65), 1 M NH4Cl, 25% MeCN).  
An Agilent HP1100 binary pump HPLC was used for all SCX analysis of MycA10.  The 53 
minute gradient was as follows:  0-3min, 0% B; 3-23 min, linear ramp to 25% B; 23-33 min, 
linear ramp to 45% B; 33-43 min, linear ramp to 75% B, 43-48 min, ramp to 100% B; 48-49 
min, hold at 100% B, 49-50 min, ramp to 0% B, 50-53 min, hold at 0% B.  The gradient was 
followed by at least 30 min of re-equilibration at 0% B.  Reverse phase LC-MS (RPLC-MS) was 
conducted as described in Sub-subsection 4.3.9.4. 
4.3.8 Cloning of GrsA PheAT 
Cloning of GrsA PheAT and Sfp was completed by B.S. Evans according to standard 
procedures. Sfp was amplified using the following primers: 
Forward: 5’-CCATATGATGAAGATTTACGGAATTTAT ATGGAC-3’ and  
Reverse:  5’-CCTGGTACCTTATAAAAGCTCTTCGTACGAGACC-3’  
201 
 
containing the NdeI and KpnI restriction sites, respectively. PheAT was amplified using primers: 
Forward: 5’-ATATCCATGGTAAACAGTTCTAAAAG-3’ and  
Reverse: 5’-ATCGGATCCATTTGGTCTATACAAC-3’  
containing the NcoI and BamHI restriction sites, respectively. The plasmid is identified as pET-
Duet-1 PheAT-His6 Sfp. 
4.3.9 Sample Preparation and Analysis Employing Optimized Two-dimensional LC-based 
PrISM 
4.3.9.1 Preparation of samples for proteomic investigations of PheAT 
100 mL of LB broth supplemented with ampicillin (final concentration of 100 µg/mL) 
was inoculated with one colony of E. coli BL21(DE3) transformed with pET-Duet-1 PheAT-His6 
Sfp and grown overnight at 37 °C with shaking at 225 rpm. Ten mL of the starter culture was 
added to 1 L of LB supplemented with ampicillin (final concentration 100 µg/mL) and placed at 
37 °C with shaking at 225 rpm until an O.D.600 of ~0.6. At this time, the incubation temperature 
was dropped to 20 °C and IPTG was added to a final concentration of 1 mM. The culture was 
incubated with shaking at 18 °C for an additional 20 h, at which time 500 mL cell culture were 
harvested by centrifugation (10 min, 4 °C, 4,400 x g). Cell pellets were resuspended in buffer B 
(25 mM Tris-HCl (pH 7.5–7.8)) and lysed by sonication (4 cycles of 30 s sonication followed by 
30 s rest on ice). The soluble lysate was collected by centrifugation (30 min, 4 °C, 47,810 x g). 
Protein concentration of the soluble lysate was determined by the Bradford assay (Bradford 
1976). Five mg of protein were digested in a reaction mixture of 0.05 M NH4HCO3 (pH 7.8), 3 
M urea and trypsin (ratio of 1:10 total trypsin: substrate) by incubating at 30 °C for 20 min, and 
the reaction was quenched by freezing at –80 °C or by the addition of SCX solvent A. 
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4.3.9.2 Preparation of B. brevis samples 
B. brevis, purchased from the American Type Culture Collection (B. brevis ATCC 9999)
S. viridochromogenes DSM 40736 was grown on solid 
, 
was grown on nutrient agar plates overnight at 37 °C. One colony from growth was selected and 
added to 50 mL YP + NaCl growth media and incubated with shaking at 250 rpm at 37 °C 
overnight. Ten mL of the starter culture were added to 2 L YP + NaCl and placed at 30 °C with 
shaking at 250 rpm. The O.D.600 of the culture was monitored to determine when cells were to be 
harvested, and after ~15 min of identical O.D.600 measurements (indicating stationary phase, ~8 h 
after culture inoculation) cells were harvested by centrifugation (10 min, 17,600 x g, 4 °C). Cell 
pellets were resuspended in buffer B and lysed by sonication (4 cycles of 30 s sonication 
followed by 30 s rest on ice). The soluble lysate was collected by centrifugation (15 min, 4 °C, 
47,810 x g). Protein concentration was determined by the Bradford assay (Bradford 1976). Five 
mg of protein were digested in a reaction mixture of 0.05 M NH4HCO3 (pH 7.8), 3 M urea, and 
trypsin (ratio of 1:10 trypsin: substrate) by incubating at 30 °C for 20 min, and the reaction was 
quenched by freezing at –80 °C or addition of SCX solvent A. 
4.3.9.3 Preparation of S. viridochromogenes samples 
ISP2 medium (Difco) for 4–5 d at 
30 °C. One colony was selected and added to 15 mL of MYG media (1 L contains 10 g malt 
extract, 4 g yeast extract, 4 g glucose (pH 7.3)) in a baffled flask and grown for 4–5 d at 30 °C 
with shaking at 225 rpm. Seven mL of the starter culture was fully homogenized using a sterile 
glass homogenizer and added to 1 L MYG. The culture was incubated at 30 °C with shaking at 
225 rpm until significant phosphinothricin tripeptide (PTT) production was observed by 
bioassay. Protocols for performing the bioassay for PTT production have been described 
previously (Blodgett, Zhang et al. 2005). In brief, B. subtilis ATCC 6633 was grown in minimal 
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medium (1 L contains 3 g KH2PO4, 7 g K2HPO4, 0.5 g sodium citrate-dihydrate, 0.1 g MgSO4-
7H2O, 1 g (NH4)2SO4, and 2 g glucose) at 37 °C until an O.D.600 of ~0.4. 200 µL of the culture 
was plated on minimal media (same recipe as above, with addition of 12 g agar/L). Six mm 
paper disks were placed on top of the plated lawn, and 9 µL of supernatant from S. 
viridochromogenes growth was placed on the disk (9 µL of MYG media was used as a control). 
The plates were placed at 37 °C for overnight growth and monitoring of PTT production. The 
bioassays were performed daily after the first overnight growth of the 1 L cultures. After PTT 
production was observed, cells were harvested by centrifugation (20 min, 4 °C, 17,600 x g) and 
resuspended in buffer B. Cells were lysed by two passages through a French press operating at 
high pressure, and the soluble lysate was collected by centrifugation (45 min, 4 °C, 47,810 x g).  
Trypsin digests were performed as previously described. 
4.3.9.4 SCX-RPLC-MS/MS analysis of PheAT, B. brevis and S. viridochromogenes samples 
SCX chromatography was carried out using a Shimadzu Prominence high performance 
(HP)LC. The column used for SCX analysis was a Polysulfoethyl A column (PolyLC) with a 4.6 
mm inner diameter and a length of 200 mm. The column was equilibrated for 60 min with SCX 
solvent B followed by equilibration for 30 min with SCX solvent A at a flow rate of 1 mL/min 
prior to each analysis.  An entire tryptic digest was loaded onto the SCX column and eluted with 
a step gradient (Table 4.1) using SCX solvents A and B flowing at 0.5 mL/min. Fractions were 
collected every 2 min in 96 well plates and analyzed by FTMS immediately or stored at –20 °C 
until further analysis. SCX fractions were subjected to RPLC-MS/MS according to the following 
method. On-line RPLC-MS/MS data were collected using a ThermoFisher 12 T LTQ-FT Ultra 
coupled to an Agilent autosampler and Agilent HP1100 binary pump HPLC system. The 
columns used for all RPLC analysis were Jupiter C18 or C4 1 mm × 150 mm columns 
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(Phenomenex). The gradient used for all RPLC analysis is provided in Table 4.2, with RPLC 
solvent A being H2O + 0.1% formic acid and RPLC solvent B being MeCN + 0.1% formic acid 
flowing at 100 µL/min. 150–300 µL of each SCX fraction was injected onto the RPLC column 
for MS analysis. 
4.3.9.5 Parameters for MS analysis 
All MS methods included the following events: (i) FT scan, m/z 500–2,000, (ii) FT scan, 
nozzle-skimmer dissociation (75V), detect m/z 200–600, (iii) data-dependent MS/MS on the top 
X (X = 3 for high-resolution MS/MS data collection and X = 6 or 10 for unit resolution MS/MS 
data collection) peaks in a given spectrum using collision induced dissociation (CID) or infrared 
multi-photon dissociation (IRMPD). 
4.3.9.6 Data analysis and peptide identification for full proteome analysis 
All data were analyzed using QualBrowser, part of the Xcalibur software
 For detection of thioester-bound intermediates, the system of PheAT overexpressed in E. 
coli was used.  As a control, purified PheAT protein was analyzed first.  To a starter culture of 
100 mL LB supplemented with ampicillin (final concentration of 100 µg/mL) was added a single 
colony of E. coli BL21(DE3) harboring pET-Duet-1 PheAT-His6 Sfp.  The starter culture was 
grown overnight at 37 °C with shaking at 200 rpm.  Twenty mL of the starter culture were added 
 packaged with 
the ThermoFisher LTQ-FT, and custom inhouse software. Selected ion chromatograms (SICs) 
were generated for the Ppant ejection ions of interest. Based upon the elution of the Ppant 
ejection ion, the time of elution was analyzed for the presence of predicted active site peptides of 
the proteins in question (masses calculated based upon published sequences). MS/MS data 
generated by CID or IRMPD were analyzed manually. 
4.3.10 Preparation of Phenylalanine-loaded PheAT and Analysis by SCX-RPLC-MS/MS 
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to 2 L LB supplemented with ampicillin (final concentration of 100 µg/mL) and grown at 37 °C 
until an O.D.600 of ~0.6, at which point 2 mL of 1 M IPTG were added to induce protein 
expression.  The temperature was dropped to 18 °C and the culture grown for an additional 16-20 
h with shaking at 250 rpm.  500 mL culture were harvested by centrifugation (10 min, 4,200 x g, 
4 °C) and resuspended in 5 mL buffer C (25 mM Tris-HCl (pH 7.4), 10% v/v glycerol, 200 mM 
NaCl).  The cells were lysed by sonication (3 cycles of 30 s sonication followed by 30 s rest on 
ice) and the soluble lysate collected by centrifugation (60 min, 4 °C, 47,000 x g).  The soluble 
lysate was incubated with 500 µL Ni-NTA agarose resin (Qiagen) for 3 h at 4 °C and then 
transferred to a polypropylene column.  The resin was washed with 20 mL of buffer C, 20 mL of 
buffer C with 10 mM imidazole, and 15 mL of buffer C with 50 mM imidazole.  The protein was 
eluted with 3 elution steps of 5 mL buffer C with 100 mM imidazole, 5 mL of buffer C with 200 
mM imidazole, and 5 mL of buffer C with 500 mM imidazole.  The elution fractions were 
combined and dialyzed overnight using a 20 mL Slide-a-Lyzer 3.5 kDa MWCO cassette 
(ThermoFisher Scientific) into buffer D (25 mM Tris-HCl (pH 7.5), 10% v:v glycerol).  The 
dialyzed sample was concentrated to ~1 mL using a Vivaspin 20 3.5 kDa MWCO centrifugal 
concentrator (Millipore) and the final protein concentration was determined by the Bradford 
assay (Bradford 1976).  To generate phenylalanine (Phe)-S-PheAT and 2H5-Phe-S-PheAT (ring 
labeled Phe), 1 mg protein was incubated with 5 µL 10 mg/mL Sfp, 10 mM ATP, 10 mM Phe, 
10 mM 2H5-Phe, and 5 µL of 10 mg/mL CoA in 50 mM HEPES (pH 7.5), 10 mM MgCl2, and 1 
mM TCEP (final volume of 350 µL) for 5 h at 30 °C.  The protein was precipitated by the 
addition of ammonium sulfate to a final concentration of 0.85 g/mL at 4 °C and the precipitate 
collected by centrifugation at 15,000 x g.  The precipitated protein was resuspended in 200 µL 
0.1 M NH4HCO3 (pH 7.8), 200 µL of 6 M urea, 1 mM TCEP and 5 µL of 25 mg/mL trypsin and 
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incubated for 20 min at 30 °C.  The digestion reaction was quenched by freezing at -80 °C and 
analyzed by SCX-RPLC-MS/MS as described above. 
For analysis of in vivo formed thioesters, PheAT unpurified from the E. coli proteome 
was analyzed.  To a starter culture of 100 mL LB supplemented with ampicillin (final 
concentration of 100 µg/mL) was added a single colony of E. coli BL21(DE3) harboring pET-
Duet-1 PheAT-His6 Sfp.  The starter culture was grown overnight at 37 °C with shaking at 200 
rpm.  Twenty mL of the starter culture were added to 2 L LB plus ampicillin (final concentration 
of 100 µg/mL) and grown at 37 °C until an O.D.600 of ~0.6, at which point 2 mL of 1 M IPTG 
were added to induce protein expression.  The temperature was dropped to 18 °C and the culture 
grown for an additional 16-20 h with shaking at 250 rpm.  500 mL culture were harvested by 
centrifugation (10 min, 4,200 x g, 4 °C) and resuspended in 5 mL buffer E (25 mM MOPS (pH 
6.5), 10% v/v glycerol, 1 pellet Complete protease inhibitor cocktail (Roche), and 250 µL 0.1 M 
PMSF).  The cells were lysed by sonication (3 cycles of 30 s sonication followed by 30 s rest on 
ice) and the soluble lysate collected by centrifugation (60 min, 4 °C, 47,000 x g).  The proteins in 
the sample were precipitated by the addition of ammonium sulfate (3.17 g (NH4)2SO4 added to 
5.5 mL lysate) and incubation at 4 °C, and the precipitate was collected by centrifugation (10 
min, 4 °C, 47,000 x g).  The protein pellet was resuspended in 1 mL of 0.1 M NH4HCO3 (pH 
7.8) and the total protein concentration determined by the Bradford assay (Bradford 1976).  
Approximately 5 mg of total protein were digested in a reaction mixture of 0.1 M NH4HCO3 (pH 
7.8), 3 M urea, 2 mM DTT and 20 µL of 25 mg/mL trypsin for 20 min at 30 °C.  The reaction 
was quenched by freezing at -80 °C and analyzed by SCX-RPLC-MS/MS as described above. 
For pepsin digestion, E. coli BL21(DE3) harboring pET-Duet-1 PheAT-His6 Sfp was 
grown as above.  The 2 L culture was harvested by centrifugation (10 min, 4 C, 42,000 x g) and 
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the cells were resuspended in a solution of 75% formic acid, 10% MeCN, and 15% H2O.  The 
cells were lysed by sonication and the soluble fraction collected as above.  To an aliquot of the 
soluble lysate was added 50 µL of 25 mg/mL pepsin and the digestion reaction was incubated for 
15-60 min before it was analyzed immediately by SCX. 
4.3.11 Preparation of Samples for Analysis of the PrISM Limit of Detection 
 To a starter culture of 100 mL LB plus ampicillin (final concentration of 100 µg/mL) was 
added a single colony of E. coli BL21(DE3) harboring pET-Duet-1 PheAT-His6 Sfp.  The starter 
culture was grown overnight at 37 °C with shaking at 200 rpm.  Ten mL of the starter culture 
was added to 1 L LB supplemented with ampicillin (final concentration of 100 µg/mL) and 2 X 
1.5 L LB supplemented with ampicillin (final concentration of 100 µg/mL) and placed at 37 °C 
with shaking at 250 rpm.  After growth to an O.D.600 of ~0.75, the 1 L culture was supplemented 
with 1 mL of 1 M IPTG to induce protein overexpression.  The cultures were grown an 
additional 20 h at 18 °C.  Several dilutions of the cultures were made after growth was completed 
to dilute the induced cells:  A) 200 mL induced culture, 200 mL uninduced culture (dilution 
factor:  2X); B) 80 mL induced culture, 320 mL (dilution factor: 5X); C) 40 mL induced culture, 
360 mL uninduced culture (dilution factor: 10X); D) 4 mL induced culture, 396 mL uninduced 
culture (dilution factor: 100X); E) 0 mL induced culture, 400 mL uninduced culture.  The cells in 
each 400 mL sample were harvested by centrifugation (10 min, 4 °C, 4,200 x g) and the resulting 
cell pellet was resuspended in 10 mL of buffer E.  The cells were lysed and the soluble proteins 
ammonium sulfate precipitated as described above.  The precipitate was resuspended in 3 mL of 
0.1 M NH4HCO3 (pH 7.8) and the protein concentration was determined by the Bradford assay 
(Bradford 1976).  Each sample was digested with trypsin as described above and stored at -80 °C 
until analysis by SCX-RPLC-MS/MS as previously described.  A similar analysis was performed 
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using MycA10 overexpression in E. coli (E. coli harboring mycA10-pET-28A).  The only 
changes were in the buffer used for resuspension and lysis (MycA studies used buffer F (25 mM 
Tris-HCl (pH 7.5), 200 mM NaCl, 10% v/v glycerol), in the elimination of the ammonium 
sulfate precipitation step, and in the use of serial dilutions of 1:1 induced: uninduced to 1:10,000 
induced: uninduced. 
4.4 RESULTS AND DISCUSSION  
4.4.1 The PrISM Development Workflow 
Development of the PrISM workflow was the first implementation of a proteomics-based 
method for the directed detection of NRPS and PKS biosynthetic enzymes in the native producer 
of a NRP or PK natural product.  While there are genomic, transcriptomic and metabolomic 
approaches to natural product discovery (as described in Section 1.4), a proteomics approach fills 
a gap in the systems biology approach to natural product discovery and brings many benefits to 
the field.  These benefits, including the ability to directly link production of a natural product 
with its biosynthetic gene cluster, will be discussed in more detail in Chapter 5, but the power of 
proteomics is evident even from these early implementations.  Presented below are the first steps 
in the development of a proteomics platform for the discovery of new secondary metabolites. 
4.4.2 Detection of Ppant Ejection Ions from Complex Peptide Mixtures:  Proof-of-Concept 
Experiments 
Chapter 2 presented, in detail, the development of two new MS-based platforms for the 
analysis of thiotemplate biosynthetic systems.  These two assays, the Ppant ejection assay and 
the on-line LC-MS implementation of the Ppant ejection assay (Dorrestein, Bumpus et al. 2006; 
Bumpus and Kelleher 2008), were discussed in the context of their application to in vitro 
characterization of NRPS- and PKS-directed biosynthesis.  From the provided examples in the 
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application to barbamide and mycosubtilin biosynthesis, it was clear that the Ppant ejection assay 
provided a highly specific method to observe the presence of a T domain active site peptide and 
confirm its biosynthetic state while the use of the on-line method greatly increased the 
throughput of MS-based analyses.  These two assays have seen continued application for in vitro 
characterization, but their application in new ways – specifically related to characterization of 
native natural product producers and natural product discovery – was also explored.  In general, 
we set out to determine if these assays could identify T domain active site peptides in the 
proteomes of native secondary metabolite producers (first in the holo form, but then later in 
intermediate-loaded forms).  From there, our goal was to use our ability to detect these active site 
peptides in the discovery and characterization of novel natural product biosynthetic pathways. 
Section 2.3 provided detailed information on the ability to identify a T domain active site 
peptide in holo and loaded form, using the example of a T domain from mycosubtilin 
biosynthesis (Hansen, Bumpus et al. 2007).  In this implementation of the on-line Ppant ejection 
assay, a fatty acid loading mechanism was elucidated.  Chapter 3 provided additional evidence of 
the ability to detect T domain active site peptides in peptide mixtures generated from in vitro 
biosynthetic assays using the on-line Ppant ejection assay, and expanded its utility through the 
detection of multiple T domain active site peptides in a single LC-MS run (Bumpus, Magarvey et 
al. 2008; Calderone, Bumpus et al. 2008).  These examples, in addition to others not described 
here, were proof of the ability to detect the Ppant ejection ion in a complex peptide mixture.  
This was satisfaction of the first requirement for a proteomics platform - to detect proteins in 
NRP and PK biosynthetic pathways, specifically T domain active site peptides, through the on-
line Ppant ejection assay, even in complex samples.  The next sections describe the expansion of 
the on-line Ppant ejection assay to the interrogation of full proteomes. 
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4.4.3 Methods for Separation and Simplification of Complex Proteomes of Native Natural 
Product Producers 
After confirmation that we could detect a T domain active site peptide via the on-line 
Ppant ejection assay, even in a complex peptide mixture, the next step was to consider methods 
for the simplification of proteome samples.  In the PrISM proteomics platform, the final goal is 
to detect a single active site peptide from a single protein in the context of the entire proteome of 
a natural product producer.  It would be impossible to analyze a tryptic digest of an entire 
proteome of a bacterium in a single LC-MS run and expect to detect the T domain active site 
peptide from a NRPS or PKS in the background of abundant bacterial proteins, even with the 
specificity of the Ppant ejection assay.  Thus, we sought to exploit the typical large size of 
NRPSs and PKSs and develop a variety of separation platforms to reduce the complexity of 
samples prior to trypsin digestion and analysis by LC-MS and the Ppant ejection assay; these are 
described here and in Chapter 5. 
Two different precipitation techniques were employed throughout the early days of 
PrISM development.  The first, streptomycin sulfate precipitation, was used to precipitate any 
nucleic acids present the soluble cell lysate after lysis either by French press or sonication.  This 
is a standard procedure in molecular biology (Cohen and Lichtenstein 1960) and was used in the 
analysis of the B. brevis proteome by SEC, in addition to other development studies not 
discussed here.  This step was abandoned during the development of the PrISM platform at the 
point of investigation of overexpressed MycA in E. coli, as it was determined that it was not 
necessary for success of all downstream steps.  
 A precipitation technique that was used through many studies was precipitation of 
proteins using ammonium sulfate.  Ammonium sulfate precipitation is, again, another very 
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standard technique employed in biochemistry and molecular biology to fractionate samples and 
is often used as a preliminary step in the purification of a protein.  This precipitation works by 
taking advantage of the decreased solubility of protein species at increasing levels of ionic 
strength; this is commonly known as “salting out.”  As the concentration of ammonium sulfate is 
increased, in a stepwise manner, different proteins will precipitate out of the solution at varying 
levels of salt; this provides a crude fractionation step for isolation of a specific protein species 
(Spitnik-Elson 1963).  In the application to PrISM, there were two uses of ammonium sulfate 
precipitation.  First, addition of a high concentration of ammonium sulfate (>75% w:v) provided 
a way to precipitate proteins from lysis buffer to resuspend them in a buffer amenable to trypsin 
digestion.  This was performed on many of the early analyses of PheAT overexpressed in E. coli, 
MycA overexpressed in E. coli, and B. brevis.  In analysis of B. brevis, the inclusion of both 
streptomycin sulfate and ammonium sulfate precipitation steps did not seem to affect the protein 
content of the sample and HMWPs were still observed (Figure 4.4A).   
Second, ammonium sulfate fractionation (Spitnik-Elson 1963) was attempted on a variety 
of proteomes of native natural product producers, including the PTT producer S. 
viridochromogenes, in hopes of separating the HMWPs from the rest of the proteome and 
simplifying downstream analysis.  However, the results of these analyses did not allow for 
sufficient separation of the components of the proteome and were not used for further 
development of PrISM (data not shown). 
In another effort to exploit the often very large MW of NRPSs and PKSs, the separation 
strategy of size exclusion chromatography (SEC) was employed.  It was hoped that the use of 
SEC would allow isolation of HMWPs from the small molecular weight proteome and provide a 
means for targeted analysis of NRPSs and PKSs.  Should SEC be successful, the SEC fractions 
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containing HMWPs would be subjected to trypsin digestion and RPLC-MS/MS analysis using 
the Ppant ejection assay.  The organism B. brevis ATCC 9999 was selected for SEC analysis, 
and has served for years as the prototypical NRPS system (Vater, Mallow et al. 1985; Vater, 
Stein et al. 1997).  This organism is a native producer of gramicidin S, a cyclic decapeptide 
synthesized by two NRPSs, GrsA (126 kDa) and GrsB (510 kDa) (Katz and Demain 1977; 
Mootz and Marahiel 1997). GrsA contains one thiolation domain and incorporates one amino 
acid monomer, while GrsB contains four thiolation domains and is responsible for incorporation 
of the remaining amino acids and release of the final natural product.   
To test this separation strategy, the soluble proteome of B. brevis was prepared by 
streptomycin sulfate and ammonium sulfate precipitation, loaded onto a SEC column, and 
separated using FPLC.   HMWP bands were observed at the molecular weights for the NRPSs 
GrsA and GrsB from B. brevis.  As can be seen from the SDS-PAGE gels in Figure 4.4B, while 
there was some size-based separation of proteins in this sample, there was not a clear separation 
of HMWPs from other protein species.  There was also significant carryover between fractions, 
indicating that SEC would not be an optimal tool for the isolation of HMWPs and other methods 
of must be employed to reduce sample complexity. 
4.4.4 Development of an Optimized Two-dimensional Separation Platform for Detection of 
Ppant Ejection Ions and Natural Product Biosynthetic Proteins 
4.4.4.1 Requirement for two-dimensional separation of proteome samples 
As can be seen from the results in Subsection 4.4.3, proteome sample preparation by 
streptomycin sulfate precipitation, ammonium sulfate precipitation and size exclusion 
chromatography did not provide the necessary reduction in complexity of proteome samples for 
LC-MS analysis.  Thus, we elected to turn to methods used in Bottom Up proteomics (Bogdanov 
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and Smith 2005), specifically the separation of peptide mixtures post trypsin digestion by two-
dimensional (2D) LC methods incorporating both SCX and RPLC.   A well developed Bottom 
Up proteomics platform called MudPIT, for multi-dimensional protein identification technology, 
has been very successful employing the SCX-RPLC platform for separation of peptides before 
introduction into the mass spectrometer (Washburn, Wolters et al. 2001).  The combination of 
these two separation methods is now a very common form of sample preparation and analysis for 
Bottom Up proteomics (Gonzalez-Begne, Lu et al. 2009; Kline and Wu 2009).  We sought to 
adapt these separation techniques for PrISM to aid our identification of T domain active site 
peptides.  Additionally, the selection of SCX (which as conducted at <pH 3) as our first 
dimension of separation could aid in preserving any base-labile thioester-bound intermediates on 
T domains, important in future advancements for PrISM (Subsection 4.4.8). 
4.4.4.2 Efforts to increase the amount of holo protein available 
Prior to the development of a robust SCX separation platform, methods to increase the 
total amount of holo NRPS and PKS T domains in each protein sample were explored.  There 
have been many studies on the modification of T domain active site serines with modified CoA’s 
harboring a variety of substituents.  These methods have been exploited to label T domains in 
vivo and used to visualize the expression of NRPS and PKS enzymes (Meier, Mercer et al. 2006; 
Meier, Mercer et al. 2008; Mercer, Meier et al. 2009).  Additionally, well established methods 
for the synthesis and use of a fluorophore-labeled CoA have been reported and employed to 
confirm the activity of phosphopantetheinyl transferases (PPTases) and T domain-containing 
protein constructs (La Clair, Foley et al. 2004; McLoughlin, Mazur et al. 2005).  Using the 
fluorophore BODIPY-FL-N-(2-aminoethyl)-maleimidyl-S-CoA (BODIPY-CoA, Figure 4.5A), 
one could even monitor the elution of a T domain active site peptide in RPLC analysis to identify 
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a fraction to target for MS analysis as described in previous chapters (Dorrestein and Kelleher 
2006).   
In the context of PrISM, it would be beneficial to know of there were any apo-T domains 
remaining in the proteome sample, and if there were, it would ease analysis by converting them 
to their holo form to increase the probability of generating and observing a Ppant ejection ion.  
Using the precedent of modifying T domains with BODIPY-CoA, purified proteins, recombinant 
proteins expressed in E. coli but unpurified, and the proteomes of native producers of secondary 
metabolites were screened for the ability for NRPSs and PKSs to be fluorescently labeled.  If a 
fluorescently tagged protein was observed, this would indicate that incubation of the protein or 
proteome with CoA and a PPTase prior to analysis by SCX-RPLC-MS/MS and the Ppant 
ejection assay would be advantageous. 
 Unpurified proteins from an E. coli cell lysate were first used to analyze our ability to 
observe phosphopantetheinylation by BODIPY-CoA.  MycA10 (see Section 2.4 for a detailed 
description of this protein (Hansen, Bumpus et al. 2007)) was overexpressed in E. coli but left 
unpurified from the E. coli soluble proteome.  The entire peptide mixture was incubated with the 
PPTase Sfp, MgCl2 and BODIPY-CoA and visualized by SDS-PAGE for the presence of 
fluorescent bands.  As seen in Figure 4.5B, it was possible to visualize MycA loaded with the 
BODIPY fluorophore by SDS-PAGE, confirming the ability to observe phosphopantetheinylated 
bands even in complex mixtures.  To test this same strategy on the entire proteome of a native 
natural product producer, the gramicidin S producer B. brevis was grown as described and its 
entire soluble proteome incubated with BODIPY-CoA, MgCl2, and Sfp.  Again, fluorescent 
bands appeared in the presence of both Sfp and BODIPY-CoA that were not present in the 
control samples (Figure 4.5C).  These bands appear at the expected molecular weights for GrsA 
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(126 kDa) and GrsB (510 kDa), the NRPSs responsible for production of gramicidin S (Matteo 
1975; Katz and Demain 1977; Mootz and Marahiel 1997).  These experiments indicated that it 
could be beneficial to include this phosphopantetheinylation step (using unlabeled CoA) prior to 
trypsin digestion and SCS separation to increase the amount of holo protein available. 
4.4.4.3 Initial development of protocols for protein precipitation and SCX chromatography 
From the above data on the incubation of proteome samples with the enzymes and 
substrates required for phosphopantetheinylation, it appeared that it may be beneficial to perform 
the phosphopantetheinylation reaction prior to analysis by SCX-RPLC-MS.  However, the 
requirement of inclusion of MgCl2 in the holo forming reaction mixture does not provide a 
sample that can be analyzed by SCX.  There must be steps to remove the protein sample from the 
MgCl2 containing buffer and replace them in a buffer suitable for both trypsin digestion and SCX 
separation.   
 To test this approach, MycA10 was overexpressed in E. coli but the recombinant protein 
was left unpurified from the E. coli proteome.  The entire protein mixture was incubated in the 
presence of the Sfp, MgCl2 and BODIPY-CoA and analyzed by SDS-PAGE for the presence of 
fluorescent bands (described above).  The observation of fluorescent bands (from both intact 
MycA and degradation products) indicated that MycA could be phosphopantetheinylated in vitro 
(Figure 4.5B).  The phosphopantetheinylation reaction was repeated using CoA without the 
fluorescent label to generate holo-MycA.  It is at this stage that there must be a buffer exchange 
step to prepare the sample for trypsin digestion and SCX separation.  Using a commercially 
available kit for protein precipitation and resuspension, the Universal Protein Precipitation Agent 
(UPPA, G-Biosciences), the phosphopantetheinylation reaction was precipitated according to the 
manufacturer’s instructions and resuspended in a final solution of 60 mM Tris (pH 7.5).  Using 
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this procedure, it was possible to precipitate and resuspend up to 4 mg of total protein, an amount 
of protein suitable for 2D LC separation and eventual LC-MS analysis.   
 After establishment of the precipitation and resuspension procedure, the SCX separation 
protocol was optimized for separation of the complex peptide mixture.  MycA10 was prepared as 
above, incubated with both BODIPY-CoA and CoA (in separate samples), precipitated and 
resuspended using UPPA, and trypsin digested.  A control sample was prepared by omitting the 
UPPA preparation step before trypsin digestion and SCX analysis.  Using a standard column for 
SCX separation of peptides as described in Section 4.3 and a solvent system with a citric acid 
buffer base and employing an increasing concentration of ammonium chloride for SCX, the 
precipitated and unprecipitated samples were separated by SCX.  While the sample that was not 
prepared using UPPA resulted in unsuccessful SCX separation and no peaks observed in the 
chromatogram (Figure 4.6A), the chromatogram of the sample post UPPA preparation showed 
significantly improved SCX separation and peaks were distributed throughout the entire 
chromatogram (Figure 4.6B).  From this, it was concluded that if the phosphopantetheinylation 
reaction was to be employed, the precipitation step would be required prior to SCX separation; 
this protocol was carried forward for future analysis as described below.   
To exploit the generation of holo-MycA using BODIPY-CoA and Sfp in the activity 
assay to test for phosphopantetheinylation, this sample was also separated by SCX, monitoring 
for absorbance at 500 nm (as opposed to 220 nm or 280 nm used for standard peptide samples).   
The observation of an absorbance peak in the chromatogram should indicate elution of a 
phosphopantetheinylated peptide (BODIPY-S-MycA10) and should also correspond to the 
elution of the holo-MycA active site peptide in the sample using the CoA lacking the 
fluorophore.  An intense peak was observed at ~32 minutes in the SCX chromatogram of the 
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BODIPY-CoA-loaded sample (Figure 4.6C).  When this same SCX fraction from the 
corresponding CoA assay was analyzed by LC-MS and the Ppant ejection assay, a holo-MycA10 
active site peptide was observed (Figure 4.6D).  This was additional evidence that the loading of 
the BODIPY linked Ppant arm could assist in the identification of holo active site peptides.  
However, many of the subsequent studies below sought to identify in vivo formed holo protein, 
eliminating the incubation with Sfp and CoA and the UPPA precipitation step. 
4.4.5 Limit of Detection for the PrISM Platform 
In development of any new platform, it is critical to understand the limits at which the 
assay(s) can be completed successfully.  It the case of PrISM, understanding our ability to detect 
the Ppant ejection ion from a holo T domain in the background of an entire proteome is crucial.  
To analyze this in a qualitative manner, the system of overexpression of PheAT (the adenylation-
thiolation didomain from GrsA involved in gramicidin S biosynthesis in B. brevis) (Mootz and 
Marahiel 1997) and the PPTase Sfp (Quadri, Weinreb et al. 1998) together in E. coli was 
employed.  Cultures containing E. coli harboring the PheAT and Sfp coexpression plasmid were 
prepared, with a portion of the cultures receiving IPTG to induce protein overexpression and the 
remaining cells relying on the leaky expression of the plasmid’s T7 promoter to express a small 
amount PheAT and Sfp.  Serial dilutions of the induced culture were made into the uninduced 
culture, and each sample was analyzed by SDS-PAGE for a qualitative assessment of PheAT 
expression and by SCX-RPLC-MS/MS for the detection of the holo Ppant ejection ion.  A 
similar analysis was performed using MycA10 overexpressed in E. coli.   
In the analysis of the PheAT samples by SCX-RPLC-MS/MS and the on-line Ppant 
ejection assay, the holo Ppant ejection ion and the corresponding T domain active site peptide 
were observed in the samples with the smallest amount of induced culture (1:100 and 1:500 
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IPTG induced culture: uninduced culture); these peptides were also observed in the sample 
containing only uninduced culture (Figure 4.7).  In these fractions, the Ppant ejection ion 
coeluted with the active site peptide with both a C-terminal and N-terminal missed cleavage from 
incomplete digestion with trypsin; this indicated that low levels of protein may result in 
incomplete digestion and this should be accounted for during all manual and automated analysis 
by looking for peptides with missed cleavages.  It was encouraging to observe the Ppant ejection 
ion from the sample generated solely by leaky expression of the promoter, as this was indicative 
of the ability to detect low abundance species. 
4.4.6 Detection of Thioester-bound Intermediates by PrISM 
When considering the future of PrISM and the application of its methods for direct 
observation of T domain active site peptides from native producers of natural products, an 
obvious extension is to detect not only holo peptides but those that harbor thioester-bound 
intermediates.  This presents many challenges, the most significant being the lability of the 
thioester bond at >pH 7.  It was yet to be determined if the previously developed PrISM 
protocols could preserve the bound intermediates for detection by the Ppant ejection assay.  To 
test the ability to retain the intermediates, proof-of-concept experiments using the PheAT and 
Sfp overexpression system in E. coli were analyzed for the in vivo loading of Phe onto the T 
domain of PheAT.  As control reaction, purified PheAT was loaded in vitro with an equimolar 
mixture of Phe and 2H5-Phe (ring labeled), digested with trypsin and analyzed by SCX-RPLC-
MS/MS and the on-line Ppant ejection assay.  In this analysis, the holo, Phe-loaded (Phe-S-
PheAT) and 2H5-Phe-loaded (2H5-Phe-S-PheAT) species were observed as the fully digested 
tryptic peptides (Figure 4.8) as well as peptides with an N-terminal missed cleavage.   
When PheAT overexpressed in E. coli but unpurified from the E. coli proteome was 
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analyzed for the presence of in vivo formed Phe-S-PheAT, both the holo and Phe-loaded T 
domain active site peptides were observed (Figure 4.9).  The Ppant ejection ions for holo- and 
Phe-S-PheAT were observed at m/z 261.1267 (an error of 0.0 ppm from the theoretical Ppant 
ejection ion and m/z 408.1949 (an error of -0.7 ppm from the theoretical ejection ion), 
respectively.  The intact peptides for the holo and Phe-loaded active site peptides were observed 
as peptides with an N-terminal missed cleavage (holo: 2+, m/z  2026.0047, 2049.994 Da, 2.4 
ppm error from theoretical; Phe-loaded: 2+, m/z 1099.5411, 2197.066 Da, 3.7 ppm error from 
theoretical).  The ratios of holo-PheAT to Phe-S-PheAT shown in Figure 4.9 do not accurately 
reflect the ratio of total holo to loaded active site peptide.  The data shown is for a single SCX 
fraction and a single form of the active site peptide (with an N-terminal missed cleavage), but the 
peptides eluted across three SCX fractions and were present in multiple forms.   However, one 
can make the qualitative statement, based upon the assessment of all data that the holo form was 
in higher abundance than the loaded form.   
After observation of Phe-S-PheAT in the background of the E. coli proteome, many 
efforts were made in the optimization of PrISM protocols to retain more of the bound 
intermediate; this would be necessary if in vivo intermediates were to be observed in native 
producers with potentially much lower levels of T domain expression.  Because the intermediate 
bound to the T domain is attached via a thioester bond that is labile above pH 7, many buffer 
systems designed for lysis at <pH 6 were employed, including 25 mM MOPS (pH 5.5-6) and 50-
150 mM ammonium bicarbonate (pH 4).  Using the MOPS buffer system, there was no increase 
in the ratio of loaded: holo-PheAT observed.  Using the ammonium bicarbonate system, cell 
lysis was extremely poor and very little protein was recovered from the sample.  Because of the 
inefficient lysis at pH 4, digestion under these acidic conditions with the endoproteinase GluC 
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(which is active at both pH 4 and pH 8 (Houmard and Drapeau 1972)) was not possible.  These 
same approaches were applied to the proteome of B. brevis and S. viridochromogenes, with the 
goals of observing T domain bound intermediates on the holo T domains previously identified.   
However, to date, no bound intermediates have been observed.  Additionally, I attempted 
growing the cells and preparing the soluble lysates in the presence of varying concentrations of 
phenylmethanesulphonylfluoride (PMSF) was, in hopes that PMSF would inhibit the release of 
the final intermediates by the thioesterase (TE) domain and cause a backup of intermediates 
along the assembly line (Samel, Wagner et al. 2006).  These PMSF inhibition experiments did 
not result in any increase in the amount of thioester-bound intermediates observed.   
A final attempt at preserving the thioester-bound intermediate was using pepsin as the 
protease for digestion.  Pepsin is most active between pH 1.2-2 (its native function is as a 
protease in highly acidic environment of the stomach), making it an ideal choice for a digestion 
to retain bound intermediates.  However, the cleavage specificity of pepsin is very loose when 
compared to that of trypsin (which cleaves only C-terminally to lysine or arginine), with the 
majority of cleavages occurring at six different amino acids (and other even more non-specific 
cleavages have been observed) (Fruton 2002).  This makes proteomic analysis complicated 
because the design of databases for automated analysis of MS/MS data requires knowledge of 
the specific cleavage site(s) for the protease used; the possibility of more than six cleavage sites 
for a single enzyme would result in an unmanageable database for an entire proteome.  Despite 
these complications, pepsin digestion was conducted using PheAT overexpressed in E. coli but 
unpurified from the background of the E. coli proteome.  After lysis of the cells into 75% formic 
acid, digestion with pepsin and analysis by SCX-RPLC-MS/MS, PheAT T domain active site 
peptides in the holo and Phe-loaded forms were observed (Figure 4.10).  Because no database 
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could be created for automated analysis, manual analysis was required to identify the Ppant 
ejection ion and its parent species; this was eased by the fact that data-dependent MS/MS using 
IRMPD resulted in Ppant ejection from a peptide at a specified m/z.   
In SCX fraction 26, a nozzle-skimmer dissociation-generated Ppant ejection ion was 
observed at m/z 261.1265, <1 ppm from the theoretical mass of the holo Ppant ejection ion; this 
ejection ion coeluted with a Ppant ejection ion generated from IRMPD MS/MS of a 1+ species at 
m/z 987 (Figure 4.10A-C).  When the MS/MS data were manually annotated, the sequence G-G-
D-S*-I-K-A was obtained (S* is the PheAT active site serine but with an observed mass 
equivalent to dehydroalanine (DhA), resulting from Ppant ejection and confirming 
phosphopantetheinylation) (Figure 4.11).  When the remaining SCX fractions were mined for a 
singly charged peptide at m/z 1134 (corresponding to the in vivo loading of Phe onto the pepsin 
generated active site peptide), the Phe-S-PheAT pepsin peptide was identified in the adjacent 
SCX fraction (fraction 28).  This peptide coeluted with the expected Ppant ejection ion generated 
by nozzle-skimmer dissociation, detected at a mass error of <1 ppm.  However, because the 
peptide was of low abundance, it was not selected for data-dependent MS/MS by IRMPD 
(Figure 4.10D-F).   
While only a qualitative statement regarding an increase in abundance of the amino acid-
loaded species by applying PrISM at <pH 2 can be made (due to elution of peptide species in 
multiple SCX fractions and the generation of multiple active site serine containing peptides), it 
does not seem that these efforts made a significant increase in the amount of loaded protein that 
survives until MS analysis.  This could be due to the naturally low abundance of amino acid-
loaded species generated in vivo or the continued loss of the intermediate during PrISM sample 
processing.  While the pepsin digestion protocol is not amenable to analysis of full proteomes, it 
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could be employed for systems where a specific T domain is targeted for analysis (and the 
sequence of the T domain is known), facilitating manual data analysis of the peptides of interest.  
However, in the context of PrISM in discovery mode, the pepsin digestion protocol was not 
developed further. 
4.4.7 Development of an Optimized SCX-RPLC-MS/MS Platform for Native Protein Samples 
Despite the early successes in identifying holo T domain active side peptides in the 
background of the E. coli proteome, the multiple steps employed (such as the generation of holo 
protein via incubation with Sfp and CoA, followed by the required UPPA preparation step) 
deviated from the overall goal of development a robust and high-throughput proteomic platform. 
Even the later stage identifications of in vivo formed holo and loaded T domains in the E. coli 
test systems still involved an ammonium sulfate precipitation step that decreased the throughput 
of the method.  Additionally, because retaining thioester-bound intermediates did not seem 
tractable during this stage of development, this aspect of PrISM was postponed until a robust 
discovery platform was established.  Thus, development and optimization continued on a 
platform that did not require generation of holo protein or ammonium sulfate precipitation, but 
instead examined samples for the presence of in vivo generated holo protein.  In this new 
implementation of PrISM, cultures are grown as in the previous method, but the cell pellets are 
lysed directly into a buffer amenable to trypsin digestion and SCX.  Should this be successful, it 
would set the stage for application of the PrISM platform to analysis of a wider variety of 
samples, including environmental isolates whose genomes have not been sequenced and are 
suspected of producing novel natural products. 
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4.4.7.1 Detection of a phosphopantetheinylated peptide from an overexpressed target in the E. 
coli proteome 
As proof-of-concept employing the optimized SCX-RPLC-MS/MS platform for PrISM, 
the PheAT overexpression system in E. coli was employed; again, PheAT was coexpressed with 
Sfp to generate holo protein in vivo (Quadri, Weinreb et al. 1998).  The resulting holo-PheAT 
protein was left unpurified in an E. coli whole cell extract and an aliquot of this proteome was 
subjected to Bottom Up proteomic analysis using MudPIT-like protocols (Washburn, Wolters et 
al. 2001) initiated with a 20 min trypsin digestion with a 1:10 protease: substrate ratio.  The 
entire peptide mixture was separated in the first dimension by SCX, and each SCX fraction 
analyzed by RPLC-MS/MS using a 12 T hybrid linear ion trap-FTMS (ThermoFisher LTQ-FT).  
Each LC-MS run had automated data-dependent fragmentation (Loo 1991; Little 1994) of five 
peptides each duty cycle, and those ejecting the Ppant cofactor produce a distinctive ion at m/z 
261.1267.    In one of twenty SCX fractions analyzed a Ppant ejection product was observed that 
matched within 1 ppm to the predicted mass for a holo Ppant ejection ion (Figure 4.12B).  When 
summing across all intact mass scans collected during this time, a peptide was observed with a 
mass of 1638.70 Da, matching within 6 ppm of the theoretical mass for the PheAT active site 
tryptic peptide.    Note the baseline of Figure 4.12B.  This is a depiction of the specificity of this 
methodology.   
4.4.7.2 Application of PrISM to gramicidin S biosynthesis in B. brevis 
 Moving from an overexpressed system in the E. coli proteome to a native system in a 
Bacillus, the organism B. brevis ATCC 9999 was selected (Vater, Mallow et al. 1985; Vater, 
Stein et al. 1997).  B. brevis was grown in supplemented YP medium at 30°C for 7-8 h (Matteo 
1975).  The soluble B. brevis proteome was subjected to Ppant proteomics as above, and each 
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SCX fraction mined for holo active site peptides from GrsA and GrsB (Washburn, Wolters et al. 
2001).  Ppant ejection ions were identified for four of the five thiolation domains in these two 
proteins, and the corresponding active site peptides were identified with 5-15 ppm mass accuracy 
(Figure 4.13B-D).  These results confirm the ability to identify thiolation domain peptides 
expressed at endogenous levels in the context of a native proteome.  Gramicidin S production at 
the time of proteomic sampling by PrISM was confirmed by small molecule MS of the culture 
supernatant (Figure 4.13E).  This was the first example of the PrISM platform successfully 
identifying holo-T domain active site peptides in the native producer of a natural product.  These 
data signaled that the simplified lysis and separation procedure, eliminating all precipitation and 
holo forming reaction steps, were sufficient for PrISM implementation.   
4.4.7.3 Application of PrISM to phosphinothricin tripeptide biosynthesis in S. 
viridochromogenes  
Moving from the Bacillus genome to an actinomycete, the PrISM platform was applied to 
the soluble proteome of S. viridochromogenes DSM 40736, a native producer of the herbicide 
phosphinothricin tripeptide (PTT) (Hoerlein 1994).  S. viridochromogenes was grown in liquid 
media for 4-5 d under previously determined conditions (Blodgett, Zhang et al. 2005), and PTT 
production was detected by bioassay against B. subtilis ATCC 6633 grown on minimal medium 
(Figure 4.14).  The proteome of the organism was collected and subjected to rapid trypsin 
digestion, followed by SCX and RPLC-MS/MS.  Three enzymes with four thiolation domains 
(PhsA, PhsB and PhsC) are known to be involved in tripeptide formation during PTT 
biosynthesis (Grammel, Schwartz et al. 1998; Blodgett, Zhang et al. 2005). As shown in Figure 
4.14B-C, the thiolation domain from PhsA and the N-terminal thiolation domain from PhsB were 
readily detected.  These results illustrate the scalability of PrISM to more complex proteomes 
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and its ability to connect the production of a natural product with the expression of its 
biosynthetic gene cluster, as subsequent small molecule MS also showed detection of PTT 
(Figure 4.14D-E).   
4.4.8 Challenges in the Initial Implementations of PrISM  
4.4.8.1 False positives in Ppant ejection ion identification 
 In the course of development, we have seen occasional peptides which will produce a 
fragment ion at m/z 261.1267 during the nozzle-skimmer dissociation scan, yet are not related to 
NRPS and/or PKS proteins; an example of this is provided in Figure 4.15.  An environmental 
isolate of the genera Streptomyces was grown under standard conditions, and subjected to the 
PrISM platform.  In SCX fraction 32, a small molecular ion was observed at m/z 261, indicating 
that a holo T domain active site peptide could be present.  The SCX fraction was subjected to 
off-line RPLC fractionation and MS analysis using a 12 T LTQ-FT (ThermoFisher Scientific, 
using direct infusion with a NanoMate Triversa (Advion)) to identify the parent peptide of the 
putative Ppant ejection ion and identify the peptide using MS/MS.  Regions of the spectrum 
containing intact peptide ions were subjected to IRMPD to generate Ppant ejection ions, and the 
region containing species at m/z 758 and m/z 763 resulted in an ion at m/z 261.  When the peptide 
at m/z 763 was isolated and subjected to IRMPD, the putative Ppant ejection ion was detected 
again, confirming it as the parent ion to this fragment (Figure 4.15A-C).  MS/MS using both CID 
and electron capture dissociation (ECD) (Zubarev, Horn et al. 2000) was conducted on the 3+ 
peptide at m/z 763 for de novo sequencing of the peptide for identification (Figure 4.15D).  When 
this peptide was subjected to BLAST analysis, instead of the peptide sequence showing 
homology to an NRPS or PKS T domain, it showed the highest homology to trypsin.  Thus, 
MS/MS of this peptide generated a small molecular ion in mass equivalent to the Ppant ejection 
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ion, yet it was not phosphopantetheinylated.  This peptide was observed in many samples, adding 
an additional level of complexity to PrISM analysis through the detection of Ppant ejection false 
positives. 
Although high mass accuracy is sufficient to discriminate most of the dipeptidyl 
fragments at nominal m/z 261, the methionine (Met)-sulfoxide-(leucine (Leu)-isoleucine (Ile)) b2 
(or y2 – H2O) ion has the exact same molecular formula as the Ppant product (Figure 4.16).  To 
discriminate against detecting this ion, a pseudo-MS3 approach was developed (Thomas 2008).  
Figure 4.17A shows the MS3 fragment ion spectrum of the Ppant ion ejected from an injection of 
CoA.  To decrease the false discovery rate for phosphopantetheinylated peptides, each high 
resolution nozzle-skimmer dissociation scan for Ppant ejection is followed by a low resolution 
nozzle-skimmer dissociation scan where the species at m/z 261 is fragmented and selected ion 
monitoring (SIM) is employed for the fragment ions at m/z’s 243, 184 and 159.  Figure 4.17B-E 
illustrates this process as applied to the PheAT construct.  Figure 4.17C-D shows coelution of the 
low resolution MS3 ions with the high resolution MS2 ion seen, confirming that the ion detected 
at m/z 261 is a true Ppant ejection ion from a holo peptide.   The trypsin peptide described above 
exemplifies the value of this assay, as the MS3 ion was not detected despite the generation of an 
ion at m/z 261 during nozzle-skimmer dissociation (Figure 4.16).  A similar assay has been 
reported for the analysis of recombinant T domain containing protein constructs for analysis in 
low resolution MS instruments (Meluzzi, Zheng et al. 2007). 
4.4.8.2 Additional challenges in PrISM 
 In these initial applications of the PrISM platform to proof-of-concept systems, the use of 
the SCX-RPLC-MS/MS platform was a suitable choice because the sequences of the 
biosynthetic proteins under investigation were known.  This allowed for manual searching of MS 
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and MS/MS data for the peptide masses of interest and their correlation with observed Ppant 
ejection ions.  Therefore, MS/MS identification of T domain active site peptides was not an 
absolute requirement when coelution of a true Ppant ejection ion was observed with a 
predetermined T domain peptide intact mass.  However, in discovery mode, one would be 
analyzing organisms without sequenced genomes and without any prior knowledge of 
biosynthetic capacity.  Thus, there is the requirement for robust MS/MS to not only generate 
Ppant ejection ions but to also identify the T domain active site peptides.  This is necessary for 
use of homology searches to identify peptides from NRPSs and PKSs and generate primers for 
PCR analysis of the organisms genomic DNA.  Additionally, using the 2D LC-MS platform, the 
proteomic background of the sample is very high compared to the level of NRPS and PKS 
protein actually being analyzed; it would be advantageous to simplify the sample even further for 
targeted analysis of NRPS and PKS proteins.  Chapter 5 discusses this development in detail, 
including the application of a PAGE-based approach to sample preparation.  
4.4.9 The Future of PrISM 
 The development of the components of PrISM set the stage for further optimization and 
development into a true discovery platform.  In Chapter 4, SCX-RPLC-MS/MS was used to 
identify T domain active site peptides in known producers of natural products.  However, there 
were challenges in the initial implementations of PrISM.  To address these challenges and to 
expand the PrISM platform beyond proof-of-concept experiments and into true discovery mode, 
significant changes to the method were adopted that make use of characteristics of NRPS and 
PKS proteins and the instrumentation available in the Kelleher Research Group.  These advances 
and their successes are discussed in Chapter 5. 
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4.5 FIGURES 
 
 
Figure 4.1  The workflow for PrISM.  A. Microbial strains are grown in liquid culture. B. The 
proteome of the strain is subjected to Bottom Up proteomics.  C.  LC-FTMSn is conducted on 
the resulting peptide mixture, with expressed T domain active site peptides identified by the 
Ppant ejection assay.  D. Peptide sequences are used to generate primers to amplify portions of 
the expressed gene cluster.  E. The gene cluster is identified and sequenced, which informs 
targeted detection of the natural product produced as depicted in panel F. 
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Figure 4.2  The Ppant ejection assay.  A.  An apo thiolation domain is converted to the holo 
form by the action of a PPTase.  When the holo protein (or active site peptide) is subjected to 
MS/MS, the Ppant arm is ejected off in one of two hypothesized mechanisms, resulting in two 
small molecular and two peptide (a charge reduced apo + 80 Da and an apo - 18 Da) marker 
ions.  B. Two small molecular marker ions are generated during Ppant ejection (shown here 
with masses for the holo form).  A charge reduced peptide marker ion is shown for the 
measured mass of the apo protein + 80 Da, resulting from the loss of the smaller Ppant ejection 
molecular ion.  C. Representative data from the on-line Ppant ejection assay, where the elution 
of the Ppant ejection ion (shown in red in the selected ion chromatogram for m/z 261.1263-
261.1273) leads to identification of the active site containing peptide. 
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Figure 4.3  Representative growth curve for B. brevis.  B. brevis is grown in YP + NaCl at 30 
°C.  After two consecutive measurements of the same O.D.600, indicating stationary phase 
(typically after ~8 h), the cultures were harvested and prepared for PrISM analysis. 
231 
 
 
Figure 4.4  Representative results from streptomycin sulfate precipitation, ammonium sulfate 
precipitation and size exclusion chromatography of the B. brevis soluble proteome.  A.  SDS-
PAGE analysis of streptomycin sulfate and ammonium sulfate precipitation of the B. brevis 
soluble proteome.  In Gel A1, lanes 1 and 2 contain recombinant GrsA.  In odd numbered lanes 
in Gel A1 and even numbered lanes in Gel A2, Sfp was included as these were used in the 
BODIPY-CoA activity assay.  Lanes 4-7 in Gel A1 correspond to the supernatant from 
streptomycin sulfate precipitation.  Lanes 8-9 in Gel A1 and lanes 3-6 in Gel A2 correspond to 
the supernatant from ammonium sulfate precipitation.  Lanes 7-10 in Gel A2 correspond to the 
resuspended ammonium sulfate precipitate.  See Table 4.3 for detailed identification of lanes.  
B.  SDS-PAGE analysis of fractions from SEC of the B. brevis soluble lysate.  Lane 2 in Gel B1 
is an aliquot of the total soluble lysate loaded on the SEC column.  The remaining non-marker 
lanes correspond to SEC fractions A1 (earliest elution, lane 3 on Gel B1) to B5 (latest elution, 
lane 10 on Gel B2).  See Table 4.3 for detailed identification of lanes. 
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Figure 4.5  Labeling of thiolation domains with BODIPY-CoA.  A.  The structure of BODIPY-
FL-N-(2-aminoethyl)-maleimidyl-S-CoA.  B.  Labeling of the T domain of MycA10 unpurified 
from the E. coli proteome.  Gel B1 was scanned using an excitation wavelength of 500 nm to 
observe protein bands harboring BODIPY-CoA.  Lanes 4 and 7 show the highest signal, as 
expected based upon the contents of the reaction loaded in those lanes.  Fluorescence in 
neighboring lanes is due to overflow of wells 4 and 7 when loading.  Gel B2 shows the total 
protein loaded by Coomassie staining.  C.  Labeling of GrsA and GrsB in the proteome of B. 
brevis.  As show in lane 9 of Gel C1, in the presence of both Sfp and BODIPY-CoA, two new 
fluorescent bands appear at the approximate molecular weights of GrsA (126 kDa) and GrsB 
(510 kDa). 
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Figure 4.6  Identification of a MycA10 holo active site peptide.  A.  SCX chromatogram from 
analysis of MycA10 unpurified from the E. coli proteome after incubation with Sfp and CoA to 
generate holo-MycA10.  No UPPA sample preparation was completed, resulting in no SCX 
separation.  B.  SCX chromatogram from analysis of MycA10 unpurified from the E. coli 
proteome after incubation with Sfp and CoA to generate holo-MycA10.  The UPPA sample 
preparation step was completed, resulting in optimal separation by SCX.  C.  SCX 
chromatogram from analysis of MycA10 unpurified from the E. coli proteome after incubation 
with Sfp and BODIPY-CoA, generating a fluorophore labeled active site peptide.  By 
monitoring absorbance at 500 nm, the peak at 32 min was identified as containing a holo active 
site peptide.  D.  The MycA10 holo active site peptide observed from SCX fraction 32 from (B). 
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Figure 4.7  Limit of detection of the Ppant ejection ion in the PrISM platform.  In all, (i) is the 
total ion chromatogram (TIC) from the T domain active site peptide containing SCX fraction 
(fraction 16 or 18), (ii) is the selected ion chromatogram (SIC) for the holo Ppant ejection ion, 
and (iii) is the SIC for the holo active site peptide.  A, B, and C are all analyses of the holo 
active site peptide from PheAT unpurified from the background of the E. coli proteome.  A.  
Observation of the holo-PheAT active site peptide at a ratio of 1:100 induced culture: uninduced 
culture.  B.  Observation of the holo-PheAT active site peptide at a ratio of 1:500 induced 
culture: uninduced culture.  C.  Observation of the Ppant ejection ion and holo-PheAT T domain 
active site peptide in a culture with no induction of overexpression, resulting from leaky 
expression of the T7 promoter on the PheAT containing plasmid. 
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Figure 4.8  Observation of a thiolation domain active site peptide in its holo and loaded forms 
by PrISM.  A-C are from analysis of in vivo generated holo-PheAT purified from the E. coli 
proteome and incubated with ATP, Phe and 2H5-Phe (ring labeled) to generate amino acid-
loaded PheAT.  A.  Top:  TIC of SCX fraction 18 analyzed by RPLC-MS.  Middle:  SIC for the 
holo-PheAT active site peptide.  Bottom:  SIC for the Phe-loaded PheAT active site peptide.  B.  
The PheAT holo T domain active site peptide.  C.  The Phe-S-PheAT and 2H5-Phe-S-PheAT 
active site peptides.  These results confirmed the ability to detect thioester-bound substrates on 
T domains. (2H5 = D) 
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Figure 4.9  Observation of an in vivo formed thioester-bound intermediate using PrISM.   
PheAT was overexpressed in E. coli but left unpurified from the background of the E. coli 
proteome and probed for formation of Phe-S-PheAT in vivo.  A.  Top:  TIC from RPLC-MS 
analysis of SCX fraction 18 from a separation of the proteome sample.   Remaining panels:  
SICs for the Ppant ejection ions and intact active site peptides from holo-PheAT and Phe-S-
PheAT.  B.  The holo-PheAT and Phe-S-PheAT active site peptides, both observed with an error 
of <4 ppm.  C.  The Ppant ejection ions from holo-PheAT and Phe-S-PheAT, both observed 
with an error <1 ppm. 
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Figure 4.10  Observation of the PheAT active site peptide using pepsin digestion.  A.  The Ppant 
ejection assay using nozzle-skimmer dissociation (NSD) and MS/MS using IRMPD both 
generated an ion at m/z 261 (middle panels).  The IRMPD MS/MS event targeted a 1+ ion at 
m/z 987 (bottom).  B.  The holo-PheAT active site peptide at m/z 987.  See Figure 4.11 for the 
MS/MS fragmentation and identification of this peptide.  C.  The holo-PheAT Ppant ejection 
ion as generated by NSD.  D.  A Ppant ejection ion (top middle) and intact peptide mass 
corresponding to Phe-S-PheAT (bottom) are observed.  This peptide was not selected for data-
dependent MS/MS by IRMPD (bottom middle).  E.  The Phe-S-PheAT active site peptide.  F.  
The Phe-S-PheAT Ppant ejection ion as generated by NSD. 
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Figure 4.11  MS/MS fragmentation of the pepsin generated holo-PheAT active site peptide.  A.  
IRMPD MS/MS spectrum of a 1+ ion at m/z 987, corresponding to the holo-PheAT active site 
peptide.  B.  Fragmentation map of the pepsin generated PheAT holo active site peptide.  S* 
corresponds to the mass of Dha, generated by loss of the Ppant arm from the active site serine 
during MS/MS. 
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Figure 4.12  Identification of the PheAT active site peptide in a complex peptide mixture using 
an optimized PrISM method.  A.  TIC for SCX fraction 16.  Inset:  representation of PheAT 
showing the phosphopantetheinylated T domain.  B.  SIC for the holo Ppant ejection ion 
generated by NSD.  Inset:  ejection ion observed.  C.  SIC for holo-PheAT T domain active site 
peptide.  Inset:  PheAT holo T domain active site peptide.   
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Figure 4.13  Application of PrISM to detection of expressed NRPSs involved in gramicidin S 
biosynthesis in B. brevis ATCC 9999.  A.   Schematic of NRPSs involved in gramicidin S 
biosynthesis in B. brevis.  In Figure 4.13B-D, the top panel corresponds to the TIC for the SCX 
fraction, the middle panel corresponds to the SIC for the Ppant ejection ion (m/z 261.1267), the 
bottom panel is the SIC for the phosphopantetheinylated active site peptide, and the inset in the 
bottom panel is the mass spectrum for a single charge state of the peptide.  B.  Active site 
peptide from GrsA-T1.  C.  Active site peptide from GrsB-T2.  D.  Active site peptide from 
GrsB-T3.  E. Identification of gramicidin S in culture supernatant by LC-MS. 
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Figure 4.14  PrISM identification of phosphopantetheinylated peptides involved in PTT 
biosynthesis in S. viridochromogenes. A.  Schematic of NRPS proteins responsible for 
incorporation of two alanine units into PTT.  B.  Active site peptide from the PhsA-T domain.  
C.  Active site peptide from the PhsB-T1 domain identified.  D.  Bioassay for the presence of 
PTT against B. subtilis ATCC 6633.  E. LC-MS identification of the PTT small molecule. 
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Figure 4.15  Detection of a false positive Ppant ejection ion.  A.  Mass spectrum from off-line 
MS analysis of SCX fraction 32 from a separation of a Streptomyces soluble proteome.  B.  A 
3+ peptide at m/z 763 was observed that generated a fragment ion at m/z 261 during MS/MS 
(C).  D.  ECD MS/MS spectrum of the peptide at m/z 763, resulting in a peptide sequence that 
showed highest homology to trypsin, not a T domain.  The C-terminal amino acid in this peptide 
is a methionine.  
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Figure 4.16  Observance of Ppant ejection false positives.  A.  Structure and chemical formula 
of the holo Ppant ejection ion.  B.  Structure and chemical formula of the dehydrated 
isoleucine/leucine (Ile/Leu)-methionine (Met)-sulfoxide (resulting form protein oxidation).  
This species can be generated during MS/MS, resulting in a false positive Ppant ejection result.  
C.  Application of the pseudo-MS3 assay (Figure 4.17) to the trypsin peptide from Figure 4.15.  
As can be seen from the bottom middle panel, the MS3 ion at m/z 184 is not generated from the 
Ile/Leu-Met-sulfoxide fragment ion (top middle). 
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Figure 4.17  Confirmation of Ppant ejection by a pseudo-MS3 assay. A.  MS3 spectrum of the 
phosphopantetheinyl component of coenzyme A.  B.  TIC for LC-MS analysis of a digest of 
holo-PheAT.  C.  SIC for the Ppant ejection ion generated by NSD.  D.  Low-resolution SIC for 
the MS3 fragment at m/z 243.  E. Low resolution SIC for the MS3 fragment at m/z 184. 
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4.6 TABLES 
Table 4.1  Gradient used for strong cation exchange chromatography. 
Time (min) % SCX solvent B 
0 0 
5 0 
43 
57 
(increase 3% SCX solvent B 
every 2 min) 
47 
67  
(increase 5% SCX solvent B 
every 2 min) 
49 80 
52 100 
53 0 
60 0 
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Table 4.2  Gradient used for reverse phase liquid chromatography. 
Time (min) % RPLC solvent B 
0 5 
5 5 
40 50 
45 75 
50 95 
51 95 
52 5 
70 5 
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Table 4.3  SDS-PAGE lane assignments for analysis of the B. brevis proteome by streptomycin 
sulfate precipitation, ammonium sulfate precipitation and size exclusion chromatography 
(Figure 4.4). (* - Sfp included for BODIPY-CoA phosphopantetheinylation assay; SSP – 
streptomycin sulfate precipitation; ASP – ammonium sulfate precipitation) 
 
Gel A1 Silver stained 
    Lane Sample 
     1 Broad range marker (BioRad) 
   2 Recombinant GrsA (GrsA*) 
   3 Recombinant GrsA plus recombinant Sfp (Sfp*) 
 4 B. brevis, supernatant from SSP 
   5 B. brevis, supernatant from SSP plus Sfp* 
 6 B. brevis, concentrated supernatant from SSP 
 7 B. brevis, concentrated supernatant from SSP plus Sfp* 
 8 B. brevis, supernatant from ASP 
   9 B. brevis, supernatant from ASP plus Sfp* 
 10  -  
     
       Gel A2 Silver stained 
    Lane Sample 
     1  -  
     2 Broad range marker (BioRad) 
   3 B. brevis, flow through from concentration of ASP 
 4 B. brevis, flow through from concentration of ASP plus Sfp* 
5 B. brevis, concentrated supernatant from ASP 
 6 B. brevis, concentrated supernatant from ASP plus Sfp* 
7 B. brevis, resuspended pellet from ASP 
  8 B. brevis, resuspended pellet from ASP plus Sfp* 
 9 B. brevis, concentrated resuspended pell from ASP 
 10 B. brevis, concentrated resuspended pell from ASP plus Sfp* 
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Table 4.3 (cont.) 
 
Gel B1 Silver stained 
  Lane Sample 
   1 Broad range marker (BioRad) 
 2 B. brevis, resuspended pellet from ASP 
3 FPLC fraction A1 
 4 FPLC fraction A2 
 5 FPLC fraction A3 
 6 FPLC fraction A4 
 7 FPLC fraction A5 
 8 FPLC fraction A6 
 9 FPLC fraction A7 
 10 FPLC fraction A8 
 
     Gel B2 Silver stained 
  Lane Sample 
   1 FPLC fraction A9 
 2 Broad range marker (BioRad) 
 3 FPLC fraction A10 
 4 FPLC fraction A11 
 5 FPLC fraction A12 
 6 FPLC fraction B1 
 7 FPLC fraction B2 
 8 FPLC fraction B3 
 9 FPLC fraction B4 
 10 FPLC fraction B5 
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Table 4.4  SDS-PAGE lane assignments for the analysis of MycA10 and B. brevis using 
BODIPY-CoA (Figure 4.5). 
 
Gel B1 Scanned (excitation λ:  500 nm) 
 
Gel C1 Scanned (excitation λ:  500 nm) 
           Lane Sample 
    
Lane Sample 
   1 Broad range marker (BioRad) 
  
1 Broad range marker (BioRad) 
 2 MycA in E. coli, Soluble lysate 
 
2 - 
   3 MycA in E. coli, Soluble lysate 
 
3 B. brevis soluble lysate 
 4 MycA in E. coli, Soluble lysate 
 
4 - 
   5 MycA in E. coli, Resuspended ASP 
 
5 B. brevis soluble lysate 
 6 MycA in E. coli, Resuspended ASP 
 
6 - 
   7 MycA in E. coli, Resuspended ASP 
 
7 B. brevis soluble lysate 
 8  -  
    
8 - 
   9  -  
    
9 B. brevis soluble lysate 
 10  -  
    
10 - 
   
           Gel B2 Coomassie stained 
        
           Lane Sample 
         1 Broad range marker (BioRad) 
       2 MycA in E. coli, Soluble lysate 
      3 MycA in E. coli, Soluble lysate 
      4 MycA in E. coli, Soluble lysate 
      5 MycA in E. coli, Resuspended ASP 
      6 MycA in E. coli, Resuspended ASP 
      7 MycA in E. coli, Resuspended ASP 
      8  -  
         9  -  
         10  -  
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CHAPTER 5: A PROTEOMICS APPROACH TO DISCOVERY OF NATURAL 
PRODUCTS AND THEIR BIOSYNTHETIC PATHWAYS, PART 2 
 
The information and contents of this chapter were taken from the following article with 
permission from the publisher: Stefanie B. Bumpus, Bradley S. Evans, Paul M. Thomas, Ioanna 
Ntai and Neil L. Kelleher (2009). “A proteomics approach to discovery of natural products and 
their biosynthetic pathways.” Nature Biotechnology, 27(10):951-956.  B. S. Evans isolated and 
screened Bacillus strains from soil collected in Louisiana and conducted the genomic analysis of 
NK2018; S.B. Bumpus completed all other work presented in Chapter 5 unless otherwise noted.  
Please see Section 4.1 for a detailed list of acknowledgements of the others who contributed to 
Chapter 5.   
 
5.1 INTRODUCTION 
 Chapter 4 introduced a new method, PrISM (Proteomic Investigation of Secondary 
Metabolism), for the detection of natural product biosynthetic enzymes in the native producer of 
the secondary metabolite (Figure 4.1).  In its first iteration, the PrISM platform involved the 
growth and lysis of a bacterial culture, an optional phosphopantetheinylation reaction step to 
increase the abundance of holo thiolation (T) domains, multiple precipitation steps, and a two-
dimensional (2D) liquid chromatography-mass spectrometry (LC-MS) platform using strong 
cation exchange chromatography (SCX), reverse phase LC (RPLC) (Washburn, Wolters et al. 
2001) and the on-line phosphopantetheinyl (Ppant) ejection assay (Dorrestein, Bumpus et al. 
2006; Bumpus and Kelleher 2008).  This version of PrISM identified holo T domain active site 
peptides from T domain containing protein constructs (e.g. MycA10 and PheAT (Mootz and 
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Marahiel 1997; Hansen, Bumpus et al. 2007)) overexpressed in Escherichia coli but left 
unpurified from the E. coli proteome.   Additionally, this PrISM method allowed observation of 
in vivo formed thioester-bound intermediates on the PheAT protein.   
 In the second iteration of PrISM, the method was simplified in the sample preparation 
steps prior to LC-MS analysis to analyze in vivo formed holo proteins and increase the 
throughput of analysis.  Using a simplified lysis step and eliminating all additional incubation 
and precipitation steps, bacterial cultures were analyzed directly via the 2D LC-MS platform 
employing Ppant proteomics.  Using this technique, multiple holo T domain active site peptides 
were identified from the native natural product producers Bacillus brevis and Streptomyces 
viridochromogenes (Matteo 1975; Blodgett, Zhang et al. 2005).  Manual data analysis used the 
generation of a Ppant ejection ion to guide the search for T domain active site peptides whose 
masses were predicted from the known amino acid sequence of the biosynthetic enzymes.  While 
no thioester-bound intermediates on T domains in B. brevis and S. viridochromogenes were 
identified, these two results were the first indication that PrISM could successfully identify 
biosynthetic proteins expressed at native levels and connect this expression with the production 
of a natural product.   
 Despite these early successes of PrISM, there were still challenges to face.  The most 
important challenges were in the continued reduction of proteome sample complexity and in the 
development of robust data analysis protocols.  For each proteome analyzed in the first 
implementations of PrISM, the proteome was digested with trypsin and the full tryptic digest 
separated by SCX.  This resulted in at least twenty SCX fractions that each must be analyzed by 
RPLC-MS and the on-line Ppant ejection assay and mined for Ppant ejection ions and peptides of 
interest.  Such a time consuming method – resulting in one full day of instrument usage per 
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sample analyzed – did provide a global proteomic view of the organism under specific growth 
conditions, but was not yet as robust as PrISM needed to be for high-throughput implementation.  
In the area of data analysis, the B. brevis and S. viridochromogenes examples were easily 
analyzed manually because the amino acid sequences of NRPSs involved in natural product 
production were known.  However, the ultimate goal of the PrISM platform is to discover novel 
natural products, and this is likely to be most successful in newly isolated bacterial strains and 
other less well characterized strains without sequenced genomes.  Thus, the manual search for 
peptides of interest becomes impossible.  Instead, one must search the tandem mass spectrometry 
(MS/MS) data generated from LC-MS analysis against a database of known proteins, relying on 
homology with known NRPSs and PKSs to identify peptides in the proteome.  With as many as 
twenty LC-MS runs per proteome analysis, the data analysis step would become a hindrance to 
PrISM success. 
 With these challenges in mind, the PrISM platform was adapted to encompass additional 
techniques in Bottom Up proteomics (Bogdanov and Smith 2005) and exploit characteristics of 
many NRPS and PKS enzymes.  As discussed in Chapter 1, many NRPSs and PKSs are very 
large, with molecular weights (MWs) often >500 kDa.  This separates them from most other 
species in the bacterial proteome and provides a means to for producers of NRPS and PKS 
natural products.  This feature also suggests a new sample preparation platform.  In the screening 
phase, bacterial strains would be grown under a variety of conditions in small liquid cultures, 
their soluble proteomes collected, and each proteome screened for the presence of high 
molecular weight proteins (HMWPs), indicating NRPS and/or PKS expression (Figure 4.1B).  In 
the sample preparation phase, a new MW-based protein separation would be employed. 
 While MudPIT-based Bottom Up proteomics currently sees widespread use, other 
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Bottom Up proteomics platforms are also well established.  Developed prior to MudPIT, a 
common method for proteomics is separation of a proteome sample by 2D polyacrylamide gel 
electrophoresis (PAGE), separating proteins first by their isoelectric points and then by their 
molecular weights (Gorg, Drews et al. 2009).  Spots from the 2D gel are excised, subjected to in-
gel trypsin digestion and analyzed by RPLC-MS for peptide identification (Gygi, Corthals et al. 
2000).  In an associated method, 1D PAGE is employed as the single separation step prior to 
RPLC-MS analysis, in a method referred to here as GeLC-MS.  In this platform, a full proteome 
is separated by molecular weight using traditional PAGE methods.  Protein bands are excised 
from the gel, subjected to in-gel trypsin digestion and then analyzed by RPLC-MS (Mortz, Vorm 
et al. 1994; Cooper and Lee 2004).  While this 1D gel-based separation does not provide the 
resolution of the 2D PAGE platform, it does provide a method for the separation of HMW NRPS 
and PKS proteins from the remainder of the bacterial soluble proteome.  Using this MW-based 
separation, HMWP bands could be excised from the PAGE gel, subjected to standard in-gel 
digestion procedures and analyzed by RPLC-MS and the Ppant ejection assay using a nano-
capillary LC-MS system (nanoLC-MS).  The analysis of a single proteome sample would 
thereby be decreased from 20 LC-MS runs (one per SCX fraction) to a single LC-MS run for 
each HMWP. 
 To implement this new gel-based PrISM platform, bacterial isolates were collected from 
two different sets of soil samples, screened for the presence of HMWPs, and analyzed for NRPS 
and PKS content as well as for new natural products.  Chapter 5 discusses the application of 
PrISM to Bacillus isolate NK2018, as well as a variety of isolates from soil collected in 
Wisconsin.   
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5.2 EXPERIMENTAL 
Trypsin (TRL3) for digests of bacterial proteomes was purchased from Worthington 
Biochemicals. Sequencing grade trypsin (Promega) was used for all in-gel digestions. E. coli 
BL21(DE3) cells were purchased from EMD Biosciences. All other chemicals used were 
purchased from either ThermoFisher Scientific or Sigma-Aldrich unless otherwise noted. 
5.2.1 Isolation of Strains of Bacillus and Preparation of Proteome Samples 
The isolation of strains from soil collected in Louisiana and screening for the presence of 
HMWPs was conducted by B. S. Evans.  The strains were named NK2001-NK2022.  Protocols 
will be published in his doctoral dissertation.  
Strain NK2018 was chosen for further analysis based on presence of HMWP bands on an 
sodium dodecyl sulfate (SDS)-PAGE gel (Figure 5.1). A starter culture of nutrient broth (50 mL) 
was inoculated with a single colony of strain NK2018 and grown overnight at 30 °C. An aliquot 
(5 mL) was used to inoculate 1 L nutrient broth for 24 h or 48 h growth at 30 °C. Cells were 
isolated by centrifugation (10,000 x g, 10 min, 4 °C) and resuspended in a minimal amount of 
100 mM NH4HCO3 (pH 7.8). Cells were lysed by sonication (5 cycles of 30 s sonication on ice 
followed by 30 s incubation on ice) and debris was cleared by centrifugation (20 min, 4 °C, 
47,810 x g). Protein concentration was estimated by the BCA assay (ThermoPierce
 
).  A similar 
procedure was used for preparation of all other NK2001-NK2022 strains. 
5.2.2 Gel-based Proteomic Analysis of NK2018 
 The gel-based proteomic analysis of strain NK2018 was conducted by P.M. Thomas and 
has been previously reported (Thomas 2008).  The protocol is very similar to that described in 
Subsection 5.2.8. 
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5.2.3 2D LC-Based Proteomic Analysis of NK2018 
 The NK2018 soluble proteome was prepared as described above.  For trypsin digestion, 
4-5 mg total protein was incubated in 2 M fresh urea and 10 mM dithiothreitol with trypsin at a 
ratio of 1:10 protease: substrate for 2 h at 37 °C.  The reaction was quenched by the addition of 
SCX solvent A (20 mM citric acid (pH 2.65), 25% acetonitrile (MeCN)).  The entire tryptic 
digest was loaded onto the SCX column. 
SCX chromatography was carried out using a Shimadzu Prominence high performance 
(HP)LC
On-line RPLC-MS/MS data were collected using a hybrid linear ion trap-Fourier-
transform MS (FTMS) (
. The column used for SCX analysis was a Polysulfoethyl A column (PolyLC) with a 4.6 
mm inner diameter and a length of 200 mm. The column was equilibrated for 60 min with SCX 
solvent B (20 mM citric acid (pH 2.65), 25% MeCN, 1 M NH4Cl) followed by equilibration for 
30 min with SCX solvent A at a flow rate of 1 mL/min prior to each analysis.  An entire tryptic 
digest was loaded onto the SCX column and eluted with a step gradient (Table 4.1) using SCX 
solvents A and B flowing at 0.5 mL/min. Fractions were collected every 2 min in 96 well plates 
and analyzed by FTMS immediately or stored at –20 °C until further analysis. SCX fractions 
were subjected to RPLC-MS/MS according to the following method.  
ThermoFisher Scientific 12 T LTQ-FT) coupled to an Agilent 
autosampler and Agilent HP1100 binary pump HPLC system. The columns used for all RPLC 
analysis were Jupiter C18 or C4 1 mm × 150 mm columns (Phenomenex). The gradient used for 
all RPLC analysis is provided in Table 4.2, with RPLC solvent A being H2O + 0.1% formic acid 
and RPLC solvent B being MeCN + 0.1% formic acid flowing at 100 µL/min. 150–300 µL of 
each SCX fraction was injected onto the RPLC column for MS analysis.  For off-line analysis of 
Ppant ejection positive RPLC fractions, 100 µL fractions were collected manually using the 
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same column and gradient as above. 
On-line LC FTMS data were collected on a 12 T LTQ-FT (ThermoFisher Scientific) and 
methods included the following events: (i) FT scan, m/z 500–2,000, (ii) FT scan, nozzle-skimmer 
dissociation (75 V), detect m/z 200–600, (iii) data-dependent MS/MS on the top X (X = 3 for 
high-resolution MS/MS data collection and X = 6 or 10 for unit resolution MS/MS data 
collection) peaks in a given spectrum using collision induced dissociation (CID) or infrared 
multi-photon dissociation (IRMPD). All data were analyzed using QualBrowser, part of the 
Xcalibur software
For off-line FTMS analysis of Ppant ejection positive RPLC fractions, all MS data were 
collected using a 12 T LTQ-FT (ThermoFisher Scientific).  Fractions were injected using a 
robotic nanospray system (Advion Nanomate).  For each fraction, intact peptide data were 
collected using the FTMS and peptide containing regions of the spectrum were subjected to 
MS/MS using IRMPD to generate Ppant ejection ions.  Once a region of interest was identified, 
all peptides in that region were isolated individually and subjected to IRMPD.  Peptides resulting 
in Ppant ejection were subjected to MS/MS to generate the apo + 80 Da and apo – 18 Da species 
using IRMPD with high resolution data collected in the FTMS.  The apo + 80 Da species was 
isolated and subjected to MS3 using CID to generate the apo – 18 Da species with low resolution 
data collected using the ion trap MS.  Finally, the apo – 18 Da species was subjected to MS4 
using CID with detection in the ion trap MS to generate the fragment ions used in peptide de 
 packaged with the LTQ-FT, and custom inhouse software. Selected ion 
chromatograms (SICs) were generated for the Ppant ejection ions of interest. Based upon the 
elution of the Ppant ejection ion, the time of elution was analyzed for the presence of peptides 
showing all Ppant ejection marker ions. MS/MS data generated by CID or IRMPD were 
analyzed manually. 
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novo sequencing.  All MSn data were manually analyzed using Qualbrowser. 
5.2.4 Genomic Analysis of NK2018 
The genomic analysis of NK2018 was completed by B.S. Evans and will be described in 
detail in his doctoral dissertation.  
A 100 mL starter culture of NK2018 was grown in supplemented M9 minimal medium 
(per 1 L: 800 mL H2O, 200 mL M9 salts (a 1 L 5X solution contains 64 g Na2HPO4·7H2O, 15 g 
KH2PO4, 2.5 g NaCl and 2.5 g NH4Cl), 20 mL 20% glucose, 1 mL 1 M MgSO4, 100 µL 1 M 
CaCl2 and 10 mL Difco nutrient broth)) at 30 °C for 2 d. An aliquot of this starter culture was 
used to inoculate (at a 1:100 dilution) either a 100 mL or 500 mL volume of M9 minimal 
medium (minus nutrient broth) and was grown for 3–10 d at 30 °C. Culture purity was assessed 
by examination with a light microscope and by conducting selected NK2018 PCRs on genomic 
DNA purified from each culture (data not shown).  Cultures were harvested by centrifugation 
(10,000 x g, 10 min) and the culture supernatant filter sterilized. The cell pellets were used to 
prepare protein samples as described previously for PrISM analysis. These samples were used to 
confirm the presence of HMWPs by SDS-PAGE (Figure 5.2) and for PrISM proteome analysis 
(using the gel-based proteomic analysis as described below) to confirm the species as NK2018 
The peptides used for primer design have been published 
previously (Thomas 2008).   Please see the doctoral dissertations of P.M. Thomas (University of 
Illinois at Urbana-Champaign, 2008) and B.S. Evans (University of Illinois at Urbana-
Champaign, 2010) for the following:  PCR methods, agarose gel separation of all PCR products, 
list of all peptides used for primer design, list of all primers used in NK2018 genomic analysis, 
the sequences of all PCR products, and a comparison of PCR product sequences with the B. 
cereus AH1134 genomic DNA sequence. 
5.2.5 Identification of NK2018 Natural Products 
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and to assay production of NRPS and PKS related proteins (Figure 5.3). Culture supernatant was 
concentrated 15 to 20 fold through rotary evaporation and stored at –80 °C until further analysis.  
RPLC-MS analysis was conducted on all culture supernatants using a Phenomenex 
Gemini-NX C18 column (5 µ particle size, 110 Å pore size) with either a 2 mm or 4.6 mm inner 
diameter. All LC-MS analysis was conducted on a ThermoFisher Scientific LTQ-FT operating at 
7 T and connected in-line with Surveyor MS pump and autosampler. An external fraction 
collector was added if HPLC fractions were to be collected simultaneously with MS analysis. 
For LC-MS analysis, a shallow gradient was used as shown in Table 5.1, where solvent A was 
H2O + 0.1% formic acid and solvent B was MeCN + 0.1% formic acid. Each FTMS analysis 
included a full scan (m/z 300–2000) with data-dependent MS/MS using CID on the top 3 ions in 
each full scan. The MS/MS data were analyzed using an inhouse software package and 
ThermoFisher Xcalibur Qualbrowser
 S.B. Bumpus and I. Ntai traveled to Sauk County, Wisconsin, USA to collect a variety of 
soil samples from the recently emptied Lake Delton (due to a breach of the lake dam).  Three 
collection points were selected.  Collection point #1 had a mixture of both sandy and muddy 
soils and soil samples were collected at both areas.  Collection point #2 was near the center of 
. Additional LC-MS separation of these samples was 
conducted, collecting HPLC fractions at 1 min intervals and drying the fractions under vacuum. 
Fractions were resuspended in electrospray solution (49% H2O, 49% methanol (MeOH), 2% 
formic acid) and analyzed by direct infusion into a ThermoFisher LTQ-FT Ultra operating at 12 
T using a TriVersa robot system (Advion) for sample delivery. Extensive MSn analysis using 
CID was conducted on the species of interest to gain as much structural information as possible 
with fragment ions detected at both high and low resolution. 
5.2.6 Collection of Soil from Lake Delton (Wisconsin, USA) 
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the lake (and near many residential areas) and samples were collected from the dry soil.  
Collection point #3 was near the joining of Lake Delton and Mirror Lake and there was still a 
significant amount of water in this collection point.  Shallow soil samples were collected in 
addition to water samples.  To collect a soil core, a 1 in inner diameter PVC pipe was cut into 1 
m long units and capped at one end.  The uncapped end was inserted into the collection point and 
hammered into the ground (marking the depth with tape on the pipe).  The soil filled pipe was 
carefully removed and capped.  The soil was removed from the pipe and transferred to a 50 mL 
conical vial and stored at 4 °C until strain isolation.  Figure 5.4 shows each collection point. 
5.2.7 Isolation of Bacterial Strains from Wisconsin Soil  
For each soil collection point, 100-200 mg soil sample were transferred into a sterile 1.5 
mL centrifuge tube.  One mL of H2O was added to the tube and the soil was resuspended using a 
Vortex for 10 min.  Serial dilutions of the sample were made from 1X down to 1/100,000X in 
sterile H2O (with the volume of each diluted sample maintained at 1 mL).  Each of the serial 
dilutions was heated at 95 °C for 20 min and then allowed to cool to room temperature.  100 µL 
of each sample was plated on a nutrient agar plate and placed at 30 °C for 2 d (or until colonies 
appeared).  Up to 8 colonies were selected from each plate with growth and restreaked 
individually onto new nutrient agar plates to begin the isolation procedure; all plates were 
incubated at 30 °C for at least 24 h.  Five rounds of colony selection and restreaking were 
performed to isolate ~60 individual strains.  Strains were stored as glycerol stocks made from 
250 µL of an overnight culture with 250 µL of 75% glycerol and stored at -80 °C.  Genomic 
DNA was purified from each isolate using a Qiagen DNeasy Blood and Tissue DNA Kit
 
.  The 
strains were named NK2023-NK2095. 
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5.2.8 Screening of Wisconsin Isolates for HMWPs 
 For all growth conditions screened, 5 mL of liquid medium (e.g. nutrient broth (Difco) or 
M9 minimal medium) were inoculated with a single colony from a nutrient agar plate and placed 
on a drum roller at 30 °C for 48 h.  The entire 5 mL culture was harvested by centrifugation (4 
°C, 10 min, 5,000 x g) and resuspended in 50-100 µL of 2X SDS-PAGE loading buffer (50 mM 
Tris-HCl (pH 6.8), 20% v/v glycerol, 4% w/v SDS, 0.2% w/v bromophenol blue).  The 
resuspended cells were incubated at 95 °C for 20 min to complete cell lysis and the soluble lysate 
was collected by centrifugation (10 min, 16,000 x g).  Twenty µL of each soluble fraction was 
analyzed by SDS-PAGE.  After SDS-PAGE, gels were stained overnight with colloidal 
Coomassie G250 (Dyballa and Metzger 2009) and destained overnight with H2O.   
5.2.9 In-gel Digestions and nanoLC-MS/MS of HMWPs from NK20XX Strains 
All SDS-PAGE separation of HMWP+ soluble proteomes for in-gel digestions was 
conducted using preparative 10% PAGE gels with a 4% stacking gel and a 10% resolving gel or 
a 4-20% T Tris-HCl gel (BioRad, 10 well, 30 µL/well).  100-200 µL of sample in 2X SDS-
PAGE loading buffer were heated at 95 °C for 5 min before being loaded onto the gel, separated 
by SDS-PAGE, stained overnight with Coomassie G250 colloidal stain and destained for several 
hours in H2O.  HMWP protein bands (>150 kDa) were excised with a razor blade and cut into 
pieces smaller than 2 mm3 (Figure 5.5). These gel samples were then destained, reduced with 
dithiothreitol (DTT), alkylated with iodoacetamide and digested with trypsin according to a 
previously published protocol for in-gel digestion (Mortz, Vorm et al. 1994; Patterson and 
Aebersold 1995). Peptides were extracted, lyophilized, rehydrated (Mortz, Vorm et al. 1994; 
Patterson and Aebersold 1995) with 0.1% acetic acid and bomb loaded onto a self packed C4 
nano-LC guard column (75 µm × 10 cm, 10 to 20 µm particle size). This guard column was then 
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placed upstream of a ProteoPepII C18 column (75 µm × 10 cm, New Objective) and peptides 
were eluted over a 68 min linear gradient of H2O and MeCN with 0.1% formic acid at a flow rate 
of 300 nL/min (produced by an Eksigent 1D nanoLC) into a 7 T ThermoFisher LTQ-FT. 
Samples were analyzed using the on-line Ppant ejection assay as well as data-dependent low 
resolution CID for MS/MS on the top 5 precursors. LC-MS/MS data from each in-gel digestion 
run were processed into DTA files with BioWorks 3.2 (ThermoFisher). These data were 
searched against the non-redundant protein database (nr) (or a custom database built to include 
all bacterial proteins and all NRPS and PKS proteins in the nr database) with the open mass 
spectrometry search algorithm (OMSSA) using standard settings for the detection of intact 
peptides at high resolution (FTMS) and MS/MS fragment ions with unit resolution (ion trap MS) 
(0.01 Da intact peptide tolerance, 0.5 Da fragment ion tolerance) (Geer, Markey et al. 2004). 
Phosphopantetheinylated peptides were observed as the carboxyamidomethylated-pantetheinyl 
(Ppant-Cam) ejection products (318.1482 Da), generated from alkylation of the free Ppant thiol 
with iodoacetamide during the standard in-gel digestion procedure. 
5.2.10 Genomic Analysis of Lake Delton Isolates 
Briefly, genomic DNA was isolated from 5 mL cells (overnight culture at 30 °C in 
nutrient broth) using a Qiagen DNeasy Blood and Tissue DNA Kit. PCR was performed on 
BioRad DNA Engine thermal cycler. Primers were designed based upon MS/MS peptide 
sequence data.  Forward and reverse primers were designed for each peptide sequence using the 
most likely codon usage as well as fully degenerate primers.  Reactions (per 25 µL) were 
composed of 5 µL 5X GoTaq Flexi reaction buffer (Promega), 2 µL 2.5 mM dNTPs, 1.3 µL 50 
mM MgCl2, 0.5 µL template DNA, 0.25 µL Taq polymerase, 0.25 µL each primer (100 µM 
each), and 15.45 µL H2O. Based on the annealing temperature of the primers to the template 
268 
 
DNA and the length of the PCR product, the following PCR method was used: 1) 94 °C, 3 min; 
2) 94 °C, 30 s; 3) 55 °C, 30 s; 4) 68 °C, 3.5 min; 5) Repeat 2-4 34 times; 6) 68 °C, 10 min.  PCR 
products were separated on a 1% agarose gel (in 1X TAE, ethidium bromide: 0.5 µg/mL) and 
visualized with a UV transilluminator. Product sizes were compared to a 1 kb standard 
(Invitrogen
 Fifteen mL of liquid medium (typically MYG) were inoculated with a single colony of an 
actinomycete strain (e.g. Streptomyces sviceus (a generous gift from The Broad Institute, Boston, 
).  
5.2.11 Lysis of Bacterial Strains Grown on Agar Plates 
 Fifteen mL of liquid medium (either MYG (per L: 10 g malt extract, 4 g yeast extract, 4 g 
glucose (pH 7.3)) or nutrient broth) were inoculated with a single colony of a Bacillus or 
Streptomyces strain.  The culture was incubated at 30 °C for 2-3 d.  One mL of the culture was 
plated on a 150 mm agar plate with a cellophane membrane on top of the agar and incubated at 
30 °C for 4-10 d.  The cellophane layer was transferred to a 400 mL centrifuge tube and the cells 
were washed from the membrane with 50 mM Tris-HCl (pH 8.8).  The cells were transferred to a 
40 mL centrifuge tube, harvested by centrifugation (4 °C, 47,000 x g, 30 min), resuspended in 50 
mM Tris-HCl (pH 8.8) supplemented with 2 mg/mL lysozyme, and incubated at 37 °C for 1 h.  
The cell pellet was recollected by centrifugation (4 °C, 47, 000 x g, 20 min).  The cell pellet was 
resuspended in 50 mM Tris-HCl (pH 6.8), 20% v/v glycerol and 5% w/v SDS.  The resuspension 
was incubated at 60 °C for 1 h and then boiled for 20 min to complete cell lysis.  The soluble 
lysate was collected by centrifugation (4 °C, 20 min, 47,000 x g) and a 50 µL aliquot diluted in 
2X SDS-PAGE loading buffer.  The soluble lysates were analyzed by SDS-PAGE for the 
presence of HMWPs as described previously. 
5.2.12 Optimized Methods for Lysis of Actinomycetes 
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MA USA), S. laurentii ATCC 31255, S. viridochromogenes DSM 40736 or an environmental 
Streptomyces isolate) and grown at 30 °C for 2-4 d.  Five mL of the starter culture were used to 
inoculate 200 mL of the same liquid medium and placed at 30 °C with shaking at 200 rpm.  A 
200 mL culture was inoculated for each growth time point to be analyzed.  At the end of each 
growth time point (e.g. 3, 6 and 9 d), cells were harvested by centrifugation (10 min, 4 °C, 
10,000 x g), the supernatant discarded or filter sterilized and stored at -80 °C, and the cells frozen 
at -80 °C.  Cell pellets were thawed at 4 °C and resuspended in 50 mM Tris-HCl (pH 8.8) 
supplemented with 2 mg/mL lysozyme and incubated at 37 °C for 45-60 min.  The cells were 
reharvested by centrifugation (10 min, 4 °C, 47,000 x g) and resuspended in 50 mM Tris-HCl 
(pH 6.8), 5% w/v SDS and 20% v/v glyercol.  The resuspension was incubated at 60 °C for 1 h 
and boiled for 20 min to complete cell lysis.  The soluble lysate was collected by centrifugation  
(20 min, 4 °C, 47,000 x g) and a 50 µL aliquot diluted into 2X SDS-PAGE loading buffer.  The 
soluble lysates were analyzed by SDS-PAGE for the presence of HMWPs as described 
previously. 
5.3 RESULTS  
 In developing the overall PrISM workflow (Figure 4.1), three systems with increasing 
complexity were interrogated (Chapter 4). First analyzed was a didomain enzyme from the 
gramicidin S system (PheAT from gramicidin S synthetase A, 70 kDa) (Matteo 1975), using 
Bottom Up proteomics in conjunction with the Ppant ejection assay. The single tryptic peptide 
(Asp564-Lys575; 1638.70 Da) from PheAT harboring the Ppant arm was detected against the full 
complement of E. coli proteins (Figure 4.12). Next analyzed was the native producer of 
gramicidin S, B. brevis, as it entered early stationary phase (Matteo 1975). Prior LC-FTMS 
analysis of a crude extract of B. brevis had verified production of this 10-mer NRPS at this stage 
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of the life cycle. Using this system, four of the five carrier peptides from the GrsA (127 kDa) and 
GrsB (510 kDa) proteins were detected by Bottom Up proteomics (Figure 4.13). A similar 
overall result was obtained for the phosphinothricin tripeptide biosynthetic system in the 
substantially more complicated proteomic background of the native producer, S. 
viridochromogenes DSM 40736 (Blodgett, Zhang et al. 2005) (Figure 4.14). 
5.3.1 Application of PrISM to Identification of NRPSs and PKSs in Strain NK2018 
 With proof-of-concept experiments in hand for the first half of the PrISM workflow 
(Figure 4.1A-C) in both Gram-positive (e.g. B. brevis and S. viridochromogenes) and Gram-
negative bacteria (e.g. E. coli), the PrISM method was applied to strains isolated from the 
environment without the benefit of DNA sequence or other information a priori. Bacillus spores 
were isolated from heat treated soil samples (Travers, Martin et al. 1987) and twenty-two isolates 
stored for proteomic analysis after 16S rDNA sequencing for taxonomic dereplication. SDS-
PAGE was used as an initial screen for these twenty-two strains, after growth for two days at 30 
°C in nutrient broth with sampling at 8, 16, 24, 36 and 48 h. Five of the twenty-two strains 
showed expression of HMWPs (consistent with NRPS/PKS expression) in at least one time 
point, including the NK2018 strain, which was subjected to full proteome analysis using both 
SCX-RPLC-MS of the full proteome and nanoLC-MS of in-gel digests of high molecular weight 
proteins. 
Using Bottom Up proteomics combined with the Ppant ejection assay, twenty cation 
exchange fractions (from separation of a tryptic digest of the NK2018 proteome by SCX) were 
analyzed by RPLC-MS/MS using a linear ion trap-FTMS operating at 12 T (ThermoFisher 
Scientific LTQ-FT).  In two of these SCX fractions, a 2+ peptide at m/z 1038.98 (2075.94 Da) 
was identified as harboring a Ppant arm (Figure 5.6).  To identify this peptide, an aliquot of the 
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SCX fraction was separated by off-line RPLC using the gradient in Table 4.2.  Fractions 
corresponding to the elution time of the Ppant ejection ion observed in the on-line LC-MS run 
were mined for a peptide that generated the Ppant ejection marker ions (Dorrestein, Bumpus et 
al. 2006) when subjected to MS/MS.   
The fraction was scanned across the region of m/z 500-1500 for peptides generating the 
Ppant ejection ion; isolation of the peptide at m/z 1038.98 generated not only the small molecule 
Ppant ejection ions of interest but also the two expected peptide marker ions at m/z 1816.9 (apo + 
80 Da) and m/z 1718.9 (apo – 18 Da) (Figure 5.7 andFigure 5.8A).  The species at m/z 1817 was 
isolated in the ion trap mass spectrometer (ITMS) (Figure 5.8B), and subjected to MS3 to 
generate loss of the phosphate group and leave the apo – 18 Da species at m/z 1718 (Figure 
5.8C).  The apo – 18 Da species was isolated in the ITMS (Figure 5.8D) and subjected to MS4 
with detection of all fragment ions in the ITMS.  Analysis of the resulting spectra, in 
combination with fragment ions generated from the initial MS/MS of the parent peptide, allowed 
de novo sequencing of the ten amino acid sequence shown in Figure 5.8E.   
These MSn experiments on the Ppant producing peptide provided sufficient de novo 
sequence information for its identification as the acyl carrier protein (ACP) active site peptide 
from fatty acid biosynthesis (Figure 5.8E). The ten amino acid sequence generated, 
[GADSPpant(I/L)DVVE(I/L)], was sufficient for differentiation of this peptide as a fatty acyl ACP 
(AcpP), because the sequence motif flanking the active site serine is distinct from that found in 
either NRPSs or PKSs (Mercer and Burkart 2007). The identification of this peptide provides a 
positive control for identification of phosphopantetheinylated peptides and de novo generation of 
long stretches of peptide sequence information, a critical step for design of good primers for 
PCR. 
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Two-dimensional LC-MS analysis of the NK2018 soluble proteome resulted in 
characterization of the phosphopantetheinylated peptide described above, but did not result in 
any other holo T domain active site peptides (despite the fact that multiple HMWP bands were 
observed).  To target the putative NRPSs and/or PKSs, the HMWPs from NK2018 were 
analyzed by in-gel trypsin digestion and nanoLC-MS.  In this analysis, multiple Ppant ejection 
ions were observed within 1 ppm of the theoretical mass (for the Ppant arm modified with 
iodoacetamide during sample preparation) (Figure 5.9). Additionally, peptides were identified 
that showed all peptide and small molecular markers ions resulting from elimination of the Ppant 
arm (discussed below).  Analysis of all MS/MS data using OMSSA (Geer, Markey et al. 2004) 
identified peptides with significant sequence homology to gene products from the strain B. 
cereus AH1134 (whose genome was published in September 2006); the peptides came from two 
putative biosynthetic gene clusters in B. cereus AH1134, referred to here as cluster no. 1 and 
cluster no. 2.  These peptides were used to design degenerate primers to probe the NK2018 
genome, and the resulting PCR products also showed very high homology to B. cereus AH1134 
gene sequences.  This data demonstrated that NK2018 was orthologous to B. cereus AH1134, 
and the genome sequence of this organism was used as a scaffold for the continued analysis of 
NK2018.   
A large number of the genes in cluster no. 1 are orthologous to those that produce the 
aminopolyol antibiotic zwittermicin A (ZmA). Zwittermicin A has a broad spectrum of activity 
against both Gram-positive and Gram-negative bacteria as well as certain eukaryotes (Silo-Suh, 
Stabb et al. 1998). A total synthesis was recently reported (Rogers, Dalisay et al. 2008) and the 
sequence of individual biosynthetic proteins has been reported over the past four years (Kevany, 
Rasko et al. 2009). A 2009 report based on the B. cereus AH1134 sequence homologous to that 
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expressed in NK2018 revealed that the zwittermicin A biosynthetic gene cluster is much larger 
than expected and predicted to produce three zwittermicin A related small molecules (Kevany, 
Rasko et al. 2009).  Two of the phosphopantheinylated peptides observed during nanoLC-MS 
and identified by manual analysis of the high molecular weight protein in-gel digestion match 
within 3 ppm to thiolation domain active site peptides from ZmaB and ZmaK (Figure 5.10).   
Targeted searching for small molecules allowed detection of zwittermicin A and a 
previously undetected methionine containing NRPS product, thus completing the PrISM 
approach (cf. Figure 4.1F).  For the identification of ZmA and related products, the LC-MS data 
files were searched manually for the theoretical masses of ZmA (1+, m/z 397.2041) and the ZmA 
related product as predicted in recent reports (1+, m/z 333.1479) (Kevany, Rasko et al. 2009); 
representative results of these analyses are shown in Figure 5.11.  The masses corresponding to 
ZmA and the related compound shown were detected in concentrated supernatant from NK2018 
grown in M9 minimal medium for 7-10 d, in addition to half strength trypticase soy broth (0.5X 
TSB) as previously reported (I. Ntai; Kevany, Rasko et al. 2009).   
5.3.2 Identification of an Uncharacterized Biosynthetic Gene Cluster and Novel Natural 
Products in NK2018 
PrISM analysis also uncovered evidence for expression of a second cluster from Bacillus 
strain NK2018 (cluster no. 2) by detecting peptides from the two module NRPS protein depicted 
as C2S2 in Figure 5.12. Annotation of the flanking ~50 kb of sequence from B. cereus AH1134 
around the gene for the protein identified from this cluster is shown in Figure 5.12. Three genes 
predicted to encode NRPSs are present in this gene cluster, along with a nearby efflux protein, a 
phosphopantetheinyl transferase and a type II thioesterase. There are homologs of this gene 
cluster known in other B. cereus strains, such as B4264 and G9842, and multiple B. 
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weihenstephanensis strains, but the gene cluster is clearly an orphan with no corresponding 
natural product known. As discussed below, the PrISM platform enabled identification of this 
new gene cluster by detection of the expressed gene products and linked this expression with 
secondary metabolite production.  
Previously described NRPS rules that make predictions for substrate specificity of 
adenylation domains based upon characterized domains (Stachelhaus, Mootz et al. 1999; Challis, 
Ravel et al. 2000; Rausch, Weber et al. 2005) were used to predict a seven residue, NRPS-type 
natural product with amino acids including serine (Ser), alanine (Ala) and threonine (Thr), in 
addition to two glutamine (Gln) or glutamic acid (Glu) residues at the C terminus. Targeted 
analysis of NK2018 extracts for peptides of this type uncovered a set of six related species that 
were analyzed and sequenced using MS/MS. De novo sequencing, as described in detail below, 
generated a sequence of six amino acids common to all. This sequence, Glycine (Gly)-Ala-Ser-
histidine (His)-Gln-Gln, provides a reasonable match to the adenylation domain substrates 
predicted. One empirical formula predicted for the species at m/z 908.4845 (within 1 ppm error) 
was C40H65N11O13; the lipoheptapeptide shown in Figure 5.13 is a putative structure for this 
chemical formula that is strongly supported by the MS data and a previous report of lipopeptides 
of similar structure (Hathout, Ho et al. 2000) (Figure 5.14 and Table 5.2). 
Manual interrogation of LC-MS files of culture supernatant from NK2018 grown in M9 
minimal medium revealed a set of species (m/z 908.4845, 922.5007, 936.5165, 926.4951, 
940,5112, and 954.5272) differing in mass by either 14 or 18 Da.  Detailed MS/MS analysis was 
conducted on this series of six related peptides and implicates the structure shown; the predicted 
chemical structures, based on MS/MS data and previous reports of other Bacillus lipopeptides, 
are presented in Figure 5.13.  The MS/MS data discussed below are presented in Figures 5.15-
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5.18.  The parent ion is denoted as M.  Please refer to Figure 5.13 for a fragmentation map of the 
parent ion at m/z 926.4951. In addition to the new compounds reported here, the previously 
reported kurstakins were detected after NK2018 growth in supplemented minimal medium (at all 
time points analyzed; I. Ntai); the intact masses matched to the previously reported lipopeptides 
and on-line LC-MS/MS analysis of these compounds showed the characteristic marker fragment 
ion at m/z 609 (Hathout, Ho et al. 2000). 
MS/MS on the six parent ions (Figure 5.13) resulted in several fragment ions, shown in 
Figure 5.15.  It is important to note that MS/MS data revealed fragment ions with several losses 
of 17 Da, 18 Da and 28 Da from the loss of H2O, NH3 and CO, respectively.  This is indicative 
of a peptide species containing amino acid side chains capable of water (e.g. Ser, Thr) and/or 
ammonia (e.g. Gln) loss.  An abundant ion consistently resulted from the loss of water from the 
parent ion (M-H2O), followed by additional losses as described previously.  Fragment ions were 
identified that were equal in mass to M-Gln (b6-H2O) and M-Gln-Gln (b5-H2O) (in addition to 
water and ammonia losses), suggesting that these species contain two consecutive Gln residues.  
These large ions also showed a variance of 14 Da between species; the significance of this will 
be discussed below. 
An additional fragment ion (y6) was observed at either m/z 609.2704 (M = m/z 908.4845, 
922.5007, or 936.5165) or m/z 627.2813 (M = m/z 926.4951, 940.5112, 954.5272).  When the 
fragment ions smaller than this ion were examined, a series of ions were observed that were 
separated by the mass shifts of His-Ser-Ala-Gly.  The mass of the smallest ion in the MS/MS 
spectrum from m/z 926.4951, resulting from loss of His, had a mass equal to the mass of two Gln 
residues.  When the chemical structure of an amino acid chain built of these six amino acids 
(Gln-Gln-His-Ser-Ala-Gly) was examined, it was observed that the masses of the theoretical y 
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ions of this peptide matched exactly to those observed in the mass spectra of the parent ions at 
m/z 926.4951, 940.5112, 954.5272.  This is clear evidence that these species contain this amino 
acid sequence.  The parent ions at m/z 908.4845, 922.5007, 936.5165 are all 18 Da less the other 
three parent ions, indicating that a water loss has occurred in this amino acid sequence (Figure 
5.16).  The water loss is assigned to the formation of a lactone ring between the Ser residue and 
the C-terminal Gln residue, similar to that in the kurstakins (Hathout, Ho et al. 2000).  The 
detection of the smallest ion containing two Gln residues indicates that these residues correspond 
to the large fragment ions observed (b5-H2O and b6-H2O).  This leads to the assignment of the 
low molecular weight ions as a y-ion series that can be best explained by a molecule containing 
the following amino acid sequence:  Nt-Gly-Ala-Ser-His-Gln-Gln-Ct. 
As mentioned previously, the large b ions observed in the MS/MS spectra for parent ions 
at m/z 926.4951, 940.5112 and 954.5272 showed a shift of 14 Da (Figure 5.17); similar shifts 
were observed for the species at m/z 908.4845, 922.5007, and 936.5165.  Upon initial 
observation, this mass shift was attributed to either methylation of the peptide species, 
incorporation of alternate amino acids that differ by a methylene group, or the addition of a fatty 
acid tail.  Bioinformatics analysis of C2 revealed that many of the amino acids in the elucidated 
sequence are predicted to be incorporated into the C2 product, yet there was not the presence of 
the predicted N-terminal Thr.  It was observed in the MS/MS spectra of the parent ion m/z 
926.4951 that the mass of the y6 ion was equal to the mass of the parent ion minus the total mass 
of a Thr plus a C12 hydroxylated fatty acid (FA).  This is consistent with the MS/MS data, as the 
loss of this terminal portion would result in the y ion series observed.  The retention of the 14 Da 
mass shift by the large b ions observed is also consistent with the incorporation of fatty acid 
chains differing by a methylene group, as the fatty acid tail would be retained in these fragment 
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ions.  The chemical structure of the fatty acids tails incorporated into the lipopeptide series is 
reported in Figure 5.13.   
MS/MS clearly shows these six liopheptapeptide species (Figure 5.13), which differ by 
exactly 18.0103 Da and 14.0162 Da and have highly related fragmentation patterns (Figure 5.16-
5.17). These mass differences are unambiguously due to differences of CH2 and H2O, which are 
best explained by incorporation of longer fatty acid chains and lactone ring formation, 
respectively. The intact and fragment masses support the assignments of a ring open form (gain 
of 18 Da) and the lactone ring as drawn in Figure 5.13 and reported for the homologous 
kurstakins (Hathout, Ho et al. 2000) (Figure 5.14). Further, amide fragmentation adjacent to the 
threonine residue localizes the 14 Da variations and the hydroxyl group to the fatty acid tail, with 
the hydroxyl group assigned to position 3 based on the precedents from other Bacillus 
lipopeptides such as surfactin. However, the hydroxyl group is not involved in lactone ring 
formation, a conclusion supported by detailed interpretation of MS/MS data. The structures of 
these reported natural products and associated bioinformatic analysis strongly support the 
assignment of cluster no. 2 as the previously unreported biosynthetic gene cluster for these 
compounds. The unique domain organization of this cluster involves two extra condensation 
domains, one of which is hypothesized to facilitate NRPS initiation by loading the fatty acyl 
chain in conjunction with the type II thioesterase, analogous to the SrfD protein in surfactin 
biosynthesis (Steller, Sokoll et al. 2004). 
5.3.3 PrISM Analysis of Strain NK2021 
 In the continued screening of the NK2001-NK2022 strains, SDS-PAGE analysis of 
NK2021 grown in nutrient broth for 72 h resulted in three intense HMWP bands (Figure 5.19).  
Each of these bands were excised and subjected to in-gel trypsin digestion followed by analysis 
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with nanoLC-MS using a 7 T LTQ-FT (ThermoFisher Scientific) and the data searched for 
peptides homologous to NRPSs and/or PKSs; the base peak chromatogram for the LC-MS 
analysis is shown in Figure 5.19A.  Representative MS/MS spectra are shown in Figure 5.20 and 
highlight the quality of data that can be obtained even if the chromatogram is not heavily 
populated with peptide ions.  When the data were searched using OMSSA, the top protein hits 
were the zwittermicin A biosynthetic proteins ZmaK and ZmaA (Kevany, Rasko et al. 2009), in 
addition to identifying keratin and trypsin contaminants.  Thus, the zwittermicin A-producing 
cluster had again been identified.  This is not surprising, as previous reports indicate that the 
zwittermicin A biosynthetic gene cluster is widespread among B. cereus and B. thuringiensis 
strains (Stabb, Jacobson et al. 1994; Raffel, Stabb et al. 1996), and many recently deposited 
genome sequences of these organisms also contain the ZmA biosynthetic gene cluster.  While 
16S rDNA amplification and sequencing of NK2021 indicated the strain is most closely related 
to B. shandongensis, there are currently no complete genome sequences of this organism to 
determine if the zwittermicin A biosynthetic gene cluster is as widespread.  These results 
indicate that PrISM will face a similar challenge to all other discovery platforms in the 
rediscovery of previously identified secondary metabolites, especially when  screening similarly 
isolated strains grown under identical conditions.  However, because the biosynthetic enzymes 
were identified, PrISM dereplicated on the first pass analysis and avoided the search for a small 
molecule that was characterized previously.  By exploiting the power of PrISM to screen a wide 
variety of strains grown under diverse conditions this challenge can be avoided and 
uncharacterized biosynthetic systems will be uncovered. 
 5.3.4 Isolation of Strains from Lake Delton and Screening for HMWPs 
 After completion of PrISM analysis on strain NK2018, there was a rapid increase in the 
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application of PrISM to a variety of environmental isolates from the Louisiana soil.  This work, 
completed by B.S. Evans and I. Ntai, has already been successful in identifying additional NRPS 
and PKS enzymes in multiple strains, some of which do not show homology to any other known 
biosynthetic systems (in addition to the analysis of NK2021 above).  Additionally, they have 
provided a means for I. Ntai to develop new separations platforms for analysis of complex 
proteomes; these methods extend PrISM from the gel-based molecular weight-based separation 
into a molecular weight-based separation amenable to in-solution trypsin digestion.   
 Concurrent with these activities, efforts were made to isolate additional strains of 
Bacillus and screen them for their biosynthetic capacity and expression of NRPSs and PKSs.  
Soil was collected from Lake Delton in Wisconsin, USA; this manmade lake was recently 
emptied during a breach of the dam due to severe flooding, exposing acres of soil.  
Approximately 60 strains were isolated from ~15 different soil samples collected at Lake Delton 
and these strains were screened for their production of HMWPs in both nutrient broth and M9 
minimal medium (Figures 5.21-5.22).  In nutrient broth, eighteen of the strains were HMWP+; 
twelve strains were HMWP+ in M9 minimal medium.  On three occasions, pairs of isolates 
showed very similar protein band patterns (e.g. strains NK2023 and NK2024), indicating 
duplication of isolation.  However, the diversity of proteome patterns is evident from the gels 
shown and allowed for proteomic investigation of a wide variety of organisms 
5.3.5 Identification of Biosynthetic Proteins from Lake Delton Isolates by PrISM 
 Based upon the SDS-PAGE screening results for NK20XX strains isolated from the Lake 
Delton soil, strains were selected for PrISM analysis using the newly developed gel-based 
platform.  The strains were grown in larger volume liquid culture (ranging from 10 mL to 200 
mL) and prepared for soluble proteome analysis as described.  The proteomes were separated by 
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SDS-PAGE and HMWP bands were excised and subjected to in-gel trypsin digestion followed 
by nanoLC-MS analysis and the on-line Ppant ejection assay.  Sufficient protein was recovered 
from a 10 mL culture to conduct a single in-gel digestion and nanoLC-MS analysis of HMWPs.   
In analyzing NK20XX strains for NRPS and PKS proteins, strain NK2047 showed more 
putative NRPS and PKS peptide identifications than other strains analyzed.  Several of the higher 
quality MS/MS spectra are shown in Figure 5.23; it is important to note that these same spectra 
often also putatively identified other proteins, but in most cases the most confident identification 
was the NRPS or PKS protein.  In total, ten different peptides were selected that showed 
predicted homology to NRPS or PKS proteins and a set of degenerate primers was designed 
based upon the peptide sequences (Table 5.3).  For each peptide sequence four primers were 
designed, including a forward and reverse degenerate primer and a forward and reverse primer 
designed from the most likely codon usage as determined from the codon usage of B. 
thuringiensis servovar kurstaki.  In addition, a set of degenerate primers for conserved sequences 
from NRPS adenylation (A) domains and PKS ketosynthase (KS) and acyltransferase (AT) 
domains  was designed by B.S. Evans; the design of these primers will be described in his 
doctoral dissertation to be published by the University of Illinois in 2010 (Table 5.3).  For a 
complete PCR, one must have a pair of primers for DNA amplification.  However, a peptide 
sequence provides only a single primer.  The use of the A, KS and AT degenerate primers 
provides the second member of the primer pair for PCR analysis. (In some cases, PrISM analysis 
may result in multiple peptides identified from a single protein.  This would allow for design of 
PCRs that do not required the A, KS and/or AT degenerate primers but instead employ primer 
pairs designed from pairs of identified peptides.)   
Using a 96 well plate format, ~320 PCRs were conducted where each primer designed 
281 
 
from an NK2047 peptide hit was paired with each of the A, KS and AT degenerate primers.  As 
a control reaction, PCR amplification of the NK2047 16S rDNA sequence was employed.  Each 
PCR reaction was analyzed by separation on a 1% agarose gel and the resulting products were 
visualized with a UV transilluminator.  In the analysis of NK2047, none of the PCR reactions 
resulted in an observable band.  There are several reasons why this could be the case.  First, the 
majority of MS/MS data collected were not of the quality one would hope to use for peptide 
sequence determination and primer design.  For example, when the nanoLC-MS/MS data for all 
analyses of NK2047 were combined, a putative polyketide synthase from Penicillium marneffei 
was identified by three unique peptides; the MS/MS spectra for these are shown in Figure 5.24.  
When these MS/MS spectra are compared to that of the 1062.5 Da peptide identifying DNA 
polymerase, the difference in quality is obvious.  Additionally, upon examination of the intact 
species eluting at the reported time of MS/MS on the 6+ charge state of the 3302.6 Da PKS 
peptide, it was observed that the only species eluting at that time were 1+ contaminants.  This 
was encountered many times during PrISM analysis of the Wisconsin isolates, and complicated 
analysis through spurious identification of NRPS and PKS proteins.  
Second, for amplification during PCR, there must be an appropriate base pair distance 
between the two primers used.  The peptides designed from NK2047 putative peptide 
identifications may not have been the suitable distance from the A or KS degenerate primers 
needed for successful amplification.  Finally, the peptides identified from NK2047 were obtained 
before a new, optimized in-gel digestion procedure was used.  This may explain the low quality 
nanoLC-MS data and low confidence in identifications (see discussion below).  Upon subsequent 
analysis of NK2047 with improved in-gel digestion, peptide extraction and nanoLC-MS data 
acquisition, HMWPs not related to NRPSs and/or PKSs were identified (e.g. DNA-directed RNA 
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polymerase (134 kDa)) and there were no confident identifications of NRPS and/or PKS 
proteins. 
Several other Bacilli isolated from Lake Delton were analyzed by the PrISM platform, 
and the proteins identified from each of these analyses are summarized in Table 5.4.  At this 
time, no other NRPS or PKS enzymes have been confidently identified from these strains; other 
HMWPs have been identified.  The challenges faced in these analyses are discussed in Section 
5.4, including specific examples of PrISM application to strains NK2001-NK2095. 
5.3.6 Optimization of Methods for the Future of PrISM 
 In all previously discussed results, the proteome samples were generated from strains 
grown in liquid culture, and in all but one case, the PrISM analysis was conducted on a member 
of the genus Bacillus.  Because PrISM should not be limited to a specific set of growth 
conditions or a specific group of organisms, methods for the lysis of cultures grown on agar 
plates and for the lysis of actinomycetes were examined.  In analysis of Bacillus, resuspension of 
a cell pellet in 2X SDS-PAGE loading buffer (which contains a high percentage of SDS) 
followed by boiling provided an efficient route to cell lysis (e.g. Figure 5.22).  However, because 
Streptomyces were consistently harder to lyse, a new protocol was developed.  Cultures are 
harvested as before, but then are incubated in a buffer containing 2 mg/mL lysozyme to weaken 
cell membranes (Sohler, Romano et al. 1958).  This is followed by incubation in a buffer 
containing a high percentage of SDS (>5%) prior to boiling to complete the cell lysis.  As can be 
seen from the SDS-PAGE gel images in Figures 5.25 and 5.26, this protocol was successful in 
lysing a variety of actinomycetes as efficiently as the Bacillus lysis achieved previously.  Upon 
examination of the Coomassie stained gels of the strains S. sviceus and S. laurentii sampled over 
a period of nine days, a reduction in the total protein recovered is observed.  This is not 
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unexpected, as previous reports have indicated similar phenomena in other Streptomyces strains 
(Miguelez, Hardisson et al. 1999); this is further indication that development of robust 
actinomycete lysis protocols must continue, in order to obtain sufficient proteome content for 
analysis of strains producing a natural product after many growth days. 
Often, species of Streptomyces do not sporulate when grown in liquid medium and often 
the production of a natural product is closely associated with the induction of sporulation (Kieser 
2000).  Thus, it would be advantageous to develop PrISM protocols for analysis of proteomes of 
species grown on a solid medium.  For efficient lysis of both Bacillus and Streptomyces strains 
grown on agar plates, 1 mL of a small (<20 mL) culture of a specific strain was plated on a 150 
mm diameter agar plate covered with a thin cellophane membrane.  This membrane allows for 
efficient cell growth and provides an easy means of removal for the cells after growth is 
complete.  Cells are washed from the membrane and subjected to lysis according to the methods 
described previously; Figure 5.27 provides an example of this growth and lysis procedure as 
applied to Bacillus strain NK2078 and S. sviceus.  Efficient lysis of these strains was obtained to 
generate enough protein for analysis by in-gel digestion and the complete PrISM platform.   
5.4 DISCUSSION  
These applications of PrISM extend prior work on isolated NRPS and PKS enzymes 
(Dorrestein and Kelleher 2006) and initial reports of microbial proteomics (Schley, Altmeyer et 
al. 2006; Rodriguez-Garcia, Barreiro et al. 2007) or selective labeling of 
phosphopantetheinylated proteins (Meier JL 2008) into a general method for targeted proteome 
analysis.  NRPS, PKS and fatty acid biosynthetic gene products from diverse organisms are 
detected with antibody-like specificity for Ppant containing proteins common to all thiotemplate 
systems. Detection of a biosynthetic enzyme in a microbial proteome provides a valuable entrée 
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into an unsequenced genome at the protein level, enabling identification of NRPS and PKS type 
natural products and the genes responsible for their synthesis.  The integrated PrISM approach 
augments genomic methods and directs efforts toward expressed genes, a strong indication that 
the corresponding natural product is also being produced. 
Given the potential of different systems biology-based approaches to direct natural 
products discovery in ways different from classical bioassay-based discovery, it is important to 
place PrISM in the context of comparable DNA, RNA and small molecule-based methods. The 
rapid increase in genome sequence information unquestionably opens the door for developing 
sequence-based discovery and characterization methods, such as those involving genome mining, 
RNA-based analysis and heterologous expression of full gene clusters. But although genome 
mining provides information on the biosynthetic potential of an organism, it does not reveal 
which secondary metabolic pathways are actually expressed. In contrast, proteomics permits 
direct observation of proteins resulting from gene expression and detects whether enzymes are 
correctly post-translationally modified. Although induction of cryptic gene clusters and 
heterologous expression of full pathways has been achieved, these approaches are fairly 
challenging (Zerikly and Challis 2009). Well developed RNA-based methods for monitoring 
gene expression, such as RT-PCR or transcriptomics, are not generally used in the context of an 
unsequenced genome. A structure-based approach using direct chemical screening can reveal 
small molecules produced by bacterial strains under a variety of growth conditions. It does not, 
however, provide information on the biosynthetic machinery for those metabolites. As 
technology improves for all -omic analyses, PrISM will fill an important gap and accelerate 
development of complementary approaches in the systems biology of natural products research. 
It is important to address the many challenges faced in the first higher-throughput 
285 
 
implementation of the full PrISM workflow.  These challenges included developing an efficient 
and reproducible in-gel digestion and peptide extraction procedure, the presence of a variety of 
non-NRPS and –PKS HMWPs in the samples, low quality MS and MS/MS data and lack of a 
high-throughput data analysis platform. 
Before quality nanoLC-MS/MS data can be collected, there must be efficient in-gel 
trypsin digestion and extraction of peptides.  Many of the first attempts at in-gel digestions were 
complicated by the use of gel slices that were too large (preventing efficient uptake of reagents) 
and extraction procedures that did not result in full peptide removal from the gel slices (resulting 
in very few peptides observed during nanoLC-MS/MS).  Figure 5.28A shows a representative 
chromatogram from an early attempt at in-gel digestion of NK2023 HMWPs; the small number 
of peaks observed in the base peak chromatogram and their relatively low intensity indicate that 
peptide digestion and/or extraction were not complete, despite the presence of a high molecular 
weight band.  When a new in-gel digestion protocol was implemented (provided by Kelleher 
Research Group member MingXi Li, who received the protocol from a top laboratory in Bottom 
Up Proteomics (directed by Matthias Mann, Max Planck Institute of Biochemistry)), there was a 
marked increase in the number of tryptic peptides retrieved from in-gel digestion and in the 
quality of nanoLC-MS data obtained.  A comparison of a base peak chromatogram from 
nanoLC-MS analysis of an in-gel digestion of a HMWP from strain NK2023 highlights this 
improvement (Figure 5.28B). 
 Even with robust in-gel digestion procedures, for PrISM to be successful, one must 
obtain high quality MS/MS data of peptides for the identification of homologs of NRPS and PKS 
proteins and for subsequent design of degenerate primers for PCR.  The challenge of obtaining 
high quality peptide identifications is also closely linked with the data analysis platform, 
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OMSSA.  OMSSA was employed for database searching of MS and MS/MS data with high 
resolution precursor and unit resolution MS/MS data.  Throughout PrISM analysis of number 
NK20XX strains, various qualities of MS/MS data were obtained.  In the earliest 
implementations, contaminants in the in-gel digestion sample resulted in MS spectra that were 
highly populated with 1+ ions, triggering data-dependent MS/MS events on non-peptide species.  
This resulted in spurious peptide identifications that did not accurately represent the species in 
the sample.  For example, a 3302.6 Da peptide was identified as a PKS peptide generated from a 
HMWP in strain NK2047; the MS/MS event was actually triggered by a 1+ contaminant eluting 
late in the chromatogram (Figure 5.29A-B).  Also, MS/MS events on low abundance peptides or 
peptides of higher charge (>3+) often resulted in low quality MS/MS spectra that resulted in 
many incorrect protein identifications from a single poor quality MS/MS event.  For example, 
Figure 5.29C-D shows two spectra resulting in incorrect identifications of a 4+ peptide with an 
intact mass of 3484.9 Da; the list in Figure 5.29E shows a subset of the proteins “identified” by 
this peptide.  The OMSSA algorithm identifies peptides based on both the measured intact mass 
of the parent peptide and also the number of matching fragment ions detected.  This resulted in 
identification of proteins apparently based largely on detection of a peptide with an intact mass 
that matched to a theoretical peptide within the specified mass tolerance, even if MS/MS data did 
not match the peptide amino acid sequence well.  This necessitates detailed, manual interrogation 
of MS/MS data to confirm that the identification is accurate.   
Another challenge related to MS/MS data and OMSSA analysis is the identification of 
many protein species from the same peptide.  Take, for example, the 2210 Da peptide shown in 
Figure 5.30.  High quality MS/MS data were obtained for this species, and it was identified as a 
tryptic peptide from the self cleavage of trypsin.  However, this same peptide resulted in 
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identification of numerous species (including NRPS and PKS proteins), despite the fact that the 
MS/MS data in no way correlated to the sequence of the identified peptide.  During analysis, this 
peptide was observed many times and subjected to MS/MS, but the exact intact mass was not the 
same with each MS and MS/MS scan (and often had calculated intact mass off by as much as 1 
Da).  Thus, in the range of 2210.075 Da-2211.15, 85 proteins were identified from this trypsin 
peptide (a representative selection of these is presented in Figure 5.30).   This necessitated 
intense manual interrogation of all data files to filter out “real” protein identifications.  Often, 
these challenges resulted in an overpopulation of the OMSSA results with incorrect NRPS and 
PKS identifications; this was a very discouraging aspect of the PrISM implementation, as in 
almost none of the cases were the NRPS and PKS proteins identified the true result.  For PrISM 
to be successful, alternate searching strategies (such as de novo sequencing for homology-based 
identification (Ma, Zhang et al. 2003)) or use of alternative algorithms (Yates, Eng et al. 1995; 
Perkins, Pappin et al. 1999) must be employed. 
An additional challenge faced was identification of other HMWPs in the PrISM analysis 
of the NK20XX strains.  Table 5.4 provides a list of all in-gel digestions completed as well as the 
confident protein identifications (at least two unique matching peptides and manual confirmation 
of MS/MS results) from those analyzed by nanoLC-MS.  In several cases, there were multiple 
proteins identified in a single LC-MS run; often these proteins were of the appropriate molecular 
weight (>100 kDa), but there were identifications of low mass species as well (Figure 5.31).  The 
identifications of the HMWPs serve as a positive control for the extraction of peptide species and 
the quality of MS/MS data obtained during the nanoLC-MS analysis.  They also highlighted the 
need for high quality MS/MS to be obtained if one is to be confident in the identification of a 
peptide as a NRPS or PKS species, as often the same intact peptide mass identified numerous 
288 
 
proteins as described above.  However, the presence of these HMWPs in the soluble proteomes 
of samples analyzed indicates that one must be careful not to assume that all HMWPs will be 
NRPS or PKS related.  Table 5.5 shows a representative sampling of the predicted number of 
high molecular weight proteins in six organisms with sequenced genomes.  In four strains of 
Bacillus (B. anthracis NRLL 3495, B. cereus AH1134, B. licheniformis ATCC 14580 and B. 
thuringiensis (strain Al Hakam)), an average of 1% of the predicted proteome has a molecular 
weight of >100 kDa, and an average of  7% of all proteins >100 kDa are NRPSs or PKSs.   
Additional challenges in our implementation of PrISM included the translation of 
sequence information from MS into PCR products and a self imposed bias toward >100 kDa 
NRPS, PKS and hybrid systems. While a global proteomics method (such as the SCX-RPLC-
MS/MS platform described in Chapter 4) would provide a more complete view of the metabolic 
state of the organism, our targeted approach facilitates higher-throughput analysis of the NRPS 
and PKS proteins of interest.  To characterize NRPS and PKS proteins <100 kDa, one could elect 
to further develop the 2D LC-MS platform or do in-gel digestions and LC-MS analysis across 
the entire molecular weight range of the sample.  To improve the ability to design degenerate 
PCR primers, efforts must be made to increase the quality of MS/MS data returned from LC-
MS/MS analysis.  This can be achieved through multiple injections and targeted MS/MS of 
samples confirmed to have NRPS or PKS enzymes and through implementation of PrISM using 
FTMS at higher magnetic field for detection of low abundance fragment ions.  All challenges 
familiar to natural product structure elucidation still apply to PrISM, including elucidation of 
complex polyketide structures.  While NRPs are often easily sequenced using MS/MS analysis, 
structural characterization of polyketide structures by MS and MS/MS introduces additional 
challenges.  Other biochemical and analytical techniques must be employed for complete 
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characterization; these could include growth of the producer in the presence of isotopically 
labeled substrates and analysis by nuclear magnetic resonance (NMR). 
One extension of this method is in the detection of NRPS and PKS thiolation domains 
with the natural product intermediate still covalently attached.  This has been shown to be 
possible by detecting the in vivo formation of Phe-loaded PheAT in E. coli (however, the ratio of 
holo to loaded protein was never better than 75%:25%), but numerous attempts to detect 
thioester-bound intermediates generated during gramicidin S and PTT biosynthesis were 
unsuccessful.  While these intermediates are likely present, the thioester bond tethering the 
intermediate is easily hydrolyzed under conditions necessary for sample preparation.  Many 
adjustments to the methods presented here were attempted to preserve the T domain bound 
intermediates; these efforts included the use of thioesterase inhibitors, very rapid digestion times, 
lysis buffers used at acidic pH, and digestion under acidic conditions (see Chapter 4 for detailed 
discussion).   
Very soon after the publication of the PrISM platform, a second proteomics-based system 
for the discovery of NRPS and PKS biosynthetic gene clusters was published.  This method uses 
an orthogonal active site identification system (OASIS) to selectively label NRPS and PKS 
catalytic domains in vivo using a covalent label for selective purification of the enzymes prior to 
trypsin digestion and analysis by Bottom Up proteomics (Meier, Niessen et al. 2009).  By 
growing NRP and PK producing strains in the presence of modified CoA analogues, the authors 
identified numerous T domains from known producers of natural products; they also identified 
thioesterase domains from the biosynthetic gene clusters.  This method could provide important 
information on the control and regulation of natural product biosynthetic pathways and allows 
for a unique (and non-MW-based) method to target these enzymes.  However, complications 
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could arise from perturbation of native natural product production through the introduction of 
active site labels which prohibit further involvement of the domain in biosynthesis, possibly 
halting biosynthesis.  Additionally, one must synthesize the active site probes, instead of relying 
on an in vivo generated marker for identification, as used in the Ppant ejection assay.   Still, both 
PriSM and OASIS provide the first entrees into NRPS- and PKS-directed biosynthesis in vivo at 
the proteomic level, bolstering the role proteomics will play in natural product discovery. 
It will be interesting to see how molecular screening methods contribute to natural 
product discovery as they ramp up for application to hundreds or even thousands of strains. It is 
projected PrISM will be most valuable for screening conditions and strains where novel NRP/PK 
scaffolds are produced. PrISM achieves dereplication at the biopolymer level where relatives of 
well characterized systems are quickly flagged (because of high sequence identity to known 
domains and modules). For such cases, one will elect to simply not continue down the PrISM 
workflow (Figure 4.1) or choose to spot check the putatively homologous cluster with a small set 
of easy PCRs. 
With PrISM, proteomics performs the initial survey in the natural product discovery 
pipeline. Subsequent small molecule detection modalities, such as bioassays, MS or NMR, can 
then be used to assess structure and activity. Therefore, PrISM achieves a net reversal of the 
traditional “small molecule first” discovery process. Streamlined versions of PrISM will realize 
efficiencies of scale and detect enzyme fingerprints from bacterial strains cultured on plates, 
fungi, and even environmental samples for meta-proteomics (Lo, Denef et al. 2007), such as 
complex marine microorganism-invertebrate assemblages (Simmons, Coates et al. 2008) with 
extension to all types of secondary metabolism also possible. 
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5.5 FIGURES 
 
 
Figure 5.1  Identification of HMWPs in NK2018.  Strains NK2004 and NK2018 were grown in a 
variety of media at 30 °C and aliquots were removed for proteome preparation at multiple time 
points.  Soluble proteome samples were analyzed by SDS-PAGE and a selection of the samples 
are shown here.  Strain NK2018 produced HMWPs under a variety of conditions and was 
selected for full PrISM analysis. (NB – nutrient broth, MH – Mueller-Hinton broth). 
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Figure 5.2  Confirmation of HMWP production by NK2018 in M9 minimal medium. Lane 1:  
Bio-Rad Kaleidoscope Precision Plus Protein Standard.  Lane 2:  Proteome of NK2018 grown in 
M9 minimal medium for 3 d at 30 °C. 
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# Peptides 
# Unique 
Peptides Protein Description MW Length 
NK2018 
Homolog 
1 1 
putative non-ribosomal peptide synthetase                   
[Nocardia farcinica IFM 10152] 595.0 kDa  5579 C2S3 
7 3 
beta-ketoacyl synthase                                                   
[Bacillus cereus AH1134] 377.8 kDa  3336 ZmaA 
2 1 
putative peptide synthetase/polyketide synthase                                      
[Bacillus cereus]  291.1 kDa  2562 ZmaK 
 
 
Figure 5.3  Identification of NRPS and PKS peptides from NK2018 cultured in M9 minimal medium.  The proteins were identified by 
nanoLC-MS of an in-gel digestion of the HWMP band at ~250 kDa and MS/MS data analysis using OMSSA. 
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Figure 5.4  Collection of soil samples from Lake Delton (Wisconsin, USA).  Photographs of the three collection points for soil 
samples used for strain isolation. 
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Figure 5.5  Representative gels used for in-gel digestions of strains isolated from Lake Delton.  
These gels highlight the proteomic diversity encountered in analysis of the strains.  The strain 
name is given above the gel.  All strains were grown for 48 h at 30 °C in nutrient broth. 
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Figure 5.6  Observation of a Ppant ejection ion from the NK2018 proteome analyzed by SCX-
RPLC-MS/MS.  A.  Base peak chromatogram from on-line RPLC-MS analysis of SCX fraction 
18.  B.  Selected ion chromatogram (SIC) for the holo Ppant ejection ion (m/z 261.1267).  C.  
Confirmation of Ppant ejection using the pseudo-MS3 assay.  The Ppant ejection ion in (B) was 
subjected to MS3 and the marker ion at m/z 184 was observed.  D.  The Ppant ejection ion was 
observed at an error of ~1 ppm from the theoretical mass. 
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Figure 5.7  Confirmation of Ppant ejection using off-line FTMS.  A.  Off-line FTMS spectrum of 
the peptide contents of the fraction collected from 42.5-43 min during RPLC separation of SCX 
fraction 18.  B.  A Ppant ejection ion is observed when the all peptides in (A) are subjected to 
nozzle-skimmer dissociation.  C.  The species at m/z 1039 was isolated to check for Ppant 
ejection.  D.  When subjected to IRMPD, the peptide at m/z 1039 generates a Ppant ejection ion 
that corresponds exactly to the theoretical mass for Ppant ejection. 
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Figure 5.8   Identification of an active site peptide from fatty acid synthase acyl carrier protein 
(AcpP) in NK2018.  A. MS/MS on the holo peptide identified by the Ppant ejection assay, 
highlighted by the presence of the apo + 80 Da species.  B-C. The apo + 80 Da species was 
isolated and subjected to MS3, highlighted by the observation of the loss of phosphate to generate 
the apo – 18 Da species.  D. The apo - 18 Da species is isolated and subjected to MS4.  E. 
Sequence tag generated from MS4 analysis.  This peptide corresponds to an active site peptide 
containing a phosphopantetheinylated serine. (FT - Fourier-transform MS, IT – ion trap MS). 
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Figure 5.9  Observation of Ppant ejection ions from HMWPs in the NK2018 proteome.  A.  Base 
peak chromatogram of a nanoLC-MS separation of the HMWP band at ~250 kDa from the 
NK1028 soluble proteome.  B.  SIC for the Ppant ejection ion (m/z 318.1481, due to the 
sulfhydryl alkylation by iodoacetamide during sample preparation).  C.  Ppant ejection ion 
detected at ~ 38 min, matching within 1 ppm of the theoretical Ppant-Cam ejection ion mass. 
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Figure 5.10  Phosphopantetheinylated peptides identified from ZmA biosynthetic proteins during 
nanoLC-MS of NK2018 HMWPs.  A. Total ion chromatogram (TIC) for nanoLC-MS analysis of 
in-gel digestions.   B. SIC for the Ppant-Cam product (m/z 318.1482) generated by nozzle-
skimmer dissociation.  C. Identification of a phosphopantetheinylated T domain active site 
peptide from ZmaK.  D. Identification of a phosphopantetheinylated T domain active site peptide 
from ZmaB. 
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Figure 5.11  Identification of metabolites from the zwittermicin A biosynthetic gene cluster. 
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Thioesterase
Ppant Transferase
C2S3: NRPS (C-A-T-C-A-T-C-A-T-E-C-A-T-Te)
C2S2: NRPS (C-A-T-C-A-T)
C2S1: NRPS (C-A-T-C)
Macrolide Efflux Protein
Lipase/Acylhydrolase
 
 
Figure 5.12  Annotation of NK2018 cluster no. 2.  ORF annotations are from BLAST analysis of 
the corresponding sequence from B. cereus AH1134.  Shown is the region of the B. cereus 
AH1134 genome containing the NRPS biosynthetic gene cluster. 
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Figure 5.13  Lipoheptapeptides identified from culture supernatant of NK2018 grown in M9 
minimal medium and theoretical structures for each mass detected.  A. Mass spectrum of six 
lipopeptides produced by NK2018 grown in M9 minimal medium for 10 d.  All masses are 
reported as the neutral monoisotopic mass.  B. Theoretical structures for the six species observed 
in (A).   
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Figure 5.14  Representative structure of a Bacillus kurstakin lipopeptide. 
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Figure 5.15  Series of non-ribosomal peptides identified from NK2018.  A.  TIC from LC-MS analysis of the culture supernatant from 
NK2018 grown in M9 minimal medium for 10 d.  B. SIC for the peptide species at m/z 926.4951.  C. Predicted substrates for cluster 
no. 2 adenylation domains.  D. Set of at least six related peptides observed during LC-MS analysis.  E. Representative MS/MS data of 
the species at m/z 926.4951 with detection of the fragment ions by FTMS.  Amino acid mass differences between peaks (in colored 
boxes) are shown.  F. Fragmentation map for the proposed lipopeptide structure (m/z 926.4951). 
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Figure 5.16  Selected MS/MS analysis of the putative non-ribosomal peptides identified:  
localization of the 18 Da mass shifts.  Comparison of a portion of the MS/MS data from three of 
the peptides of interest, localizing the 18 Da shifts to the detected y ion series.  These mass 
differences are best explained by structures in either lactone ring open or ring closed form. 
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Figure 5.17  Selected MS/MS analysis of the putative non-ribosomal peptides identified:  
localization of the 14 Da mass shifts.  A.  Comparison of a portion of the MS/MS data from three 
of the peptides of interest, localizing the shift of 14 Da to the high molecular weight b ions.  This 
corresponds to the 14 Da shifts localizing to the N-terminus of the peptide on the fatty acid 
chain. 
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Figure 5.18  Structural assignment of y ions from the MS/MS analysis of the peptide species at 
m/z 926.4951.  The largest ion (pink box) most likely results from fragmentation between Thr 
and Gly, where the mass difference between the ion at m/z 627.2813 and the parent ion at m/z 
926.4951 (299.2138 Da) can be accounted for by the mass of threonine plus a hydroxylated C12 
fatty acid chain. 
 
 
 
 
 
 
 
 
 
 
 
309 
 
 
 
Figure 5.19  HMWPs are observed in NK2021.  A.  Base peak chromatogram from nanoLC-MS 
analysis of NK2021 HMWPs.  B.  SDS-PAGE visualization of three HMWPs from NK2021. 
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Figure 5.20  Peptides identified from a NK2021 HMWP.  A. A peptide identified from ZmaK.  
B.  A peptide identified from ZmaA.  C.  A peptide identified from ZmaA.  Shown are the 
peptide sequences and the fragment ions detected. 
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Figure 5.21  Screening of strains isolated from Lake Delton for HMWP production in nutrient 
broth.  Each lane is identified by a NK20XX strain number.  Lanes marked with an asterisk (*) 
showed HMWP bands.   
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Figure 5.22  Screening of strains isolated from Lake Delton for HMWP production in M9 
minimal medium.  Each lane is identified by a NK20XX strain number.  Lanes marked with an 
asterisk (*) showed HMWP bands.   
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Spectrum 
Intact Mass 
(Da) 
Mass Error 
(Da) 
Charge Sequence Identification 
A 2766.455 0.023 4 TRETVLGALAHQDHPFHQLVNDLR 
amino acid adenylation enzyme/thioester 
reductase family protein                                                          
[Streptosporangium roseum DSM 43021] 
B 2786.405 -0.007 3 QVAINSALRVEDTEIGVETVLDMER 
polyketide synthase, putative                                           
[Talaromyces stipitatus ATCC 10500] 
C 2057.066 0.005 3 ISAmVADFTNLLLVEFMK 
amino acid adenylation domain protein                                                  
[Desulfitobacterium hafniense DCB-2] 
D 1931.003 0.006 3 LVRATGAGGALAmPESTWK 
type I polyketide synthase                                                   
[Streptomyces sp. NRRL 11266] 
 
Figure 5.23  Representative MS/MS spectra from analysis of NK2047 HMWPs. 
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Spectrum 
Intact Mass 
(Da) 
Mass Error 
(Da) 
Charge Sequence Identification 
A 
3362.479 -0.011 5 VIPDDRFASFIDSSNNQGGGNMTQCNYLDK 
polyketide synthase, putative                                           
[Penicillium marneffei ATCC 18224] 
B 
3302.614 -0.059 6 DGEATLAVAGASQLMLTPDQSIAMTSVGTLINK 
polyketide synthase, putative                                           
[Penicillium marneffei ATCC 18224] 
C 
1930.007 -0.024 3 HPRMSILEVGAHAGRATK 
polyketide synthase, putative                                           
[Penicillium marneffei ATCC 18224] 
D 
1062.563 0.007 2 RYDLANVGR 
DNA-directed RNA polymerase, beta 
subunit [Bacillus cereus G9842] 
 
Figure 5.24  NRPSs and PKSs are not identified confidently in NK2047.
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Figure 5.25  Lysis of two members of the genus Streptomyces using alternate lysis protocols.  
Lane 2 corresponds to the Bio-Rad Broad Range Marker.  The gel is silver stained.  Lanes 3-7 
correspond to the soluble lysate of Streptomyces isolate WM6355 grown for 3-7 d in MYG and 
lysed by incubation with lysozyme at 37 °C.  Lanes 9-14 correspond to the soluble lysate of S. 
sviceus lysed by both lysozyme treatment and incubation in a 5% SDS solution.  For lanes 9-14, 
odd numbered lanes correspond to the soluble lysate recovered post lysozyme treatment, while 
even numbered lanes correspond to the soluble lysate recovered post lysozyme treatment and 
incubation in 5% SDS at 60 °C. 
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Figure 5.26  Additional examples of lysis of two Streptomyces species.  The top row of gels 
corresponds to the soluble lysate recovered after incubation with lysozyme at 37 °C. The bottom 
row of gels corresponds to the soluble lysate recovered after lysozyme incubation followed by 
incubation in 5% SDS at 60 °C. The gels on the left are the soluble lysates generated from lysis 
of Streptomyces isolate WM6349 and the gels on the right are the soluble lysates recovered from 
lysis of S. laurentii.   
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Figure 5.27  Lysis of Bacillus strain NK2078 and S. sviceus cultured on ISP2 and ISP4 solid 
media. 
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Figure 5.28  Optimization of in-gel digestion procedures.  A.  Base peak chromatogram of 
peptides from NK2023 HMWPs using a non-optimal in-gel digestion procedure.  B.  Base peak 
chromatogram of peptides from NK2023 HMWPs using an optimized in-gel digestion procedure. 
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Figure 5.29  Spectral examples of PrISM challenges.  A.  MS/MS spectrum resulting from data-dependent MS/MS of a target at m/z 
544 (B).  OMSSA identified this is a 6+ peptide of PKS origin, when in fact the parent ion is a 1+ contaminant.  The table shows the 
OMSSA output.  C-D.  MS/MS spectra of the target parent ion of 3484.9 Da.  MS/MS of this species resulted in identification of >15 
different protein species, none of which matched to the MS/MS data obtained.  Despite multiple MS/MS events on this target, no 
confident identification could be determined.  E.  Truncated list of proteins identified by the 3484.9 Da peptide.  
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E. 
Intact 
Mass 
(Da) 
Mass 
Error 
(Da) 
Charge Sequence Identification 
3484.899 -0.009 4 NWFKSGAPGVWmSAGAVAIAVIMTIGLLAVIAVR 
binding-protein dependent transport system inner 
membrane protein [Pseudomonas syringae pv. 
oryzae str. 1_6] 
3484.899 -0.005 4 VAMGVIGIIYESRPNVTSDAAALTLKSGNAVVLR putative gamma-glutamyl phosphate reductase [Streptococcus pneumoniae ATCC 700669] 
3484.899 -0.004 4 GLALIPmGAALAATLPQIVTTVLASAAGDPFLSYR putative integral membrane protein [Clavibacter michiganensis subsp. sepedonicus] 
3484.899 -0.003 4 AADLYRSPSLLWADCALLLLWLGLLWTKAR UbiA prenyltransferase [Desulfatibacillum alkenivorans AK-01] 
3484.899 0.001 4 MAATALATPLLLAASPHPGRPAPHDPGKEAAKLSK M28 family peptidase [Streptomyces griseus subsp. griseus NBRC 13350] 
3484.899 0.004 4 mASSTHVPIAAIATAPGRGGIGVVRISGPDLSALAR RecName: Full=tRNA modification GTPase mnmE 
3484.899 0.006 4 mWTLRSVAVRAAALGLAAGVSAAGLSGVTAVAGTASR hypothetical protein SACE_2355 [Saccharopolyspora erythraea NRRL 2338] 
3484.899 0.008 4 TGEGKTLVATAPAYLNALTGKGVHIVTVNDYLAK RecName: Full=Protein translocase subunit secA 
3484.899 0.013 4 LVKQFTEQLMARTDYHTAILPLGDGLAISRK O-methyltransferase family 3 [Exiguobacterium sp. AT1b] 
3484.899 0.015 4 RSYAIYSLALAAMNLAIVYPLWPYMGIIRR hypothetical protein Rcas_0761 [Roseiflexus castenholzii DSM 13941] 
3484.899 0.021 4 LVAGTALYAVVEQALLGQLAYSHVSKRSQEQR gll4274 [Gloeobacter violaceus PCC 7421] 
3484.899 0.022 4 VRLRVMHPMDTGLVAGIPAFHIETLVLADASR conserved hypothetical protein; putative exported protein [Cupriavidus taiwanensis] 
 Figure 5.29 (cont.) 
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Peptide Mass (Da) ∆m (Da) Protein Description 
GNGmGTEIQSEFTALEIGKGR 2210.075 0.007 
1-deoxy-D-xylulose-5-phosphate 
synthase [Vibrio splendidus 
LGP32] 
SGmAIGLAGLFLEAHPDPNSAK 2211.125 0.022 
2-dehydro-3-
deoxyphosphooctonate aldolase 
[Actinobacillus 
pleuropneumoniae L20] 
mVATTADSAEKIIIFDTTLR 2211.122 -0.029 
2-isopropylmalate synthase 
[Oxalobacter formigenes 
OXCC13] 
ARCEELATmVGLPHNLLDR 2210.111 0.014 
ABC transporter ATP-binding 
protein [Bradyrhizobium 
japonicum USDA 110] 
KVYGEAEHVDNVVNPALETK 2211.113 -0.004 
ABC transporter, quaternary 
amine uptake transporter 
[Burkholderia pseudomallei 
MSHR346] 
YALVTMCIGGGQGIAAVFERV 2211.098 -0.015 Acetyl-CoA C-acetyltransferase [Variovorax paradoxus S110] 
VAAAAQAHAEADRATFLETLR 2211.116 -0.024 
Acyl-CoA dehydrogenase type 2 
domain [Methylobacterium 
chloromethanicum CM4] 
SGLKEEFEWAEKNGmQIAK 2210.078 0.005 agmatinase [Bacillus coagulans 36D1] 
 
Figure 5.30  OMSSA identifies multiple proteins from a single peptide.  Top:  MS/MS spectrum 
of the 2210 Da peptide from self cleavage of trypsin.  Table:  Representative list of proteins 
(other than trypsin) identified from this peptide.  NRPS and PKS identifications are shown in 
yellow. 
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Peptide Mass (Da) ∆m (Da) Protein Description 
TASGFNAQWKEIVYPIVCK 2210.105 -0.012 
amino acid adenylation domain 
protein [Rhodopseudomonas 
palustris TIE-1] 
mADTPVSAAPVDLAAALSARIR 2211.155 -0.017 
aminotransferase class I and II 
[Methylobacterium 
radiotolerans JCM 2831] 
IYSSLLDAAASESAARRTAMK 2211.119 -0.012 ATP synthase gamma chain [Rhodococcus opacus B4] 
YNKEKNTIEFEKIAEEVK 2211.125 -0.019 
ATPase AAA-2 domain protein 
[Dictyoglomus turgidum DSM 
6724] 
YTEVALTAAAELSARFINDR 2210.105 -0.028 
ATP-dependent Clp protease 
ATP-binding subunit ClpA 
[Nitrosomonas eutropha C91] 
AAGLAYGPAFQRVAATSmAEGR 2210.111 0.018 
Beta-ketoacyl synthase 
[Gluconacetobacter 
diazotrophicus PAl 5] 
EQFKMILDATDQDIKFNR 2211.122 0.022 
conserved hypothetical protein 
[Clostridium butyricum E4 str. 
BoNT E BL5262] 
ILESGMEAEYFNIILENVK 2211.137 0.024 conserved hypothetical protein [Edwardsiella ictaluri 93-146] 
GATPESSGSYGFVRLEGDLLR 2210.081 -0.014 conserved hypothetical protein [Escherichia sp. 3_2_53FAA] 
GYFFNEIYSETVPRKSFK 2211.101 0.002 conserved hypothetical protein [Vibrio fischeri MJ11] 
KCNFQENEISLANLFIDR 2210.09 0.012 
conserved hypothetical protein, 
putative hydrolase (HAD 
superfamily) [Escherichia coli 
ED1a] 
ISSNKNmDLSQNKTNTANSK 2210.078 0.012 
cytochrome C biogenesis 
protein transmembrane region 
family  
HMEHIFTVPDLDFLARGGR 2210.114 0.01 degV family protein [Bacillus coagulans 36D1] 
GALHVSPEELQCVKERCAK 2210.099 0.008 
dienelactone hydrolase 
[Parvibaculum lavamentivorans 
DS-1] 
 
 Figure 5.30 (cont.) 
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Figure 5.31  Identification of non-NRPS and non-PKS high and low molecular weight proteins.   Proteins identified by the MS/MS 
spectra above are described in the Figure 5.31 table. 
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Figure 5.31 (cont.) 
325 
 
5.6 TABLES 
Table 5.1  HPLC gradient for LC-MS analysis of culture supernatants. 
 
Time (min) % RPLC solvent B 
0 0 
10 0 
30 20 
40 100 
44 100 
46 0 
60 0 
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Table 5.2  Exact masses and putative empirical formulas for the detected NK2018 
lipoheptapeptides. 
m/z   
Mass 
(Da)   Formula 
908.4845  907.4765  C40H65O13N11 
922.5007  921.4927  C41H67O13N11 
936.5165  935.5085  C42H69O13N11 
926.4951  925.4871  C40H67O14N11 
940.5112  939.5032  C41H69O14N11 
954.5272  953.5192  C42H71O14N11 
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Table 5.3  NRPS and PKS peptides identified from NK2047 and the primers designed. 
 
 
328 
 
Table 5.3 (cont.) 
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Table 5.4  Summary of PrISM analysis of NK20XX strains. 
NK20XX Medium 
Growth 
Temp ( °C) 
Growth 
Time (h) 
Confident Protein 
Identifications# 
Number of 
NRPS/PKS 
Peptides 
NK2021 M9 30 96  -    
NK2021 NB 30 72  -    
NK2005 M9 30 48  -    
NK2007 M9 30 48  -    
NK2001 NB 30 24 keratin, trypsin   
NK2003 NB 30 24 
keratin, trypsin, putative 
NRPS 1 
NK2006 NB 30 24 
keratin, trypsin, putative 
NRPS 1 
NK2007 NB 30 24  -    
NK2013 NB 30 24 trypsin   
NK2017 NB 30 24 trypsin   
NK2006 mannitol 30 24 
keratin, EF-G (75 kDa), RNA 
polymerase (134 kDa), 
carbamoyl phosphate synthase 
(118 kDa), glutamate synthase 
(169 kDa), putative NRPS 
(282 kDa) 1 
NK2006 NB 30 24 keratin, trypsin   
NK2007 NB 30 24 keratin, trypsin   
NK2013 NB 30 24 keratin, trypsin   
NK2008 mannitol 30   
RNA polymerase (134 kDa), 
EF-Tu (76 kDa), pyruvate 
carboxylase (129 kDa), 
trypsin, ClpC (91 kDa), 
succinyl-CoA ligase (42 kDa), 
HtrC (155 kDa), ppGpp 
synthase (182 kDa)   
NK2019 MHB 30 48 
trypsin, keratin, LemA protein 
(22 kDa), EF-Tu (43 kDa), 
RNA polymerase (134 kDa)   
NK2001 NB 30 24 keratin, trypsin   
NK2023 M9 30 48 trypsin   
NK2059 NB 30 24 trypsin, keratin   
NK2087 NB 30 24 
RNA polymerase (135 kDa), 
pyruvate carboxylase (128 
kDa), trypsin   
NK2021 NB 30 72 
keratin, glutamate 
dehydrogenase (48 kDa), 
ZmaA, ZmaK 7 
NK2005 M9 30 48 keratin    
NK2009 M9 30 48 
keratin, serine protein kinase 
(73 kDa)   
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Table 5.4 (cont.) 
NK20XX Medium 
Growth 
Temp ( °C) 
Growth 
Time (h) 
Confident Protein 
Identifications# 
Number of 
NRPS/PKS 
Peptides 
NK2013 M9 30 48 keratin, trypsin   
NK2006 SMM 30 48 
keratin, reticulocyte binding 
protein (258 kDa)m spore coat 
protein (16 kDa)   
NK2008 mannitol 30 24 
RNA polymerase (134 kDa), 
heat shock protein (155 kDa), 
trypsin, carbamoyl phosphate 
synthase (117 kDa)   
NK2007 mannitol 30 24 
hydrolase (23 kDa), 50S 
ribosomal protein (20 kDa), 
dipipocolinate synthase 
subunit B (20 kDa)   
NK2017 starch 30 24 
keratin, trypsin, aconitate 
hydratase (100 kDa), succinate 
dehydrogenase (65 kDa)   
NK2023 NB 30 48 keratin, trypsin   
NK2023 NB 30 48 (1A, 1B combined)   
NK2041 NB 30 48 keratin, trypsin   
NK2047 NB 30 48 trypsin * 
NK2047 NB 30 48 trypsin * 
NK2047 NB 30 48 trypsin * 
NK2059 NB 30 48 trypsin   
NK2060 NB 30 48 
trypsin, keratin, autolysin 
precursor (137 kDa),    
NK2060 NB 30 48 (6A, 6B combined)   
NK2066 NB 30 48 
trypsin, RNA polymerase (133 
kDa), keratin   
NK2085 NB 30 48 keratin, trypsin   
NK2047 NB 30 48 trypsin * 
NK2047 NB 30 48 
trypsin, folypolyglutamate 
synthase (47 kDa) * 
NK2047 NB 30 48  -  * 
WM6355 MYG 30 144 keratin, EF-Tu (43 kDa)   
WM6355 MYG 30 144 
keratin, trypsin, EF-Tu (43 
kDa), dihydrolipoamide 
dehydrogenase (50 kDa), 
arginine deiminase (46 kDa), 
glycine dehydrogenase (102 
kDa)   
WM6355 MYG 30 144 
keratin, pyruvate 
dehydrogenase (102 kDa), 
glycine dehydrogenase (102 
kDa)   
WM6355 MYG 30 144 keratin, ATPase (104 kDa)   
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Table 5.4 (cont.) 
NK20XX Medium 
Growth 
Temp ( °C) 
Growth 
Time (h) 
Confident Protein 
Identifications# 
Number of 
NRPS/PKS 
Peptides 
WM6355 MYG 30 144 
keratin, chaperone assisted 
ATPase (106 kDa), 
dihydrolipoyl dehydrogenase 
(50 kDa)   
WM6349 MYG 30 216 
RNA polymerase (145 kDa), 
keratin, groEL (57 kDa), 
protein translocase (107 kDa), 
30S ribosomal protein (55 
kDa), alpha-KG 
decarboxylase (139 kDa), 
phosphoenolpyruvate 
carboxylase (101 kDa), 
carbamoyl-phosphate synthase 
(118 kDa), valyl-tRNA 
synthetase (96 kDa)   
WM6349 MYG 30 216 (6349 A-3 combined)   
WM6349 MYG 30 216 (6349 A-3 combined)   
NK2047 NB 30 48 
keratin, EF-Tu (45 kDa), 
methylmalonyl CoA mutase 
(122 kDa) * 
NK2047 NB 30 48 
RNA polymerase (134 kDa), 
keratin, thioredoxin (14 kDa) * 
NK2047 NB 30 48 keratin * 
NK2047 NB 30 48 keratin, EF-Tu (43 kDa) * 
NK2023 NB 30 48 
RNA polymerase (151 kDa), 
MBP (43 kDa), heat shock 
protein (155 kDa), Rnase E 
(118 kDa),glutamate synthase 
(169 kDa),  EF-Tu (43 kDa)   
NK2023 NB 30 48 MBP (43 kDa)   
NK2060 NB 30 48  -    
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Table 5.4 (cont.) 
 
NK20XX Medium 
Growth 
Temp ( °C) 
Growth 
Time (h) 
Confident Protein 
Identifications# 
Number of 
NRPS/PKS 
Peptides 
NK2065 complete MM 30 48  -    
NK2065 complete MM 30 48  -    
NK3034 NB 30 48  -    
NK2055 NB 30 48 trypsin   
NK2055 NB 30 48 (NK2055 A, B, C combined)   
NK2055 NB 30 48 (NK2055 A, B, C combined)   
NK2060 NB 30 48 trypsin, keratin   
NK2087 NB 30 48 
keratin, trypsin, EF-Tu (43 
kDa), RNA polymerase (135 
kDa)   
NK2087 NB 30 48 (NK2087 A, B combined)   
NK2090 NB 30 48 trypsin   
NK2090 NB 30 48 (NK2090 A, B, C combined)   
NK2090 NB 30 48 (NK2090 A, B, C combined)   
# At least two unique peptides and manual validation of MS/MS data 
 * A single list of all NK2047 putative NRPS and PKS peptides was determined from all NK2047 runs 
 - No proteins identified 
    Adjacent rows corresponding to the same strain indicate multiple HMWPs 
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Table 5.5  Survey of bacterial HMWPs. 
 
Strain 
Predicted 
Proteins 
Proteins 
with MW 
>100 kDa 
NRPS 
and PKS 
Proteins 
with 
MW 
>100 
kDa 
% >100 
kDa         
(of Total 
Protein) 
% NRPS and 
PKS                    
(of >100 kDa) 
Bacillus anthracis (strain CDC 684 / NRRL 3495) 5900 69 2 1 3 
Bacillus cereus AH1134 5925 82 13 1 16 
Bacillus licheniformis (strain DSM 13 / ATCC 
14580) 
4676 61 4 1 7 
Bacillus thuringiensis (strain Al Hakam) 4800 71 1 1 1 
Streptomyces sviceus ATCC 29083 8275 112 3 1 3 
Streptomyces coelicolor 8375 169 17 2 10 
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Table 5.6  HMWPs in B. cereus AH1134. 
Protein Name 
Amino 
Acids 
NRPS 
and 
PKS 
Microbial collagenase (EC 3.4.24.3) 878   
Valyl-tRNA synthetase (EC 6.1.1.9) 881   
Bacitracin synthetase 3 (BA3) (EC 5.1.1.11) (EC 
5.1.1.13) 883 X 
DNA mismatch repair protein MutS 890   
Transcription antiterminator, BglG family 891   
Multidrug resistance protein B 892   
Sensor protein (EC 2.7.13.3) 896   
Magnesium-translocating P-type ATPase (EC 3.6.3.2) 901   
Sensory box/ggdef family protein 906   
Sensory box/ggdef family protein 909   
Putative helicase 918   
Putative uncharacterized protein 920   
Isoleucyl-tRNA synthetase (EC 6.1.1.5) 921   
Conserved domain protein 927   
Putative DnaQ family exonuclease/DinG family 
helicase 934   
Conserved domain protein 953   
2-oxoglutarate dehydrogenase, E1 component (EC 
1.2.4.2) 955   
Excinuclease ABC, A subunit 958   
Putative microbial collagenase (EC 3.4.24.3) 965   
Type III restriction protein res subunit 966   
Putative microbial collagenase 971   
Putative uncharacterized protein 974   
Molybdopterin oxidoreductase family protein 978   
Molybdopterin oxidoreductase family protein 979   
Transporter, AcrB/AcrD/AcrF family 1014   
Cyclic peptide transporter 1027   
Putative exonuclease 1029   
Isoleucyl-tRNA synthetase (EC 6.1.1.5) 1033   
Transporter, AcrB/AcrD/AcrF family 1038   
LPXTG-motif cell wall anchor domain protein 1055   
Putative helicase 1064   
Bifunctional P-450:NADPH-P450 reductase 1 1065   
Wall-associated protein 1067   
Membrane protein, MmpL family 1068   
Carbamoyl-phosphate synthase, large subunit (EC 
6.3.5.5) 1072   
LPXTG-motif cell wall anchor domain protein 1086   
DNA polymerase III, alpha subunit (EC 2.7.7.7) 1108   
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Table 5.6 (cont.) 
Protein Name 
Amino 
Acids 
NRPS 
and 
PKS 
Phage infection protein 1111   
Polysaccharide deacetylase/glycosyl transferase, group 
2 family protein 1113   
Conjugation protein, trag/trad family 1115   
Putative uncharacterized protein 1120   
Methionine synthase (EC 2.1.1.13) 1132   
S-layer domain protein 1143   
Pyruvate carboxylase (EC 6.4.1.1) 1148   
Putative uncharacterized protein 1160   
ATP-dependent nuclease, subunit B 1171   
Transcription-repair coupling factor (EC 3.6.1.-) 1176   
DNA-directed RNA polymerase (EC 2.7.7.6) 1177   
Linear gramicidin synthetase subunit C (EC 5.1.1.-) 1193 X 
DNA-directed RNA polymerase (EC 2.7.7.6) 1203   
Putative uncharacterized protein 1219   
Respiratory nitrate reductase, alpha subunit (EC 
1.7.99.4) 1227   
ATP-dependent nuclease, subunit A 1241   
Collagen triple helix repeat protein 1262   
Putative uncharacterized protein 1265   
Lpxtg-motif cell wall anchor domain protein 1307   
Collagen triple helix repeat domain protein 1309   
Cell division protein 1323   
Putative uncharacterized protein 1344   
Polyketide synthase type I 1352 X 
Tetratricopeptide repeat protein 1400   
Peptidase families S8 and S53 (EC 3.4.21.-) 1413   
DNA polymerase III, alpha subunit, Gram-positive type 
(EC 2.7.7.7) 1433   
Phage minor structural protein 1435   
Putative glutamate synthase, large subunit 1478   
Peptide synthetase 1 1498 X 
Ftsk/spoiiie family protein 1501   
Linear gramicidin synthetase subunit C (EC 5.1.1.-) 1518 X 
Amino acid adenylation, putative 1640   
Collagen adhesion protein 1961   
Linear gramicidin synthetase subunit D (EC 1.-.-.-) (EC 
5.1.1.-) 2156 X 
Non-ribosomal peptide synthase 2178 X 
Nonribosomal peptide synthetase DhbF 2385 X 
Conserved repeat domain protein 2490   
Amino acid adenylation 2532 X 
Linear gramicidin synthetase subunit C (EC 5.1.1.-) 2562 X 
Non-ribosomal peptide synthase, putative 2610 X 
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CHAPTER 6:  CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1 SUMMARY 
Non-ribosomal peptides (NRPs) and polyketides (PKs) are two families of natural 
products with a large number of important biotherapeutic agents (Felnagle, Jackson et al. 2008).  
Biosynthesized by large enzyme complexes called non-ribosomal peptide synthetases (NRPSs) 
and polyketide synthases (PKSs), respectively, these families of natural products are investigated 
for their promise of providing even more bioactive compounds (Fischbach and Walsh 2006).  
The assembly of NRPs and PKs is a covalent process, with each biosynthetic intermediate 
covalently tethered to the biosynthetic enzymes at conserved thiolation (T) domains throughout 
assembly.  For this reason, these biosynthetic systems are prime targets for investigations by 
mass spectrometry (MS), as each biosynthetic event is measured as a mass shift to the 
biosynthetic enzymes.  The use of MS, specifically high-resolution Fourier-transform MS 
(FTMS), for the in vitro analysis of NRPSs and PKSs has been widespread and provided 
important information on biosynthetic processes (Dorrestein and Kelleher 2006; Bumpus and 
Kelleher 2008).  However, the development of additional MS-based tools for analysis would 
increase the value of MS as an analytical platform for NRPS- and PKS-directed natural product 
assembly.  
In Chapter 2, the evolution of FTMS interrogation of NRPS and PKS systems was 
discussed.  In the earliest MS analyses, in vitro biosynthetic reactions containing recombinant 
NRPS and/or PKS proteins were proteolytically or chemically digested, separated off-line by 
liquid chromatography (LC), and each LC fraction was analyzed individually by FTMS for T 
domain active site peptides of interest and any biosynthetic intermediates they may harbor 
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(Dorrestein and Kelleher 2006).  While this process was very successful in a variety of 
biochemical characterizations (Hicks, O'Connor et al. 2004; McLoughlin and Kelleher 2004; 
Dorrestein, Yeh et al. 2005), it was laborious and time consuming.  To alleviate these challenges, 
a suite of FTMS-based tools for characterization of NRPS and PKS systems was developed.  The 
first tool was the phosphopantetheinyl (Ppant) ejection assay (Dorrestein, Bumpus et al. 2006).  
This assay makes use of the elimination of the Ppant arm from a holo T domain active site 
protein or peptide during tandem mass spectrometry (MS/MS); the observation of the Ppant arm 
small molecular ion confirms one is analyzing a T domain active site peptide or protein. 
Additionally, the Ppant ejection ion is generated for intermediate-loaded T domains as well and 
the measurement of the mass of this small molecular ion provides confirmation of the 
biosynthetic state of the protein.  The Ppant ejection assay has been implemented in analysis of 
dozens of different T domains of all sizes, including the intact protein GrsA (126 kDa); here, the 
Ppant ejection assay differentiated between the loading of substrates that differed by only 5 Da 
(Dorrestein, Bumpus et al. 2006).  In off-line LC combined with FTMS, the Ppant ejection assay 
allowed for rapid identification of T domains and provided an additional level of confidence in 
the MS data obtained. 
The next advance in analysis was development of an on-line LC-MS platform for 
investigation of NRPS and PKS systems.  As stated previously, off-line LC combined with 
FTMS required the laborious task of analyzing each LC fraction collected for a peptide or 
protein of interest.  To decrease this analysis time from many hours (or even days) to a single ~1 
h analysis, an on-line LC-MS method was designed that incorporated measurement of intact 
peptide masses with MS/MS for peptide identification and the Ppant ejection assay for 
localization and identification of T domain active site peptides (Bumpus and Kelleher 2008).  
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The integration of all FTMS data allows for rapid and robust characterization of a complete 
tryptic digest of an in vitro biochemical reaction.  In Chapter 2, the on-line LC-MS platform 
combined with the Ppant ejection assay was applied to studies of mycosubtilin biosynthesis, 
specifically in determination of the loading mechanism for biosynthetic initiation.  This platform 
successfully confirmed an ATP-dependent loading mechanism of a fatty acyl starter unit and 
highlighted the complementarity of FTMS with other biochemical methods (Hansen, Bumpus et 
al. 2007).  The on-line Ppant ejection assay has revolutionized the analysis of NRPS and PKS 
systems in the Kelleher Research Group, greatly decreasing the time required for in vitro 
analysis resulting in rapid characterization of biosynthetic events. 
In Chapter 3, FTMS was used to characterize a variety of biochemical transformations 
occurring in the early stages of biosynthesis of the hybrid NRP-PK bacillaene (Butcher, 
Schroeder et al. 2007; Moldenhauer, Chen et al. 2007).  Specifically, the loading of the starter 
monomer unit on the hybrid NRPS-PKS PksJ was examined, in addition to analysis of 
ketoreduction and enoyl reduction catalyzed by PksJ and PksE.  Using FTMS, the unpredicted 
loading of an α-ketoacyl starter unit was confirmed, leading to the conclusion that an α-
ketoreduction must occur during bacillaene biosynthesis (based upon the α-hydroxy unit in the 
natural product structure).  FTMS determined this ketoreduction was catalyzed by a 
ketoreductase domain in PksJ that carried out both canonical PKS β-ketoreduction in addition to 
α-ketoreduction of the α-ketoisocaproic acid starter unit (Calderone, Bumpus et al. 2008).  The 
structure of bacillaene also revealed a fully saturated carbon backbone in the portion assembled 
by PksJ; however, there was not the required enoyl reductase domain in PksJ to complete the full 
saturation of the backbone.  PksE, an additional protein in the bacillaene assembly line, was 
characterized by FTMS as an in trans enoyl reductase capable of catalyzing the enoyl reduction 
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during bacillaene biosynthesis.  PksE is highly homologous to enoyl reductases involved in 
prokaryotic polyunsaturated fatty acid (PUFA) biosynthesis (e.g. PfaD), and additional FTMS 
studies confirmed the enoyl reductase activity of PfaD on substrates loaded on the PUFA 
synthase PfaA from S. oneidensis MR-1 (Bumpus, Magarvey et al. 2008).   
These studies advanced FTMS analysis of NRPS and PKS systems through on-line LC-
MS analysis combined with the Ppant ejection assay as applied to systems containing multiple 
thiolation domains; PksJ harbored two tandem T domains while PfaA contained four.  New 
proteolytic digestion protocols were developed to generate T domain active site peptides with 
different masses, and samples containing multiple T domains were analyzed in a single LC-MS 
run with individual T domains identified by the elution times of Ppant ejection ions.  
Additionally, FTMS was the most direct route to observe ketoreduction and enoyl reduction, as 
the resulting mass shifts of 2 Da were easily observed. Combined, Chapters 2 and 3 present 
examples of the power of FTMS for investigations of NRPSs and PKSs, and discussion of the 
future of these in vitro analyses is presented below. 
Moving away from in vitro analysis of NRPS and PKS biosynthetic processes, Chapters 4 
and 5 described the development of a novel platform for the discovery of new natural products 
and the detection of NRPS and PKS enzymes in native NRP and PK producers.  Prior to the 
development of this method, called PrISM (for the Proteomic Investigation of Secondary 
Metabolism), there were no proteomics methods to complement the metabolomic, genomic and 
transcriptomic methods used in the systems biology approach to natural product discovery.  In 
the general application of this method, bacterial strains are grown in liquid culture and their 
soluble proteomes are screened for the presence of high molecular weight proteins (HMWPs), 
indicative of NRPS and/or PKS expression.  The proteomes of those strains exhibiting HMWPs 
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are analyzed by the on-line LC-MS Ppant ejection assay to confirm NRPS and/or PKS 
expression and Bottom Up proteomics to generate peptide sequence information.  Peptides 
identified as originating from NRPSs and/or PKSs are used to design degenerate primers to 
probe the genome of the strain under investigation and generate DNA sequence information for 
the biosynthetic gene clusters.  The full sequence of these gene clusters is used to direct the 
search for the corresponding natural product. 
In the early development of PrISM, the goals were to develop protocols for the 
preparation of proteome samples and completion of proof-of-concept experiments for the 
detection of holo T domain active site peptides in complex peptide mixtures.  For efficient 
Bottom Up proteomics analysis, there must be separation procedures prior to analysis by LC-
MS; several separation techniques were employed in PrISM development.  Because NRPSs and 
PKSs often have much larger molecular weights than other bacterial proteins, the separation 
techniques of ammonium sulfate fractionation and size exclusion chromatography were assayed 
for their ability to separate NRPSs and PKSs from the small molecular weight proteome prior to 
trypsin digestion.  However, these separation techniques did not provide adequate sequestration 
of NRPS and PKS proteins from the remainder of the proteome.  Instead, much success was 
achieved by adapting the standard Bottom Up proteomics platform of full proteome trypsin 
digestion followed by a two-dimensional (2D) separation involving strong cation exchange 
chromatography (SCX) and reverse phase liquid chromatography (RPLC) (Washburn, Wolters et 
al. 2001).  By incorporating the use of coenzyme A analogues, the 2D separation platform, and 
the on-line Ppant ejection assay, holo T domain active site peptides were detected from 
recombinant protein expressed in Escherichia coli but unpurified from the E. coli proteome.  
Development of the first PrISM platform, further reducing sample preparation steps, resulted in 
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identification of multiple holo T domain active site peptides from the native producers of the 
non-ribosomal peptides gramicidin S (Matteo 1975; Mootz and Marahiel 1997) and 
phosphinothricin tripeptide (Blodgett, Zhang et al. 2005).  While these early successes confirmed 
the ability to detect biosynthetic proteins expressed at endogenous levels in natural product 
producers, the implementation of PrISM as a true discovery and characterization would require 
further development. 
To address the host of challenges presented in development of a proteomics platform for 
natural product discovery – specifically in application to bacterial environmental isolates without 
sequenced genomes – the PrISM platform was adapted to incorporate a gel-based screen for the 
presence of HMWPs and a HMWP in-gel digestion procedure prior to LC-MS analysis.  
Members of the genus Bacillus were isolated from soil samples collected from two different 
locations in the United States and screened for the expression of HMWPs.  Several HMWP 
positive strains were analyzed by the PrISM platform, resulting in the identification of numerous 
NRPSs and PKSs and detection of new natural products.  In strain NK2018 (a homolog of B. 
cereus AH1134), the zwittermicin A biosynthetic gene cluster was identified along with a new 
natural product predicted to be a second small molecule assembled by the cluster (Kevany, 
Rasko et al. 2009).  Additionally, new members of the kurstakin family of natural products 
(Hathout, Ho et al. 2000) were identified and PrISM provided the first linkage of the kurstakins 
to their biosynthetic gene cluster.  Initial analysis of ~60 strains isolated from a recently flooded 
lake area revealed a plethora a HMWP positive strains and allowed for the first medium-
throughput PrISM implementation.  This ongoing PrISM analysis revealed additional challenges 
that must be addressed for full PrISM success, including the need for more robust in-gel 
digestion procedures and a more reliable and higher-throughput data analysis platform. 
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6.2 THE FUTURE OF NRPS AND PKS RESEARCH 
The future of MS analysis of NPRS and PKS systems is very exciting in the areas of both 
in vitro biochemical characterization and in proteomics methods for natural product discovery.  
In in vitro analysis, reduction in the amount of sample needed for analysis (through 
implementation of nanocapillary LC-MS (nanoLC-MS) platforms) will allow studies of proteins 
which are not easily overexpressed recombinantly.  Also, an extension of the analysis of PUFA 
biosynthesis and simultaneous identification of multiple active sites in a single LC-MS analysis 
can be envisioned.  The opportunity to investigate multiple active sites (both from T domains and 
other PKS domains that harbor intermediates (Watanabe and Townsend 2002; Crawford, 
Korman et al. 2009)) provides an avenue for complete biochemical characterization of a complex 
system and the opportunity to perform in depth kinetic analysis.   
In the area of natural product discovery, there are numerous advances that must be made 
to secure the robust application of proteomics to the field.  First, proteomics should be 
incorporated into the already established metabolomics and genomics approaches; the 
complementarity of these methods is obvious and should be exploited.  By connecting the 
genetic and small molecule profiles of an organism with protein expression data, a more 
complete view of natural product production is obtained.  Second, methods for retaining in vivo 
generated biosynthetic intermediates must be developed, as the information garnered will be 
invaluable to complete understanding of the control of biosynthetic processes.  These methods 
may include the growth of the organism in the presence of synthetic substrate analogues to halt 
biosynthesis at a given active site (Meier, Niessen et al. 2009), the development of methods for 
sample preparation in thioester friendly environments, or the genetic manipulation of samples to 
cause a “molecular traffic jam” along a biosynthetic pathway (Moldenhauer, Chen et al. 2007).   
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Third, PrISM and other proteomics platforms must be applied to more complicated 
biosynthetic systems and new types of organisms.  The biosynthetic capacities of the 
actinomycetes and cyanobacteria are immense, yet no proteomic platform has been applied to 
natural product discovery in these systems (Singh, Kate et al. 2005; Gross 2007).  Additionally, 
one can imagine a “meta-proteomics” implementation of PrISM for analysis of environmental 
samples (as opposed to strains grown under laboratory conditions (Lo, Denef et al. 2007; Maron, 
Ranjard et al. 2007)).  For this to be successful there must be advances in the detection of low 
abundance protein species in the background of very complicated samples.  Finally, for PrISM 
and other proteomics methods to truly take their place as discovery platforms, there is the need 
for automation of the process and high-throughput implementation.  This will require the 
automation of the screening for HMWPs, in-gel digestions of HMWPs, LC-MS and robust data 
analysis.  Only when these aspects of PrISM are fully developed will a proteomics platform be 
the most efficient method for a first pass analysis of a natural product producer. 
The importance of discovering new natural products and understanding these complex 
biosynthetic pathways will only increase as the need for new and improved biotherapeutic agents 
continues to grow.  The work presented here highlights the invaluable role MS has played in 
biosynthetic characterization of natural product biosynthesis and the role MS will play in the 
years to come.  For systems harboring covalent biosynthetic intermediates, there is not another 
tool that can provide such direct evidence for a specific biosynthetic event.   The future of MS 
analysis and its important role in the natural product discovery process will rely on the continued 
development of sample preparation and data collection methods.  Fully realizing the potential of 
these platforms will have an important place in the discovery of new bioactive natural products 
and have far reaching effects in the areas of human health and disease control. 
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